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1. Introduction 
 
1.1 Mouse mammary gland development 
 
The development of the mammary gland is regulated by the endocrine system (Neville 
et al., 2002). Various steroid and peptide hormones coordinated the development of 
the  mammary  gland  in  mammals  with  respect  to  the  reproductive  status  and  the 
requirement for milk by the offspring (Hennighausen and Robinson, 2005; Neville et al., 
2002).  The  major  morphological  developmental  alterations  of  the  mammary  gland 
occur postnatal in the adult mammal during the distinct stages of puberty, pregnancy 
and lactation (reviewed in Hennighausen and Robinson, 2005, 2001, 1998). 
During fetal development a mammary anlage is established that originates from the 
skin (Fig. 1.1). After birth a moderate ductal elongation and branching occurs from the 
nipples into the fat pad corresponding to the general growth rate of the mammal. With 
the  onset  of  puberty  and  the  secretion  of  gonadal  hormones  estrogen  and 
progesterone  the  mammary  ducts  begin  to  elongate  and  branch  out  into  the  entire 
mammary gland fat pad. The mammary fat pad or stroma is a connective tissue that 
supports  the  epithelial  tissue  compartment.  It  harbors  mainly  adipocytes,  fibroblasts 
and cells from the vasculature and haematopoietic system. During puberty bulb shaped 
structures  at  the  ends  of  the  ducts  referred  to  as  terminal  end  buds  (TEB)  are 
observed. These TEB structures contain highly proliferative precursor cells, which give 
rise to mammary epithelial and myoepithelial cells (Hennighausen and Robinson, 1998; 
Humphreys et al., 1996). The TEB structure disappears once the entire fat pad is filled 
with ducts and the virgin animal has matured with about 12 weeks of age. Additional 
ductal branching forms and disappears with each estrous cycle (Masso-Welch et al., 
2000).  Beginning  with  pregnancy  an  extensive  ductal  branching  and  lobulo-alveolar 
proliferation that is controlled mainly by prolactin, placental lactogens and progesterone 
occurs.  This  extensive  proliferation  of  the  ductal  and  alveolar  cells  continues 
throughout pregnancy and early lactation. The alveoli are ball like structures made up 
of luminal and basal epithelial cells that surround a central lumin. The luminal epithelial 
cells undergo functional differentiation during late pregnancy and lactation to produce 
and secrete the milk components into the alveoli lumen. The basal myoepithelial cells 
are contractile and thus able to transport the milk components into the alveoli lumen in 
direction of the nipples along the ducts during lactation. By parturition the mammary fat 
pad  is  completely  filled  with  secretory  lobulo-alveolar  structures,  that  produce  milk 
during lactation. Cytokines, like prolactin and possibly ERBB4 ligands confer the main 
signaling  that  controls  the  proliferation,  differentiation  and  survival  of  the  mammary Introduction 
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epithelium during pregnancy and lactation (Hennighausen and Robinson, 2005) (Fig. 
1.1).  
 
 
 
Figure 1.1 The different stages of mammary gland development are regulated by specific 
hormone and gene products. 
Schematic picture depicting the postnatal developmental stages of the mammary gland. The 
oval shapes represent the mammary fat pad (stroma). During puberty  the ovarian produced 
hormones estrogen and progesterone drive the ductal elongation and branching of the epithelial 
ducts from the nippel out into the fat pad. The terminal end buds (TEB) are depicted as bulbs at 
the tips of the growing and elongating epithelial ducts. In the mature virgin mouse the entire fat 
pad is filed out with extensively branched epithelial ducts (D).  
With onset of pregnancy, the hormones prolactin, progesterone and placental lactogens as well 
as other signaling factors such as  ERBB4 ligands and RANK-L control the proliferation  and 
development of alveolar epithelial cell structures (A). 
By lactation the entire mammary fat pad is filled with mature alveoli that contain differentiated 
luminal secretory cells, which produce and secrete the milk components into the lumen of the 
alveoli structures. The pituitary gland produced hormone prolactin is essential for maintaining 
lactation and the transcription factor STAT5 mediates the main prolactin and possibly ERBB4 
ligand signaling. Apart from STAT5, RANK-L/RANK, Cyclin D1 and C/EBPß are gene products 
important in the proliferation and differentiation of mammary epithelial cells. During involution, 
tissue  remodeling  and  cell  death  is  controlled  by  another  STAT  member  namely,  STAT3. 
(Adapted and modified from Hennighausen and Robinson, 2005 and 2001). 
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After the young are weaned and suckling stops, there is a loss in the prolactin signal 
that is accompanied by extensive apoptosis and remodeling of the alveolar epithelium. 
This stage is called involution. The secretory alveolar epithelium of the mammary gland 
regresses and returns back to a near mature virgin state in appearance. With each 
following pregnancy then, the mammary gland undergoes repeated cycles of growth, 
differentiation and regression that is controlled mainly by steroid and peptide hormones 
in addition to other activated signaling factors (Liu et al., 1996).  
With  the  use  of  gene  targeting  experiments  it  has  become  possible  to  identify  the 
components  in  the  signaling  pathways  and  determine  their  contribution  to  the 
development of the mammary gland. A selection of those genes found to be important 
contributors  to  mammary  gland  development  during  pregnancy  and  lactation  are 
shown (Fig. 1.1). Loss of these genes during mammary gland development results in 
the  impairment  of  correct  ductal  branching  or  alveolar  development  (reviewed  in 
Hennighausen and Robinson, 2001). 
The  development  of  the  mammary  gland  is  characterized  by  the  coordinated 
interaction  between complex signaling networks  of different hormones and signaling 
molecules leading to a functional differentiated mammary gland that secretes milk at 
the end of pregnancy. The STAT transcription factors, mostly STAT5 and STAT3, are 
essential signaling molecules.  
 
 
1.2 STAT signal pathway activation and structure 
 
There  are  seven  mammalian  Signal  Transducers  and  Activators  of  Transcription 
(STAT) family members (STAT 1, 2, 3, 4, 5A, 5B and 6) each encoded by different 
genes, which share similarities in structure and function. 
The STATs are transcription factors that are activated by a wide variety of cytokines, 
like interferons and interleukins as well as by hormones and growth factors (reviewed 
in Schindler et al., 2007; Kisseleva et al., 2002; Levy and Darnell, 2002; Bromberg, 
2001). There are several modes by which STAT proteins can be activated. Activation 
of  STATs  can  be  mediated  through  cytokine  receptors,  receptor  tyrosine  kinases 
(growth factors), G-protein-coupled receptors (peptides/chemokines) and non-receptor 
tyrosine kinases (oncoproteins, v-src) (Mertens and Darnell, 2007; Lim and Cao, 2006).  
A,  well  known  mode  of  STAT  activation  is  the  JAK-STAT  signaling  pathway  that 
mediates  cytokine  signaling.  This  pathway  is  involved  in  the  regulation  of  various 
cellular  processes including  development, proliferation, differentiation and  apoptosis. 
The  JAK-STAT  signaling  pathway  transmits  information  from  extracellular  signals 
directly to the gene promoters in the nucleus without the need for second messengers. Introduction 
  4 
Cytokine  ligands  binding  to  the  cell  surface  receptor  result  in  the  dimerization  or 
oligomerization of the receptor and initiate activation of Janus kinases (JAKs) that are 
associated with the intracellular domain of the receptor (Fig. 1.2 B).  
 
Figure 1.2 The structure of STAT and the JAK/STAT signaling pathway. 
(A) The schematic figure depicts the structural and functional domains of STAT. 
The major functional domains are displayed: amino-terminal domain (NH2), Coiled- coil domain, 
the DNA-binding domain (DBD), the linker domain, the SH2 domain (src homology domain), the 
conserved  tyrosine  (Y)  residue,  that  is  phosphorylated  during  activation  and  the  carboxy-
terminal transactivation domain (TAD).  
(B) Schematic diagram of the cytokine induced JAK/STAT signaling pathway. 
Binding of a cytokine to its cognate receptor allows dimerization of the cytokine receptor and 
transphosphorylation  and  activation  of  the  receptor  associated  Janus  kinases  (JAKs).  The 
activated JAKs phosphorylate specific tyrosine residues on the cytoplasmic tails of the cytokine 
receptor which serve as docking sites for the STAT proteins via their SH2 domain. The recruited 
STAT  proteins are then tyrosine phosphorylated by the JAKs.  This induces  the release and 
dimerization of the activated (tyrosine phosphorylated) STAT protein followed by translocation 
into the nucleus. In the nucleus the activated STATs bind to specific DNA recognition elements 
(DNA RE) in the promoters of target genes and regulate transcription. 
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The activated JAKs trans-phosphorylate specific tyrosine residues on the intracellular 
domains of the receptor. These phospho-tyrosine residues on the receptor then can 
serve  as  docking  sites  for  the  latent  cytoplasmic  STATs.  The  STAT  proteins  are 
recruited to the receptor via their SH2 domain and the JAKs phosphorylate the STATs 
on the single specific tyrosine residue found in the STATs C-terminal tyrosine activation 
domain. Homo and heterodimers of STATs are then formed by reciprocal binding of the 
phospho-tyrosine of one STAT  monomer  with the  SH2 domain of the other  partner 
STAT.  The  activated  and  dimerized  STATs  translocate  to  the  nucleus  and  bind  to 
specific  DNA-binding  elements  and  regulate  the  transcription  of  responsive  target 
genes.  
All seven mammalian STAT family members have in common six conserved structural 
domains (reviewed in Schindler et al., 2007; Kisseleva et al., 2002; Levy and Darnell, 
2002;  Bromberg,  2001)  namely,  the  amino-terminal  (NH2),  coiled-coil,  DNA-binding 
(DBD),  linker,  Src  homology  domain  2  (SH2)  and  transcriptional  activation  domain 
(TAD)  (Fig.  1.2A).  The  amino-terminal  (NH2)  domain  is  important  for  the  tetramer 
formation  between  two  STAT  dimmers  at  genomic  regions  with  two  adjacent  DNA-
binding elements and for the translocation into and out of the nucleus. The adjacent 
coiled-coil  domain  functions  as  a  protein-protein  interaction  domain.  The  coiled-coil 
domain is followed by the DNA-binding domain (DBD), which is essential for binding to 
specific DNA-binding element in promoter or enhancer regions of target genes. The 
adjacent linker domain is important for maintaining the correct conformation between 
the DBD and the adjacent SH2 domain. The SH2 domain is a phospho-tyrosine binding 
domain, which is important for receptor recruitment and dimerization. The SH2 domain 
allows for the binding of phospho-tyrosine residues on the activated cytokine receptors 
and  the  phospho-tyrosine  residue  on  other  STAT  molecules  to  form  STAT  dimers. 
Following  the  SH2  domain  is  a  tyrosine  residue  that  requires  phosphorylation  for 
activation of STAT proteins. The carboxyl-terminal (C) residues are the least conserved 
among  STAT  family  members  and  make  up  the  transcriptional  activation  domain 
(TAD),  which  is  important  for  transcriptional  activation  and  interaction  with  diverse 
transcriptional regulators. 
 
 
1.3 STAT5 
 
Initially,  STAT5  was  identified  as  a  mammary  gland  factor  (MGF)  for  which  the 
tyrosine-phosphorylation dependent activation is induced by prolactin (PRL). STAT5 is 
important in the terminal differentiation of mammary gland epithelial and expression of 
milk proteins such as ß-casein and WAP during pregnancy and lactation (Liu et al., Introduction 
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1995; Wakao et al., 1992). Inactivation of the genes that belong to the PRL signaling 
pathway in the mouse genome, revealed that the PRL receptor and STAT5 are both 
absolutely essential components for mammary gland development and function (Liu et 
al.,  1997;  Ormandy  et  al.,  1997).  Meanwhile,  it  has  become  clear  that  the  STAT5 
mediated signaling is not only relevant in  mammary gland development, but also in 
haematopoisis and immune regulation (Levey and Darnell 2002). 
Two independent genes arranged in tandem, that are localized to chromosome 11 in 
the mouse genome, code for the highly homologous proteins STAT5A and STAT5B. 
The murine STAT5A and STAT5B proteins, are 96% identical at an amino acid level 
and differ  mainly at the  C-terminus (Mui  et al., 1995).  The high sequence homolgy 
between  the  two  Stat5  genes  indicate  that  they  arose  from  a  recent  tandem  gene 
duplication event (Copeland et al., 1995).  
STAT5A and STAT5B can be activated by a wide variety of cytokines, hormones and 
growth  factors  such  as  interleukins  (IL-2,  IL-7,  IL-9,  IL-15,  IL-3,  IL-5),  GH  (Growth 
Hormone), PRL (Prolactin), EGF (Epidermal Growth Factor), EPO (Erythropoietin) and 
GM-CSF (Granulocyte/Macrophage Colony Stimulating Factor) (Bromberg, 2001). Both 
are expressed in various tissues and cell lines at comparatively equal levels (Mui et al., 
1995),  but subtle differences  in tissue  distribution of  STAT5A and STAT5B  mRNAs 
imply that they have distinct functions (Liu et al., 1995). STAT5A is more abundant in 
the  mammary  gland,  while  in  the  liver  STAT5B  is  more  prevalent  (Brisken  and 
Rajaram, 2006). 
 
 
1.3.1  In  vivo  function  of  STAT5A  and  STAT5B  determined  by  gene  targeting 
deletion in mice 
 
Although,  STAT5A  and  STAT5B  proteins  are  structurally  very  similar  and  display 
functional redundancy they also have functional differences in vivo as demonstrated by 
the phenotypes observed in various STAT5-deficient mice.  
In vivo knockout experiments have shown that STAT5A is needed for mammopoiesis 
and lactogenesis. STAT5A knockout mice display a defect in the development in the 
mammary gland and are not able to secrete sufficient milk (Liu et al., 1997). In female 
STAT5A deficient mice the mammary gland development was altered, since there was 
insufficient  milk  to  sustain  the  young  even  though  low  levels  of  milk  proteins  were 
detected.  Following  pregnancy  the  alveolar  development  in  the  mammary  gland  is 
strongly reduced in comparison to wild-type animals. Milk protein expression such as 
alpha-lactalbumin and WAP (whey acidic protein) expression was barely detectable. Introduction 
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On  the  other  hand,  STAT5B  deficient  mice  display  a  different  phenotype,  which 
appears most prominent in the male mouse. There is a loss of sexual dimorphism in 
body growth rates of male mice that is attributed to a failure in the growth hormone 
response and changed expression of genes in the liver (Teglund et al., 1998; Udy et 
al., 1997). In both male and female mice, there were effects observed on fat deposition 
and delays in hair growth (Udy et al., 1997). This indicates that depending on the tissue 
and cell type specific context, the functional STAT5A was not able to compensate for 
the loss of stat5b gene. This suggests that STAT5A and STAT5B also have distinct 
functions in vivo. In general, STAT5A is involved mainly in prolactin mediated signaling, 
while  STAT5B  is  more  important  for  mediating  growth  hormone  signaling.  Mice 
deficient in both STAT5A and STAT5B display defects in various organs (Teglund et 
al., 1998). The STAT5 deficient female mice are infertile and therefore mammary gland 
development could not be investigated. The infertility was not observed in the STAT5A 
or  STAT5B  deficient  mice  indicating  functional  redundancy  in  the  STAT5A  and 
STAT5B proteins. In addition these mice were much smaller in body size and weight 
than their wild-type littermates (Teglund et al., 1998). Also reduced numbers in bone 
marrow progenitors hint at defects in hematopoiesis within these STAT5 deficient mice 
(Teglund et al., 1998). 
The original STAT5 deficient mice where created by using a gene targeting strategy to 
delete  the  first  protein-coding  exon  (Teglund  et  al.,  1998).  These  original  STAT5 
knockout  mice  are  believed  to  still  encode  a  N-terminal  truncated,  but  possibly  still 
functional STAT5 protein at extremely low levels (Hoelbl et al., 2006; Yao et al., 2006). 
Therefore more recent studies have used stat5 knockout mice where the entire stat5a 
and stat5b locus was deleted (Cui et al., 2004). These mice display a more severe 
phenotype. Stat5-null mice, that have the entire stat5 locus deleted in their germ line, 
died mostly perinatal due to acute anemia and other still to be defined physiological 
defects (Cui et al., 2004). Studies with the stat5-null mice have further confirmed the 
importance  of  STAT5  in  erythropoiesis  and  lymphopoiesis  (Yao  et  al.,  2006)  and 
shown that STAT5 is required for normal lymphoid development  and  differentiation. 
Conditional mouse mutant models enable the study of later stages in development and 
allow  for  stage  and  cell  specific  gene  deletion.  During  pregnancy  conditional  gene 
inactivation show that STAT5 is required for mammary gland epithelial cell proliferation, 
differentiation and survival at this stage of mammary gland development (Cui et al., 
2004). 
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1.3.2 Regulation and function of STAT5 in the mammary gland 
 
In the  mammary gland both the  prolactin receptor  and  ERBB4 receptor,  a receptor 
tyrosine kinase, can activate STAT5 by phosphorylation of specific tyrosine residues to 
convey  the  proliferative  and  differentiation  signals  to  the  mammary  epithelial  cells 
(Hennighausen and Robinson, 2005) (Fig. 1.3).  
 
 
Figure  1.3  Bona  fide  STAT5  target  genes  that  are  induced  by  STAT5  signaling  in 
mammary epithelial cells.  
Binding  of  prolactin  during  pregnancy  and  lactation  to  the  prolactin  receptor  activates  the 
receptor-associated Janus Kinases 2 (JAK2) and result in the phosphorylation and activation of 
STAT5. Signaling through the ERBB4 is also able to phosphorylate and activate STAT5 and is 
thus  thought to influence  the  functional differentiation of mammary  epithelial cells. Activated 
STAT5 dimers bind the GAS motif in the DNA of the target genes and regulate transcription. 
Direct target genes that contain the GAS binding motif are shown. SOCS3 and CIS are both 
negative regulators of cytokine signaling pathway. When the RANKL growth factor ligand binds 
its  receptor  it  activates  the  NF-KappaB  signaling  pathway,  which  in  turn  influences  the 
regulation of Cyclin D1, that controls cell proliferation. Connexin 26 is a structural protein that 
functions as a component of the gap junction. ß-casein and WAP are the classic milk proteins 
that reflect the terminal differentiation state of secretory epithelial cells during pregnancy and 
lactation (Adapted and modified from Hennighausen and Robinson, 2008 and 2005).  
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The  ERBB4  receptor  is  required  for  the  phosphorylation  of  STAT5  during  late 
pregnancy (Long et al., 2003) and in addition also induces phosphorylation of specific 
serine residues of STAT5A (Clark et al., 2005; Long et al., 2003). The activation of 
STAT5  by  the  two  different  signaling  pathways  can  potentially  lead  to  activation  of 
distinct downstream targets (Brisken and Rajaram 2006). 
PRL activated STAT5 dimerizes and translocates into the nucleus where it activates 
target  genes  like  WAP  and  ß-casein  milk  protein  genes  that  have  GAS  (gamma-
interferon activated sequence) DNA-binding elements in the promoters (Watson and 
Burdon, 1996). The typical GAS DNA recognition element found in the promoters of 
these STAT target genes is characterized by a TTC(N3)GAA sequence. Although both 
STAT5A  and  STAT5B  can  bind  the  same  DNA-binding  sites  differences  can  be 
attributed to subtle differences in DNA-binding affinities and the difference found in the 
(TAD)  transcriptional  activation  domain.  Differences  in  expression  levels  of  the  two 
genes as well as different isomers in different cells and tissues can contribute to the 
functional differences in gene regulation by the two STAT5 proteins observed (Grimley 
et al., 1999). 
Although STAT5 is expressed in many tissues and is activated by a variety of cytokines 
the number of direct STAT5 target genes in the mammary gland during pregnancy and 
lactation  is  only  beginning  to  be  explored.  DNA  microarray  analysis  and  differential 
expression profiling have been used to identify genes expressed in mammary gland 
tissue  during  pregnancy  and  lactation.  Using  expression  profiles  from  transplanted 
wild-type and prolactin receptor null mammary epithelial cells, genes were identified 
that  are  dependent  on  the  PRL  signaling  pathway  during  pregnancy  (Harris  et  al., 
2006). This list includes the milk proteins caseins alpha, beta and kappa as well as the 
extracellular proteinase inhibitor (Expi) and the ets family transcription factor E74-like 
factor 5 (Elf5). Another study by Clarkson et al. (2006) also utilized microarray analysis 
to identify STAT5-regulated genes in a mammary epithelial cell line (KIM-2) that was 
induced to differentiate using a conditional activated dimer of STAT5A. Here, about 25 
principle  transcripts  were  induced,  such  as  the  milk  proteins  ß-casein  and  alpha-
casein, WAP, and SOCS2. The expression of these genes here is definitely regulated 
by STAT5, but these genes do not necessarily need to be direct target genes bound by 
STAT5, but may be regulated indirectly.  
The majority of real STAT5 target genes identified so far in mammary gland tissue are 
few and variable in their function. Some bona fide target genes of STAT5 are ß-casein, 
Whey acidic acid (WAP), SOCS3, CIS, RANK-L (receptor activator of nuclear factor 
NF-kB)-ligand), and Cyclin D1 (Fig. 1.3). The milk protein genes ß-casein and WAP are 
probably the best known STAT5 target genes in the mammary gland. The expression 
of these genes marks the terminal differentiation stage of a mature secretory mammary Introduction 
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epithelial cell. Both ß-casein and WAP contain GAS motifs in their promoters through 
which STAT5 mediates their transcriptional activation in the mammary gland epithelium 
during pregnancy and lactation (Li and Rosen, 1994; Pittius et al., 1988). There is a 
severe reduction in the expression of both milk proteins when STAT5A is not present 
and  when  both  STAT5A  and  STAT5B  are  deleted,  expression  of  both  milk  protein 
ceases (Miyoshi et al., 2001; Liu et al., 1997). Receptor activator of NF-kappaB ligand 
(RANKL) is required for the alveolar development during pregnancy (Fata et al., 2000) 
and is a direct STAT5 target gene, since RANKL has a gamma-interferon activating 
sequence (GAS element) in its promoter that confers PRL responsiveness (Srivastava 
et  al.,  2003).  Binding  of  the  growth  factor  RANKL  to  its  receptor  activates  the  NF-
kappaB signaling pathway. A downstream target gene of this signaling pathway is the 
cell  cycle  regulator  Cyclin  D1,  which  is  also  another  bona  fide  STAT5  target  gene. 
Cyclin D1 contains one STAT5 responsive GAS motif in its promoter and is important 
for the normal proliferation and development of mammary alveolar cells (Brockman et 
al., 2002). Apart from the Cyclin D1, which is involved in regulating cell proliferation, 
there are also some negative regulators of the JAK/STAT signaling pathway that are 
STAT5 target genes. The members of the suppressors of cytokine signaling (SOCS) 
are induced by  STATs and regulate cytokine signaling in  a  negative feedback loop 
(Kubo et al., 2003). There are eight members of the SOCS family (SOCS1-7) and the 
cytokine-inducible Src-homology-2 (SH2) protein (CIS) and some SOCS members bind 
to  the  phosphotyrosines  on  the  cytokine  receptors  via  their  SH2  domain  and  thus 
directly compete with the STAT-binding and activation. SOCS proteins can also target 
their  cytokine  receptor/JAK  substrate  for  degradation  by  the  ubiquitin  proteosome 
pathway via their SOCS box and thus inhibit signaling (Zhang et al., 1999).  
Both the CIS promoter (Matsumoto et al., 1997) and SOCS3 promoter (Auernhammer 
et al., 1999) contain the classic GAS STAT binding motifs. In mammary epithelial cells 
both CIS and SOCS3 are inducible by PRL and expression of either inhibits STAT5 
tyrosine phosphorylation in mammary epithelial cells (Tonko-Geymayer et al., 2002). 
An  additional  gene  that  has  been  implicated  to  be  important  in  mammary  gland 
development  is  the  gap  junction  component  Connexin  26.  Connexin  26  contains  a 
conserved STAT5 consensus site in its promoter (Kiang et al., 1997) and is essential 
for alveolar development in early pregnancy as shown by use of conditional connexin 
26 null mice (Bry et al., 2004).  
Still  much  needs  to  be  learned  about  the  program  of  altered  gene  expression  that 
controls the developmental events during mammary gland differentiation. Since STAT5 
plays a  major role  in  mediating the developmental signals  of the hormone prolactin 
during pregnancy and lactation it is crucial to identify the in vivo bona fide genomic 
targets of STAT5  Introduction 
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1.4 Regulation of transcription 
 
 
1.4.1 Basal transcription 
 
Initiation of transcription is a main step in controlling the expression of protein-coding 
genes. The initiation of transcription requires the formation of the pre-initiation complex 
(PIC)  on  the  promoter  of  the  gene.  The  PIC  includes  RNA  polymerase  II  and  the 
general transcription factors (GTFs) TFIIA, TFIID, TFIIB, TFIIF, TFIIE and TFIIH. The 
current model, based on in vitro studies and structural analysis, suggest the following 
stepwise mechanism (reviewed in Hahn, 2004; Woychik and Hampsey, 2002). In the 
initial steps there is the binding of the TATA-box binding protein (TBP), a subunit of 
TFIID, to a  TA-rich region (TATA-box) in the  promoter region  of the  gene.  TFIIA  is 
involved  in  the  stabilization  of  TBP  and  TFIID  binding  to  DNA  and  is  involved  in 
recruitment of TFIIB. TFIIB stabilizes the binding of the TFIID complex to the promoter 
and  together  with  TFIIF  recruits  the  unphosphorylated  RNA  polymerase  II  to  the 
promoter. After the recruitment of TFIIE and TFIIH, the ATP dependent TFIIH helicase 
activity initiates initial unwinding of DNA near the transcription start site. Initiation of 
transcription begins with the phosphorylation of the C-terminal domain (CTD) of RNA 
polymerase  II,  and  allows  for  the  release  of  the  polymerase  from  the  PIC  and 
elongation to begin. 
The CTD is found in the C-terminus of the largest subunit of RNA polymerase II and 
contains a highly conserved repeat sequence (YSPTSPS) that varies in the number of 
repeat  occurrences,  between  species  (Dahmus,  1995).  The  CTD  of  the  elongating 
RNA polymerase II is highly phosphorylated and therefore can serve as  a  mark for 
RNA polymerase II that is transcribing actively (Dahmus, 1995). RNA polymerase II 
beginning initial transcription is predominantly phosphorylated on the serine in the fifth 
position of the repeat sequence while during later elongation the serine in the second 
position of the repeat sequence is mainly phosphorylated (Komarnitsky et al., 2000). 
The CTD serves as a scaffold for binding of factors that are involved in the regulation 
of transcription. The binding of these factors is influenced by the CTD phosphrylation 
(Hirose and Manley, 2000).  
Even though the general transcription factors are sufficient for the initiation of the basal 
transcription  on  a  naked  DNA  template  in  vitro,  additional  factors  are  required  for 
specific gene transcription in native chromatin context. In eukaryotes the regulation of 
gene expression needs exact spatial and temporal coordination of a large number of 
general and specific transcription factors at cis–regulatory elements such as promoters 
and  enhancers  (reviewed  in  West  and  Fraser,  2005;  Smale  and  Kadonaga,  2003; Introduction 
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Orphanides and Reinberg, 2002). The cis–regulatory elements serve as center stage 
for integrating all the regulatory inputs from various signal transduction  pathways to 
regulate  the  transcription  of  the  target  gene.  Transcription  factors  bind  sequence 
specific promoter or enhancer DNA elements and recruit additional regulatory factors. 
The  recruited  factors  can  be  chromatin  remodeling  enzymes  and  histone  modifying 
enzymes that alter the chromatin structure to make it permissive for the binding of the 
basal transcription machinery and subsequent transcription. In which order and timing 
the  recruitment  of  factors  and  the  restructuring  of  the  chromatin  occurs,  varies 
depending  on  the  promoter,  stimuli,  cell  type  and  developmental  context  (Cosma, 
2002). 
 
 
1.4.2 Chromatin structure  
 
On a basic level, the transcription of genes is dependent on the DNA accessibility. The 
basic repeating unit of chromatin is the nucleosome (Kornberg, 1974). The nucleosome 
consists of 147 base pairs of DNA wrapped around a set of eight core histone proteins, 
which is composed of two copies each of the four histones H2A, H2B, H3 and H4. In 
the native chromatin context the chromatin structure hampers formation of the PIC and 
the binding of transcription factors.  
A  change  in  chromatin  structure  can  be  achieved  by  the  two  main  mechanisms  of 
chromatin remodeling as well as through specific histone modifications. First chromatin 
remodeling  is  achieved  by  enzymes,  that  use  ATP  hydrolysis  to  alter  nucleosome 
structure and positioning on the DNA, thus making previously shielded DNA accessible 
to  regulatory  factors.  And  second,  histone  modifications  are  generated  by  enzymes 
that  can  covalently  modify  the  histones  at  specific  residues  mainly  on  the  amino-
terminal ends (tails) of the histones (Kouzarides, 2002; Strahl and Allis, 2000). These 
histone  modifications themselves can  influence the stability  of the  histone-DNA  and 
inter-nucleosomal  interaction  and/or  serve  as  binding  sites  for  the  recruitment  of 
additional regulatory factors. 
 
 
1.4.3 Function of histone modifications in transcription 
 
The histones are basic proteins with amino-terminal tails that are highly conserved and 
extend  from  the  nucleosome.  These  histone  tails  are  subject  to  various  post-
translational  modifications,  such  as  acetylation  methylation,  phosphorylation, 
ubiquitination and ADP-ribosylation (Spencer and Davie, 1999; Van Holde, 1988). The Introduction 
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most  well  studied  histone  modifications  are  lysine  acetylation  and  methylation  (Fig. 
1.4). 
 
 
 
Figure 1.4 Acetylation and methylation on specific lysine residues of Histone H3 and H4. 
The nucleosome with DNA (Black ribbon) wrapped around it and the N-terminal tails extending 
from the individual core histones are show on the right. Depicted are the N-terminal tail amino 
acid sequences of human histone H3 and H4. Lysine acetylation and methylation on the N-
terminal tails of histone H3 and H4 are marked by flags. Lysines (K) are in green and their 
amino-acid  positions  are  shown  below  the  respective  modified  lysine  residue.  Green  Flags 
indicate modification associated with transcriptional active chromatin and red with repressed 
chromatin (Adapted and modified from Khorasanizadeh, 2004; Rice and Allis, 2001). 
 
Distinct enzymes are responsible for the generation of various histone modifications 
(reviewed in Kouzarides, 2007). In addition, there are  enzymes that can remove or 
modify the histone modifications, making the modification of histone tails a dynamic 
regulated  process.  An  example  for  a  very  dynamic  histone  modification  is  the 
acetylation of lysine residues on the N-terminal tails of Histone H3 and H4, which is 
mediated by enzymes containing histone acetyltransferases (HATs) activity (Brown et 
al., 2000). Histone H3 and H4 can be acetylated on various lysine residues and this 
histone modification is found to correlate with chromatin regions that are transcriptional 
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active (Turner, 1993). In contrast to the HATs, the histone deacetylases (HDACs) are 
responsible for the removal of the acetylation.  
In the past a charge neutralization model and the histone code hypothesis have been 
proposed  to  explain  the  function  of  these  histone  modifications  in  gene  regulation 
(Schones and Zhao, 2008). Acetylation and phosphorylation are examples of two post-
translational histone modifications that can change the overall charge distribution on 
the mostly positively charged N-terminal histone tails. Acetylation of the lysine residues 
in the histone tails neutralizes the positive charge. Phosphorylation of the conserved 
serine (10) in the N-terminal tail of histone H3 also results in the addition of a negative 
charge, thus decreasing the overall positive charge (Workman and Kingston, 1998). In 
vitro experiments indicate that histone acetylation leads to a relaxation and opening of 
chromatin structure (Wolffe and Hayes, 1999). These observations support a charge-
neutralization  model,  in  which  these  histone  modifications  can  lead  to  an  overall 
relaxation of the chromatin fiber (Turner, 2000). 
With the Identification of enzymes, that modify the N-terminal histone tails and proteins 
that can recognize and bind specific histone modifications, the hypothesis of a ‘histone 
code’  evolved.  The  histone  code  proposes  that  multiple  histone  modifications  work 
together sequentially or in combination to control downstream biological functions like 
gene regulation. Although this is found in some cases, deciphering a simple histone 
code, which allows the precise prediction of the functional consequence turns out to be 
much more complex and dynamic than initially thought  (Kouzarides, 2007; Liu et al., 
2005).  
Thus histone modifications have two main functional consequences in that they can 
cause not only a direct structural change in the chromatin structure, but also indirectly 
act as binding surfaces for the recruitment of effector proteins (reviewed in Kouzarides 
2007;  Berger,  2007)  that  affect  various  downstream  cellular  processes,  such  as 
transcription, DNA repair and replication (Strahl  and  Allis, 2000; Turner, 2000).  The 
proteins recruited bind to the histone modifications via specific domains. Modifications 
like acetylation are recognized by proteins containing bromodomains and methylation 
is recognized via proteins with chromodomains. The binding of these proteins to the 
modified histone tails is a mechanism by which proteins with enzymatic activities can 
be recruited into close proximity of the chromatin. 
Gene expression in general is regulated by stimulus activated transcription factors that 
bind  regulatory  regions  of  genes  and  recruit  other  chromatin-modifying  enzymes 
leading  to  the  transcriptional  activation  or  silencing  of  the  target  gene  (Kouzarides, 
2007). For the biological consequence of transcription, the post-translational histone 
modifications  have  initially  been  divided  into  two  groups  correlating  with  either Introduction 
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transcriptional active or repressed chromatin (Kouzarides, 2002; Rice and Allis, 2001; 
Zhang and Rheinberg, 2001) (Table 1).  
 
Table 1 Histone modifications correlate with transcription. 
Overview of selected modifications identified on histones. The histone modification type and the 
residue position on the histones are listed. The enzymes implicated in the particular histone 
modification are shown. Their function in transcription associated with each modification is listed 
(Adapted and modified from Li et al., 2007; Kouzarides, 2007). 
 
 
 
Analysis  using  the  chromatin  immunoprecipition  (ChIP)  methodology  combined  with 
high  resolution  DNA-microarrays  and  sequencing  techniques  has  provided  major 
genome-wide  information  on  the  location  and  distribution  of  histone  modifications. 
Initial  genome-wide  studies  in  yeast  indicated  that  certain  histone  modifications  like 
acetylation  and  methylation  correlate  with  distinct  genomic  regions  and  specific 
transcriptional states (reviewed in Schones and Zhao, 2008).  
In yeast, genome-wide determination of methylation patterns showed that methylation 
of  histone  H3  lysine  residues  at  positions  K4,  K36  and  K79  associate  with 
transcriptional  activity,  whereas  methylation  of  K9,  K27  as  well  as  histone  H4  K20 
correlate  with  transcriptional  silent  chromatin  (Fischle  et  al.,  2003;  Lachner  et  al., 
2003).  In  addition,  the  lysine  residues  on  N-terminal  tails  of  histones  can  be  either 
mono-, di-, or tri-methylated which adds an additional layer of complexity. An example 
is  the  di-  and  tri-methylation  of  histone  H3  that  is  associated  with  transcriptional 
permissive  and  transcriptional  active  euchromatin,  respectively  (Santos-Rosa  et  al., 
2002). In addition, posttranslational modifications of histone tails are found in distinct 
localized patterns within the 5’ up-stream region from the transcription start site, the 
core promoter region, the transcribed region and beyond the 3’ downstream end of the 
transcript (reviewed in Li et al., 2007; Barrera and Ren, 2006). Genome-wide studies in 
yeast  as  well  as  mammals  such  as  mouse  and  human,  have  shown  that  histone 
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acetylation  and  histone  H3  lysine  4  methylation  are  associated  with  transcriptional 
active loci  and are specifically found enhanced  5’ of the transcription start site and 
extend well into the transcribed region of the gene (Roh et al., 2006; Liu et al., 2005; 
Pokholok et al., 2005; Bernstein et al., 2005; Kim et al., 2005). 
Because it is anticipated that histone modifications mark regulatory regions such as 
enhancers and promoters and transcribed regions, histone marks have been utilized to 
predict regulatory regions (Heintzman et al., 2007; Barski et al., 2007; Birney et al., 
2007). In addition, binding of members belonging to the transcriptional apparatus, such 
as  RNA  polymerase  II,  correlate  with  specific  histone  modifications  and  the 
transcriptional activity of the genes (reviewed in Barrera and Ren, 2006) (Fig. 1.5). It 
will be necessary to map specific histone modifications, which generally associate with 
transcriptional active or inactive chromatin across the different regions of a gene, to 
learn  more about the  mechanisms  involved in regulating the transcription  of genes. 
This is specifically important for genes regulated by complex signaling pathways upon 
differentiation. 
 
 
 
Figure 1.5 Distribution patterns of certain histone modifications. 
The  distribution  patterns  across  a  hypothetical  gene  that  correlate  with  active  or  inactive 
transcription  are  shown.  Distribution  of  histone  modifications  are  marked  in  relation  to  an 
theoretical body of a gene, were the arrow symbolizes the transcription start site (TSS), the light 
colored rectangle the transcribed region across the body of the gene. Upstream of the TSS, the 
promoter and far 5’ region are located. The 3’ region is defined downstream of the end of the 
transcribed  region.  The  curves  below  the  gene  correspond  to  the  distributions  of  histone 
modifications (Ac= acetylation. Me= methylation, K= lysine, H3= histone H3 and H4= histone 
H4) that were collected mainly from genome-wide studies in yeast (Adapted and modified from 
Li et al., 2007). 
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1.5 Aim of project  
 
The initiation of gene transcription requires precise interaction between the sequence-
specific  transcription  factor  and  their  target  DNA  regulatory  sequence.  Transcription 
correlates  with  dynamic  changes  in  the  chromatin  structure  and  associated  histone 
modifications,  whereby  specific  post-translational  histone  modifications  mark  the 
regulatory and transcribed genomic regions. 
Increased knowledge about the integration of signaling pathways at the level of binding 
patterns  of  sequence-specific  transcription  factors,  components  of  the  general 
transcription machinery (such as RNA polymerase II) and dynamic histone modification 
patterns will lead to a better understanding in transcription regulation.  
The  STAT5  transcription  factor  is  required  for  the  proliferation,  differentiation  and 
survival  of the differentiated  mammary epithelium  during  pregnancy  and lactation. It 
has been proposed that this action of STAT5 in maintaining differentiation of mammary 
epithelial cells is achieved in part by activation of target gene transcription. Two classic 
known  STAT5  target  genes  are  the  milk  proteins  ß-casein  and  WAP,  which  are 
differentiation specifically expressed by epithelial cells in mammary gland tissue during 
the  developmental  stages  of  pregnancy  and  lactation.  In  this  thesis  the  in  vivo 
recruitment  of  transcription  factors  STAT5  and  the  RNA  polymerase  II,  as  well  as 
changes in histone modifications on different regions of the milk protein genes ß-casein 
and WAP are to be characterized with help of the ChIP method during different stages 
of mammary gland development. Discovery of novel DNA regulatory elements bound 
directly by STAT5A is essential to identifying additional STAT5 target genes involved in 
the maintenance and survival of differentiated mammary epithelial cells in mammary 
gland tissue during lactation. The second aim of this work is to identify novel genomic 
binding sites of the transcription factor STAT5A in mouse mammary gland tissue from 
lactating mice. The ChIP cloning method will be utilized to create a library containing 
the  chromatin  fragments  enriched  with  an  antibody  specific  against  STAT5A.  The 
cloned DNA fragments will then be sequenced to allow for the identification of STAT5-
binding motifs and determination of their location in the genome using bioinformatics 
tools. Select novel DNA STAT5A-binding regions will be verified for STAT5 binding in a 
differentiation specific manner and are then subjected to subsequent experimental and 
computational  analysis  to  further  characterize  the  novel  STAT5-binding  motifs. 
Reporter  gene  assays  and  annotated  transcript  RNA  levels  are  to  be  analyzed  for 
determining  the  functional  contribution  of  the  novel  STAT5-binding  elements  in  the 
regulation of putative target genes. Materials and Methods 
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2. Materials and Methods 
 
 
2.1 Materials 
 
2.1.1 General chemicals and Materials 
 
General  chemicals  were  obtained  in  molecular  grade  quality,  if  not  noted  otherwise 
through the companies Applichem (Darmstadt), Amersham Biosciences (Freiburg), Fluka 
(Buchs, Schweiz), Peqlab (Erlangen), Merck (Darmstadt), New England Biolabs (Frankfurt 
am Main), Roche (Mannheim), Roth (Karlsruhe) and Sigma (Taufkirchen). For inhibition of 
phosphatases  and  proteases,  the  Phosphatase  Inhibitor  Cocktail  I  and  II  from  Sigma 
(Taufkirchen)  and  the  Protease  Inhibitor  Mix  (Complete,  EDTA  free)  from  Roche 
(Mannheim) were used. 
Consumables and plastic ware used for laboratory and tissue culture were obtained from 
one of the following companies Biozyme (Oldendorf), BD Bioscience (Heidelberg), Costar 
(Bodenheim), Greiner Bio-one (Frickenhausen) and Millipore (Eschborn). 
 
 
2.1.2 Solutions and Buffers 
 
All solutions were made up in deionized water. The solutions were either autoclaved (20 
minutes (min) at 121°C and 2 bar) or filter sterilized. All other solutions and buffers used 
are mentioned in the corresponding method sections. 
 
Solution  Components 
10x TBE (electrophoresis buffer)  890 mM Tris base, 890 mM boric acid, 20 
mM EDTA, pH 8.0 
TE, pH 8.0  10 mM Tris•HCL pH 8.0, 1 mM EDTA 
DEPC-water  0.2 % (v/v) DEPC 
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2.1.3 Enzymes 
 
All  restriction  endonucleases  and  their  corresponding  buffers  were  obtained  from  New 
England  Biolabs  (NEB)  (Frankfurt  am  Main).  Other  DNA  modifying  enzymes  used  are 
listed below. 
 
Enzyme  Company 
T4 DNA Ligase  NEB, Frankfurt am Main 
Taq DNA polymerase  Invitrogen, Karlsruhe 
Alkaline Phosphatase, Calf Intestinal (CIP)  NEB, Frankfurt am Main 
 
 
2.1.4 Kits and molecular weight markers 
 
  Company 
1kb plus DNA ladder  Invitrogen, Eggenstein 
QIAGEN Plasmid Maxi Kit  Qiagen, Hilden 
QIAquick PCR Purification Kit  Qiagen, Hilden 
QIAquick Gel Extraction Kit  Qiagen, Hilden 
RNeasy Mini Kit  Qiagen, Hilden 
Omniscript Reverse Transcriptase  Qiagen, Hilden 
TA Cloning Kit  Invitrogen, Eggenstein 
TripleMaster PCR mix  Eppendorf AG, Hamburg 
 
 
2.1.5 Antibodies 
 
The listed antibodies were used in Chromatin Immunoprecipitation (ChIP). 
Depending  on  the  Antibody  two  different  TSE  2  wash  Buffers  were  used  (see  ChIP 
protocol). Immunoprecipitations washed with TSE 2 wash Buffer (TSE 2-II, 250 mM NaCl) 
that contain no SDS detergent and a lower NaCl concentration are marked with a star 
symbol.  Immunoprecipitations  were  performed  with  protein  A  agarose  (sc-2001)  when 
using rabbit IgG antibodies and protein G (sc-2002) or A/G PLUS agarose (sc-2003) were 
used for capturing mouse IgG antibodies. 
Name/ 
specificity 
Host species 
and clonal type 
µg or 
µl/ChIP 
Ref. 
Number 
Company 
 
 IgG (preimmune serum)   normal rabbit IgG  4 µg   sc-2027 
 Santa Cruz, 
 Heidelberg 
 STAT5A (a.a. 775-794)   rabbit antiserum  2-4 µg 
 STAT5A  
 
 R & D Systems, 
 Wiesbaden 
 STAT5B (a.a. 769-782)   rabbit antiserum  2-4 µg 
 STAT5B  
 
 R & D Systems,  
 Wiesbaden 
 RNA POL II  P-CTD  
  (phospho-CTD of  
 mouse monoclonal      
 IgG1  0.5-2 µg 
 Upstate  
 05-623 
 BIOMOL,  
 Hamburg Materials and Methods 
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   RNA polymerase II) 
 2M(K4)H3 
  (histone H3  dimethylated  
   at lysine 4)   rabbit antiserum  5 µl 
 Upstate  
 07-030 
 BIOMOL,  
 Hamburg 
 3M(K4)H3  
  (histone H3  trimethylated  
   at lysine 4) 
 rabbit polyclonal 
 IgG  2.5 µg   ab8580 
 Abcam,  
 Cambridge (UK) 
 3M(K27)H3 
  (histone H3  trimethylated  
   at lysine 27)   mouse ascites  5 µl 
 Upstate  
 05-851 
 BIOMOL,  
 Hamburg 
 Ac-H3  
  (acetylated histone H3) 
 rabbit polyclonal  
 IgG  2-4 µg 
 Upstate  
 06-599 
 BIOMOL,  
 Hamburg 
 Ac-H4
*  
  (acetylated histone H4) 
 rabbit polyclonal 
 IgG  5-10 µl 
 Upstate  
 06-866 
 BIOMOL,  
 Hamburg 
 Ac(K8)H4
* 
  (histone H4 acetylated  
   at lysine 8) 
 rabbit polyclonal  
 IgG  2 µg   ab1760  
 Abcam,  
 Cambridge (UK) 
 Ac(K12)H4
* 
  (histone H4 acetylated  
   at lysine 12) 
 rabbit polyclonal     
 antiserum  10 µl   ab1761 
 Abcam,  
 Cambridge (UK) 
 Ac(K16)H4
* 
  (histone H4 acetylated  
   at lysine 16)   rabbit antiserum  10 µl 
 Upstate     
 07-329 
 BIOMOL,  
 Hamburg 
 H3 (N-terminal H3) 
 rabbit polyclonal  
 IgG  5 µg 
 Upstate    
 06-755 
 BIOMOL,  
 Hamburg 
 
 
2.1.6 Oligonucleotides 
 
Oligonucleotides were ordered from MWG Biotech (München) or Invitrogen (Karlsruhe). 
All PCR Primer stocks were resuspended at 100 pmol/µl and used at a working dilution of 
10  pmol/µl.  Unless  stated  otherwise,  all  primers  were  designed  based  on  mouse  Mus 
musculus sequences 
All  Primers  were  run  in  quantitative  (q)  PCR  with  an  annealing  temperature  of  58°C, 
unless stated otherwise. 
 
 
2.1.6.1 Oligonucleotides for reverse transcript quantitative RT-PCR 
 
Primer Name  RNA  Sequence (5'→3')  Reference /GenBank Acc. 
 18S For  18S RNA   CGGCTACCACATCCAAGGA  (Baus and Pfitzner, 2006) 
 18S Rev      CCAATTACAGGGCCTCGAAA   
 YWHAZ_F  YWHAZ   GAAAAGTTCTTGATCCCCAATGC 
PrimerBank ID:6756041a1/ 
NM_011740 
 YWHAZ_R     TGTGACTGGTCCACAATTCCTT  (Wang and Seed, 2003) 
 CyclophilinBF  cyclophilin B   TGCAGGCAAAGACACCAATG 
PrimerBank ID:6755142a3/ 
NM_011149 
 CyclophilinBR     GTGCTCTCCACCTTCCGTA  (Wang and Seed, 2003) Materials and Methods 
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 ß-caseinF  ß-casein   TCACTCCAGCATCCAGTCACA  Feraci E., PhD thesis 
 ß-caseinR     GGCCCAAGAGATGGCACCA   
 WAP_zhu_F  WAP   GGAGCATTCTATCTTCATTGG  (Zhu et al., 2004) 
 WAP_zhu_R     TCAGTTCAGTCCATGTTCCA   
 SOCS3F_Doppler  SOCS3   GCTCCAAAAGCGAGTACCAGC  (Tonko-Geymayer et al., 2002) 
 SOCS3R_Doppler     AGTAGAATCCGCTCTCCTGCAG   
 NFIB_F  NFI/B   AGCACCATCATCCCGGAATAC 
PrimerBank ID: 31982161a1/ 
NM_008687 
 NFIB_R     GTACCAGGACTGGCTCGTTTG  (Wang and Seed, 2003) 
 AW106080est_140 
AW106080/ 
EST Exon1/2   TGGATGAATTCCACCCATTT  This thesis / AW106080 
 AW106080est_290     TCGTCTTTGACTGCCCTTTC   
 Bu610001_15 
BU610001/ 
EST Exon1/2   GTCTTCTGTGGAACCCAAGC  This thesis / BU610001 
 Bu610001_211     GAGTTCAGTGTATCCGAGTACTGCT   
 Zswim6_F 
Zswim6/ 
AK030163   AGACACCAACAACCACTACACC  PrimerBank ID: 26326145a1 
 Zswim6_R  Exon 14 and 3'  GGTTCTGGCACACTGTATGTTC  (Wang and Seed, 2003) 
 AK122528_1525 
Zswim6/ 
Exon 6/7   TCGGACAGTGTTCACGAGAG  This thesis / XM_358311 
 AK122528_1699      GGCTGTAGGGACGTGTTCAT   
 XM358311_632 
Zswim6/ 
Exon1/2   CTGGAGAGTGGCTGCGTAGA  This thesis / XM_358311 
 XM358311_821     CCACAACATGGGCACAATAA   
 
 
2.1.6.2 Oligonucleotides used for ChIP qRT-PCR 
 
A) Primers used in ChIP 
The transcribed gene region refers to the region within the genomic sequence of the gene 
that  is  transcribed  (mRNA).  The  ß-casein  enhancer  primers  require  an  annealing 
temperature of 55°C. 
Name 
Gene 
region  Sequence (5'→3') 
GenBank 
Acc./ 
GI Nr. 
5` Primer 
Nucleotide 
Position  Source 
ß-casein 
RosenF   Enhancer    agtctcaaggaaatactggatctattg      
(Kabotyanski  
 and Rosen    
 2006) 
ß-casein 
RosenR   Enhancer    gagtttgtgaaccatcttttactaacc          
ß-casein 
1312F    5'   tccttccatgggtgttttgt 
 NT_039308/ 
 51711197  11667321   This thesis 
ß-casein 
1561R    5'   gcaaggtaatgggaacagga    11667072    
ß-casein 
199F   Promoter  gcttctgaattgctgccttg    11663963 
 
ß-casein 
308R   Promoter  caaaaagtcccttcaattcca    11663854 
 
ß-casein 
6601F 
 
Transcribed aggtgagcaggtgacgtctt    11662038 
 
ß-casein 
7200R 
 
Transcribed tgtttgatgagtggcaaaagtt    11661882 
 Materials and Methods 
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ß-casein 
510F   3'  tgctgcctaatgagaacgtg 
NT_039308/ 
 51711197  11656781 
This thesis 
ß-casein 
728R   3'  accaagatttccaggagcaa    11656563 
 
ß-casein 
1403F   3'  tcacccctttcttcgtcatc    11655888 
 
ß-casein 
1606R   3'  catgtgccctcctcttctgt    11655685 
 
SOCS3 
2778F  Promoter  cacagccttcagtgcagag 
 AF117732.1/   
 4336990  2778-2797 
 
SOCS3 
2946R  Promoter  agagacagcggtcgtaggag    2946-2927 
 
WAP 
1059F  very 5'  caagcctcacttgtcttactttga 
 NT_039515/ 
 63615460 or  
 51766363  3537382 
 
WAP 
1247R  very 5'  gagtacgtgtgtttgtgtgtgtgt     3537194 
 
WAP 
1991F  5'  tagagggatgagtttccacgat     3536450 
 
WAP 
2139R  5'  tcctcgaggtttttgtttttgt     3536302 
 
WAP 
1772F  Promoter  agtgccagcaggacatctct     3534063 
 
WAP 
1891R  Promoter  tgtcgggcatacattgaaaa     3533944 
 
WAP 
1270F  Transcribed  tctgagaagccttagaagtgaggt     3532178 
 
WAP 
1478R  Transcribed  gggacttactgttgacaggagttt     3531970 
 
WAP 
210F  3'  agctcctgaaggaacgacaa     3530241 
 
WAP 
419R  3'  cagacgatgcccatttcttt     3530032 
 
WAP 
1236F  3'  acaagcagcataacgcacag     3529215 
 
WAP 
1401R  3'  aagggaggggtcatgagtct     3529049 
 
 
 
B) Primers used in ChIP for STAT5A library clones 
NAME  Sequence (5'→3') 
GenBank 
Accesion/ 
Build 
Primer 
Nucleotide 
Position 
STAT5 site 
Position  Source 
c153_526  CTTGTGGCATGTTATGATTGCT 
NT_039260.6/ 
Mm4_39300_36  25716165-25716186 25716096-25716104  This thesis 
c153_700  CAAATCCAGATTGCCCTTTTAC     25716340-25716319      
C194_339   TTGCTCAGTTCTTGGAAACAGA 
NT_162143.2/ 
Mm3_159849_36  19409623-19409644 19409851-19409860   
C194_533  GAGAAGACCCATGCTTGGTAAC     19409817-19409795      
c236_236F  ACTCAATGGGTTTTTGTTTTGTTT 
NT_165760.1/ 
Mm5_163274_36  7795792-7795815  7795735-7795727   
c236_425R  AGAAAAATTGCCATCTATTTGAGC     7795981-7795958  7795792-7795815    
c831swi281  GGTCTTGGCTTCTGCAGTTAGT 
NT_039590.6/ 
Mm13_39630_36  15821474-15821453 15821352-15821344   
c831swi503  CGAAATGTTGCAATGAATCTGT     15821252-15821274      
c20_1527  ACTGTGTGTGGCAGCCCTCT 
NT_165773.2/ 
Mm11_163287_37 9467848-9467867  9467876-9467980  Xin Fu, 
c20_1646  GAACTAAGGGCTGGTTTCCAAAA     9467967-9467945     Pfitzner  
c34_2108  CCGGCAGGCCTCCTATCTAT 
NT_039606.7/ 
Mm14_39646_37  599689-599708  599435-599866  group 
c34_2233  ATCTGCCTGCCCAACTTCAA     599814-599795       Materials and Methods 
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c73_707  GCAGGAGGCTAATCCAGCAA 
NT_078575.6/ 
Mm8_78640_37  9471062-9471081  9470473-9471984  Xin Fu, 
c73_824  CCTGGGAGCTTGGCTTTTCT     9471179-9471160     Pfitzner  
c398_3_604 TGAACGCCGATCATCAAAAT 
NT_039674.7/ 
Mm18_39714_37  39434516-39434535 39434662-39434846  group 
c398_3_744 CTCCGATGTCCCGAAATGAC     39434656-39434637      
c882_2028  GTCAGAGCCTTCCACGCTGT 
NT_039240.7/ 
Mm3_39280_37  50594949-50594968 50594847-50595127   
c882_2162  CACACTCCTCTCTGCCAGAAAAA     50595083-50595061      
c721_155  GAAGCAGACTTAACTTGAAAAACAAGG 
NT_039433.7/ 
Mm7_39473_37  15228875-15228901 15228869- 15229238  
c721_295  TGACTTTGGCAAGCAAGCAA     15229015-15228996     
c878_1220  AATCAAACTTGGGGCATCAG 
NT_165773.1/ 
Mm11_163287_36 27179216-27179234 27179208-27179216  This thesis 
c878_1389  ACACACACGCCTCCTAATCC     27179389-27179369 27179347-27179356    
 
 
2.1.6.3 Oligonucleotides for sequencing and chromatin amplification 
 
Primer Name  Description of use  Sequence (5'→3') 
RV3_pGL3  primer for sequencing of inserts   CTAGCAAAATAGGCTGTCCC 
GL2_pGL3  in MCS of pGL3 basic vector (Promega)  CTTTATGTTTTTGGCGTCTTCCA 
JW102   unidirectional linker oligo’s used to 
amplify ChIP chromatin  
GCGGTGACCCGGGAGATCTGAATTC 
JW103  (Oberley and Farnham Lab Protocol)  GAATTCAGATC 
 
 
2.1.6.4 Oligonucleotides for cloning 
 
A) Primers to amplify the fragment regions containing the STAT motifs corresponding to 
STAT5A library clone out of mouse genomic DNA. 
 
Primer Name  Description of use  Sequence (5'→3') 
GenBank Acc. / 
Primer nt 
position 
c153gen_1284  5'-primer to clone c153 (750 bp) CACACACAATCAGACTTTCATCC 
NT_039260.6 / 
25716487-25716465 
c153gen_2033  3'-primer to clone c153  TAAAGAAAAGAATGGGCTTGCT  25715738-25715759 
c194 680F_gDNA  5'-primer to clone c194 (800 bp) AGGTCTGAAAACTGTTGGTTGAG 
NT_162143.2/ 
19409504-19409526 
c194 1479R_gDNA 3'-primer to clone c194  AAGCTCTCCCAATAAACGTGTG  19410303-19410282 
c831 694F_gDNA  5'-primer to clone c831 (748 bp) GCTTTGAAGACACTGCTTTGAAT 
NT_039590.6/ 
15821681-15821659 
c831 1441R_gDNA 3'-primer to clone c831  AAGGTAAGGGCTACACCCTATCA 15820934-15820956  
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B) Nested primers with restriction enzyme overhangs to sub-clone the regions amplified 
from genomic DNA into pGL3 basic vector multiple cloning sites (MCS). 
 
Primer Name  Description of use  Sequence (5'→3') 
GenBank Acc. / 
Primer nt 
position 
c153_1284F_gBamH1 
5'-primer with BamHI (cgGGATCC) 
 to subclone c153   CGGGATCCCACAATCAGACTTTCATCC 
NT_039260.6/ 
25716483 -25716465 
c153_2033R_gBamH1 
3'-primer with BamHI (cgGGATCC) 
 to subclone c153   CGGGATCCAGAAAAGAATGGGCTTGCT 25715741-25715759 
c194_680F_gBglII 
5'-primer with Bgl II (gaAGATCT) 
 to subclone  c194   GAAGATCTCTGAAAACTGTTGGTTGAG 
NT_162143.2/ 
19409508-19409526 
c194_1479R_gBglII 
3'-primer with Bgl II (gaAGATCT) 
 to subclone c194   GAAGATCTCTCTCCCAATAAACGTGTG  19410300-19410282 
c831_694F_gBamH1 
5'-primer with BamHI (cgGGATCC) 
 to subclone c831  CGGGATCCTGAAGACACTGCTTTGAAT 
NT_039590.6/ 
15821677 -15821659 
c831_1441R_gBamH1 
3'-primer with BamHI (cgGGATCC) 
 to subclone c831   CGGGATCCTAAGGGCTACACCCTATCA 15820938-15820956  
c236_kpn1Fg 
5' primer with KpnI (cggGGTACC) 
 to amplify c236 in pCR2.1  CGGGGTACCGGCTTTCAGAGTTGC 
NT_165760.1/ 
7795845 -7795824 
c236_kpn1Rg 
3' primer with KpnI (cggGGTACC) 
 to amplify c236 in pCR2.1  CGGGGTACCAACAGTAACAAGGGC  7795553 -7795572 
c153_622R_kpn1 
5' primer with Kpn1 (cggGGTACC) 
 to subclone 339 bp of c153   CGGGGTACCGGTCAGGTTATTCACA  
NT_039260.6/ 
25716261 -25716246 
c153_283F_kpn1 
3' primer with Kpn1 (cggGGTACC) 
 to subclone 339 bp c153  CGGGGTACCTGACCAAACAATGAG  25715922 -25715936 
 
 
2.1.6.5 Oligonucleotides for site-directed mutagenesis 
 
Oligonucleotides for site-directed mutagenesis of STAT5 binding sites from clones located 
in  pGL3  luciferase  reporter  vectors.  The  manufactures  protocol  for  primer  design  was 
followed as outlined in the Quikchange Site-Directed Mutagenesis kit (Stratagene). The 
STAT  motifs are underlined  and the bases that were changed from  wild type (wt) are 
highlighted. 
 
Primer Name  Description of use  Sequence (5'→3') 
c236_M1TT_F 
 
sense primer for mutagenesis  
of wt STAT5 binding site I  
from AA to TT in mouse clone c236  ACTCTGCACGCCTTGGGGCTTTGTT 
c236_M1TT_R 
 
anti-sense primer for mutagenesis  
of wt STAT5 binding site I  
in mouse clone c236  AACAAAGCCCCAAGGCGTGCAGAGT 
c236_M2TT_F 
 
sense primer for mutagenesis  
of wt STAT5 binding site II  
from AA to TT in mouse clone c236  GGAGCTCTCTTTTCCAAGTTTAGACTACAC 
c236_M2TT_R  
 
anti-sense primer for mutagenesis  
of wt STAT5 binding site II  
in mouse clone c236  GTGTAGTCTAAACTTGGAAAAGAGAGCTCC 
c153_S5_mut1F  
 
sense primer for mutagenesis  
of wt STAT5 binding site I  
from TT to AA in mouse clone c153  GTTATTCTACAAAACGGCTTAACATAGAAACCTAATTC 
c153_S5_mut1R 
 
anti-sense primer for mutagenesis  
of wt STAT5 binding site I  
in mouse clone c153  GAATTAGGTTTCTATGTTAAGCCGTTTTGTAGAATAAC 
c153_S6_mut1F 
  
sense primer for mutagenesis  
of wt STAT binding site II  
from TT to AA in mouse clone c153  CTTCCTTTATCCAACCCTAGAAGGCTTCAGGAGTTTCCCGG 
c153_S6_mut1R 
 
anti-sense primer for mutagenesis  
of wt STAT binding site II   CCGGGAAACTCCTGAAGCCTTCTAGGGTTGGATAAAGGAAG Materials and Methods 
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in mouse clone c153 
c153_M1gc_M3gcF  
 
 
 
sense primer for mutagenesis  
of M1 STAT5 binding site I from AA 
to GC  
and wt STAT binding site III  
from AA to GC in mouse clone c153 GTTATTCTACAGCACGGCTTGCCATAGAAACCTAATTC 
c153_M1gc_M3gcR 
 
  
anti-sense primer for mutagenesis  
of M1 STAT5 binding site I and  
wt STAT binding site III  
in mouse clone c153  GAATTAGGTTTCTATGGCAAGCCGTGCTGTAGAATAAC 
c153_M1gc_M4cgF 
 
  
sense primer for mutagenesis  
of M1 STAT5 binding site I from AA 
to GC  
and wt STAT binding site IV  
from TT to CG in mouse clone c153  CGGCTTGCCATAGAAACCTAATTCAATCGTAAGAAAATG 
c153_M1gc_M4cgR   
anti-sense primer for mutagenesis  
of M1 STAT5 binding site I and  
wt STAT binding site IV   
in mouse clone c153  CATTTTCTTACGATTGAATTAGGTTTCTATGGCAAGCCG 
c831_S5_mut1F 
 
sense primer for mutagenesis  
of wt STAT5 binding site  
from TT to AA in mouse clone c831  GGTTTACTCGGGAGGAACATGGAACTGGCGTGGC 
c831_S5_mut1R 
 
anti-sense primer for mutagenesis  
of wt STAT5 binding site  
in mouse clone c831  GCCACGCCAGTTCCATGTTCCTCCCGAGTAAACC 
 
 
2.1.7 Plasmids 
 
2.1.7.1  Expression vectors for  mammalian cells (General  expression vectors and 
reporter plasmids) 
 
A) General expression vectors 
Name/ vector type  Coding Insert 
Reference/ 
Source 
 pXM 
 pXM backbone expression vector  
 containing adenoviral promoter   Moriggl et al., 1996 
 pXM-STAT5A   mouse STAT5A   Moriggl et al., 1996 
 pMX IRES GFP 
 pMX backbone IRES-GFP based  
 bicistronic retroviral vector   Onishi et al., 1996 
 pMX STAT5A IRES GFP   mouse STAT5A    Onishi et al., 1996 
 pMX STAT5A 1*6 IRES GFP   constitutive active mouse STAT5A    Onishi et al., 1996 
 pMX dnSTAT5A IRES GFP   dominant negative mouse STAT5A Y705F   Döll, F., PhD thesis 
 pMX STAT5A Δ750 IRES GFP 
 dominant negative mouse STAT5A  
 with deletion of transcription activation domain  Döll, F., PhD thesis 
 
 
 
B) Luciferase reporter plasmids  
 
Name  Clone DNA Insert 
GenBank 
Acc. 
Nucleotide 
position 
pGL3 basic 
Luciferase reporter backbone vector  
is enhancer-less and promoter -less  Promega    Materials and Methods 
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pGL3 ba c153 L_10  c153 (743bp) wild type  NT_039260.6 25716483-25715741 
pGL3 ba c153(336)_WT_6F 
c153 (339bp) forward orientation  
wild type    25715922-25716261 
pGL3 ba c153(336)_WT_3R 
c153 (339bp) reverse orientation  
wild type     25716261-25715922 
pGL3 ba c153(336)_M1_35R 
c153 (339bp) reverse orientation  
with mutation in STAT site I    25716261-25715922 
pGL3 ba c153(336)_M2_48R 
c153 (339bp) reverse orientation  
with mutation in STAT site II    25716261-25715922 
pGL3 ba c153(336)_M1+M2_55R 
c153 (339bp) reverse orientation  
with mutation in STAT site I and II    25716261-25715922 
pGL3 ba c153(336)_M1-3_11R 
c153 (339bp) reverse orientation  
with mutation in STAT site I, II and III    25716261-25715922 
pGL3 ba c153(336)_M1-2+4_16R 
c153 (339bp) reverse orientation  
with mutation in STAT site I, II and IV    25716261-25715922 
pGL3 ba c153(336)_M1-4_20R 
c153 (339bp) reverse orientation  
with mutation in STAT site I, II, III and IV   25716261-25715922 
pGL3 ba c194_11F 
c194 (793bp) forward  orientation  
wild type  NT_162143.2 19410300-19409508 
pGL3 ba c194_29R 
c194 (793bp) reverse  orientation  
wild type    19409508-19410300 
pGL3 ba c236(293)_5F 
c236 (293bp) forward  orientation  
wild type  NT_165760.1 7795553-7795845 
pGL3 ba c236(293)_6R 
c236 (293bp) reverse  orientation  
wild type    7795845-7795553 
pGL3 ba c236(293)_M1_1R 
c236 (293bp) reverse  orientation  
with mutation in STAT site I    7795845-7795553 
pGL3 ba c236(293)_M2_7R 
c236 (293bp) reverse  orientation  
with mutation in STAT site II    7795845-7795553 
pGL3 ba c236(293)_M1+M2_22R 
c236 (293bp) reverse  orientation  
with mutation in STAT site I and II    7795845-7795553 
pGL3 ba c831 L_6  c831 (740bp) wild type  NT_039590.6 15820938-15821677 
pGL3 ba c831 L_6_M1_21 
c831 (740bp)  
 with mutation in the STAT5 site     15820938-15821677 
 
 
2.1.8 Bacteria and bacterial culture media 
 
To prepare plasmid (p) DNA for subsequent molecular DNA applications, the Escherichia 
coli  host  strain  DH5α  was  used.  The  bacterial  cultures  were  grown  in  standard  Luria 
Bertani (LB) medium (10 g/l Tryptone, 10 g/l NaCl, 5 g/l yeast extract). The LB culture 
broth was made up in deionized water and autoclaved. Ampicillin was used as a selection 
agent, since all pDNA used in this work carried the ampicillin resistance gene. Ampicillin 
was added at a final working concentration of 100 µg/ml. 
 
E.coli host strain  Genotype 
DH5α  endA1 hsdR17 (rk
- mk
-) supE44 thi 
-λ
- recA1 gyrA96 relA1 
80dlac
qZD M15 
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2.1.9 Tissue culture reagents and cell lines 
 
2.1.9.1 Tissue culture reagents 
 
  Company 
DMEM (Dulbeccos minimal Essential 
Medium), 4,5 g/l D-Glucose 
BioWhittacker, Verviers (Belgium) 
RPMI 1640 (Roosevelt Park memorial 
Institute Medium) ), 4,5 g/l D-Glucose 
BioWhittacker, Verviers (Belgium) 
L-Glutamine  PAA, Pasching (Austria) 
Penicillin/Streptomycin  PAA, Pasching (Austria) 
Fetal Calf Serum (FCS)  Invitrogen, Eggenstein 
Phosphate Buffered Saline (PBS) (1x)  PAA, Pasching (Austria) 
Trypsin-EDTA (1x)  Invitrogen, Eggenstein 
Isotone II  Becton Dickinson, Heidelberg 
Prolactin from sheep pituitary (1,000 I.U.)  Sigma-Aldrich, Taufkirchen 
Insulin  Sigma-Aldrich, Taufkirchen 
Dexamethasone   Sigma-Aldrich, Taufkirchen 
Dimethylsulfoxide (DMSO)   Sigma-Aldrich, Taufkirchen 
 
The tissue culture media is supplemented with 10% (v/v) FCS, 2 mM L-Glutamine, 50 
U/ml  penicillin  and  50  µg/ml  Streptomycin  unless  stated  otherwise.  For  complement 
inactivation the FCS is heat inactivated for 30 minutes (min) at 56°C.  
 
 
2.1.9.2 Cell lines 
 
Cell line  Cell type  ATCC number/ 
source 
Culture media 
HeLa TA  human cervical 
adenocarcinoma cell line, 
with Tet-transactivator 
CCL-2  DMEM 
HC11  mouse mammary epithelial 
cell line  
Ball et al., 1988  RPMI 1640 
Growth medium: 10 ng/ml 
EGF, 5 µg/ml Insulin 
Starve Medium: 2% (v/v) 
FCS, 5 µg/ml Insulin 
 
 
2.1.10 Online Bioinformatic resources and tools 
 
PCR primer design: 
•  Primer 3 program (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) 
by Rozen and skaletsky (2000) 
 
Normalization of real-time PCR expression data: 
•  geNorm (http://medgen.ugent.be/~jvdesomp/genorm/) Materials and Methods 
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Database DNA similarity search software: 
•  BLAST (http://www.ncbi.nlm.nih.gov/BLAST/) 
 
•  BLAT (http://genome.ucsc.edu/cgi-bin/hgBlat) 
 
DNA bioinformatic Databases: 
•  NCBI (http://www.ncbi.nlm.nih.gov/) 
•  UCSC Genome Browser (http://genome.ucsc.edu/) 
•  Ensembl Genome Browser (http://www.ensembl.org/index.html) 
 
Transcription factor Motif search software: 
•  TESS:Transcription  Element  Search  System  (http://www.cbil.upenn.edu/cgi-
bin/tess/tess) 
•  Genomatrix/ MatInspector (http://www.genomatix.de/products/MatInspector/) 
 
Other software: 
•  SOURCE (http://source.stanford.edu/cgi-bin/source/sourceSearch) 
GeneReports linked to UCSC Browser 
 
•  Dragon Genome Explorer Promoter Search and Gene Regions  
(http://research.i2r.a-star.edu.sg/promoter/); Dragon TSS Desert Masker ver. 2.0  
and Dragon Promoter Finder ver.1.5 
 
Online ChIP Assay protocols: 
•  http://genomecenter.ucdavis.edu/farnham/farnham/protocol.html 
Farnham lab protocols for Chromatin Immunoprecipitation (ChIP) protocol for Tissues and 
Cloning and ChIP-CpG island microarray binding analysis. 
 
UCSC Genome Bioinformatics Browser sequence alignments: 
The genomic assemblies used in the alignment of each species by the UCSC Genome 
Bioinformatics Browser is as follows: mouse, (Feb 2006, mm8); rat (Nov 2004,rn4); rabbit 
(May  2005,  oryCun1);  human  (Feb  2006,  hg18);  chimp  (Jan  2006,  panTro2);  dog 
(May2005, canFam2); cow (Mar 2005, bosTau); armadillo (May 2005, dasNov1); elephant 
(May2005, loxAfr1); tenrec (Jul 2005, echTel1); opossum (Jan 2006,monDom4); chicken 
(Feb 2004, galGal2). 
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2.2 Methods 
 
2.2.1 General molecular methods for cloning and working with nucleic acids 
 
2.2.1.1 Production of competent cells 
 
The  preparation  of  competent  bacteria  (E.  coli  strain  DH5α)  was  performed  after  the 
protocol adapted from Hanahan (Hanahan, 1983). Competence of E. coli can be induced 
by treatment with calcium chloride before DNA addition. The calcium destabilizes the cell 
membrane  and  allows  for  a  calcium  phosphate-DNA  complex  to  adhere  to  the  cell 
surface. The DNA is then readily taken up when the cells are exposed to a brief heat 
shock of 42°C. Briefly, a bacterial culture was grown while shaking at 37°C in about 150 
ml LB broth until an OD600 of 0.3-0.4 has been reached. Cells are then centrifuged (2,000 
x g, 10 min, 4°C) and the cell pellet is gently resuspended in 50 ml ice-cold solution I (100 
mM RbCl2, 50 mM MnCl2, 30 mM potassium acetate, 10 mM CaCl2, 15% (v/v) glycerol, pH 
5.8). The cells are then incubated on ice for 2 hours followed by centrifugation (2,000 x g, 
10 min, 4°C). The cell pellet is gently resuspended in 4 ml solution II (10 mM MOPS, 10 
mM RbCl2, 75 mM CaCl2, 15% (v/v) glycerol, pH 7.0) and incubated on ice for additional 
15 minutes. 100 µl of competent cells are transferred into sterile microcentrifuge tubes 
and frozen in liquid nitrogen. Competent cells are stored at  
-80°C. 
 
 
2.2.1.2 Transformation of bacteria 
 
Competent bacteria are thawed on ice. Plasmid DNA (50 ng to 1 µg) is added to 50-100 µl 
competent cells, mixed gently and incubated on ice for at least 20 min. 
Cells are subjected to a brief heat shock for 90 seconds (sec) at 42°C to facilitate DNA 
uptake and then incubated on ice for 2 minutes. 400 µl of LB media is added and the cells 
incubated at 37°C on a shaker for 1 hour. The bacteria are then spread on appropriate 
antibiotic-containing plates to select for bacteria carrying the desired plasmid DNA with 
the resistance marker. The plates are incubated over night at 37°C to allow colonies to 
grow for further processing. 
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2.2.1.3 Isolation of plasmid DNA (A Mini preparation procedure) 
 
The  mini  preparation  procedure  of  plasmid  DNA  is  based  on  the  principle  of  alkaline-
detergent lysis  method (Birnboim, 1983) and followed by a butanol  precipitation of the 
DNA. 
Briefly, 1.4 ml of a bacterial culture grown over night is transferred into a microcentrifuge 
tube  and  pelleted  by  centrifugation  (6,000  x  g,  for  1  min).  The  bacterial  pellet  is  first 
resuspended in P1 buffer (50 mM Tris•Cl pH 8.0, 10 mM EDTA, 100 µg/ml RNase A) and 
then in 100 µl of P2 buffer (200 mM NaOH, 1 % (w/v) SDS) to lyse the cells followed by 
vigorous inversion of the tubes. After a 5 minutes incubation time 75 µl of P3 buffer (3 M 
potassium acetate, pH 5.5) is added and the tubes are inverted again several times. This 
is followed by another 5 minutes incubation time upon which the tubes are centrifuged 
(20,000 x g, 10 min). The cleared bacterial lysate is then transferred to new tubes and 1.5 
volumes 6 M Guanidinisothiocyanate (GITC) and 2 volumes of butanol are added. The 
tubes are inverted several times and then centrifuged (20,000 x g, 10 min) to pellet the 
precipitated DNA. The DNA pellet is washed with 70% ethanol, air dried and resuspended 
in 50 µl water. In general the yield of plasmid DNA was 1-2 µg/ml of bacterial culture. The 
buffers  P1,  P2  and  P3  used  in  this  protocol  were  part  of  the  QIAGEN
®  Plasmid  kits 
(Qiagen, Hilden). 
 
 
2.2.1.4 Isolation of plasmid DNA (A Maxi preparation procedure) 
 
For the isolation of pure, transfection grade plasmid DNA the QIAGEN
® Plasmid Maxi kit 
(Qiagen, Hilden) was used. The growth of bacterial cultures and purification of plasmid 
DNA was performed according to the manufacturers specifications. The purified plasmid 
DNA  was resuspended in  water or  TE buffer (pH 8.0) and stored at –20°C.  The  DNA 
concentration was determined by UV spectrophotometry. 
 
 
2.2.1.5 Measurement of DNA concentration 
 
The DNA concentration can be determined by measuring the absorbance at 260 nm (A260) 
in a conventional spectrophotometer using a quartz cuvette. One unit of absorbance at 
260 nm wavelength corresponds to 50 µg/ml double stranded (ds) DNA. The total amount 
of DNA is calculated as follows: 
Measured (A260) x dilution factor of sample x 50 = µg ds DNA / ml Materials and Methods 
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When only small sample amounts of DNA are available the DNA concentration can be 
measured  directly  using  only  1  µl  of  sample  DNA  with  the  NanoDrop®  ND-1000 
spectrophotometer (NanoDrop Technologies, Wilmington USA). 
 
 
2.2.1.6 Restriction endonuclease digestion of DNA  
 
Restriction endonucleases recognize, bind and cleave DNA at specific target sequences. 
As a general rule one unit of restriction endonuclease digests 1 µg of substrate DNA in 1 
hour. 
Plasmid  DNA  (0.5-5  µg)  was  digested  with  suitable  restriction  enzymes  using  the 
digestion  conditions  (appropriate  choice  of  buffers,  enzyme  unit  concentration,  optimal 
restriction  reaction  temperatures  and  length  of  digestion  time)  suggested  by  the 
manufacturers. 
 
2.2.1.8 5’-dephosphorylation of DNA 
 
To prevent the self-ligation of the linearized vector DNA during ligation the 5’ phosphate 
from  the  vector  DNA  was  removed  with  calf  intestinal  phosphatase  (CIP)  (NEB, 
Frankfurt/Main). For every 1 µg of linearized vector DNA 0.5 Units of CIP was added and 
incubated for 1 hour at 37°C. 
 
 
2.2.1.7 Ligation of DNA 
 
T4  DNA  ligase  (NEB,  Frankfurt/M)  was  used  for  cloning  of  restriction  fragments  and 
joining linkers to blunt ended DNA according to manufacturers suggestions. The T4 DNA 
ligase catalyzes the formation of a phosphodiester bond between the 5’ phosphate and 
the 3’ hydroxyl end of two juxtaposed double stranded DNA molecules. Briefly, for cloning 
purposes  approximately  25-50  ng  of  linearized  and  5’-dephosphorylated  plasmid  DNA 
vector was used at a vector:insert ratio of 1:1 (as determined on analytical agarose gels). 
Ligation reactions were performed with at least 4.0 Weiss units of T4 DNA ligase in a final 
reaction volume of 10 µl and incubated overnight in a water bath set at 16°C.  
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2.2.1.9 Fill in of 5’-overhangs to form blunt ends in ds DNA 
 
The DNA polymerase I, large (Klenow) fragment from E.coli was used to create blunt ends 
on double stranded DNA and thus allow for effective ligation to other ds DNA with blunt 
ends.  For  example shearing of chromatin results in overhangs which need to be blunt 
ended before ligation to linker or vector DNA.  
This DNA polymerase I contains a 5’→3’ polymerase activity for filling in 5’ overhangs as 
well as a 3’→5’ exonuclease activity that removes 3’ overhangs to form blunt ends. The 
reaction for the DNA polymerase I, large (Klenow) fragment (NEB, Frankfurt /Main) was 
set up according to manufacturers instructions.  
 
 
2.2.1.10 Annealing of single stranded DNA oligonucleotides 
 
To  obtain  the  unidirectional  double-stranded  oligonucleotide  linker  for  generating  ChIP 
chromatin amplicons the two oligos JW102 and JW103 were annealed by mixing in a 1:1 
ratio 6.7 µl of each oligonucleotide (10 µM) in 86.6 µl water as described (Oberley M. and 
P. Farnham Lab Protocol; Section II, Generating Chromatin Amplicons; Day 1). The oligos 
were boiled for 5 min in a water bath and allow to slowly cool down to room temperature. 
The unidirectional double-stranded oligonucleotides are then stored at –20°C. 
 
 
2.2.1.11 Agarose gel electrophoresis of DNA 
 
Based on the size of the DNA fragments to be separated agarose gels of 1 to 2% (w/v) 
were made up with 1x TBE buffer. The same 1x TBE electrophoresis buffer was used to 
run  the  agarose  gel.  To  visualize  the  DNA  samples  0.5  µg/ml  ethidium  bromide  was 
added prior to poring and running the agarose gel. Ethidium bromide is a fluorescent dye 
that intercalates between the base pairs of double stranded DNA molecules and allows for 
the visualization of the ethidium bromide-DNA complex under UV light. The DNA samples 
are mixed with 1 volume of 10x gel loading buffer (65% (w/v) sucrose, 10 mM Tris-HCl 
(pH 7.5), 10 mM EDTA, 0.2% (w/v) bromophenol blue) and loaded into the appropriate 
wells of the agarose gel. The 1 kb plus DNA ladder (Invitrogen, Eggenstein) served as 
molecular weight marker. Separation of DNA fragments was achieved by running the gels 
at 60 to 120 Volts for the appropriate time depending on the size of DNA to be separated 
and the concentration of the agarose gel. 
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2.2.1.12 Isolation of DNA from agarose gels 
 
DNA fragments that had been separated by standard agarose gel electrophoresis where 
extracted  and  cleaned  up  using  the  QIAquick  Gel  Extraction  kit  (Qiagen,  Hilden) 
according to manufacturers instructions. 
 
 
2.2.1.13 Polymerase chain reaction (PCR) 
 
A  standard  polymerase  chain  reaction  (PCR)  allows  for  the  selective  amplification  of 
specific  DNA  regions.  To  amplify  specific  DNA  regions  from  mouse  genomic  DNA  for 
reporter gene assays the TripleMaster PCR mix (Eppendorf AG, Hamburg) was used 
since  it  contains  a  mixture  of  three  different  proteins  (Taq  DNA  polymerase,  3’-5’ 
proofreading enzyme and polymerase enhancing factor) that aid in a high fidelity PCR 
through GC-rich DNA templates. The PCR reaction mix and the PCR program was set up 
as outlined in the manual of the TripleMaster PCR mix.  
 
 
2.2.1.14 Isolation of RNA from eukaryotic cell lines and tissues 
 
Isolation of total RNA was done using the peqGOLD TriFast
TM (Peqlab, Erlangen) and the 
RNeasy Mini Kit (Qiagen, Hilden) according to manufacturers instructions.  
Briefly, for cells lines, the peqGOLD TriFast
TM (Peqlab, Erlangen) solution was used, since 
it allowed storage at –80°C right after harvesting the cells. For each ml TriFast solution 
used, 200 µl chloroform was added to the sample.  The samples are vortexed and then 
phenol chloroform phases are separated by a 45 min centrifugation at 12,000 x g. The top 
aqueous  phase containing the  RNA  was transferred to  new tubes  and  mixed 1:1  with 
100% Ethanol and then purified using the RNeasy mini kit columns. 
For tissue samples, approximately 30 mg of mammary gland tissue was homogenized still 
frozen in  RLT Buffer (Qiagen,  Hilden) containing  ß-Mercaptoethanol (1  ß-ME:100  RLT 
buffer) for 1-2 minute at setting 5 using the Ultra-Turrax T25 basic (IKA Werke, Staufen) 
disperser. The RNA was then purified using the RNeasy mini columns and the RNA was 
eluted  from  the  columns  with  DEPC  treated  water.  The  RNA  was  then  immediately 
reverse transcribed or stored at –80°C. 
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2.2.1.15 Measurement of RNA concentration 
 
The RNA concentration can be determined by measuring the absorbance at 260 nm (A260) 
in  a  spectrophotometer  using  a  quartz  cuvette.  One  unit  of  absorbance  at  260  nm 
wavelength  corresponds  to  40  µg/ml  RNA.  The  total  amount  of  RNA  is  calculated  as 
follows: 
Measured (A260) x dilution factor of sample x 40 = µg RNA / ml 
Alternatively RNA concentration can be measured directly using only 1 µl of sample RNA 
with the NanoDrop® ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington 
USA). 
 
 
2.2.1.16 Reverse transcription of RNA (RT-PCR) 
 
For the first strand cDNA synthesis isolated template RNA was reverse transcribed using 
the Omniscript
® Reverse Transcription kit from Qiagen (Hilden). The reaction set up was 
performed as outlined in the manufacturers instructions. Briefly, to reverse transcribe 2 µg 
of total RNA the following reaction components were mixed in a final volume of 20 µl: 1x 
RT buffer, dNTP mix (final concentration 0.5 mM each dNTP), 200 ng hexamer primer 
pd(N)6  (Amerscham  Pharmacia  Biotech,  Upsala,  Sweden),  20  units  RNase  Inhibitor 
(RNaseOut, Invitrogen, Karlsruhe) and 4 units of Omniscript Reverse Transcriptase. The 
reverse  transcription  reaction  was  incubated  for  1  hour  at  37°C  followed  by  heat 
inactivation of the reverse transcriptase for 5 min at 95°C. In subsequent quantitative real-
time PCR reactions 1-3 µl of this cDNA was then used. 
 
 
2.2.1.17  Quantitative  real-time  PCR  (i-Cycler  MyiQ  Single  Color  Real-time  PCR 
Detection System)  
 
For quantitative real-time PCR the i-Cycler PCR machine from Bio-Rad (München) was 
used for every qPCR reaction, 0.5-3 µl of template (DNA or cDNA) together with 0.5 µl of 
each specific  primer  (10 pmol/µl) and  12,5  µl of ABsolute
TM QPCR  SYBR
®  Green  Mix 
(Abgene, Epsom, UK) were mixed in a final reaction volume of 25 µl. The reactions were 
set up in 96 well ThermoFast
® PCR plates and sealed with optically clear adhesive sheets 
(Abgene, Epsom, UK).  
For  amplification  the  following  PCR  program  was  used:  95°C  for  15  minutes  (activate 
DNA polymerase in the ABsolute
TM QPCR SYBR
® Green Mix), 95°C for 30 seconds, 58°C 
for 30 sec (annealing) and 72°C for 30 sec (elongation) for maximal 45 cycles. Materials and Methods 
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All PCR reactions were performed in triplicates to compensate for experimental errors.  All 
measurements are presented in form of threshold cycle (CT) values as determined by the 
BIO-RAD MyiQ
TM software. 
 
 
2.2.1.18 Analysis of the quantitative Real-Time PCR Data 
 
A) qRT-PCR data analysis for reverse transcript RT-PCR: 
The threshold cycle (CT) data obtained from qRT-PCR on the i-Cycler PCR machine were 
analyzed as described in the ΔCT-Method (Bio-Rad, München). 
The  cycle  threshold  values  obtained  for  the  regulated  gene  of  interest  (GOI)  and  the 
stably  expressed  housekeeping  gene  (HKG)  are  used  to  calculate  their  relative 
expression levels in different samples (example uninduced versus induced samples). 
 
In general relative expression levels is calculated as described below: 
Relative expression = 2 
–(SΔCT-CΔCT) 
 
where: 
ΔCT is the difference in the CT values between the GOI and the HKG as calculated by 
(GOI CT)-(HKG CT). 
SΔCT -CΔCT is the difference between the sample ΔCT and the control ΔCT. 
The control sample (for example a non-induced sample point) acts as a fixed reference 
point and here the relative expression level has been arbitrarily set to 1.  
 
B) Calculations for the relative expression levels of putative STAT5 library target genes: 
To take into account overall experimental variation within the qRT-PCR experiments, each 
individual gene of interest (GOI) was normalized against the geometric average of three 
HKG’s. This was done using the ‘example-calculations’ Excel file provided at the ‘geNorm’ 
web page (http://medgen.ugent.be/~jvdesomp/genorm/). This excel file contains example 
calculations for normalization using more than one reference (HKG) gene. For the results 
presented here the HKG used as references were 18S RNA, YWHAZ and cyclophilinB). 
The  file  was  also  modified  to  accommodate  the  analysis  of  the  4  different  sample 
conditions and the normalized expression levels of the GOI was displayed in a diagram 
after rescaling to the geometric mean on a linear scale. 
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C) qRT-PCR data analysis for ChiP: 
The  threshold  cycle  (CT)  data  obtained  form  the  ChIP  assays  on  the  i-Cycler  PCR 
machine  were  analyzed  by  a  modified  ΔCT-Method  as  described  by  Rascle  and  Lees 
(2003). 
All data is displayed as % of Input DNA that represents the % of DNA occupancy. The 
samples were all run in triplicates and normalized to the Input average. 
 
% Input DNA = 2
∧(CT Input- CT IP) x ratio x 100 
 
Ratio for normalization (ratio): 
 
INPUT ratio = 
(µl of Input DNA used per PCR reaction / µl final volume Input was resuspended in after 
DNA purification) x µl of pre-cleared lysate saved for Input 
 
IP ratio = 
(µl of IP DNA used per PCR reaction / µl final volume IP was resuspended in after DNA 
purification) x µl of pre-cleared lysate used per ChIP IP 
 
INPUT ratio value /IP ratio value = ratio for normalization. 
 
A fold difference of at least 3 fold is considered the minimum to be significant, since less 
than 3 fold difference could be due to a 1 CT shift (Edelstein et al., 2005). 
 
 
2.2.2 Tissue culture methods 
 
 
2.2.2.1 General methods for tissue culture 
 
All cell culture work was performed under sterile laminar flow hoods. The cell lines are 
cultured in an incubator at 37°C with a relative humidity of 95% and a CO2 concentration 
of 5%. Cells are cultured either on cell culture dishes or in flasks. 
For induction of cells with lactogenic hormones the following final concentrations are used: 
 
Prolactin (PRL)  5 µg/ml 
Dexamethasone   0.1 µM 
Insulin  5 µg/ml 
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The mouse mammary epithelial cell line HC11 was grown to confluency in RPMI 1640 
medium  supplemented  with  10%  heat  inactivated  fetal  bovine  serum,  1%  penicillin-
streptomycin  and  5  µg/ml  insulin  (Sigma),  10  ng/ml  EGF  (Sigma).  Before  hormone 
induction  HC11  cells  were  washed  1x  with  PBS  and  kept  in  EGF  free  RPMI  medium 
containing 2% FCS and and 5 µg/ml insulin (Welte et al., 1994). HC11 cells were induced 
with 5 µg/ml PRL (31 U/mg, Sigma), and 0.1 µM dexamethasone (Sigma) or left untreated 
for indicated time points. 
 
 
2.2.2.2 Passaging of cells 
 
Adherent cells are washed one time with PBS (1x) and then incubated with Trypsin/EDTA 
for 5 to 10 minutes at 37°C. Once detached, the cells are suspended in the corresponding 
media containing FCS and seeded out onto dishes at the desired dilution. 
 
 
2.2.2.3 Cryogenic preservation, storage and thawing of mammalian cells 
 
A  near  confluent  dish  of  adherent  cells  is  first  detached  with  trypsin.  The  cells  are 
suspended in 10 ml media and pelleted by cetrifugation (400 x g, 5 min). The supernatant 
is removed  and the cell  pellets is resuspended  in a cryoprotective  medium  (10%  (v/v) 
Dimethylsulfoxide (DMSO), 90% (v/v) FCS) and dispensed at 1 ml aliquots into several 
cryogenic vials. The vials are slowly frozen at -20°C for 24 hours and then transferred into 
a  -80°C  freezer  or  for  permanent  storage  into  the  vapor  phase  (-140°C)  of  a  liquid 
nitrogen freezer. 
The cells are thawed quickly with gentle agitation in a 37°C water bath and immediately 
resuspended in pre-warmed medium to dilute the DMSO.  The cells are pelleted (100 x g, 
5 min) and then resuspended in fresh medium and seeded out in a suitable culture vessel. 
 
 
2.2.2.4 Determination of cell numbers with the COULTER Counter 
 
To  determine  the  concentration  of  cells  in  suspension,  the  cells  get  diluted  1:20  with 
Isotone II and the number of particles is measured with the Coulter counter (Beckman 
Coulter, Krefeld). Only particles between 5-18 µm in size get counted since living cells are 
found in this size fraction.  
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2.2.2.5 Transient transfections of eukaryotic cells with Superfect reagent. 
 
HeLa TA cells were transfected using the Superfect transfection reagent (Qiagen, Hilden) 
according to the manufacturers instructions. 
In the case of hormone stimulation for a reporter gene assay the cells were induced one 
day after transient transfection and cultivated for an additional 16 hours. 
 
 
2.2.3 Molecular Biology techniques 
 
 
2.2.3.1 Cell lysates preparation for reporter gene assays 
 
For  reporter  gene  assays  the  cells  are  cultured  in  12  well  plates.  Adherent  cells  are 
washed 2x with ice-cold PBS (1x) buffer and scraped off the surface of the well. Cells from 
each well are transferred with 1 ml of ice-cold PBS buffer into a 1.5 ml Eppendorf tube 
and centrifuged (1,000 x g, 5 min). Each cell pellet is then lysed with 50 µl of Lysis buffer 
(25 mM Glycylglycin pH 7.8, 8 mM MgSO4, 1 mM EDTA, 1 mM DTT, 15% (v/v) Glycerol, 
1% (v/v) Triton X-100). After 10 minutes incubation on ice, the cell lysates are centrifuged 
(16,000 x g, 10 min). The supernatant is then transferred into new tubes and can be either 
used directly or stored at –20°C until further use. 
 
2.2.3.2 Determination of luciferase and ß-galactosidase activity 
 
To determine the luciferase activity 10 µl of each cell lysate is pipetted into a separate well 
of a white 96-well plate and is analyzed in a Luminometer (MicroLumat LB96 P, EG&G 
Berthold,  Bad  Wilbad)  after  addition  of  50  µl  of  Luciferin  reaction  buffer  (20  mM 
Tricine/NaOH,  pH  7.8,  1.02  mM  [MgCO3]4•Mg[OH]2•H2O,  2.67  mM  MgSO4,  0.1  mM 
EDTA, 33 mM DTT, 270 µM Coenzyme A, 470 µM luciferin, 530 µM ATP). 
The luciferase catalyzes the oxidation of the luciferin substrate in the presence of ATP, 
molecular oxygen and magnesium ions. After the addition of the luciferin the emitted light 
from  this  reaction  is  measured  in  the  luminometer  for  a  total  of  30  seconds  at  a 
wavelength of 562 nm. 
For  the  determination  of  the  ß-galactosidase  activity,  3.3  µl  of  the  corresponding  cell 
lysate and 33.3 µl of ß-galactosidase reaction buffer (1 mM MgCl2, 100 mM Phosphate 
buffer [NaPO4], pH 8.0, 1% (v/v) Galacton (Tropix, Bedford) ) is pipetted into a new white 
96-well plate. The plate is sealed with aluminum foil to protect against light and incubated 
for 45 min under agitation at room temperature (RT). Materials and Methods 
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 The  light  emission  is  measured  in  the  Luminometer  under  the  same  condition  as  the 
luciferase activity after addition of the 50 µl of enhancer solution (200 mM NaOH, 10% 
(v/v) Emerald chemiluminescent amplifier (Tropix, Bedfort). The measured ß-galactosidase 
activity is used to normalize the luciferase activity.  
The  normalized  Luciferase  value  for  a  given  sample  is  obtained  by  multiplying  the 
measured luciferase value with the quotient of the average ß- galactosidase value (sum of 
all ß-gal measurements in that data set) and the measured corresponding ß-galactosidase 
value. At least two independent assays were performed and analyzed. 
 
 
2.2.3.3 Preparation of mammary gland tissue from mice 
 
Balb/c mice were bought from the Charles River Company (Sulzfeld) and maintained at 
the in-house Georg-Speyer-Haus Animal facility. 
Mammary gland tissue was harvested from adult virgin mice (at least 5 weeks old), 10-
18.5 days pregnant mice, 5 days lactating mice and mice that had weaned their pups for 
at least a weak (Involuting).  
In the mouse, the mammary glands form extensive subcutaneous sheets of tissue that 
extend from the cervical to the inguinal regions as five ventrolateral pairs. 
Mammary gland tissues from glands 2, 3, 4 and 5 were isolated from female Balb/c mice 
as described (Ball, 1998; Pullan and Streuli, 1996). The thoracic glands 2 and 3 and the 
inguinal glands 4 and 5 were chosen, since they were most easily removed also from 
virgin mice. Mammary glands were placed on ice immediately after harvesting. 
 
 
2.2.3.4 Standard Chromatin Immunoprecipitation (ChIP) assay 
 
A) ChIP assay using mammary gland tissue: 
ChIP assays using mammary gland tissue were performed in part as described by the 
Farnham lab protocol (section 2.1.10) and as described below. 
Mammary gland tissue was harvested from female Balb/c mice (section 2.2.3.3). 
For mammary gland tissue from virgin mice and mice having undergone involution about 
(10-12  mice)  8-11  gram  tissue  are  required,  while  for  mammary  gland  tissue  from 
pregnant  and  lactating  mice  (1-2  mice)  only  2-3  gram  of  mammary  gland  tissue  are 
required  for  a  ChIP  assay.  The  differences  in  the  number  of  mice  and  amount  of 
mammary gland tissue harvested was adjusted to yield approximately similar size of cell 
pellets after tissue homogenization. Mammary gland tissue from virgin mice provided in 
general the lowest yield in terms of cell pellet volume and dictated the amounts finally Materials and Methods 
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used  in  the  immunoprecipitations  between  the  different  developmental  stages.  After 
harvesting, the mammary gland tissue is chopped into approximately equal thick pieces 
with a scalpel, to ensure comparable formaldehyde cross-linking conditions between the 
different stages. The tissue is transferred to a 50 ml falcon tube and washed two times 
with PBS (1x). Formaldehyde (Merk) is then added to a final concentration of 1% and 
rotated at room temperature for 20 min. The cross-linking reaction is stopped by adding 
glycine to a final concentration of 0.125 M. Rotation of the samples is continued at room 
temperature for 5 min. The samples are then centrifuged at low speed and washed two 
times with ice cold 1x PBS. The tissue is then chopped up with a scalpel into a very fine 
paste.  To  disaggregate  the  tissue  even  further,  small  pea  size  amounts  of  paste  are 
added together with about 1 ml ice cold 1x PBS to a loose fitting dounce homogenizer 2 
cm
3 (B. Braun, Melsungen) and disaggregated. The resulting solution is strained through 
a 40 µm nylon cell strainer (Becton Dickinson Labware) using ice cold 1x PBS.  
The  samples  are  centrifuged  at  low  speed  to  pellet  the  cells  and  to  decant  the 
supernatant. The cell pellets are then washed extensively for at least three times with ice-
cold 1x PBS. If a top reddish layer has formed on the cell pellet it needs to be removed. 
Before proceeding with the lysis, the cell pellets between the different mammary gland 
stages are adjusted to equal size. (About 50 µl of cell pellet volume in a 1.5 ml Eppendorf 
tube can be used for about 7 immunoprecipitations). 
Cell  pellets are then resuspended in  1  or  2  ml  of lysis buffer  (1% (w/v) SDS,  10  mM 
EDTA, 50 mM Tris-HCl pH 8.1, phosphatase Inhibitor cocktails I and II (Sigma), protease 
inhibitor Complete (Roche)). The final volume of the cell lysis buffer is adjusted so that 
there  are  no  cell  clumps.  The  samples  are  incubated  on  ice  for  20  minutes  and  then 
sonicated three times for 15 seconds each with a 3 mm tip using a Branson sonifier W-
250 (Heinemann, Gmünd) at setting 5.  
Supernatants  were  then  recovered  by  centrifugation  at  16,000  x  g  for  10  min  at  4°C. 
Supernatants from different conditions were all diluted equally 3 to 10 times in dilution 
buffer (1% (v/v) Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-HCl pH 8.1) and 
subjected to one round of immunoclearing for 2 hr at 4°C with 2 µg sheared salmon sperm 
DNA, 2.5 µg preimmune serum and 20 µl of protein A-agarose or A/G plus agarose (of 
50% slurry). Fifty microliters of precleared lysate was kept as the input for real-time PCR. 
Equal volumes (1.5 ml) of precleared lysate was used in each immunoprecipitation (IP) 
with the antibodies for every condition. Immunoprecipitation was performed overnight with 
specific antibodies, then 2 µg sheared salmon sperm DNA and 20 µl of protein A or A/G 
agarose (of 50% slurry) were further added for 1-2 hr at 4°C. The immunoprecipitates 
(IPs) were washed sequentially for 5 min each in TSE I (0.1% (w/v) SDS, 1% (v/v) Triton 
X-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.1, 150 mM NaCl), TSE II (0.1% (w/v) SDS, 1% 
(v/v) Triton X-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.1, 500 mM NaCl) and buffer III Materials and Methods 
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(0.25 M LiCl, 1% (v/v) NP-40, 1% (w/v) deoxycholate, 1 mM EDTA, 10 mM Tris-HCl pH 
8.1). Agarose beads precipitated were then washed three times with TE buffer and eluted 
three times with 1% (w/v) SDS, 0.1 M NaHCO3. The IP eluates were pooled and together 
with the input were heated at 65°C overnight to reverse the formaldehyde cross-linking.  
Supernatants were then incubated for 1 hr at 45°C with proteinase K (40 µg each) and 
RNase  (0.8  µg)  and  DNA  was  purified  using  PCR  Spin  columns  (Qiagen).  DNA  from 
immunoprecipitations was resuspended in 100 µl of sterile water and DNA from input was 
resuspended  in  300  µl  of  sterile  water.  Quantitative  real-time  PCR  (qRT-PCR)  was 
performed with 1-3 µl of DNA and performed in triplicates. Immunoprecipitation data were 
normalized to input DNA (2
∧(CT Input- CT IP) x ratio x 100) and amounts of DNA recovered in 
the IPs were expressed as percentage of input DNA, as described in the work of Rascle et 
al. (2003). The ChIP results presented were performed on chromatin from at least two 
independent ChIP experiments with similar trends. 
 
B) ChIP assay using a mammary epithelial cell line: 
ChIP assays for the mammary epithelial cell line HC11 were performed as described in 
Litterst et al. (2003).  Briefly, HC11 cells were grown to high confluency and maintained 
for 2 days in EGF-free RPMI 1640 medium containing 2% (v/v) fetal calf serum and  5 
µg/ml insulin. The cells were stimulated with prolactin (5 µg/ml) and dexamethasone (0.1 
µM) for the different time points indicated and cross-linked with 1% (v/v) formaldehyde 
under  agitation  for  10  minutes  at  room  temperature.  During  this  time  the  plates  were 
gently  agitated on a rocker.  The cross-linking reaction  was stopped by the  addition  of 
glycine to a final concentration of 0.125 M and agitated for an additional 5 minutes. The 
HC11 cells were then rinsed with ice-cold PBS and harvested by scraping them of the 
plate. The cells were collected by centrifugation, washed 1x in PBS and then resuspended 
in  1  ml  of  lysis  Buffer.  The  cell  lysis  and  subsequent  steps  in  the  ChIP  assay  were 
performed as described above in section A. About one 10 cm
2 culture dish of confluent 
HC11  cells  (approximately  13  million  cells)  was  used  for  about  three 
immunoprecipitations. 
 
 
 
 
 
 
 
 
 Materials and Methods 
  42 
2.2.3.5 Construction of a library containing STAT5A-binding targets using the ChIP 
method 
 
The  strategy  was  to  create  a  library  containing  putative  STAT5A-binding  targets 
immunoprecipitated in ChIP assay from mammary gland tissue (Fig. 2.1). 
The standard ChIP protocol was performed using a STAT5A antibody to capture STAT5A 
associated chromatin, followed by an adaptation of the ChIP cloning protocol from Peggy 
Farnham’s Lab, to create a library with these captured DNA fragments. Using an antibody 
against  STAT5A  a  standard  ChIP  assay  was  performed  on  chromatin  obtained  from 
mammary gland tissue of a 5 day lactating mouse. A standard quantitative RT-PCR was 
performed using the IgG and STAT5A generated immunoprecipitations (IPs) with primers 
corresponding to the known positive control to verify that the ChIP assay was successful 
before  proceeding  further.  The  positive  control  ß-casein  promoter  primes  should  show 
clear enrichment for each individual STAT5A IP over IgG.  
Since  immunoprecipitations  from  tissue  yield  very  low  amount  of  DNA  a  total  of  7 
individual  STAT5A  IPs  were  pooled.  In  addition,  to  make  certain  that  enough  DNA  is 
available,  a  ligation-mediated  PCR  technique  (LMPCR)  to  create  an  amplicon  of  the 
pooled STAT5A IP as outlined by protocols from P. Farnham Lab (http:// genomecenter 
.ucdavis.edu/  farnham/  farnham/  protocol.html;  ChIP-CpG  island  microarray  binding 
analysis) was used. With LMPCR chromatin from a STAT5A IPs can be amplified that 
accurately represents the starting DNA population. The LMPCR method involves the blunt 
ending of the immunoprecipitated chromatin, ligation of a unidirectional double-stranded 
oligonucleotide linker and finally PCR amplification of the resultant DNA population. The 
linker-ligated chromatin from the  STAT5A IP  was then PCR  amplified one time for 15 
cycles (as described in Oberley M. and P. Farnham lab protocol; section II, Generating 
Chromatin Amplicons; day 1 and day 2: steps 4 to 7). The cloning of the STAT5 chromatin 
library  into  the  pCR  2.1  vector  was  done  as  described  in  the  TA  Cloning  Kit  from 
Invitrogen.  From the  30  µl STAT5A amplicon (18 ng/µl) 1  µl  was  used for the ligation 
reaction with the pCR 2.1 vector. 2 µl of the ligation reaction was then used to transform 
competent TOP10F’ E. coli cells. 90 µl of the total 300 µl of transformed cells was plated 
out on LB plates containing X-Gal/IPTG. This allows for a blue/white screening for the 
selection  of  white  colonies  that  contain  vectors  with  inserts.  The  left  over  210  µl  of 
transformed  cells  were  stored  at  –80°C  in  15%  (v/v)  glycerol.  Therefore  the  STAT5A 
library presented here represents a sub-fraction of the total STAT5A library. All possible 
white colonies (containing inserts) were picked from the plates and plasmid mini preps 
were  made  to  isolated  the  plasmid  DNA.  The  restriction  analysis  was  performed  with 
EcoRI and subjected to an agarose gel electrophoresis run to determine insert fragment 
size.  Clones  containing  inserts  around  500  bp  and  larger  were  sequenced  using  M13 Materials and Methods 
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Reverse primer. Larger fragments were chosen, since they are less likely to contain non-
specific DNA according to the advice in the lab cloning protocol of P. Farnham.  
 
 
 
 
 
 
Figure 2.1 Schematic diagram of the workflow used for the cloning ChIP procedure.  
For  both  the  standard  and  cloning  procedure  the  initial  ChIP  assay  steps  are  similar.  The 
mammary gland tissue is harvested from a female mouse and cross-linked using formaldehyde. 
This step cross-links any protein-protein and protein-DNA interactions. Sonication then shears and 
solubilizes  the  chromatin.  Immunoprecipitation  with  an  antibody  against  STAT5A  allows  for  the 
capture of DNA that was associated with the antibodies target. The formaldehyde cross-linking is 
reversed and the DNA purified. A quantitative RT-PCR with primers that amplify a known STAT5A 
target (such as ß-casein promoter) completes the standard ChIP. To create a library containing 
novel  DNA  fragments  associated  with  the  factor  of  interest  the  ChIP  cloning  procedure  was 
followed. The purified DNA was LMPCR amplified and then cloned into the plasmid vector pCR 
2.1,  which  allows  for  a  blue/white  screening.  The  screening  allows  for  the  selection  of  white 
colonies containing inserts. Select clones containing inserts were then sequenced. 
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3. Results 
 
 
3.1  Factor  recruitment  and  changes  in  histone  modifications  at  the 
endogenous  ß-casein  and  WAP  gene  regions  during  mammary  gland 
differentiation  
 
The  purpose  of  the  mammary  glands  is  to  nourish  young  with  milk  and  undergoes 
repeated cycles of growth, differentiation and regression with each pregnancy. Since 
the main events of differentiation in the mammary gland take place during the adult 
stages of pregnancy and lactation, the mammary gland is used as a model to study 
differentiation in adult mammals. Differentiation in the mammary gland is characterized 
by the activation of milk proteins such as ß-casein and whey acidic protein (WAP) in 
the  mammary  epithelial  cells.  The  differentiation-specific  expression  of  these  genes 
requires the ordered interaction of different hormone-regulated transcription factors, the 
recruitment of co-factors, histone modifications and the remodeling of chromatin in the 
promoter region. In tissue this complex interplay has not yet been investigated well, 
therefore it is important to look at this process in mammary gland tissue at different 
developmental stages. 
The hormone prolactin (PRL) is essential for the growth and functional differentiation of 
mammary gland tissue and for the transcriptional activation of milk proteins (Topper 
and  Freeman,  1980).  The  transcription  factor  STAT5  mediates  the  PRL  induced 
expression of the milk proteins. When both STAT5A and STAT5B are absent, neither 
ß-casein nor WAP are expressed (Miyoshi et al., 2001). In the absence of STAT5A 
alone, the expression of the milk proteins is already severely reduced (Liu et al., 1997). 
Later studies, using conditional STAT5  mutant mice, have further substantiated that 
STAT5 is intimately involved in the regulation of mammary epithelial cell proliferation, 
differentiation and survival (Cui et al., 2004).  
 
The  aim  of  this  study  was  to  investigate  factor  recruitment  and  changes  in  histone 
modifications  that  associate  to  the  endogenous  chromatin  of  two  milk  proteins  (ß-
casein  and  WAP) during  different stages of  mammary  gland  differentiation.  For this 
purpose the Chromatin immunoprecipitation (ChIP) assay has been chosen, since this 
method  can  be  used  to  evaluate  the  in  vivo  presence  of  proteins  that  occur  on 
endogenous target chromatin. Mammary gland tissue from female Balb/c mice in the 
following  four  development  stages:  adult  virgin  (V),  pregnant  (P),  lactation  (L)  and 
involution (I) were examined.  Results 
  45 
First the  expression of the two target  genes to  be studied  was verified. In order to 
quantify the abundance of ß-casein and WAP mRNA in mammary gland during the four 
different developmental stages quantitative real-time PCR (qRT-PCR) was performed. 
Total  RNA isolated from  mammary  gland tissue was reverse transcribed into cDNA 
using  hexamer  primers.  The  ß-casein  and  WAP-cDNA  was  then  amplified  with 
sequence specific primers in triplicate qRT-PCR reactions. The levels of ß-casein and 
WAP mRNA were normalized to the abundance of 18S ribosomal RNA.  
A clear induction for both the ß-casein mRNA and WAP mRNA was detected during 
pregnancy (Fig. 3.1A and B).  During lactation the analysis revealed an even stronger 
expression level compared to pregnancy for both ß-casein and WAP. In comparison, 
nearly no expression for both genes could be detected in tissue from adult virgin mice, 
which was similar to involution, where only minimal levels were detected for ß-casein.  
These results confirm the differentiation-specific regulated expression of the two milk 
protein genes during pregnancy and lactation. These genes are therefore suitable for 
the analysis of histone modification during mammary gland differentiation. 
 
Figure  3.1  Confirmation  of  ß-casein  and  WAP  mRNA  expression  in  mammary  gland 
tissue. 
RNA samples were prepared from mammary gland tissue of Balb/c mice during different stages 
of mammary gland development (virgin (V), pregnancy (P), lactation (L) and involution (I)).  The 
expression levels of ß-casein (A) and WAP (B) transcripts relative to 18S ribosomal RNA were 
determined by quantitative real-time PCR. 
 
In  order  to  determine  transcription  factor  binding  and  the  distribution  of  histone 
modifications multiple primer sets covering specific regions across the ß-casein and 
WAP  genes  were  designed.  These  primers  were  used  in  qRT-PCR  to  analyze  the 
immunoprecipitated  (IP)  DNA  of  the  ChIP  assays.  For  the  ß-casein  gene  multiple 
primers  sets  were  designed  spanning  the  region  possessing  a  predicted  enhancer 
region (-6kb) (Kabotyanski et al., 2006; Rijnkels et al., 2003), the 5’ region (–3.5kb), the 
promoter  region  with  two  STAT  recognition  sites  (-0,1kb),  the  transcribed  region 
(transcribed) (+1,7kb), and the 3’ region (+7.2kb) (Fig. 3.2A). For the WAP gene the 
primer were used to cover the 5’ region (-3,0kb), the promoter region possessing the 
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STAT  recognition  site  (-0,5kb),  the  transcribed  region  (+1,2kb),  and  the  3’  region 
(+4,2kb) (Fig. 3.3A). These primers allow for the analysis of transcription factor binding 
to different regions of the genes (e.g. promoter  and transcribed region), but also to 
scan  for  changes  in  the  distribution  of  histone  modifications  in  the  far  up-  (e.g. 
enhancer) and downstream regions of these genes.  
 
 
3.1.1 Both STAT5a and STAT5b bind to the enhancer and promoters of the ß-
casein and WAP gene in mammary gland tissue 
 
To  investigate  direct  STAT5  DNA  binding  in  vivo,  ChIP  assays  were  performed  in 
tissue  from  mice  at  different  stages  of  mouse  mammary  gland  development.  The 
phenotype of conventional STAT5a-knockout mice demonstrated that STAT5a is the 
main  mediator  of  mammary  gland  development  (Liu  et  al.,  1997)  ChIP  was  also 
performed for STAT5B, since both phosphorylation activated STAT5A and STAT5B are 
able to bind the same DNA binding motifs, the gamma-interferon activation site (GAS). 
Latent  STAT5A  and  STAT5B  proteins  are  found  in  the  mammary  tissue  of  virgin, 
pregnant, lactating and involuting mice at comparable levels, but in the phosphorylation 
activated state, the highest levels of both STAT5s is observed during pregnancy and 
throughout  lactation  (Liu  et  al.,  1996).  In  addition,  early  in  vitro  experiments  using 
electrophoretic  mobility  shift  assays  (EMSA)  had  demonstrated  that  during  lactation 
both STATA and STATB display DNA-binding activity as hetero- and homodimers (Liu 
et al., 1996). Therefore, antibodies specific for either STAT5A or STAT5B were used to 
immunoprecipitate cross-linked chromatin. Purified genomic DNA was then subjected 
to qRT-PCR  with primers amplifying the  different regions  of the  ß-casein and  WAP 
genes  described  above  (Fig.  3.2A,  Fig.  3.3A).  Both  STAT5A  and  STAT5B  were 
recruited to the STAT5 binding sites of the endogenous ß-casein and WAP promoter 
regions in lactating and in pregnant mouse mammary gland tissue (Fig. 3.2B and C, 
Fig. 3.3B and C). In addition, binding of both STAT5A and STAT5B was detected at the 
distal enhancer of the ß-casein (-6kb) in pregnant and lactating mice. In comparison, 
no binding of either STAT5A or STAT5B was observed at the 5´, transcribed region or 
3´  region  of  the  ß-casein  or  the  WAP  gene.  Interestingly,  analysis  of  the  ß-casein 
upstream sequence predict a classical STAT5 binding at -3525 to -3507 nucleotide 5´ 
from the transcription start site (TSS) of the ß-casein gene, which is covered by the 5’ 
primers.  However,  no  binding  to  this  region  could  be  detected  in  ChIP.  This  may 
suggest that this STAT5 site is not accessible to STAT binding or that the antibodies 
used failed to recognize STAT5 due to epitope masking. These data suggests that in 
mammary  gland  tissue  both  STAT5A  and  STAT5B  are  recruited  to  the  STAT5 Results 
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recognition  elements  in  the  promoters  of  the  endogenous  ß-casein  and  WAP  gene 
during pregnancy and lactation. 
 
 
Figure  3.2  Recruitment  of  the  transcription  factors  STAT5A,  STAT5B  and  RNA 
polymerase II to the endogenous ß-casein gene in mammary gland tissue. 
A. Schematic structure of the murine ß-casein gene. 
Square boxes represent  two  STAT binding sites,  together with their positions relative to  the 
transcription initiation site (black +1 arrow). The relative locations of the primers covering the 
enhancer, 5’, promoter, transcribed and 3’ regions of the gene used in evaluating transcription 
factor recruitment and histone modifications are depicted by black arrows. 
B,C and D. Mammary gland tissues were harvested from virgin (V), pregnant (P), lactating (L) 
and  involuting  (I)  mice  and  analyzed  by  ChIP  with  antibodies  specific  against  STAT5A 
(STAT5A),  STAT5B  (STAT5B),  phosphorylated  CTD  RNA  polymerase  II  (RNA  pol  II)  and 
unrelated IgG antibody (IgG). Antibody co-precipitated DNA samples were analyzed by real-
time PCR with primers amplifying the different regions of the ß-casein gene depicted in A. The 
immunoprecipitation  data  were  normalized  to  input  DNA  and  amounts  of  DNA  recovered 
expressed as a percentage of input DNA. 
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Figure  3.3  Recruitment  of  the  transcription  factors  STAT5A,  STAT5B  and  RNA 
polymerase II to the endogenous WAP promoter in mammary gland tissue. 
A. Schematic structure of the murine WAP gene. 
The  square  box  represents  one  STAT  binding  site  relative  to  the  transcription  initiation  site 
(black +1 arrow). The relative locations of the primers covering the, 5’, promoter, transcribed 
and  3’  regions  of  the  gene  used  in  evaluating  transcription  factor  recruitment  and  histone 
modifications are depicted by black arrows. 
B,C and D. Mammary gland tissues were harvested from virgin (V), pregnant (P), lactating (L) 
and  involuting  (I)  mice  and  analyzed  by  ChIP  with  antibodies  specific  against  STAT5A 
(STAT5A),  STAT5B  (STAT5B),  phosphorylated  CTD  RNA  polymerase  II  (RNA  pol  II)  and 
unrelated IgG antibody (IgG). Antibody co-precipitated DNA samples were analyzed by real-
time PCR with primers amplifying the different regions of the WAP gene depicted in A. The 
immunoprecipitation  data  were  normalized  to  input  DNA  and  amounts  of  DNA  recovered 
expressed as a percentage of input DNA. 
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3.1.2  RNA  polymerase  II  is  recruited  to  the  promoter,  transcribed  region  and 
3´region of the ß-casein and WAP genes during pregnancy and lactation 
 
In Eukaryotes, transcription of protein-coding genes is performed by RNA polymerase 
II.  Being  the  major  component  of  the  basic  transcription  machinery,  its  presence 
indicates transcriptional activity. 
To examine if the RNA polymerase II is recruited to the milk protein genes ChIP assays 
were  performed  using  an  antibody  specific  against  the  phosphorylated  C-terminal 
domain  (p-CTD)  of  RNA  polymerase  II.  The  p-CTD  form  of  RNA  polymerase  II  is 
considered to be a transcriptional active form of RNA polymerase II. The results from 
the ChIP assays show that p-CTD RNA polymerase II is associated most strongly with 
the STAT5 binding sites containing promoter region and the transcribed region of both 
the ß-casein and the WAP genes in pregnant and lactating mammary gland tissue (Fig. 
3.2D and 3.3D). This is in agreement with the confirmed expression of ß-casein and 
WAP  in  mammary  gland  tissue  at  these  differentiation  stages  (Fig.  3.1).  The  RNA 
polymerase II is  also found to be associated, although to a  lesser extent, at the 3’ 
region of both the ß-casein and WAP genes in the mammary gland from pregnant and 
lactating mice (Fig. 3.2D and 3.3D). In comparison to the other regions, no such strong 
recruitment of the p-CTD RNA polymerase II to the distal enhancer region of ß-casein 
was  detected.  These  results  show  co-localization  of  the  transcriptional  active  RNA 
polymerase  II  to  the  endogenous  ß-casein  and  WAP  genes,  during  pregnancy  and 
lactation when these two genes are expressed. 
 
 
3.1.3  Distribution  of  histone  modifications  during  different  mammary  gland 
stages 
 
The  N-terminal  tails  of  histones  H3  and  H4  can  be  modified  by  various  post-
translational modifications such as acetylation and methylation (Fischle et al., 2003). 
The specific histone modifications can be spread over large stretches of chromatin or 
be  found  concentrated  at  specific  regions  of  genes.  Specific  N-terminal  tail  histone 
modifications  have  been  associated  with  actively  transcribed  euchromatin  or  silent 
heterochromatin. To determine what histone modifications occur on the ß-casein and 
WAP  genes  in  the  various  mammary  gland  stages,  antibodies  specific  for  modified 
histone  N-terminal tails  were used in  ChIP assay together  with  multiple  primer sets 
covering the various regions.  
 
 Results 
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3.1.4  Increased  histone  acetylation  at  the  ß-casein  and  WAP  genes  during 
pregnancy and lactation 
 
Antibodies  specific  for  acetylated  histone  H3  (Ac-H3)  showed  an  increase  of 
acetylation at the promoter and transcribed region of the ß-casein gene in pregnant 
mice (Fig. 3.4B). Maximal acetylation levels were observed in mammary gland tissue 
from  lactating  mice.  At  this  differentiation  stage,  enhanced  acetylation  was  also 
observed  on  the  enhancer  and  the  5´region  of  the  ß-casein  gene.  The  increased 
histone acetylation indicates a more open chromatin structure that is associated with 
transcriptional active chromatin. In comparison to the other regions the lowest levels of 
histone H3 acetylation was found at the 3’ region of the ß-casein gene. Interestingly, a 
slight increase in histone H3 acetylation was still observed on the transcribed region of 
the ß-casein gene during involution, when the expression of this gene has subsided, 
suggesting a possibly still open chromatin structure. For WAP, there was an increase 
of  histone  H3  acetylation  (Ac-H3)  during  lactation  at  the  5’,  promoter  and  the 
transcribed region (Fig. 3.5B). Antibodies specific for acetylated histone  H4 (Ac-H4) 
showed a pronounced aceylation of this core histone during lactation at the 5´region of 
both the  ß-casein and  WAP gene (Fig. 3.4C  and 3.5C). An increase of  histone  H4 
acetylation could also be detected in tissue from pregnant and lactating mice at the 
(enhancer for ß-casein), 5’, promoter, and transcribed region of both genes (Fig. 3.4C 
and 3.5C). Interestingly, levels of histone H4 (Ac-H4) acetylation during lactation are 
more enriched at the 5’ regions of both genes. 
In tissue from pregnant and lactating  mice there is  a clear increased acetylation  of 
histones  H3  and  H4  indicating  a  more  open  chromatin  structure  at  the  regions 
investigated. This enhanced acetylation of these core histones correlates nicely with 
the transcriptional activity of both the ß-casein and WAP genes during pregnancy and 
lactation.  
The observed enrichment pattern of acetylated histone H4 (Ac-H4), especially at the 5’ 
regions  of  both  ß-casein  and  WAP  was  reconfirmed  with  another  antibody  specific 
against  Tetra-acetylated  histone  H4  (data  not  shown).  This  antibody  against  tetra-
acetylated histone H4 recognizes the N-terminal tail of Histone H4 that is acetylated 
specifically at lysines (K) 5, 8, 12 and 16. Therefore the individual lysines of Histone H4 
were further investigated to see if any differences in the pattern and distribution could 
be detected. 
 
 
 Results 
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Figure 3.4 Distribution of histone lysine (K) acetylation across the endogenous ß-casein 
gene in mammary gland tissue. 
(A) Schematic representation of the ß-casein gene.  
The relative locations of the primers used in evaluating the histone modifications in different 
regions of the ß-casein gene are depicted by black arrows.  
(B)  Mammary  gland  tissues  were  harvested  from  virgin  (V),  pregnant  (P),  lactating  (L)  and 
involuting (I) mice and analyzed by ChIP with antibodies specific for acetylated histone H3 (Ac-
H3), acetylated histone H4 (Ac-H4), acetylated lysine 8 of histone H4 (Ac(K8)H4), acetylated 
lysine  12  of  histone  H4  (Ac(K12)H4),  acetylated  lysine  16  of  histone  H4  (Ac(K16)H4)  and 
unrelated IgG antibody (IgG). Antibody co-precipitated DNA samples were analyzed by real-
time PCR with primers amplifying the regions of the ß-casein gene depicted in (A). 
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Figure  3.5  Distribution  of  histone  lysine  (K)  acetylation  across  the  endogenous  WAP 
gene in mammary gland tissue. 
(A) Schematic representation of the ß-casein gene. The relative locations of the primers used in 
evaluating the histone modifications in different regions of the ß-casein gene are depicted by 
black arrows.  
(B)  Mammary  gland  tissues  were  harvested  from  virgin  (V),  pregnant  (P),  lactating  (L)  and 
involuting (I) mice and analyzed by ChIP with antibodies specific for acetylated histone H3 (Ac-
H3), acetylated histone H4 (Ac-H4), acetylated lysine 8 of histone H4 (Ac(K8)H4), acetylated 
lysine  12  of  histone  H4  (Ac(K12)H4),  acetylated  lysine  16  of  histone  H4  (Ac(K16)H4)  and 
unrelated IgG antibody (IgG). Antibody co-precipitated DNA samples were analyzed by real-
time PCR with primers amplifying the regions of the WAP gene depicted in (A). 
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3.1.5 Local histone acetylation of specific lysine residues occurs on the ß-casein 
and WAP genes during mammary gland differentiation 
 
To determine individual lysines that are acetylated on the N-terminal tails of histone 
H4, antibodies specific against acetylated lysine 8 histone H4 (Ac(K8)H4), acetylated 
lysine 12 histone  H4 (Ac(K12)H4) and  acetylated lysine 16 histone  H4 (Ac(K16)H4) 
were used in ChIP (Fig. 3.4D, E, F and 3.5D, E, F). The pattern of individual acetylated 
lysines  on  histone  H4  partly  mirror  the  pattern  observed  for  the  general  acetylated 
histone H4 (Ac-H4), with a more pronounced enrichment of acetylated lysine 8 and 12 
found specifically during lactation at the 5´ region of both the ß-casein and the WAP 
gene (Fig. 3.4 and 3.5). In comparison, the least enrichment for this modification was 
observed in the enhancer and 3’ region of the ß-casein gene. This indicates that there 
is a localized acetylation of histone H4 lysines at the 5´ region of both the ß-casein and 
the WAP gene in mammary gland tissue from lactating mice. 
In the ChIP assay using the antibody specific to histone H4 acetylated on lysine 16, 
there was a preferential enrichment found in the mammary gland tissue from pregnant 
and  lactating  mice (Fig. 3.4F  and 3.5F).  To  note, is that there is  already a  general 
higher background level of lysine 16 acetylation observed with this antibody in tissue 
from virgin mice and mice having undergone involution. When taking into account that 
in quantitative RT-PCR a  minimum of a 3 fold enrichment is required to consider  a 
result  significantly  enriched  (Edelstein  et  al.,  2005),  this  modification  appears  only 
enriched at the 5’ region during lactation. 
Overall,  the  general  enrichment  of  histone  H3  and  histone  H4  acetylation  in  the 
upstream  and  transcribed  region,  together  with  the  specific  histone  H4  lysine 
acetylation  at  the  5´  region  of  both  ß-casein  and  WAP,  indicate  a  open  chromatin 
structure that is associated with transcriptional active chromatin during pregnancy and 
lactation.  
 
 
3.1.6  Changes  in  histone  methylation  at  the  ß-casein  and  WAP  genes  during 
mammary gland differentiation 
 
In addition to acetylation, methylation of specific lysine residues on the N-terminal tail 
of histones has a strong correlation with transcriptional active or inactive chromatin. 
The  histone  H3  N-terminal  tail  can  be  methylated  on  various  lysine  residues.  The 
methylation  of  lysine  4  (K4)  of  histone  H3  has  been  associated  with  transcriptional 
permissive and active genes.  Specifically, di-methylation of (K4) histone H3 is found in Results 
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both active and inactive euchromatic genes whereas tri-methylation is found on active 
euchromatic genes (Santos-Rosa et al., 2002).  
In contrast, methylation of lysine 9 or 27 (K9 or K27) of histone H3 or lysine 20 (K20) of 
histone  H4  have  been  associated  with  transcriptional  repressed  genes  (Martin  and 
Zhang, 2005; Lachner et al., 2003; Nishioka et al., 2002; Rice and Allis, 2001). 
In order to determine what role histone methylation plays in the regulation of the ß-
casein  and  WAP  genes  during  mammary  gland  differentiation,  antibodies  against 
specific  methylated  histone  tails  residues  were  used  in  ChIP  assays.  Antibodies 
specific for di-methylated histone H3 (2M(K4)H3) show an increase of di-methylated 
(K4) histone  H3 in tissue from pregnant and lactating  mice at the  enhancer (for  ß-
casein), 5’, promoter, transcribed region and 3’ region of the ß-casein gene (Fig. 3.6B). 
Similar results were obtained for the WAP gene (Fig. 3.7B). However, the observed di-
methylated (K4) H3 was less elevated during pregnancy and lactation at the 3’ region 
when  compared  to  the  other  regions  of  the  WAP  gene  (Fig.  3.7B).  In  addition,  the 
levels of di-methylated (K4) H3 during involution decrease again for WAP, while levels 
often  remain  elevated  in  the  promoter  and  transcribed  region  of  ß-casein  gene 
(compare Fig. 3.6B and 3.7B). This was observed in four independent ChIP assays. 
Assuming that the ß-casein gene is silent at a transcriptional level during involution, 
this indicates that the di-methyl (K4) H3 mark may persist for considerable time after 
transcription  has  subsided.  The  di-methyl  (K4)  H3  mark  has  been  described  as  a 
modification that may act as a post-activation signal that serves to mark chromatin as 
having recently been transcriptionally active (Kouskouti and Talianidis, 2005).  
 
 
3.1.7 The presence of tri-methylated (K4) histone H3 correlates with the active 
transcriptional state of ß-casein and WAP gene during pregnancy and lactation 
 
Antibodies specific for tri-methylated histone H3 (3M(K4)H3) showed enrichment of tri-
methylated (K4) histone H3 in tissue from pregnant and in lactating mice for both the ß-
casein and WAP genes (Fig. 3.6C and 3.7C). The enrichment of tri-methylated (K4) 
histone  H3  was  observed  in  the  transcribed  region  of  both  the  ß-casein  and  WAP 
genes  and often, but not always in the promoter region  of the  ß-casein gene.  This 
mark, associated with active euchromatic genes, correlates well with the active state of 
the ß-casein and the WAP gene in mammary gland tissue from pregnant and lactating 
mice. 
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Figure 3.6 Distribution of histone H3 lysine methylation across the endogenous ß-casein 
gene in mammary gland tissue. 
(A) Schematic representation of the ß-casein gene. The relative locations of the primers used in 
evaluating the histone modifications in different regions of the ß-casein gene are depicted by 
black arrows.  
(B)  Mammary  gland  tissues  were  harvested  from  virgin  (V),  pregnant  (P),  lactating  (L)  and 
involuting (I) mice and analyzed by ChIP with antibodies specific for di-methylated (K4) histone 
H3 (2M(K4) H3), tri-methylated (K4) histone H3 (3M(K4) H3), tri-methylated (K27) histone H3 
(3M(K27)  H3),  unmodified  N-terminal  histone  H3  (H3)  and  unrelated  IgG  antibody  (IgG). 
Antibody co-precipitated DNA samples were analyzed by real-time PCR with primers amplifying 
the regions of the ß-casein gene depicted in (A). 
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Figure  3.7  Distribution  of  histone  H3  lysine  methylation  across  the  endogenous  WAP 
gene in mammary gland tissue. 
(A) Schematic representation of the WAP gene. The relative locations of the primers used in 
evaluating the histone modifications in different regions of the WAP gene are depicted by black 
arrows.  
(B)  Mammary  gland  tissues  were  harvested  from  virgin  (V),  pregnant  (P),  lactating  (L)  and 
involuting (I) mice and analyzed by ChIP with antibodies specific for di-methylated (K4) histone 
H3 (2M(K4) H3), tri-methylated (K4) histone H3 (3M(K4) H3), tri-methylated (K27) histone H3 
(3M(K27)  H3),  unmodified  N-terminal  histone  H3  (H3)  and  unrelated  IgG  antibody  (IgG). 
Antibody co-precipitated DNA samples were analyzed by real-time PCR with primers amplifying 
the regions of the WAP gene depicted in (A). 
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3.1.8 Tri-methylated lysine 27 of histone H3 is associated with the ß-casein and 
the WAP gene in mammary gland tissue 
 
Apart  from  the  histone  methylation  of  lysines  that  correlates  with  chromatin  that  is 
transcriptional  active,  there  are  three  histone  modifications,  namely  methylation  of 
lysine 9 and 27 of histone H3 and methylated lysine 20 of histone H4, that have been 
described to be associated with transcriptional repressed chromatin. 
To  examine  if  histone  modifications  that  correlates  with  transcriptional  repressed 
chromatin, may also be associated with the target genes in a differentiation specific 
manner, ChIP assays were performed with antibodies specific to tri-methylated (K9)H3 
or  tri-methylated  (K20)H4.  The  results  did  not  show  significant  enrichment  of  tri-
methylated (K9)H3 or tri-methylated (K20)H4 at either genes in the different stages of 
mammary gland tissue investigated (data not shown). A faint enrichment was observed 
in ChIP assays using an polyclonal antibody recognizing di-methylated (K9)H3 at the 
ß-casein promoter (data not shown). It is therefore possible that some di-methylation of 
lysine 9 on histone H3 is present. In comparison the ChIP analysis performed with the 
antibody against tri-methylated (K27) H3 show significant enrichment over control IgG 
(Fig. 3.6D and 3.7D). This modification could be detected at all stages of mammary 
gland differentiation in both ß-casein and WAP genes and it was not restricted to a 
specific region. Slightly elevated levels of tri-methylated lysine 27 on histone H3 were 
found in tissue from virgin and involuting mice mainly in the transcribed region of ß-
casein  in  two  independent  ChIP  assays.  This  may  correlate  with  the  expected 
transcriptional silence of the two milk proteins in mammary gland tissue from virgin and 
involuting mice. 
 
 
3.1.9 Histone H3 abundance 
 
To gain information on the general abundance of histone H3 in the different regions 
investigated,  a  ChIP  analysis  was  performed  using  an  antibody  against  the  core 
histone H3. ChIP assays performed with this antibody gave only low background levels 
close to the control IgG (Fig 3.6E and 3.7E). Since this antibody detects the unmodified 
N-terminal tail of Histone H3, these results imply that in the regions investigated the 
majority of histone  H3  N-terminal tails  might be modified  and therefore  may  not  be 
recognized by this antibody. Additional, ChIP assays were performed with an antibody 
recognizing the C-terminal domain of histone H3. Contrary to the above antibody, the 
results  gained  with  this  antibody  showed  an  enrichment  in  tissue  from  lactating  or 
some times pregnant mice (data not shown). When following the general notion that Results 
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within transcribed genes there is a displacement or loss of histones (Morillon et al., 
2006), these results are contrary to what was expected. It is not clear either of these 
results reflect the actual abundance of histone H3 in the mammary gland at the regions 
investigated.  If  the  latter  antibody  possibly  recognizes  a  specific  variant  of  the  C-
terminal  domain  of  histone  H3  that  is  prevalent  during  lactation,  the  data  may  not 
reflect the actual abundance of histone H3. 
 
 
3.1.10  Histone  modifications  and  transcription  factor  binding  at  STAT5 
responsive genes in mammary epithelial cell lines 
 
To ensure that the histone modifications observed in the mammary gland tissue arise 
from chromatin modifications of epithelial cells and are not partly due to other cell types 
found in the tissue, histone modifications were analyzed in a pure mammary epithelial 
cell  line.  The  HC11  cell  line  can  be  used  as  a  model  system  to  study  mammary 
epithelial cell differentiation in vitro (Ball et al., 1988). Confluent grown HC11 cells can 
be differentiated by removal of EGF and addition of the lactogenic hormones prolactin, 
insulin  and  glucocorticoids  leading  to  the  expression  ß-casein  (Welte  et  al.,  1994). 
Because ß-casein transcription has been shown to be dependent on the synergistic 
action  of  both  STAT5  and  the  glucocorticoid  receptor  (Wyszomierski  et  al.,  1999; 
Lechner  et  al.,  1997;  Stoecklin  et  al.,  1997;  Doppler  et  al.,  1989),  a  three  day 
pretreatment of HC11 cells with the glucocorticoid hormone analog, dexamethasone 
was performed. The capability of the mammary epithelial cell line HC11 to express ß-
casein in response to lactogenic hormone stimulation after a three day dexamethasone 
pretreatment was verified by using real-time PCR. 
The values were normalized to the abundance of 18S ribosomal RNA. As a control the 
expression of another  STAT5 target gene namely SOCS3,  which  act as a  negative 
feed back regulator of STAT5 was monitored as well (Tonko-Geymayer et al., 2002).  
Induction  of  the  ß-casein  mRNA  was  first  detected  0.5  hour  after  stimulation  with 
lactogenic  hormones.  A  gradual  rise  in  the  induction  of  ß-casein  mRNA  could  be 
observed over the next 4 hours of lactogenic hormone treatment (Fig. 3.8A left panel). 
In  contrast  to  ß-casein,  the  SOCS3  induction  is  transient  in  HC11  cells,  with  high 
mRNA levels reached already after 0.5 hours of induction (Fig. 3.8A, right panel). This 
is in accordance to what has been described in others studies (Tonko-Geymayer et al., 
2002). 
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Figure 3.8 Confirmation  of ß-casein and  SOCS3  mRNA expression and recruitment of 
STAT5 to the target gene promoters in mammary epithelial cells . 
(A) RNA samples were prepared from HC11 cells that were pretreated with dexamethasone for 
3  days  and  then  induced  with  lactogenic  hormones  PRL  (5  µg/ml),  insulin  (5  µg/ml)  and 
dexamethasone (0,1 µM) for the different hour (h) time points indicated. The expression levels 
of ß-casein and SOCS3 transcripts relative to 18S ribosomal RNA were determined by real-time 
PCR. 
(B) Schematic structure of the murine ß-casein and SOCS3 promoter. Square boxes represent 
two STAT binding sites, together with their bp positions relative to the transcription initiation site 
(black +1 arrow). The relative locations of the primers covering the STAT5 recognition elements 
are marked by black arrows. 
(C) After 3 day dexamethasone pretreatment HC11 cells were treated with lactogenic hormones 
PRL  (5  µg/ml),  insulin  (5  µg/ml)  and  dexamethasone  (0,1  µM)  for  the  different  time  points 
indicated. Cells were harvested and analyzed by ChIP with an antibody specific for STAT5A 
and unrelated IgG (IgG).   Antibody-coprecipitated DNA samples  were analyzed by real-time 
PCR  with  primers  flanking  the  region  of  the  STAT5  recognition  elements  of  the  specified 
promoters depicted in (B). 
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Next the binding of STAT5A to the endogenous ß-casein and the SOCS3 promoter 
was  analyzed.  For  ChIP  analysis  primers  were  used  that  flank  the  two  STAT5 
response elements in the ß-casein and SOCS3 promoter (Fig. 3.8B).  
ChIP assays were performed with differentiation competent HC11 cells pre-treated with 
dexamethasone for 3 days and then stimulated with lactogenic hormones over various 
time points. No significant binding of STAT5A to the ß-casein promoter at any time 
point  of  induction  was  observed,  although  STAT5A  was  found  to  be  inducible  and 
specifically bound to the endogenous SOCS3 promoter (Fig. 3.8C). This data indicates, 
that  the  ß-casein  promoter  in  the  mammary  epithelial  cell  line  HC11  might  not  be 
accessible for STAT5 binding and even induction of differentiation by the lactogenic 
hormones  may  not  be  efficient  enough  to  open  the  chromatin  structure.  This  is  in 
contrast to the results observed for the SOCS3 promoter, where activation of STAT5 
by prolactin induction is sufficient to recruit STAT5A to the promoter.  
 
 
3.1.11 Tri-methylated lysine 27 of histone H3 is also associated with the ß-casein 
gene promoter in the mammary epithelial cell line HC11 
 
To determine if the tri-methylation of lysine 27 on histone H3 observed in the mammary 
gland tissue is part of the repressed chromatin state of the ß-casein promoter in the 
HC11  mammary  epithelial  cell  line,  ChIP  analysis  was  performed  with  the  antibody 
against 3M(K27)H3. ChIP assays were performed with differentiation competent HC11 
cells stimulated with lactogenic hormones over prolonged time points. For this assay 
the three day dexamethasone pretreatment was omitted, since it has been described to 
have a slight repressive effect on SOCS3 mRNA expression (Tonko-Geymayer et al., 
2002). A significant association of 3M(K27) histone H3 could be observed on the ß-
casein promoter of the HC11 cells (Fig. 3.9A, left panel). No significant change in the 
level of lysine 27 tri-methylation was detected on the ß-casein promoter region even 
after prolonged induction of up to 68 hours with lactogenic hormones. In comparison to 
the  ß-casein  promoter  only  an  insignificant  association  of  histone  H3  tri-methylated 
lysine 27 to the SOCS3 promoter was observed at all time points of induction (Fig. 
3.9A, right panel). The high levels of histone H3 lysine 27 tri-methylation found at the 
ß-casein  promoter  indicates  that  there  are  a  significant  number  of  HC11  cells  that 
display this histone mark. This is the same mark that has also been observed in the 
mammary  gland  tissue  and  is  considered  a  mark  to  be  associated  with  repressed 
chromatin (Fig. 3.6D). In comparison, the SOCS3 promoter was not found to be in a 
repressed state considering the levels of tri-methylated (K27) histone H3.  
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Figure  3.9  Histone  acetylation,  methylation  and  recruitment  of  STAT5  and  RNA 
polymerase to the ß-casein and SOCS3 promoters in mammary epithelial cells.  
HC11  cells  were  treated  with  lactogenic  hormones  PRL  (5  µg/ml),  insulin  (5  µg/ml)  and 
dexamethasone (0,1 µM) for the different hour time points indicated. Cells were harvested and 
analyzed  by  ChIP  with  antibodies  specific  for  tri-methylated  lysine  27  of  histone  H3 
(3M(K27)H3),  STAT5A  and  STAT5B,  phosphorylated  CTD  RNA  polymerase  II  (RNA  pol  II), 
acetylated  histone  H3  (Ac-H3)  and  H4  (Ac-H4),  di-methylated  lysine  4  of  histone  H3 
(2M(K4)H3),  tri-methylated  lysine  4  of  histone  H3  (3M(K4)H3),  and  unrelated  IgG  (IgG).  
Antibody-coprecipitated DNA samples were analyzed by real-time PCR with primers flanking 
the region of the STAT5 recognition elements of the specified promoters. 
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3.1.12  Both  STAT5A  and  STAT5B  are  recruited  to  the  SOCS3  promoter  of 
differentiation competent HC11 cells  
 
To  determine  if  not  only  STAT5A,  but  also  STAT5B  can  be  recruited  to  the 
endogenous  ß-casein  and  SOCS3  promoters,  antibodies  specific  for  STAT5A  and 
STAT5B were used in the ChIP.  
Both STAT5A and STAT5B were found to be inducible and specifically bound to the 
endogenous SOCS3 promoter in response to prolactin and dexamethasone treatment 
in HC11 cells (Fig. 3.9B, right panel). In comparison, no significant recruitment of either 
STAT5A or STAT5B was observed for the STAT5 RE of the ß-casein distal enhancer 
(data not shown) and promoter  (Fig.  3.9B, left  panel).  This  remained so  even  after 
lactogenic hormone treatment for up to 68 hours by which time ß-casein is detected by 
RT-PCR (data not shown). These results are in accordance with the former data (Fig. 
3.8C).  
 
 
3.1.13  RNA  polymerase  II  and  histone  modifications  are  found  at  the  SOCS3 
promoter, but not at the ß-casein promoter 
 
Additional, ChIP assays were performed to clarify if RNA polymerase II or any histone 
modifications that are commonly associated with transcriptional active genes could be 
detected at the ß-casein or SOCS3 promoter. ChIP assays performed with the p-CTD 
RNA polymerase II antibody showed association of RNA polymerase II to the SOCS3 
promoter  during  all  time  points,  while  no  recruitment  of  RNA  polymerase  II  was 
observed on the ß-casein promoter (Fig. 3.9C). To note, is that a significant level of p-
CTD  RNA  polymerase  II  is  already  associated  with  the  SOCS3  promoter  in 
unstimulated  cells  (Fig.  3.9C,  left  panel).  This  suggests  that  RNA  polymerse  II  has 
already been recruited to the SOCS3 promoter independent of prolactin induction and 
that the SOCS3 gene may already be transcriptional active at a basal level (Fig. 3.9C).  
ChIP  assays  performed  with  anti-acetylated  Histone  H3  antibody  showed  elevated 
levels  of  acetylated  histone  H3  at  the  SOCS3  promoter  during  all  time  points  of 
induction, yet no significant levels of acetylated histone H3 were observed on the ß-
casein promoter (Fig. 3.9C).  While for acetylated H4 the levels remained overall low 
(Fig.  3.9C).  Since  increased  histone  acetylation  is  associated  with  open  and 
transcriptional active chromatin, the elevated histone H3 acetylation suggests an open 
chromatin structure for the SOCS3 promoter.  
ChIP analysis with 2M(K4)H3 and 3M(K4)H3 antibodies show enrichment of 2M(K4)H3 
and  3M(K4)H3  at  the  SOCS3  promoter  during  all  time  points,  while  hardly  any Results 
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significant  levels  of  these  histone  modifications  were  observed  on  the  ß-casein 
promoter (Fig. 3.9D). The 3M(K4)H3 methylation found in active euchromatic genes 
correlates  well  with  the  transcriptional  active  SOCS3  gene,  while  for  ß-casein  this 
histone modification was not observed at any significant elevated levels.  
Overall, recruitment of the transcription factor STAT5 and the histone modifications that 
correlate with transcriptional active genes could be observed at the SOCS3 promoter, 
but at a comparative level not at the ß-casein promoter in HC11 cells stimulated with 
lactogenic hormones.  
 
 
3.2 Identification of novel STAT5A-binding sites in mammary gland tissue 
from a lactating mouse using ChIP 
 
The goal of this part of the study was to use mammary gland tissue from a lactating 
mouse to identify new differentiation specific STAT5 targets. Mammary epithelial cell 
differentiation has come to full terms during lactation. STAT5 is expressed during all 
stages  of  mammary  gland  development  and  is  found  at  high  levels  in  active 
phosphorylated form during early lactation (day 5) in mammary gland tissue (Liu et al., 
1996). During this time the two milk proteins and STAT5 target genes ß-casein and 
WAP,  which  are  considered  markers  for  mammary  epithelial  cell  differentiation,  are 
expressed.  Differentiation  of  mammary  gland  is  regulated  by  transcription  factor 
STAT5,  as  knockout  mice  show  defects  in  the  development  of  epithelial  mammary 
cells.  It  has  been  demonstrated  that  STAT5  is  essential  for  the  proliferation, 
differentiation  and  survival  of  mammary  epithelium  during  pregnancy  and  lactation 
using  transgenic  mice  in  which  the  STAT5  gene  could  be  conditionally  inactivated 
during  different  stages  of  mammary  gland  development  (Cui  et  al.,  2004).  Thus, 
lactating mammary gland tissue is a good model system to identify new differentiation 
specific STAT5 targets. 
 
 
3.2.1  Verification  of  STAT5A  binding  to  known  differentiation  specific  STAT5 
target genes 
 
STAT5 binding sites are known and defined in the ß-casein and WAP genes (Li and 
Rosen,  1994;  Happ  and  Groner,  1993).  The  TTC(N3)GAA)  consensus  sequence  is 
characterized as a STAT5 binding site (Soldaini et al., 2000). In order to determine that 
the approach to identifying differentiation specific STAT5 targets is valid, the binding of 
both STAT5A and STAT5B to the ß-casein and WAP promoters had to be confirmed. Results 
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Primers were designed to amplify the STAT5 regulatory regions and used in a ChIP 
assay. Mammary gland tissue was taken from the 4 different developmental stages of 
the  mammary  gland,  namely  from  virgin,  pregnant,  lactating  and  involution  Balb/c 
mouse tissue. The tissue was cross-linked with formaldehyde and the chromatin was 
harvested.  This  was  followed  by  an  immunoprecipitation  using  antibodies  specific 
against STAT5A and STAT5B. As a nonspecific control polyclonal rabbit IgG was used. 
Both STAT5A and STAT5B bind to the ß-casein and WAP promoters during pregnancy 
and lactation, but not in mammary gland tissue from virgin and involuting mice (Fig. 
3.10A and B).  
 
Figure 3.10 Recruitment of STAT5A and STAT5B to the novel STAT5 targets in mammary 
gland tissue.  
Mammary gland tissue was harvested from virgin (V), pregnant (P), lactating (L) and involuting 
(I) mice and analyzed by ChIP with antibodies specific for STAT5A and STAT5B and unrelated 
IgG antibody (IgG).  Antibody co-precipitated DNA samples were  analyzed by real-time  PCR 
with  primers amplifying  the regions flanking  the STAT5-binding sites of  the  two  milk protein 
promoters (ß-casein and WAP) and the novel STAT5 motif-containing clones (c153, c194, c236, 
c831). The quantitative real-time  PCR was performed in triplicates.  The immunoprecipitation 
data was normalized to input DNA and amounts of DNA recovered expressed as a percentage 
of  input  DNA.  The  data  depicted  are  representative  of  the  trend  observed  in  at  least  two 
independent ChIP assays. 
 
No  ß-casein  or  WAP  promoter  was  detected  when  the  non-specific  rabbit  IgG  was 
used  for  immunoprecipitation,  showing  that  the  immunoprecipitation  is  specific  for 
E F
0,0
0,1
0,2
0,3
0,4
0,5
V P L I
%
 
I
N
P
U
T
 
D
N
A c194
STAT5A
IgG
STAT5B
0,0
0,1
0,2
0,3
0,4
0,5
V P L I
%
 
I
N
P
U
T
 
D
N
A c236
STAT5A
IgG
STAT5B
0,0
0,1
0,2
0,3
0,4
0,5
V P L I
%
 
I
N
P
U
T
 
D
N
A
c831
STAT5A
IgG
STAT5B
0,0
0,1
0,2
0,3
0,4
0,5
V P L I
%
 
I
N
P
U
T
 
D
N
A c153
STAT5A
IgG
STAT5B
C D
0,0
0,2
0,4
0,6
0,8
1,0
1,2
V P L I
%
 
I
N
P
U
T
 
D
N
A ß-casein promoter
STAT5A
IgG
STAT5B
0,0
0,2
0,4
0,6
0,8
1,0
1,2
V P L I
%
 
I
N
P
U
T
 
D
N
A
WAP promoter
STAT5A
IgG
STAT5B
A BResults 
  65 
STAT5A and STAT5B. More importantly, this shows that STAT5A and STAT5B bind 
the promoters specifically during the  developmental stages that are associated  with 
mammary epithelial cell differentiation. Therefore, it should be feasible to isolate new 
differentiation  specific  STAT5  targets  using  mammary  gland  tissue  from  a  lactating 
mouse. 
 
 
3.2.2  Approach  used  for  ChIP  based  cloning  and  the  identification  of  novel 
STAT5-binding sites in cloned DNA regions 
 
The  Chromatin  immunoprecipitation  is  the  ideal  method  to  obtain  data  on  the  DNA 
binding activity of transcription factors in vivo. The ChIP method has the potential for 
the isolation of all the DNA regions that are associated with the transcription factor at 
the time of cross-linking. The immunoprecipitatied ChIP products can be ligated into a 
vector, which allows for screening and selection of clones containing appropriate sized 
inserts.  These  inserted  DNA  regions  can  then  be  sequenced  and  their  location 
identified. Therefore, the ChIP assay was used to isolate novel STAT5 binding targets 
from mouse mammary gland tissue of a lactating mouse. A mixture of computational 
and experimental approaches were used to analyze the novel STAT5 motif containing 
sequences  obtained  from  this  STAT5A  library  (Fig.  3.11).  The  genomic  location  of 
these sequences in the mouse genome, as well as the transcription factor (STAT5) 
recognition motifs within these regions were identified using a computational approach. 
The  in  vivo  binding  of  STAT5  to  the  novel  STAT5A  target  sites  was  re-confirmed 
experimentally  by  ChIP.  The  comparative  genomic  analysis,  whereby  the  mouse 
STAT5 containing sequences are aligned to other vertebrate species, provided further 
information  to  the  degree  of  evolutionary  conservation  of  confirmed  STAT5  motif 
containing  sequences.  Additional  experimental  approaches  such  as  reporter  gene 
assays were used to provide insight into the functionality of the confirmed STAT5 sites. 
RNA  transcripts  located  in  proximity  were  also  analyzed  for  potential  differentiation 
specific regulation that parallels STAT5 binding during mammary gland development.  
The analysis for select novel STAT5 motif containing clones from this ChIP created 
STAT5A library are presented in the subsequent sections. 
 
 
 
 Results 
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Figure  3.11  Computational  and  experimental  approaches  used  to  analyze  the  DNA 
sequences of the STAT5A ChIP-enriched library clones. The inserted DNA fragments from 
the  STAT5A  ChIP-enriched  library  clones  are  sequenced.  To  gain  more  information  on  the 
individual clones they are analyzed both by computational and experimental approaches. 
 
 
 
The enriched, STAT5-bound chromatin obtained from mammary gland tissue from a 
lactating mouse was cloned into a bacterial vector to produce a STAT5A chromatin 
library. Bacteria were transformed and blue/white screening performed to select white 
colonies containing plasmids with inserts. 967 white colonies were picked and plasmid 
minipreps were made and restriction digests performed to select only those plasmids 
containing inserts larger than 400 bp. This was done according to the ChIP cloning 
protocol from the Peggy Farnham lab, because clones with larger insert size are less 
likely to contain non-specific DNA. Approximately 350 clones with inserts of more than 
400 bp were sequenced. Any clones that failed in sequencing were not resubmitted. 
As the first cloned insert sequences became available these were aligned against the 
mouse genome using the NCBI BLAST program to determine their location within the 
ChIP cloning
Sequenced inserts
Genome
Computational  Approach:
• Search for the identity and position
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• Identify and locate STAT5 binding motifs
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• Comparative genomics
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clone regions to 12 other vertebrate
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• Validate binding of STAT5A
 to novel STAT5A binding sites 
• Test STAT5 containing elements
in reporter gene assays 
for functionality
• Test annotated RNA transcripts
 in proximity for
 differentiation specific regulation
 during mammary gland developmentResults 
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genome. In addition, the available sequence of each clone was searched manually for 
STAT5 and STAT recognition motifs. STAT5, like other members of the STAT family, 
can bind to the broad consensus sequence TT(N5)AA with the optimal sequence being 
TTC(N3)GAA for STAT5 (Ehret et al., 2001; Soldaini et al., 2000). 
The STAT5, STAT and STAT-like sites were defined as follows; STAT5: TTC(N3)GAA, 
STAT: TT(N5)AA and STAT-like: (TT(N1-2,4,6)AA). Priority was given to those clones 
with one or more classic STAT5 sites and fragments with STAT sites nearest to known 
genes as determined by the NCBI BLAST search. 18 clones were originally selected, 
that contained STAT5 or STAT-like sites identified in the sequenced portions of the 
clones (Table 2). Primers were designed to these STAT5 sites for 11 clones (c76, c90, 
c98, c153, c177, c192, c194, c236, c376, c831 and c878) and for 7 clones with STAT/ 
STAT-like sites (c180, c234, c240, c241, c372, c836 and c854) (Table 2).  
Of these initial 18 clones selected, only 4 (c153, c194, c236 and c831) that contained 
STAT5 sites were successfully immunoprecipitated in ChIP (See next section 3.2.3). 
Since  the  clones  had  been  sequenced  just  with  reverse  primers,  additional  insert 
sequences,  which  might  contain  potential  STAT5  sites  would  have  been  missed. 
Therefore,  once  the  sequencing  of  all  submitted  clones  was  completed  (yielding 
sequences for a final 294 clones) the search for STAT5-binding sites within the cloned 
regions was repeated, but this time extending the region searched an additional 1000 
bp upstream and downstream of the original cloned fragments. This extension of the 
clone  regions  was  done  by  aligning  the  individual  clone  sequences  to  the 
corresponding region found in the mouse genome using an automated BLAST search 
set to a minimum sequence identity of 95% (performed by Dr. Bulashevska from the 
DKFZ,  Heidelberg).  The BLAST  aligned location points in the  mouse genome  were 
extended by 1000 bp upstream and downstream for each individual clone sequence 
alignment. These extended sequence were then extracted, thus created a new data set 
for analysis. This data set containing all the extended regions was searched for STAT5 
binding  sites  using  the  MatInspector  Bioinformatics  software  from  Genomatrix 
(performed by Dr. Bulashevska from the DKFZ, Heidelberg). The STAT5 binding site 
motif  was  stringently  defined  by  TTC(N3)GAA.  Preliminary  analysis  of  the 
Bioinformatics  output from  MatInspector showed that  of the extracted clone regions 
searched approximately 25% had STAT5 binding motifs. Some of these clones could 
be found multiple times at different locations in the genome and were thus excluded 
from further analysis, since they appeared mostly not to be unique and often composed 
of  DNA  with  low  complexity.  Some  of  these  clones  belong  to  repetitive  sequence 
elements  for  example  c863  aligns  to  a  long  interspersed  nuclear  element  (LINE). 
Designing  useful  ChIP  primers  for  these  regions  containing  repetitive  sequences  is 
therefore challenging. Results 
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Table  2  Location  of  select  clones  containing  STAT  and  STAT-like  sequence  motifs 
relative to known genes. 
List displaying the initial 18 clones selected for verification of STAT5 binding by ChIP assay. 
The location of the clones is indicated in relation to the nearest genes as determined by NCBI 
BLAST search within the mouse genome. The sequence of the individual STAT5, STAT and 
STAT-like motifs found for each clone are shown. 
 
 
 
 
 
 Results 
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To  note  is  that  most  of  the  initial  STAT-like  motifs  containing  clones,  found  in  the 
original 18 clone selection list (Table 2) turned up again in this MatInspector based 
STAT5 motif search with additional new STAT5 recognition motifs in the surrounding 
1000 bp. As in the case of c241, which only had STAT-like motifs in the original clone 
sequence, a new STAT5 site was found located approximately 500 bp away from the 
site the original primers amplified. This may explain why it did not enrich significantly in 
the reconfirmation IPs, when taking into account that the average sheared fragment 
size is about 500 bp.  
From the extended data set searched by the MatInspector program for STAT5 binding 
sites, 7 new candidate clones containing STAT5 sites were selected and tested in ChIP 
assays for STAT5 binding. The selection of these additional new clones was based on 
having at least two or more STAT5 motifs preferentially in close proximity to each other 
and  located  near  known  genes  (Table  3,  lists  all  confirmed  clones  including  the 
confirmed clones identified from MatInspector extended data set, c372 and c721 not 
shown).  
 
Table 3 Location of the 9 confirmed clones relative to known genes. 
The STAT5-binding sites were analyzed using the UCSC genome Bioinformatics browser BLAT 
search (http://www.genome.ucsc.edu/cgi-bin/mmBLAT) for the nearest gene. The locations of 
the  clones  in  relation  to  known  genes  or  RNA  transcripts  were  determined  by  using  the 
accompanying EMBL transcript identifications displayed in the browser. 
 
 
 
 
Clone Nearest gene Accession number STAT5 motif location Ensembl transcript ID
c20 24b2/STAC2 AJ608761/ 
NM_146028
about 11,6 kb 5' ENSMUST00000043983
( SH3 and cysteine rich domain 2)
c34 Arhgef3  NM_027871 within Intron 2-3 ENSMUST00000049206
( Rho guanine nucleotide exchange factor (GEF) 3)
c73  Inpp4b  NM_001024617 within last Intron 22-23 ENSMUST00000042529
(Inositol polyphosphate-4-phosphatase, type II) 
c153 Nfib-010, EST Aw106080 Intron 1-2 of EST OTTMUST00000021179 
(Nuclear factor I/B) (vega transcript ID)
c194 Unknown EST BE373654 about 57 kb 3' of EST NA
c236 Unknown clone, EST BC050254/
 BU610001
Intron 1-2 of EST ENSMUST00003833694
EST AK017143 Intron1-2 ENSMUSESTG00003735796
EST AK042126 Intron 3-4 of EST ENSMUSESTG00003735796
c398 Rbm27  AY461716 5' upstream + Intron1-2 ENSMUST00000091920
 (RNA-binding motif protein 27)
c831 Zswim6 AK122528 Intron1-2 (101 kb) ENSMUST00000052377
(Zinc finger, SWIM domain containing 6)
c882 Igsf3  NM_207205 Intron1-2 ENSMUST00000043983
 (Immunoglobulin superfamily, member 3)Results 
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These  clones  had  initially  not  been  identified  as  STAT5  containing  sites,  since  the 
STAT5 sequences are located outside the original sequenced clone fragments. This is 
exemplified  when  comparing  the  nucleotide  positions  of  the  sequenced  clone 
fragments for clones c20, c34, c73, c398 and c882 to the position of the annotated 
STAT5 sites identified in vicinity by MatInspector using the extended sequence dataset 
(Table 4, c372 and c721 not shown).  
Overall, searching the immediate surrounding sequence at the locations of the original 
clone fragments  by Bioinformatic  means, appears to  be an alternative to the costly 
sequencing of the insert sequences from both directions. 
 
Table  4  Nucleotide  and  chromosome  positions  of  the  STAT5-binding  sites  for  the  9 
clones confirmed as STAT5 binding targets.  
The 9 clones and the sequences of the STAT5 binding sites are listed with their nucleotide and 
chromosome positions. The sequences of the listed clones including +/- 1000 bp of surrounding 
sequence  were  searched  for  STAT5-binding  motifs  as  defined  by  TTC(N3)GAA  using  the 
transcription factor binding site search program Matinspector from Genomatrix (Version 6.2, Okt 
2006). A second STAT5 motif, which conforms to the defined STAT5 motif sequence was not 
identified by the Matinspector
TM within clone c236 and is therefore not listed. 
 
 
 
3.2.3 Confirmation of STAT5A and STAT5B binding to novel target sequences 
 
To make sure that the STAT binding sites identified are real STAT5 targets, primers 
that flank these putative binding sites were designed and tested in ChIP assays during 
the different stages of mouse mammary gland development. 
ChIP  assays  were  performed  with  antibodies  against  either  STAT5A  or  STAT5B, 
because STAT5A and STAT5B can bind to the same response elements. A total of 25 
(18 old + 7 new) different clones were analyzed for STAT5 recruitment using ChIP. In 
mouse  mammary gland tissue from lactating  and pregnant  mice, both  STAT5A  and 
STAT5B  were  recruited  to  the  putative  STAT5  binding  sites  of  the  following Results 
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endogenous clone regions: c153, c194, c236, c831 and c20, c34, c73, c398, and c882 
(Fig. 3.10C-F and Fig. 3.12A-E).  
 
 
 
Figure 3.12 Recruitment of STAT5A and STAT5B to the novel STAT5 target sequences in 
mammary gland tissue.  
Mammary gland tissue was harvested from virgin (V), pregnant (P), lactating (L) and involuting 
(I) mice and analyzed by ChIP with antibodies specific for STAT5A and STAT5B and unrelated 
IgG antibody (IgG).  Antibody co-precipitated DNA samples were  analyzed by real-time  PCR 
with primers amplifying the regions flanking the STAT5-binding sites of additional novel STAT5 
motif-containing clones (c20, c34, c73, c398, c882, c372, c721, c878). The real-time PCR was 
performed  in  triplicates.  The  immunoprecipitation  data  was  normalized  to  input  DNA  and 
amounts of DNA recovered expressed as  a percentage of input DNA. The data  depicted is 
representative of the trend observed in at least two independent ChIP assays. 
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In comparison, no STAT5 recruitment was observed during the stage of involution or in 
the mammary gland tissue from virgin mice. The ChIP assay was specific for STAT5A 
and STAT5B, since only very low levels of the clone regions were captured in the IP 
with the non-specific control IgG antibody. These results show that both STAT5A and 
STAT5B can bind 9 novel STAT5 target regions specifically during the mammary gland 
developmental stages of pregnancy and lactation. The recruitment of STAT5B mirrors 
the trend observed for STAT5A. Clone regions like c372, c721 and c878 are example 
of regions that represent borderline cases in terms of STAT5 recruitment (Fig. 3.10F-
H). The overall values of bound DNA (% input DNA) are low in comparison to the other 
clone regions, but specific STAT5 recruitment can still be observed when compared to 
non-specific recruitment of IgG during lactation. These clone regions might represent 
regions that are bound by STAT5 with lower affinity. 
Overall, the results show the isolation of 9 unique/novel STAT5 targets, which recruit 
both STAT5A and STAT5B proteins. This recruitment is seen mainly during pregnancy 
and lactation when mammary epithelial cells undergo proliferation and differentiation. 
Therefore the ChIP assay was used successfully to isolate new differentiation specific 
STAT5 targets from lactating mammary gland mouse tissue. And these independent 
ChIP  assays  show  that  the  DNA  sequences  isolated  represent  true  STAT5  binding 
sites. 
The individual STAT5-binding sites for the 9 clones are listed (Table 3). Most of the 
clones,  except  c153  and  c831  contain  at  least  two  or  more  classic  STAT5  binding 
motifs within 1000 bp from the original cloned fragment. 
To  have a  more controlled environment, where the contribution of individual signals 
can  be  dissected,  ChIP  assays  for  STAT5  recruitment  to  the  novel  STAT  binding 
regions  were  tested  in  the  HC11  cells  line,  which  is  a  representative  model  for 
mammary epithelial cell differentiation. Interestingly, like in the case of ß-casein, none 
of the 9 newly cloned STAT5 target regions showed STAT5 recruitment in confluent 
HC11  cells  induced  with  lactogenic  hormones  over  various  time  points  (Fig.  3.13, 
compare A with C-H and no data shown for c20, c398 and c882). On the other hand, 
the  positive  control  SOCS3  faithfully  showed  STAT5  recruitment  in  the  same  ChIP 
experiments  (Fig.  3.13B).  These  results  show  that  in  HC11  cells  induced  with 
lactogenic hormones, no STAT5 recruitment was observed to the ß-casein or any of 
the novel STAT5-binding regions when compared to the SOCS3 promoter. This might 
indicate that possibly additional signals are required before STAT5 recruitment to these 
sites in this cell line can be observed. 
 
 
 Results 
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Figure 3.13 Recruitment of STAT5A and STAT5B to the novel STAT5 target sequences in 
mammary epithelial cells. 
After  a  3  day  pre-treatment  with  dexamethasone,  confluent  HC11  cells  were  treated  with 
lactogenic hormones prolactin (5 µg/ml), insulin (5 µg/ml) and dexamethasone (0,1 µM) for the 
different time points (hours) indicated. The cells were harvested and analyzed by ChIP with 
antibodies specific for STAT5A and STAT5B and unrelated IgG antibody (IgG). Antibody co-
precipitated DNA samples were analyzed by real-time PCR with primers amplifying the regions 
flanking the STAT5-binding sites. Results for two known STAT5-binding genes (A) ß-casein and 
(B) SOCS3, as well as six novel STAT5 motif-containing clones (C-H) c34, c73, c153, c236, 
c194 and c831 are depicted. The quantitative real-time PRC was performed in triplicates. The 
immunoprecipitation  data  was  normalized  to  input  DNA  and  amounts  of  DNA  recovered 
expressed  as  a  percentage  of  input  DNA.  The  data  depicted  is  representative  of  the  trend 
observed in at least two independent ChIP assays. 
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3.2.4 Investigation into RNA polymerase II recruitment and histone 2M(K4)H3 
modifications at four of the novel STAT5 binding sites 
 
Specific  N-terminal  tail  histone  modifications  have  been  associated  with  actively 
transcribed euchromatin or silent heterochromatin. In general di-methylation of lysine 4 
of histone H3 correlates with a permissive state of euchromatin in which genes can be 
either active or potentially active (Santos-Rosa et al., 2002). To assess if the STAT5-
binding  regions  are  located  in  such  a  euchromatin  environment  and  if  changes 
between the two mammary gland developmental stages (virgin and lactation) can be 
observed,  ChIP  assays  were  performed  with  antibodies  against  di-methyl(K4)H3.  In 
addition, ChIP was performed with an antibody against the phosphorylated C-terminal 
domain of RNA polymerase II, since the RNA polymerase II is the major component of 
the  pre-initiation  complex  and  its  association  with  a  STAT5-binding  region  would 
indicate transcriptional  activity. This analysis  was performed on the first four clones 
c153, c194, c236 and c831 initially identified and verified to recruit STAT5. The results 
for c153 show that there is a strong increase in RNA polymerase II recruitment to the 
region during lactation (Fig. 3.14A). In the virgin tissue there are  elevated levels  of 
2M(K4)H3 already present, which increase 3-fold during lactation (Fig. 3.14.B). These 
results suggest that RNA polymerase II recruitment is differentiation stage specific and 
the elevated presence of 2M(K4)H3 in the virgin tissue indicates that the chromatin of 
this c153 region is permissive to gene transcriptional activity. For clone c194 there is 
only a minimal association of RNA polymerase II compared to IgG and barely a 2-fold 
difference between virgin and lactating tissue (Fig. 3.14C). In comparison to c153 this 
is only a poor association of RNA pol II to this region (Fig. 3.14, compare A and C). 
The situation is similar for the histone modification, only low levels of 2M(K4)H3 are 
detected in comparison and there is barely a 3-fold difference between the virgin and 
the tissue from lactating mice (Fig. 3.14D). These results indicate that c194 contains 
less 2M(K4)H3 and there is less RNA polymerase II recruitment than found for any of 
the other three clone regions. The clone 236  displays already strong recruitment of 
RNA polymerase II in virgin tissue, with a 2-fold increase during lactation (Fig. 3.14E). 
This indicated that RNA polymerase is already associated with the region and the high 
levels of immunoprecipitated 2M(K4)H3 (Fig. 3.14F) suggest that the region is located 
in euchromatin. For c831 the levels remain low and there appears to be hardly any 
difference in RNA polymerase II recruitment between the two stages (Fig. 3.14G). The 
levels of detected 2M(K4)H3 remain high with hardly any variance between the two 
stages (Fig. 3.14H). This indicates that the c831 region is located in a euchromatin 
environment just as the other two STAT5-binding regions c153 and c236.  Results 
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Figure 3.14 Recruitment of RNA polymerase II and 2M(K4)H3 histone modification on four 
STAT5-binding target sequences.  
Mammary gland tissue was harvested from virgin (V) and lactating (L) mice and analyzed by 
ChIP with antibodies specific for phosphorylated CTD of RNA polymerase II (RNA pol II) and di-
methylated  (K4)  histone  H3  (2M(K4)H3)  and  unrelated  IgG  antibody  (IgG).  Antibody  co-
precipitated DNA samples were analyzed by real-time PCR with primers amplifying the regions 
flanking the STAT5-binding sites of the following novel STAT5 motif-containing clones (c153, 
c194,  c236,  c831).  The  quantitative  real-time  PCR  was  performed  in  triplicates.  The 
immunoprecipitation  data  was  normalized  to  input  DNA  and  amounts  of  DNA  recovered 
expressed  as  a  percentage  of  input  DNA.  The  data  depicted  is  representative  of  the  trend 
observed in at least one independent ChIP assays. 
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3.2.5 Comparative sequence analysis of the novel STAT5-binding sites between 
different vertebrate species 
 
Differentiation specific STAT5-binding has been confirmed in mammary gland tissue 
for nine individual clone regions in vivo. To gain more insight into a possible functional 
role  of the STAT5-binding sites, a computational approach in  addition to an in vitro 
functional  assay  was  chosen.  Because  sequences  containing  functionally  important 
regulatory DNA sequences are often conserved during evolution, (Thomas et al., 2003; 
Loots et al., 2000) a multiple sequence alignment of the STAT5-binding site sequences 
was performed, to determine how evolutionary conserved these STAT sites are among 
the genomes of different species. Using the UCSC Genome Bioinformatics browser, 12 
different vertebrates sequences were aligned to the mouse genome sequences. In this 
section the genomic location of the mouse STAT5-binding sites and their homology to 
other species will be described for the following nine clones: c20, c34, c73, c153, c194, 
c236, c398, c831, c882.  
 
 
3.2.5.1 The second STAT5 motif of the c20 clone shows homology between the 
mouse and rat sequence 
 
Within 175 bp from the sequenced c20 clone fragment there are two STAT5-binding 
sites (Table 3 and Fig. 3.15A). Both STAT5 site I (TTCAAGGAA) and STAT5 site II 
(TTCTTAGAA) have the classic STAT5-binding motif TTC(N3)GAA. The two STAT5-
binding sites are separated from each other by 88 bp. For the STAT5 site I none of the 
species that had sequences  aligned retained  a STAT-binding  motif. For the second 
STAT5 site, the same STAT5 motif was found conserved in the rat, but not in the other 
species  that  had  sequences  available  to  be  aligned.  This  indicates  that  there  is 
sequence homology between the two rodents (mouse and rat) at least for the second 
STAT5-binding site. This sequence homology might be linked due to its close proximity 
to  a  highly  conserved  region.  As  seen  in  the  top  histogram,  right  adjacent 
(approximately 15 bp) to the STAT5-binding site II is a region of approximately 24 bp 
with  high  sequence  conservation  between  the  mouse,  rat,  human,  chimp,  rhesus 
monkey, dog and cow (Fig. 3.15A). For this region an alignment was not possible for all 
species. 
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Figure 3.15A The second STAT5 motif of the c20 clone region shows homology between 
the mouse and rat sequence.  
The upper panel shows a histogram of a 160 bp region containing the two STAT5-binding sites 
associated  with  c20  where  increased  conservation  is  displayed  by  increased  height.  The 
nucleotide positions of both the region and STAT5-binding sites are given and are based on the 
UCSC genome browser genomic assembly (Feb 2006, mm8) in mouse Chromosome 11. The 
locations of the STAT5-binding sites within the 160 bp region are indicated by lines converging 
to  a  point.  The  middle  panel  shows  the  individual  mouse  STAT5-binding  motifs  and  their 
nucleotide  locations  as  given  in  the  alignment.  The  lower  panel  shows  the  exact  sequence 
identified  in  the  sequence  alignment  using  a  screen  capture  of  the  UCSC  genome 
Bioinformatics browser, and depicts the evolutionary conservation between the mouse genome 
and 12 other vertebrate species. The STAT5-binding sites are boxed. 
 
 
3.2.5.2 The c34 clone is located within the second intron of the Arhgef3 gene and 
all  three  STAT5  motifs  show  evolutionary  conservation  in  at  least  5  different 
mammals 
 
The three STAT5-binding sites from clone 34 are located in the second intron of the 
Rho  guanine  nucleotide  exchange  factor  (GEF)3  (Arhgef3)  gene  (Ensemble-Exon 
view). The second intron is about 97 kb in size and the STAT5 sites are located in a 
1,475 bp large segment that lies 84,577 bp downstream and 11,150 bp upstream of 
exon 2 and 3, respectively (Fig. 3.15B). For this region no alignment was available for 
the chicken and opossum.  
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Figure 3.15B The c34 clone region is located in the second intron of the Arhgef3 gene 
and has three highly conserved STAT5-binding sites.  
The upper panel depicts the schematic representation of the Arhgef3 gene with the approximate 
locations of the exons (vertical lines) and the introns (horizontal lines) (not drawn to scale). The 
location of the STAT5-binding sites are indicated below. The distance of the STAT5-binding 
sites to the second and third exon is noted below the gene structure. The lower panel shows the 
mouse STAT5-binding sites and their base pair location based on the UCSC genome browser 
genomic assembly (Feb 2006, mm8) in mouse Chromosome 14. The lower panel shows the 
exact sequences identified in  the vertebrate  alignment using a screen capture of the UCSC 
genome browser, and shows the evolutionary conservation between the mouse and 12 other 
vertebrate species. Increased conservation is displayed by increased height in the histogram. 
The STAT5-binding sites are boxed. 
 
 
The  STAT5-binding  site  I  (TTCGGGGAA)  was  exactly  conserved  in  the  3  primates 
(human, chimp and rhesus), the dog, the armadillo and the elephant (Fig. 3.15B) lower 
panel). There is one nucleotide difference between the mouse motif and the rat, cow 
and rabbit sequences, and only in the rabbit does this single nucleotide change still 
conform to the STAT motif (TT(N5)AA).  About 1,034 bp downstream of the STAT5 site 
I  is  the  second  STAT5  site  II  (TTCCAAGAA).  The  STAT5-binding  site  II  is  exactly 
c34 (Arhgef3 gene Intron 2)
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conserved  in  the  5  mammals,  namely  the  rat,  human,  chimp,  rhesus  monkey,  and 
elephant (Fig. 3.15B) lower middle panel). In the rabbit, dog, cow and tenrec there is a 
single nucleotide change in the STAT5 motif and again only the rabbit can retain the 
STAT  motif.  Another  444  bp  downstream  of  STAT5  site  II  is  a  third  STAT5  site 
(TTCTCTGAA).  Here there is 100 % conservation  between the  mouse  and 7 other 
mammals (rat, rabbit, human, chimp, rhesus monkey, dog and cow (Fig. 3.15B) lower 
right panel). Both the tenrec (TTCTCTGAA) and elephant (TTCTCCGAA) also maintain 
a STAT5 motif in their sequences. Due to a 8 bp deletion, right at the 3 prime end of 
the  STAT  motif  in  the  sequence  of  both  the  tenrec  and  elephant,  the  alignment 
program placed an empty space holder when displaying the 8 bp sequence of the other 
species. The subsequent nucleotides in the tenrec and elephant sequence are shown 
right after the star symbol representing the 8 bp deletion. Thus, the STAT5-binding site 
III conforms to the STAT5 motif for 9 different mammals, indicating a high evolutionary 
conservation  within the  mammals investigated for this STAT5 site.  The evolutionary 
conservation  observed  for  all  three  STAT5-binding  sites  in  at  least  5  different 
mammalian species indicates that these STAT5 sites might be important DNA-binding 
elements. 
 
 
3.2.5.3  The c73 clone is located  within  the last intron  of the Inpp4b  gene  and 
three  out  of the five STAT5-binding  sites show  homology  between the  mouse 
and rat sequence 
 
The five STAT5-binding sites from clone c73 are located in the last intron of the Inpp4b 
(inositol polyphosphate-4-phosphatase, type II) gene (Ensemble-Exon view). The last 
intron is approximately 49 kb in size and the STAT5 sites are located in a 956 bp large 
segment that lies 41,939 bp downstream and 6,485 bp upstream of exon 22 and 23, 
respectively (Fig. 3.15C). A comparative sequence alignment for these mouse STAT5 
sites was observed for the rat only. The mouse STAT5-site I (TTCCAGGAA) and V 
(TTCTGTGAA) show no homology to the rat in that the STAT motif was not maintained 
due  to  1-2  nucleotide  changes.  On  the  other  hand,  the  mouse  STAT5  sites  II 
(TTCAAAGAA), III (TTCTGAGAA) and IV (TTCTGTGAA) show exact homology to the 
rat  sequences.  This  suggests  that  there  is  sequence  homology  between  the  two 
rodents (mouse and rat) for these three STAT5 sites. 
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Figure 3.15C The c73 clone region is located in the last intron of the Inpp4b gene and 
contains five STAT5-binding sites of which three show homology to the rat sequence.  
The upper panel depicts the schematic representation of the Inpp4b gene with the approximate 
locations of the exons (vertical lines) and the introns (horizontal lines) (not drawn to scale). The 
locations of the STAT5-binding sites are indicated below. The distance of the STAT5-binding 
sites to exon 22 and the last exon is noted below the gene structure. The lower panel shows the 
five  mouse  STAT5-binding  sites  and  their  base  pair  location  based  on  the  UCSC  genome 
browser genomic assembly (Feb 2006, mm8) in mouse Chromosome 8. The lower panel shows 
the exact sequences identified in the vertebrate alignment using a screen capture of the UCSC 
genome browser, and shows the evolutionary conservation between the mouse and 12 other 
vertebrate species. Increased conservation is displayed by increased height in the histogram. 
The STAT5-binding sites are boxed. 
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3.2.5.4 The 339bp region of c153 clone is evolutionarily conserved and contains 
one STAT5 consensus binding site and 3 STAT-like sites 
 
Within the 743 bp region cloned for c153 there is a 339 bp region that is conserved by 
80% between mouse and human genome. As shown in the histogram most of the 339 
bp region of c153 appears to be well conserved within all the 12 vertebrate species 
except for the chicken for which no alignment was possible (Fig. 3.15D).  
 
 
 
Figure 3.15D The 339 bp region of the c153 clone is highly conserved and contains one 
STAT5 and 3 STAT-binding sites.  
The upper panel shows a histogram of the 743 bp region of c153 where increased conservation 
is displayed by increased height. The genomic location of the c153 region is marked below the 
histogram as well as the 339 bp region of c153 that is highly conserved between species. The 
nucleotide  locations  are  based  on  the  NCBI  reference  NT_039260.6/Mm4_39300_36 
chromosome 4. The location of the various STAT-binding sites, found within the conserved 339 
bp region of c153, is indicated below by lines. The middle panel shows the individual mouse 
STAT-binding sites and their reverse complementary sequences given in the alignment as well 
as their nucleotide locations. The lower panel shows the exact sequence identified in a multiple 
alignment using a screen capture of the UCSC genome browser, and shows the evolutionary 
conservation between the mouse and 12 other vertebrate species. The STAT-binding sites are 
boxed and numbered according to their initial identification in the sequence search. 
 
 
This suggests that the conserved region might be under selective constraint. Within 
this highly conserved region  are  4 putative STAT-binding sites.  The putative STAT-
binding  site  designated  as  STAT5  is  conserved  for  all  mammals  displayed,  and 
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conforms perfectly to the STAT5-binding site motif TTC(N3)GAA. The sequence of the 
motif is the same between the mouse and cow, while in the armadillo and opossum 
there is a slight variation within the central nucleotides of the motif. All other species 
display the same exact sequence for this STAT5 motif as seen in the rat. The high 
evolutionary conservation of the STAT5-binding motif between the different mammalian 
species investigated indicates that this STAT5 site is important. The mouse STAT site 
III (5’-TTCTACAAAACGGCTT-‘3) right adjacent to the STAT5-binding site is comprised 
of  a  head  to  head  STAT-binding  motif  (TT(N5)AA)  in  all  the  mammals  except  the 
primates. About 11 bp upstream of the STAT5-binding site is a STAT-binding site IV 
with  a  TT(N5)AA  motif  that  is  identical  between  the  species,  except  for  the  tenrec. 
Finally there is another STAT-like site II (TTC(N4)GAA) approximately 89 bp upstream 
of the  STAT5-binding site in the  mouse.  Here there are  gap(s) in the available rat, 
tenrec, elephant and cow sequences, while the rabbit and primates exhibit the same 
nucleotide sequence (TTTTAGGGAA) which can be interpreted variably as a TT(N3-
5)GAA  motif.    The  armadillo  matches  with  one  nucleotide  difference  the  primate 
sequence and the dog maintains a TT(N4)GAA while the opossum does not conform to 
the  TT(N3-5)AA  motif.  Overall,  this  site  shows  less  conservation  between  the 
investigated  mammals  than  the  other  STAT-binding  sites.  This  suggests  that  it  is 
evolutionary less conserved and possibly not as important as the other sites.  
 
 
3.2.5.5 The c194 region contains two putative STAT5-binding sites which show 
homology between the mouse and the rat genome 
 
The c194 clone contains two classic STAT5-binding sites and two STAT-like sites (Fig. 
3.15E). Both STAT5 site I (TTCTTGGAA) and STAT5 site II (TTCAAAGAA) have the 
classic STAT5-binding motif TTC(N3)GAA. The STAT5 site I is separated by 8 bp from 
a STAT-like site III (TTGCCTGGAA), which can be interpreted as a TT(N5)GAA motif. 
An alignment was obtained for this mouse sequence solely to that of the rat and only 
the sequence motif of the STAT-like site III was maintained. For the STAT5 site I a 
difference in the first T nucleotide of the rat sequence eliminated the classic STAT5-
binding motif. The second classic STAT5 site was conserved in sequence with the rat, 
but not with any of the primates or the dog sequence. The mouse STAT-like site IV site 
(TTCAAAAGAA) was also not conserved within any of the other species aligned. The 
sequence  conservation  of  the  c194  STAT5  and  STAT-like  binding  sites  was  weak 
between the mouse and rat, pointing to a poor evolutionary conservation of these sites. 
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Figure 3.15E The c194 clone region contains two STAT5 and two STAT-binding sites of 
which two STAT motifs show homology to the rat sequence.  
The genomic location of the 793 bp region of c194 is shown (horizontal line). The location is 
based on the NCBI reference NT_162143.2/Mm3_159849_36 chromosome 3. The positions of 
the various STAT-binding sites within the 793 bp region of c194 are indicated below. The lower 
panel shows the individual mouse STAT-binding sites and their base pair locations. The panel 
shows the exact sequence identified in the vertebrate alignment using a screen capture of the 
UCSC genome browser, and shows the evolutionary conservation of the STAT sites between 
the mouse and 12 other vertebrate species. The STAT-binding sites are boxed and numbered 
according to their initial identification in the sequence search. 
 
3.2.5.6  The  c236  region  contains  two  putative  STAT5-binding  sites  which  are 
conserved between mouse and rat genome 
 
The c236 region contains two STAT5-binding sites that both have the classic STAT5-
binding motif TTC(N3)GAA. As seen in the histogram (Fig. 3.15F) there are multiple 
stretches within the 293 bp c236 region that show a higher conservation than the other 
regions. The two STAT5-binding sites are approximately 104 bp apart, with the STAT5-
binding site II (TTCCAAGAA) being located in a section with higher homology than the 
STAT5 binding site I (AAGGGGCTT). The sequence of the mouse STAT5-binding site 
II is exactly conserved within the rat, rabbit and elephant and also in the cow with the 
exception  of  one  nucleotide  difference  within  the  center  of  the  motif.  The  primates 
retain a  STAT-like  binding  TT(N4)GAA  motif, even though there is a  deletional  gap Results 
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between the two adenines where in the aligned sequences of the other species there 
are found four adenines. The alignment program defined a gap and decided to place 
the  second  A  at  the  fourth  position.  The  sequence  of  the  STAT5-binding  site  I 
(AAGCCCCTT)  is  a  classic  STAT5  TTC(N3)GAA  motif  and  is  exactly  conserved 
between the mouse and the rat.  All 3 primates, the cow and the elephant are more 
variable in the sequence, but still maintain the STAT motif TT(N5)AA. Taken together, 
the STAT5-binding site II has a higher conservation between the species for the classic 
STAT5 TTC(N3)GAA motif, suggesting that this binding site is more relevant for the 
c236 region than the STAT5-binding site I.  
 
 
 
 
Figure 3.15F The c236 clone region contains two STAT5-binding sites that are conserved 
in rodents and retain STAT motif homology in other mammalian species.  
The upper panel shows a histogram of the 293 bp region of c236 where increased conservation 
is displayed by increased height. The genomic location of the c236 region is marked below the 
histogram and is based on the NCBI reference NT_165760.1/Mm5_163274_36 chromosome 5. 
The locations of the two STAT5-binding sites within the 293 bp region of c236 are indicated 
below. The lower panel shows the individual mouse STAT5-binding sites and their base pair 
locations as well as the reverse complementary sequence as given in the alignment. The panel 
shows the exact sequence identified in the sequence alignment using a screen capture of the 
UCSC genome browser, and shows the evolutionary conservation between the mouse and 12 
other vertebrate species. The STAT-binding sites are boxed and numbered according to their 
initial identification in the sequence search. 
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3.2.5.7 The c398 clone is located in the promoter and within the first intron of the 
RBm27  gene  and  one  of  the  three  STAT5-binding  sites  shows  evolutionary 
conservation in 9 different mammals 
 
The first and second STAT5 binding sites are located –370 bp and -197 bp upstream 
from the first exon of the  RNA-binding  motif protein 27 (RBm27) gene, respectively 
(Ensemble-Exon view) (Fig. 3.15G). The third STAT5-binding site III (TTCTTTGAA) is 
located in the first intron of the RBm27 gene (Ensemble-Exon view). The first intron is 
about  12,5  kb  in  size  and  the  STAT5  site  III  is  located  1,075  bp  downstream  and 
11,431 bp upstream of exon 2 (Fig. 3.15G).  
 
 
Figure 3.15G The c398 clone region is located in the 5’ upstream and first intron of the 
RBm27 gene and two out of the three STAT5-binding sites show high homology to other 
mammalian species.  
The upper panel depicts the schematic representation of the RBm27 gene with the approximate 
locations of the exons (vertical lines) and the introns (horizontal lines) (not drawn to scale). The 
location of the STAT5-binding sites is indicated below. The distance of the STAT5-binding sites 
to the first exon and second exon is noted below the gene structure. The lower panel shows the 
three  mouse  STAT5-binding sites and their base pair location based on  the UCSC genome 
browser  genomic  assembly  (Feb  2006,  mm8)  in  mouse  Chromosome  18.  The  lower  panel 
shows the exact sequences identified in the vertebrate alignment using a screen capture of the 
UCSC genome browser, and shows the evolutionary conservation between the mouse and 12 
other  vertebrate  species.  Increased  conservation  is  displayed  by  increased  height  in  the 
histogram. The STAT5-binding sites are boxed. 
c398 (RBm27 gene 5‘ Upstream and Intron1)
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The STAT5-binding site I (TTCCAGGAA) motif is 100% conserved between the mouse 
and the rat, rabbit, rhesus monkey, dog, cow and tenrec (Fig. 3.15G, lower left panel).  
There  is  only  one  nucleotide  difference  between  the  mouse  STAT5  motif  and  the 
human,  chimp  and  opossum  sequences.  In  the  human  and  chimp  sequence 
(TTCCAAGAA)  this  single  nucleotide  change  still  conform  to  the  STAT5  motif 
(TTC(N3)GAA).    But  in  the  opossum  sequence  the  STAT  motif  (TT(N5)AA)  is  not 
maintained. No alignment was available for the chicken, armadillo and elephant. This 
evolutionary conservation, observed for the STAT5-binding sites I in at least 9 different 
mammalian species, indicates that this STAT5 site might be an important DNA-binding 
element  found  in  the  5  prime  upstream  region  –379  bp  from  the  first  exon  of  the 
RBm27 gene. The mouse STAT5-binding site II (TTCACTGAA) motif is also found in a 
region  with  higher  sequence  homology.  With  exception  of  the  rat  though,  all  other 
species aligned did not retain the STAT motif, due to double nucleotide changes in the 
sequence. At least the mouse STAT5 sites II (TTCACTGAA), and III (TTCTTTGAA) 
show  exact  homology  to  the  rat  sequences.  This  indicates  that  there  is  at  least 
sequence  homology  between  the  two  rodents  (mouse  and  rat)  for  all  three  STAT5 
sites. 
 
 
3.2.5.8 The STAT5 binding site from the c831 clone is found within the first intron 
of the Zswim6 gene and is evolutionary conserved in 6 different mammals 
 
The STAT5A binding site from the clone c831 is located within the 101 kb intron of the 
Zinc finger, SWIM domain containing 6 (Zswim6) gene (Ensemble- Exon view) and lies 
62 kb downstream and 38 kb upstream of exon 1 and 2, respectively. No alignment 
was  available  for  the  chicken,  opossum  and  rabbit  and  only  partial  alignment  was 
available for the tenrec.  The STAT5-binding site (TTCATGGAA) was 100% conserved 
between the mouse and the following 6 species: rat, human, chimp, rhesus, dog and 
elephant (Fig. 3.15H). There is only one and two nucleotide difference in the cow and 
armadillo sequence respectively, but these changes still conform to the basic STAT-
binding  site  core  consensus  TT(N5)AA  (Soldaini  et  al.,  2000).  The  evolutionary 
conservation  of  this  STAT5-binding  site  found  in  6  different  mammalian  species 
indicates  that  this  STAT-binding  site  may  be  an  important  DNA-binding  element. 
Interesting  to  note  is  that  the  STAT5  site  is  13  bp  adjacent  to  a  region  of  high 
homology, which may warrant further investigation. 
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Figure 3.15H The c831 clone region is located in the first intron of the Zswim gene and 
contains  a  STAT5-binding  site  which  displays  high  homology  to  other  mammalian 
species.  
The upper panel depicts the schematic representation of the Zswim6 gene with the approximate 
locations of the exons (vertical lines) and the introns (horizontal lines) (not drawn to scale). The 
location of the STAT5-binding site is indicated below. The distance of the STAT5-binding site to 
the first and second exon is noted below the gene structure. The mouse STAT5-binding site and 
its  base  pair  location  are  based  on  the  NCBI  reference  NT_039590.6/Mm3_39630_36 
chromosome  13.  The  lower  panel  shows  the  exact  sequence  identified  in  the  vertebrate 
alignment using a screen capture of the UCSC genome browser, and shows the evolutionary 
conservation between the mouse and 12 other vertebrate species. Increased conservation is 
displayed by increased height in the histogram. The STAT5-binding site is boxed. 
 
 
3.2.5.9 The c882 clone is located within the second intron of the Igsf3 gene and 
the  two  STAT5-binding  sites  show  homology  between  the  mouse  and  rat 
sequence 
 
Two  STAT5-binding  sites  from  clone  882  are  located  in  the  second  intron  of  the 
Immunoglobulin  superfamily,  member  3  (Igsf3)  gene  (Ensemble-Exon  view).  The 
second intron is about 46,7 kb in size and the STAT5 sites are located in a 280 bp 
large segment that lies 30,078 bp downstream and 16,599 bp upstream of exon 2 and 
3,  respectively  (Fig.  3.15I).  No  alignment  was  available  for  the  chicken,  opossum, 
tenrec  and  elephant.  The  STAT5-binding  site  I  (TTCAGAGAA)  motif  was  exactly 
conserved between the mouse and the rat and rabbit (Fig. 3.15I lower left panel). The 
aligned sequences from the other species did not conform to the STAT motif due to Results 
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one or more nucleotide changes in the motif sequences. About 280 bp downstream of 
the STAT5 site I is the second STAT5 site II (TTCTTGGAA). For the second STAT5 
site II the exact same STAT5 motif was found conserved in the rat, but not in any of the 
other species that had sequences available to be aligned (Fig. 3.15I lower right panel). 
Taken together these two STAT5-binding sites show homology for the STAT5 motif at 
least between the two rodents (mouse and rat). 
 
 
 
Figure 3.15I The c882 clone region is located in intron 2 of the Igsf3 gene and contains 
two STAT5-binding sites that show homology to the rat sequence.  
The upper panel depicts the schematic representation of the Igsf3 gene with the approximate 
locations of the exons (vertical lines) and the introns (horizontal lines) (not drawn to scale). The 
locations of the STAT5-binding sites are indicated below. The distance of the STAT5-binding 
sites to the second and third exon is noted below the gene structure. The lower panel shows the 
two  mouse  STAT5-binding  sites  and  their  base  pair  location  based  on  the  UCSC  genome 
browser genomic assembly (Feb 2006, mm8) in mouse Chromosome 3. The lower panel shows 
the exact sequences identified in the vertebrate alignment using a screen capture of the UCSC 
genome browser, and shows the evolutionary conservation between the mouse and 12 other 
vertebrate species. Increased conservation is displayed by increased height in the histogram. 
The STAT5-binding sites are boxed. 
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Overall, no alignment of the 9 clone regions was observed to the chicken sequence, 
which is also a vertebrate but not a mammal. The mouse c153 region aligned to all 
other  11  mammalian  species  tested,  while  other  mouse  clone  regions  such  as  c73 
barely  aligned  to  the  highly  related  rat  sequence.  The  computational  analysis  has 
provided information on the exact positions of the clone regions and their STAT motifs 
within the mouse genome. The comparative genomics approach, has allowed for the 
comparison of the sequences from the mouse clone regions to the genomic sequences 
of other species. This information provides hints as to how much of the sequences are 
in  common  and  possibly  functional  important,  but  does  not  replace  the  need  for 
experimental  verification  of  the  potential  STAT5  regulatory  elements  in  the  clone 
regions. 
 
 
3.2.6 Investigation into the potential function of the novel STAT5-binding sites 
using reporter gene assays 
 
The sequence alignments made between the mouse STAT5-binding site motifs of the 
nine clones and the genomes of different vertebrate species, showed a diverse range 
in sequence homology. Some sites displayed sequence homology only to the rat or no 
homology at all, while other STAT5 motifs had high sequence homologies to different 
mammalian species. STAT5-binding motifs with high homology between species might 
be functionally important DNA-binding elements. Since STAT5 is a transcription factor 
involved in regulating transcriptional activity of target genes, an in vitro reporter gene 
assay was chosen to investigate the functional role of the STAT5-binding sites. The 
first  four  clones  (c153,  c194,  c236  and  c831)  that  had  been  initially  identified  and 
reconfirmed to bind STAT5 in ChIP were chosen for further analysis. For these four 
clones the STAT5-binding site containing regions were inserted into basic luciferase 
reporter gene constructs to determine if the STAT5-binding sites in these regions can 
support STAT5 mediated transcriptional activity. 
 
 
3.2.6.1 The region of c153 confers transcriptional activity that depends on the 
STAT binding sites 
 
To  show  that  the  c153  region  is  functional,  the  743  base  pair  region  of  c153  was 
inserted into the pGL3 basic luciferase reporter gene (Fig. 3.16A).  
 
 Results 
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Figure 3.16 The c153 region is transcriptionally responsive to STAT5. 
(A) Schematic representation of the luciferase reporter construct containing the longer 743 bp 
c153 region.. The nucleotide positions for the genomic location of the c153 region and of the 
STAT-binding  sites  are  indicated  and  based  on  the  NCBI  reference 
NT_039260.6/Mm4_39300_36  chromosome  4.  The  nucleotide  sequence  and  location  in  the 
mouse genome of  the wild  type (wt)  STAT5 and STAT-like binding sites  are indicated.  The 
STAT-binding sites are numbered according to their initial identification in the sequence search. 
(B) HeLa TA cells were transiently transfected in duplicate samples with the 743 bp c153 region 
luciferase reporter construct (c153 L_10) (1.25 µg) together with either an empty control vector 
(pMX) or with increasing amounts of wt STAT5A expression constructs (12.5 ng, 50 ng and 100 
ng). The HeLa TA cells were co-transfected with the prolactin receptor (12.5 ng) and the SV-
40_LacZ  expression  construct  (12.5  ng).  24  hours  after  transient  transfection  half  of  the 
duplicate  samples  were  treated  for  16  hours  with  prolactin  (5  µg/ml)  (dark  bars)  or  left  un-
treated (white bars). After cell lysis, transcriptional activity of the luciferase reporter gene was 
measured and normalized to ß-galactosidase activity. Each luciferase assay was repeated two 
times. 
 
 
Duplicate samples of HeLa TA cells were transiently transfected with the c153 region 
reporter construct, prolactin receptor, SV-40-LacZ and increasing amounts of the wild 
type (wt) STAT5A expression construct. For each sample the corresponding sister well 
was treated with prolactin or left untreated and the luciferase activity was determined 
and normalized to ß-galactosidase. There is only a minimal increase in transcriptional 
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activity seen upon prolactin treatment for the c153 region reporter construct when the 
cells are not co-transfected with exogenous STAT5A (Fig. 3.16B, lanes 1 and 2). This 
almost  negligible  increase  in  luciferase  activity  may  be  due  to  the  endogenous 
STAT5A. Increasing transcriptional activity by the c153 region reporter construct was 
observed  with corresponding increases in the  amounts of exogenous  STAT5A  (Fig. 
3.16B, lanes 4, 6 and 8).  Samples not induced with prolactin remained unchanged at a 
basal level (Fig. 3.16B, lanes 3, 5 and 7). These results indicate that the 743bp c153 
region is transcriptionally responsive to STAT5A in a concentration dependent manner. 
To  prove  if  the  reporter  activity  is  directly  due  to  STAT5A,  dominant  negative  and 
constitutive  active  STAT5A  mutants  were  tested  for  their  effect  on  the  c153  region 
transcriptional activity (Fig. 3.17).  
 
Figure  3.17  Schematic  representation  of  wild  type  and  mutant  STAT5  expression 
constructs.  
The wild type (wt) STAT5A or STAT5B with the major functional domains are displayed; the 
DNA-binding domain (DBD), the SH2 domain (src homology domain), the tyrosine (Y) residue, 
that is phosphorylated during activation and the C-terminal transactivation domain (TAD). In the 
dominant  negative  STAT5A  mutant  the  essential  tyrosine  residue  that  is  important  for  the 
posphorylated dimerization of two STAT proteins is mutated to phenylalanine (F). In the delta 
750 STAT5A mutant the C-terminal transactivation domain is deleted. The constitutive active 
1*6  STAT5A  mutant  has  two  point  mutations,  one  upstream  of  the  DNA-binding  domain 
(histidine (H) 299 to arginine (R)) and one in the C-terminal transactivation domain (serine (S) 
711 to phenylalanine (F)) (Onishi et al., 1998). The same mutations are present in 1*6 STAT5B 
mutant, since the amino acids surrounding the mutations are conserved in both STAT5A and 
STAT5B. 
 
The  c153  region  reporter  construct  was  transfected  into  HeLa  TA  cells  with  the 
different  mutant  STAT5  expression  constructs  (Fig.  3.18B).  Addition  of  the  control 
expression vector pMX  resulted in no change  in transcription activity  when induced 
with  prolactin,  while  addition  of  wt  STAT5A  resulted  in  a  clear  16-fold  induction  of 
luciferase activity (Fig. 3.18B, lanes 2 and 4).  Results 
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Figure 3.18 Effects of STAT5 mutants on the transcriptional activity of the c153 region.  
(A) Schematic representation of the luciferase reporter construct containing the 743 bp c153 
region. The nucleotide positions for the genomic location of the c153 region and of the STAT-
binding sites are indicated and based on the NCBI reference NT_039260.6/Mm4_39300_36 
chromosome 4. The nucleotide sequence and location in the mouse genome of the wild type 
(wt) STAT5 and STAT-like binding sites are indicated. The STAT-binding sites are numbered 
according to their initial identification in the sequence search 
(B) HeLa TA cells were transiently transfected  in duplicate samples with  the wild type c153 
region (c153) (1.25 µg) together with either an empty control vector (pMX) (100 ng) or with one 
of  the  following  STAT5  expression  constructs  (100  ng)  (Fig.  3.8),  wild  type  STAT5A  (wt 
STAT5A),  dominant  negative  STAT5A  (dn  STAT5A),  dominant  negative  delta  750  STAT5A 
(delta 750  STAT5A), constitutively active 1*6 STAT5A (1*6 STAT5A), wild type STAT5B (wt 
STAT5A), or constitutively active 1*6 STAT5B (1*6 STAT5B). The cells were co-transfected with 
the prolactin receptor (12.5 ng) and the SV-40_LacZ expression construct (12.5 ng). 24 hours 
after transient  transfection the cells were either  treated with prolactin (dark  bars) or left un-
treated  (white  bars)  for  16  hours.  After  cell  lysis  the  transcriptional  activity  of  the  luciferase 
reporter gene was measured and normalized to ß-galactosidase activity. Each luciferase assay 
was repeated at least two times. 
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No  luciferase  activity  of  the  c153  region  reporter  construct  could  be  induced  with 
prolactin when either the dominant negative mutant dnSTAT5A or the Δ750 STAT5A 
mutants was co-transfected (Fig. 3.18B, lanes 6 and 8). Since the dnSTAT5A and the 
Δ750 STAT5A mutant is defective in activating transcription, the results suggest that a 
functional STAT5A must be present to get a prolactin induced luciferase activity by the 
c153 region reporter construct. Co-transfection with the constitutive active 1*6 STAT5A 
expression construct resulted in a slightly higher than wt STAT5A luciferase activity 
(compare  lanes  4  and  10).  Contrary  to  the  expectation,  the  constitutive  active  1*6 
STAT5A construct was not able to efficiently induce luciferase activity without prolactin 
induction (lane 9 and 10).  
Previous ChIP experiments showed that STAT5A as well as STAT5B are recruited to 
the c153 region in mammary gland tissue from lactating mice, in vivo. To determine if 
STAT5B could also activate the reporter activity of the c153 region reporter construct, 
HeLa TA cells were transfected either with wt STAT5B or the constitutive active 1*6 
STAT5B  mutant  expression  constructs  together  with  the  c153  region  reporter 
construct.  Co-transfection  with  the  wt  STAT5B  resulted  in  a  5-fold  increase  in 
luciferase  activity  and  a  15-fold  increase  in  luciferase  activity  with  the  constitutive 
active 1*6 STAT5B construct when compared to the prolactin induced response of the 
control  expression  vector  (Fig.  3.18B,  compare  lanes  4,  12  and  14).  These  results 
indicate  that  not  only  STAT5A  but  also  STAT5B  can  mediate  the  prolactin  induced 
luciferase activity of the c153 region.  
Overall, the data suggests that the c153 region is transcriptionally responsive to both 
STAT5A and STAT5B 
 
 
3.2.6.2 The highly conserved 339 bp region of c153 confers reporter activity 
 
Within the 743 bp region of c153 is a highly conserved 339 bp region which has 80% 
homology  to  the  sequence  found  in  the  human  genome  (as  described  in  detail  in 
section 3.2.5.4, Fig. 3.15D). This highly conserved 339 bp region of c153 contains also 
the putative STAT sites. To focus on this evolutionary conserved region without the 
possible interference from other transcription factor binding sites found within the non-
conserved sequence of the 743 bp region, the shorter 339 bp region was sub-cloned 
into the pGL3 basic luciferase reporter construct (Fig. 3.19A). A comparison to the 743 
bp construct showed that the shorter 339 bp conserved region still retains half of the 
luciferase activity observed for the longer construct (Fig. 3.19B, compare lane 4 and 6). 
Nonetheless,  the  shorter  reporter  construct  is  still  clearly  prolactin  inducible  when 
compared to the pGL3 basic backbone construct (lanes 2 and 6).  Results 
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Figure  3.19  The  shorter  339  bp  evolutionary  conserved  region  of  c153  remains 
transcriptionally responsive to STAT5.  
(A) Schematic representation of the luciferase reporter construct containing the longer 743 bp 
c153 region and the evolutionary conserved 339 bp c153 region. The nucleotide positions for 
the genomic location of the c153 region and of the STAT-binding sites are based on the NCBI 
reference NT_039260.6/Mm4_39300_36 chromosome 4. The nucleotide sequence and location 
in the mouse genome of the wild type (wt) STAT5 and STAT-like binding sites are indicated. 
The STAT-binding sites are numbered according to their initial identification in the sequence 
search. 
(B) Duplicate samples of HeLa TA cells were transfected with empty luciferase reporter vector 
(pGL3 basic) (1.25 µg), or the reporter construct containing the long 743 bp c153 region (c153 
(743 bp)) (1.25 µg), or the evolutionary conserved 339 bp c153 region (c153 (339 bp)) (1.25 
µg). HeLa TA cells were co-transfected with wt STAT5A expression construct (100 ng), prolactin 
receptor (12.5 ng)  and  SV-40_LacZ expression construct (12.5 ng). 24 hours after transient 
transfection half of the cells in sister wells were treated for 16 hours with prolactin (5 µg/ml) 
(dark  bars)  or  left  un-treated  (white  bars).  After  cell  lysis  the  transcriptional  activity  of  the 
luciferase  reporter  gene  was  measured  and  normalized  to  ß-galactosidase  activity.  Each 
luciferase assay was repeated at least two times. 
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Because the c153 region is not in the close vicinity of a known gene or its promoter, 
the c153 region could be potentially an enhancer, which might act in an orientation-
independent  way.  Enhancers  are  cis-acting  regulatory  DNA  sequences  capable  of 
increasing  transcription  independent  of  their  distance  or  orientation  from  the  linked 
gene  (Blackwood  and  Kadonaga,  1998).  Therefore  both  orientations  of  the  339  bp 
conserved region were tested in the luciferase assay for reporter activity (Fig. 3.20B). 
Both orientations were able to activate the reporter gene activity, with one orientation is 
more  effective.  The  c153  region  in  reverse  orientation  was  chosen  for  further 
experiments, since the overall luciferase activity was more intense than observed for 
the forward orientation (Fig. 3.20B, lanes 4 and 8) and is in the same orientation within 
the  pGL3  luciferase  reporter  construct  as  the  larger  743  bp  c153  region  reporter 
construct shown in previous experiments. In the genome the c153 region is located 
approximately 62 kb from the 5 prime side of nuclear factor I/B (NFI/B). The reverse 
oriented plasmid harbors the c153 region in correct orientation and upstream position 
to the  reporter gene  as it  would be oriented towards the  NFI/B gene in the  mouse 
genome. 
 
Figure 3.20 Differences in reporter activity were observed depending on the orientation 
of the conserved 339 bp c153 region. 
(A) Schematic representation of the pGL3 basic luciferase (LUC) reporter construct depicting 
the arbitrary forward and reverse orientation of the inserted clone regions.  
(B)  Duplicate  samples  of  HeLa  TA  cells  were  transfected  with  the  pGL3  luciferase  reporter 
construct  containing  either  the  forward  or  reverse  oriented  339  bp  c153  region  (1.25  µg) 
together with either the control empty expression vector or the wild type STAT5A expression 
construct (100 ng). 24 hours after the transient transfection half of the samples were treated 
with prolactin (5 µg/ml)(dark bars) for 16 hours or left untreated (light bars). The transcriptional 
activity  of  the  luciferase  reporter  gene  was  measured  after  cell  lysis  and  normalized  to  ß-
galactosidase activity. The luciferase assay was performed one time. 
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3.2.6.3  The  STAT-binding  sites  of  the  c153  region  are  involved  in  the 
transcriptional activity  
 
To determine if the STAT5 and STAT-like binding site found within the conserved c153 
region are functional, mutations of these sites were performed and tested in luciferase 
assays. The first two nucleotides in the STAT5 site were mutated from wt TT to AA 
(Fig.  3.21A).  Later  these  nucleotides  were  mutated  instead  to  GC  to  remove  any 
influence of an artificial created binding site (Mef2) by the initial AA mutation. There is a 
10-fold increase in luciferase activity of the wt c153 reporter construct over the control 
pGL3 reporter construct when induced with prolactin (Fig. 3.21B, lanes 2 and 4). The 
double AA mutation in the particular STAT5-binding site I (M1) nearly results in a loss 
of half of the luciferase activity (Fig. 3.21B, lanes 4 and 6). This suggests that this 
STAT5-binding  site  found  in  the  c153  conserved  region  confers  part  of  the 
transcriptional activity, since the mutation of this site reduces this activity by half. Since 
half the luciferase activity remains the other putative STAT sites were also mutated. 
Mutation of the designated STAT site II (M2) did not result in a significant change of 
luciferase activity when compared to wt (Fig. 3.21B, compare lane 4 and 8). Mutation 
of both the STAT5 site I and STAT site II (M1+M2), resulted in a reduced luciferase 
activity comparable to the M1 mutant (Fig. 3.21B, compare lane 4, 6 and 10). Taken 
together this result would indicate that in comparison to the STAT5-binding site I, the 
STAT site II is not required for the observed luciferase activity, since its mutation does 
not  reduce  the  activity,  neither  alone  or  in  combination  with  the  STAT5  site  M1 
mutation.  
To find out if the other STAT-like binding sites are also involved in conferring reporter 
activity  to  the  conserved  c153  region  additional  mutations  were  introduced  into  the 
sequences of the remaining STAT-like binding sites III and IV. Additional mutations on 
the  initial  double  mutant  (M1+M2)  of  the  STAT  site  M3  or  M4  result  in  additional 
reduction of the luciferase activity (lanes 11-14). Mutation of all 4 sites (M1-4) together 
results in a significant reduction of luciferase activity in comparison to the wt reporter 
construct (compare lanes  4  and 16).  There is barely  a  2-fold increase  of luciferase 
activity remaining when compared to the pGL3 basic control vector without insert (lane 
2  and  16).  These  results  suggest  that  the  STAT-binding  sites  found  within  the 
conserved  c153  region  confer  transcriptional  activity  and  that  when  all  4  putative 
STAT-binding sites are mutated this reduces the activity significantly. It appears that 
the most important STAT sites are STAT site I, III and IV, while STAT site II seems less 
involved. Results 
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Overall the data suggests that the prolactin induced transcriptional activity observed for 
the c153 region is directly due to STAT5 and depends mostly on the STAT-binding 
sites. 
 
 
Figure  3.21  Mutation  of  the  STAT5  and  STAT-binding  site  within  the  evolutionary 
conserved c153 region reduces the transcriptional activity. 
(A)  Schematic  representation  of  the  luciferase  reporter  construct  containing  the  339  bp  evolutionary 
conserved c153 region. The nucleotide positions for the genomic location of the STAT-binding sites based 
on the NCBI reference NT_039260.6/Mm4_39300_36 chromosome 4 are given.  
The wild type (wt) STAT-binding sites are indicated, as well as the nucleotides mutated in each of the 
various  mutant  (M)  constructs.  The  c153  region  reporter  constructs  with  mutations  in  the  STAT5 
consensus site I (M1), or mutation in the STAT site II (M2) or mutations in both the STAT5 consensus site I 
and  the  STAT  site  II  (M1+M2)  are  depicted.  Subsequent mutations  were  added  to  the  double  mutant 
(M1+M2), creating additional mutations in the STAT site III (M1-M3), mutations in the STAT site IV (M1-
2+M4), or mutations in all four putative STAT sites I, II, III, and IV (M1-4). The STAT-binding sites are 
numbered according to their initial identification in the sequence search. 
(B) Duplicate samples of HeLa TA cells were transfected with empty reporter vector (pGL3 basic) (1.25 
µg), or with the reporter construct containing the wild type 339 bp conserved c153 region (WT) (1.25 µg), 
or the 339 bp conserved c153 region with mutations in one or more of the four putative STAT-binding sites 
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(1.25 µg). The cells were co-transfected with the wt STAT5A expression construct (100 ng), the prolactin 
receptor  (12.5  ng)  and  the  SV-40_LacZ  expression  construct  (12.5  ng).  24  hours  after  transient 
transfection half of the sister wells were either treated with prolactin (5 µg/ml) for 16 hours (dark bars) or 
left un-treated (white bars). The transcriptional activity of the luciferase reporter gene was measured after 
cell lysis and normalized to ß-galactosidase activity. The luciferase assays were performed at least two 
times. 
 
 
 
 
3.2.6.4 The region of c194 displays unreliable reporter gene activity in response 
to exogenous STAT5 
 
The  c194  clone  contains  two  classic  STAT5-binding  sites  and  two  STAT-like  sites 
within  a  stretch  of  about  793  bp  (Fig.  3.15E).  Comparative  sequence  analysis  has 
shown homology to the rat sequence for the two STAT sites, STAT5 site II and STAT 
like site III (Fig. 3.15E). The c194 region is not in the close vicinity of any known mouse 
gene. Because the potential function of the STAT site-containing region is not clear, 
both  orientations  of the  793 bp c194  region  were tested in the luciferase  assay for 
reporter  activity  (Fig.  3.22A).  HeLa  TA  cells  were  transiently  transfected  with  wt 
STAT5A  expression  construct  and  either  orientation  of  the  c194  region  reporter 
construct. The c194 region in reverse orientation displayed a higher luciferase activity 
than observed for the forward orientation (Fig. 3.22B, lane 4 and 8). In addition, both 
orientations were tested in an initial luciferase assay for their response to increasing 
amounts of exogenous STAT5A (data not shown). Here, the forward orientation was 
prolactin inducible, but remained at similar levels of activity regardless of the increase 
in STAT5A concentration and for the reverse c194 region reporter construct the levels 
of  luciferase  activity  varied.  This  hints  that  the  luciferase  activity  of  c194  region  is 
STAT5A responsive, but may not be concentration dependent. Due to the combination 
of low homology found in the STAT-binding sites in regard to other species and the 
unreliable induction of transcriptional activity in response to STAT5A, further analysis 
of this clone has been delayed. 
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Figure 3.22 Differences in reporter activity were observed depending on the orientation 
of the cloned regions for c194 and c236. 
(A) Schematic representation of the pGL3 basic luciferase (LUC) reporter construct depicting 
the arbitrary forward and reverse orientation of the inserted clone regions.  
(B and C) The cloned regions, c194 (793 bp) or alternatively c236 (293 bp) (1.25 µg), oriented 
in either the forward or reverse orientation within the pGL3 reporter constructs, were transfected 
in  HeLa  TA  cells  together  with  either  the  control  empty  expression  vector  or  the  wild  type 
STAT5A expression construct (each 100 ng). 24 hours after the transient transfection half of the 
duplicate samples were treated with prolactin (5 µg/ml)(dark bars) for 16 hours or left untreated 
(light bars). The transcriptional activity of the luciferase reporter gene was measured after cell 
lysis  and  normalized  to  ß-galactosidase  activity.  The  luciferase  assays  were  performed  two 
times. 
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Figure 3.23  The c236 region  is responsive to different concentrations  of  STAT5A  and 
mutants of STAT5 affect its transcriptional activity. 
(A) Schematic of  the pGL3 basic  reporter construct containing the 293 bp c236 region. The indicated 
nucleotide positions for the genomic location of the c236 region and of the two STAT-binding sites are 
based  on  the  NCBI  reference  NT_165760.1/Mn5_163274_36  chromosome  5.  The  two  wild  type  (wt) 
STAT-binding sites are depicted. 
(B) HeLa TA cells were transfected with the c236 (293 bp) region reporter construct (1.25 µg) together with 
either an empty control vector (pMX) or with increasing amounts of the wt STAT5A expression construct 
(12.5  ng,  50  ng  and  100  ng).  HeLa  TA  cells  in  duplicate  samples  were  also  co-transfected  with  the 
prolactin receptor (12.5 ng) and the SV-40_LacZ expression construct (12.5 ng). 24 hours after transient 
transfection the cells were either treated with prolactin (5 µg/ml) (dark bars) or left un-treated (white bars) 
for 16 hours. After cell lysis the transcriptional activity of the luciferase reporter gene was measured and 
normalized to ß-galactosidase activity. Each luciferase assay was repeated two times. 
(C) The c236 region reporter construct (c236) (1.25 µg) together with either an empty control vector (pMX) 
(100ng)  or  with  one  of  the  following  STAT5  expression  constructs  (100ng):  wild  type  STAT5A  (wt 
STAT5A), dominant negative STAT5A (dn STAT5A), constitutively active 1*6 STAT5A (1*6 STAT5A), or 
wild type STAT5B (wt STAT5A) (Fig. 3.8) was transiently transfected into HeLa TA cells as described 
above (B). 
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3.2.6.5 The region of c236 confers transcriptional activity that depends on the 
more conserved STAT5-binding site 
 
To show that the c236 region is functional, the 293 bp fragment was inserted into the 
pGL3  basic  luciferase  reporter  construct  (Fig.  3.23A)  and  was  tested  in  transient 
transfection assays with or without wt STAT5A expression construct. Both orientations 
of the 293 bp conserved c236 region were tested in the luciferase assay for reporter 
activity (Fig. 3.22A and C). The forward orientation showed only a 2-fold increase in 
luciferase  activity  in  response  to  PRL  treatment  (lanes  3  and  4),  while  the  reverse 
orientation  responded  to  PRL  induction  with  a  4-fold  increase  in  luciferase  activity 
(lanes  7  and  8).  The  c236  region  in  reverse  orientation  was  chosen  for  further 
experiments, even though the overall luciferase activity was less intense than for the 
forward  orientation,  because  the  background  luciferase  activity  was  lower  and  the 
results more consistently reproducible (Fig. 3.22C). 
To examine if the c236 region is responsive to different amounts of STAT5, reporter 
activity was tested with increasing concentrations of wt STAT5A expression constructs 
(Fig.  3.22B).  Increasing  amounts  of  exogenous  STAT5A  result  in  a  corresponding 
increase in luciferase activity of the c236 region reporter construct (lanes 2, 4, 6 and 8).  
Samples not induced with prolactin remained unchanged at a basal level (lanes 1, 3, 5 
and  7).  These  results  indicate  that  the  293  bp  fragment  of  the  c236  region  is 
transcriptional responsive to STAT5A in a concentration dependent manner. 
To find out if this reporter activity is due directly to STAT5A, a dominant negative and a 
constitutive  active  STAT5A  mutant  was  tested  for  their  effect  on  the  c236  region 
transcriptional activity. The c236 region reporter construct was transfected into HeLa 
TA cells with the different mutant STAT5 expression constructs (Fig. 3.23C). Addition 
of the control expression vector pMX resulted in no change of the transcription activity 
when induced with prolactin, while addition of wt STAT5A resulted in an increase of 
luciferase  activity  (lanes  1-4).  No  luciferase  activity  of  the  c236  region  reporter 
construct  could  be  induced  with  prolactin  when  the  dominant  negative  dnSTAT5A 
mutant was co-transfected (lanes 5 and 6). Since the dnSTAT5A mutant is defective in 
activating transcription, the results suggest that a functional STAT5A must be present 
to  induce  luciferase  activity  of  the  c236  region  reporter  construct  in  response  to 
prolactin. Co-transfection with the constitutive active 1*6 STAT5A expression construct 
resulted in a higher than wt STAT5A luciferase activity (compare lanes 4 and 8). As 
shown for the other reporter constructs, the constitutive active 1*6 STAT5A construct 
was not able to efficiently induce luciferase activity without prolactin induction.  
ChIP experiments have shown recruitment of STAT5A as well as a weaker recruitment 
of STAT5B to the c236 region in mammary gland tissue from lactating mice in vivo Results 
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(Fig.  3.10).  Therefore,  STAT5B  was  tested  for  its  ability  to  mediate  transcriptional 
activity of this region in the reporter gene assay. Co-transfection with the wt STAT5B 
resulted in an almost negligible increase in luciferase activity when compared to the 
prolactin induced response of the control expression vector (Fig. 3.23C, lanes 2 and 
10). The c236 region continually displays a weaker luciferase activity than the other 
clone  regions  (c153  or  c831)  tested  (compare  Fig.  3.23B  with  Fig.  3.16B  and  Fig. 
3.25B).  This  weaker  reporter  activity  matches  also  the  lower  amount  of  STAT5A 
recruitment  (%  Input  DNA  )  to  the  c236  region  in  the  ChIP  assays  (Fig.  3.10E). 
Nevertheless, the data indicates that the c236 region is transcriptionally responsive to 
STAT5A.  The  involvement  of  STAT5B  remains  unclear,  due  to  the  weak  activity 
observed.  
 
 
3.2.6.6 The evolutionary more conserved STAT5-binding sites in the c236 region 
is necessary for transcriptional activity 
 
To  determine  the  contribution  of  each  the  two  STAT5  binding  sites  towards  the 
transcriptional activity observed for the c236 region, each site was mutated and then 
tested in luciferase assay. The last two nucleotides in each STAT5 binding site were 
mutated from the wild type AA to TT (Fig. 3.24A). For the unmodified c236 reporter 
construct there is a  2,5-fold increase in luciferase activity upon prolactin stimulation 
when compared to the pGL3 basic control reporter construct (Fig. 3.24B, lanes 2 and 
4). Mutation of the less conserved STAT5 binding site I (M1) resulted in a surprising, 
but reproducible increase of prolactin induced luciferase activity (lane 6). A search with 
TESS
TM (Transcription Element Search System), a web tool for predicting transcription 
factor binding sites in DNA sequences, shows that the mutation of the STAT5 M1 site 
does  not  create  any  additional  known  transcription  factor  binding  site,  but  instead 
results in the loss of an overlapping NF-1 (-like proteins) binding site. The loss of this 
site may result in the increased luciferase activity observed for the M1 mutation, but 
further  study  would  be  needed  to  elucidate  the  actual  cause.  Mutation  of  the  more 
conserved  STAT5-binding  site  II  (M2)  resulted  in  a  strong  reduction  of  prolactin 
induced luciferase activity (Fig. 3.24B, lane 8).  
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Figure 3.24 Mutation of the more conserved STAT5-binding site within the c236 region 
strongly reduces its transcriptional activity. 
(A) The nucleotide positions for the genomic location of the 293 bp c236 region and of the two 
STAT-binding  sites  are  based  on  the  NCBI  reference  NT_165760.1/Mn5_163274_36 
chromosome  5.  The  two  wild  type  (wt)  STAT-binding  sites  are  indicated,  as  well  as  the 
nucleotides mutated in each of the mutant (M) constructs.  
(B)  Duplicate  samples  of  HeLa  TA  cells  were  transiently  transfected  either  with  the  empty 
control reporter vector (pGL3 basic) (1.25 µg), with the reporter construct containing the wild 
type c236 region (c236 (293 bp)) (1.25 µg), or the c236 region with mutations in one or both of 
its STAT5 binding sites (1.25 µg).  The c236 region reporter constructs with either mutations in 
the STAT5-binding site I (M1), mutations in the STAT5-binding site II (M2) or mutations in both 
STAT5-binding  sites  (M1+M2)  are  depicted.  The  cells  were  also  co-transfected  with  the  wt 
STAT5A  expression  construct  (100  ng),  prolactin  receptor  (12.5  ng)  and  SV-40_LacZ 
expression construct (12.5 ng). 24 hours after transient transfection half of the sister wells were 
either treated with prolactin (5µg/ml) for 16 hours (dark bars) or left un-treated (white bars). The 
Luciferase activity was determined and normalized to ß-galactosidase. Each luciferase assay 
was repeated two times. 
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Mutation of both STAT5-binding sites (M1+M2) together resulted in a clearly reduced 
luciferase activity as seen also for the M2 mutation (compare lanes 8 and 10). In the 
double  mutant  the  original  increase  in  activity  caused  by  the  M1  mutation  had  no 
influence on the loss of activity caused by the M2 mutation. Therefore the M1 mutation 
is not able to offset or rescue the loss of luciferase activity caused by the M2 mutation. 
This suggests that the conserved STAT5-binding site II of the c236 region confers the 
observed transcriptional activity and mutation of this site strongly reduces this activity. 
 
 
3.2.6.7 The Zswim6 intronic region (c831) confers transcriptional responsiveness 
 
To show that the STAT5 consensus site found within the Zswim6 intron is functional, a 
740 base pair region containing the STAT5-binding site was inserted upstream of the 
pGL3 basic luciferase reporter gene (Fig. 3.25A). The orientation of the mouse Zswim6 
intronic region corresponds to the natural position found within the Zswim6 gene (Fig. 
3.15H). Therefore the other orientation was not tested. To determine if the c831 region 
is responsive to STAT5A, luciferase reporter gene assay was performed in transiently 
transfected HeLa TA cells with the Zswim6 region reporter construct and increasing 
amounts of  wild type STAT5A expression vector (Fig. 3.25B). 
Without  co-transfected  exogenous  STAT5A,  no  significant  change  in  transcriptional 
activity was observed for the Zswim6 reporter construct induced with prolactin (lanes 1 
and 2). This suggests that endogenous levels of STAT5 in HeLa TA cells may not be 
sufficient  to  induce  transcriptional  activation  of  the  Zswim6  intronic  region  (c831) 
reporter  construct.  When  induced  with  prolactin,  increasing  amounts  of  exogenous 
STAT5A expression vector result in a corresponding gradual increase of transcriptional 
activity by the Zswim6 reporter construct, while untreated samples remain unchanged 
at a basal level (Fig. 3.25B, lanes 3-8). This shows that the Zswim6 intronic region is 
transcriptionally responsive to STAT5A in a concentration dependent manner. 
To determine if this reporter activity is specifically due to STAT5, dominant negative 
and constitutive active forms of STAT5 were also tested (Fig. 3.17 and Fig. 3.25C). 
Equal  amounts  of  these  different  forms  of  STAT5  were  individually  transfected  in 
combination with the Zswim6 reporter construct into HeLa TA cells. The control pMX 
backbone vector did not exceed basal levels whereas the addition of wild type STAT5A 
resulted in a 6-fold induction upon prolactin treatment (Fig. 3.25C, lanes 1-4).  
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Figure 3.25 The Zswim6 intronic region (c831) is transcriptional responsive to STAT5 and 
STAT5 mutants affect this transcriptional activity.  
(A) Schematic representation of the reporter construct containing the Zswim6 intronic (c831) region. The 
indicated nucleotide positions for the genomic location of the 740 base pair Zswim6 intronic region and of 
the  STAT5-binding  site  are  given  based  on  the  NCBI  reference  NT_039590.6/Mm3_39630_36 
chromosome 13. The wild type (wt) STAT5 binding site is shown. 
(B) Duplicate samples of HeLa TA cells were transiently transfected with the wild type Zswim6 intronic 
region luciferase reporter construct (c831 (740 bp)) (1.25 µg) together with either an empty control vector 
pMX  or  with  increasing  amounts  of  wt  STAT5A  expression  constructs  (100  ng).  The  cells  were  co-
transfected with the prolactin receptor (12.5 ng) and the SV-40_LacZ expression construct (12.5 ng). 24 
hours after transient transfection the cells were either treated with prolactin (5 µg/ml) (dark bars) or left un-
treated (white bars) for 16 hours. After cell lysis the transcriptional activity of the luciferase reporter gene 
was measured and normalized to ß-galactosidase activity.  
(C) The wild type Zswim6 intronic region (c831) (1.25 µg) together with either an empty control vector 
(pMX vector) (100ng) or with one of the following STAT5 expression constructs (100ng) (Fig. 3.8): wild 
type  STAT5A  (wt  STAT5A),  dominant  negative  STAT5A  (dn  STAT5A),  dominant  negative  delta  750 
STAT5A  (delta  750  STAT5A),  constitutively  active  1*6  STAT5A  (1*6  STAT5A),  wild  type  STAT5B  (wt 
STAT5A), constitutively active 1*6 STAT5B (1*6 STAT5B), was transiently transfected into HeLa TA cells 
as described above (B). 
c831 (740 bp)/Zswim6
15820938                                            15821677
TTCATGGAA wt
15821344-15821352
luciferase
A
0
500000
1000000
1500000
2000000
2500000
1 2 3 4 5 6 7 8
B
R
e
l
a
t
i
v
e
 
l
u
c
i
f
e
r
a
s
e
 
a
c
t
i
v
i
t
y
- PRL
+ PRL
STAT5A(ng) 100 50 12.5 0
c831
C
0
500000
1000000
1500000
2000000
2500000
3000000
1 2 3 4 5 6 7 8 9 10 11 12 13 14
- PRL
+ PRL
R
e
l
a
t
i
v
e
 
l
u
c
i
f
e
r
a
s
e
 
a
c
t
i
v
i
t
y
wt
STAT5A
wt
STAT5B
pMX 
vector
dn 
STAT5A
1*6 
STAT5A
delta 750 
STAT5A
1*6 
STAT5B
c831Results 
  106 
This transcriptional activity of the Zswim6 reporter construct was lost and remained at 
basal  levels  when  either  the  dominant  negative  mutant  dnSTAT5A  or  the  Δ750 
STAT5A  mutant  was  co-transfected  (lanes  5-8).    This  data indicates that functional 
STAT5 must be present to obtain a prolactin induced transcriptional activation of the 
Zswim6 intronic region reporter construct. The constitutive active 1*6 STAT5A mutant 
results in a doubling of the wt STAT5A response (compare lanes 4 and 10). Contrary to 
the  expectation  this  mutant  did  not  act  in  a  classical  constitutive  active  manner 
because  prolactin  stimulation  for  efficient  transcriptional  activation  of  the  reporter 
construct was still required (lanes 9 and 10). 
Since ChIP experiments showed that STAT5B was also recruited to the c831/Zswim6 
intronic STAT5 site in vivo (Fig. 3.10F), the question arises if STAT5B can also activate 
the reporter activity of the Zswim6 intronic region construct. Therefore HeLa TA cells 
were transfected with either wild type STAT5B or the constitutive active 1*6 STAT5B 
mutant together with the Zswim6 reporter construct (Fig. 3.25C). The Zswim6 reporter 
construct  responded  in  comparison  to  the  control  vector  with  a  4-fold  increase  in 
luciferase activity when co-transfected with wild type STAT5B and a 6-fold increase in 
luciferase activity when co-transfected with the constitutive active 1*6 STAT5B mutant 
(compare lanes 2, 12 and 14). Although weaker than STAT5A the results suggests that 
STAT5B can also directly activate the reporter activity of the Zswim6 intronic region in 
response  to  prolactin  stimulation.  Overall  the  data  shows  that  the  Zswim6  intronic 
region is transcriptionally responsive to STAT5A and STAT5B. 
 
 
3.2.6.8 The consensus STAT5-binding site in the Zswim6 intronic region confers 
reporter gene activity 
 
To determine the contribution of the STAT5-binding site to the transcriptional activity of 
the  Zswim6  intronic  region  the  STAT5A-binding  site  was  mutated.  The  first  two 
nucleotides in the STAT5 site were mutated from the wild type TT to AA (Fig. 3.26A) 
and tested in luciferase assays to determine its effect on the transcriptional activity of 
the Zswim6 reporter construct (Fig. 3.26B). In comparison to the pGL3 basic control 
reporter construct the wild type construct, resulted in a 12-fold increase in luciferase 
activity  upon  prolactin  stimulation  (lanes1-4).  Mutation  of  the  STAT5-binding  site 
resulted in a clear 4-fold reduction of prolactin induced luciferase activity (Fig. 3.26B, 
compare lanes 4 and 6). This suggests that the STAT5-binding site of Zswim6 intronic 
region  confers  transcriptional  activity  and  mutation  of  this  site  strongly  reduces  this 
activity. Results 
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Figure 3.26 Mutation of the STAT5-binding site within the Zswim6 intronic region reduces 
its transcriptional activity. 
(A) Schematic representation of the luciferase reporter construct containing the Zswim6 intronic 
region. The nucleotide positions for the genomic location of the 740 base pair Zswim6 intronic 
region  and  of  the  STAT5-binding  site  are  based  on  the  NCBI  reference 
NT_039590.6/Mm3_39630_36  chromosome  13.  The  wild  type  (wt)  STAT5  binding  site  is 
indicated, as well as the nucleotides mutated in the mutant (M1) construct 
(B) Duplicate samples of HeLa TA cells were transfected either with empty vector (pGL3 basic) 
(1.25 µg), with the luciferase construct containing the wild type Zswim6 intronic region (c831 wt) 
(1.25 µg), or the Zswim6 intronic region with mutations in the STAT5 consensus site (c831 M1) 
(1.25 µg). The HeLa cells were also co-transfected with the wt STAT5A expression construct 
(100 ng), the prolactin receptor (12.5 ng) and the SV-40_LacZ expression construct (12.5 ng). 
24  hours  after  transient  transfection  half  the  sister  wells  were  either  treated  with  prolactin 
(5µg/ml)  for  16  hours  (dark  bars)  or  left  un-treated  (white  bars).  The  luciferase  activity  was 
determined  and  normalized  to  un-treated  for  each  construct.  Each  luciferase  assay  was 
repeated two times. 
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Taken together, the previous reporter gene analysis shows that the investigated cloned 
regions can initiate transcription. The reporter gene activity is mediated by STAT5 and 
depends mainly on STAT5-binding motifs within the cloned regions (c153, c236 and 
c831) analyzed. This suggests that these genomic elements may be involved in the 
transcriptional  regulation  of  endogenous  genes.  Therefore,  the  expression  of 
transcripts associated with the cloned regions was analyzed for changes in expression 
during the different mammary gland stages. 
 
 
3.2.7 Analysis of RNA transcripts found at or near the cloned STAT5-binding site 
regions 
 
The regulation of the genome is more complex than initially thought. Many genes have 
multiple  promoters  within  which  there  are  multiple  transcription  start  sites  (TSS) 
(Sandelin et al., 2007; Birney et al., 2007; Carninci et al., 2006, 2005). The differential, 
often tissue specific usage of the promoters and TSS and the expression of coding and 
non-coding RNA’s result in further layers of complexity.  
For the cloned STAT5-binding regions there are multiple possibilities of transcripts that 
could potentially be regulated. These transcripts vary between the different available 
computational  databases.  To  determine  if  the  association  of  STAT5  with  the  novel 
binding  sites  has  functional  consequences,  the  levels  of  the  nearest  known  RNA 
transcripts were investigated for the following three clones c153, c236 and c831 (Table 
3).  The  transcript  regulation  in  the  mammary  gland  during  the  four  differentiation 
stages  of  pregnancy,  lactation,  involution  and  in  virgin  mice  was  determined  by 
quantitative real-time PCR.  
 
3.2.7.1 The expression of known STAT5 target genes and housekeeping genes 
during different mammary gland developmental stages 
 
The obtained data  was normalized to the geometric average (Vandesompele  et al., 
2002) of three housekeeping genes (HKGs), S18 ribosomal RNA  (18SRNA) transcript, 
tyrosine  3-monooxygenase/tryptophan  5-monooxygenase  activation  protein,  zeta 
polypeptide (YWHAZ)  and cyclophilinB  within the same samples.  This  was done to 
ensure that any variation within the HKG during the mammary gland lactation cycle is 
compensated. The general variance found for each individual HKG was maximal about 
2.5-fold  between  the  different  stages  (Fig.  3.27A,  B  and  C).  The  variance,  seen 
between each individual HKG normalized against the geometric average of all 3 HKG, 
was defined as an indicator of experimental fluctuation. Any variation observed that is Results 
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below 3-fold will not to be considered significant. However, one has to keep in mind 
that with this stringent method of normalization very low changes in RNA expression 
may not be detected. The relative RNA levels found in the virgin mammary gland stage 
is designated in these experiments as the undifferentiated control and is set arbitrarily 
to 1. As positive controls, the three known STAT5 target genes ß-casein, WAP and 
SOCS3 were tested for their mRNA expression levels in the four different mammary 
gland developmental stages (Fig. 3.27D-F). 
 
 
Figure 3.27 Expression analysis of housekeeping genes and known STAT5 target genes 
during mammary gland development.  
Transcript  expression  levels  were  determined  by  quantitative  real-time  PCR  in  samples  derived  from 
Balb/c mouse mammary gland tissue of four different developmental stages. The developmental stages 
are indicated at the horizontal axis of each panel. Designation of stages: V, adult non-pregnant female 
(Virgin); P, approximately 10-15 days post conceptum (pregnancy); L, day 5 of lactation (lactation); I, adult 
females  that  weaned  from  4  to  6  weeks  old  pups  (involution).  2  µg  of  total  RNA  prepared  from 
homogenized mammary gland tissue was reverse transcribed into cDNA and then the relative transcript 
amounts were quantified in triplicates by real-time PCR using the specified primers. The relative RNA level 
for each transcript was normalized against the geometric average of the following 3 housekeeping genes.  
(A, B and C) The three housekeeping genes 18S RNA, YWHAZ and cyclophilinB were used as controls for 
data normalization.  
(D, E and F) The expression of the known STAT5 target genes ß-casein, WAP and SOCS3 are shown as 
positive  controls.  The  results  shown  are  representative  of  the  trends  observed  in  two  independent 
experiments. 
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For  the  two  milk  proteins,  ß-casein  and  WAP,  the  analysis  revealed  the  expected 
elevated levels during pregnancy and lactation. At the Involution stage the expression 
levels approached the minimal detected levels found in virgin mice (Fig. 3.27D and E). 
In contrast to the milk proteins, SOCS3 displayed a different expression pattern (Fig. 
3.27D, E and F). For SOCS3, the expression levels were elevated in virgin mice and 
even  higher  during  involution  when  compared  to  pregnancy  and  lactation.  These 
results  are  consistent  with  a  detailed  study  on  the  regulation  of  SOCS3  transcripts 
during the different stages of mouse mammary gland development (Tonko-Geymayer 
et al., 2002). To note is that the overall relative RNA level for SOCS3 is significantly 
lower than for the positive controls ß-casein and WAP. This may be the result of a 
weaker expression or a more rapid turnover of the SOCS3 transcripts in comparison to 
the milk protein transcripts. 
 
 
3.2.7.2 The expression of NFI/B transcript correlates with the in vivo association 
of STAT5A to the conserved c153 region 
 
The  conserved  c153  region  containing  the  STAT-binding  sites  is  not  located  at  a 
classic promoter or within a known gene (Table 3). A search program used to identify 
any possible transcription start sites (TSS) in vicinity of the c153 region did not identify 
any TSS in the sequence 2000 bp upstream or downstream of the c153 region (Dragon 
program for TTS search). A good indicator of promoters is also the presence of nearby 
CpG islands (Bajic et al., 2004). The nearest CpG island that could be identified is at 
the 5 prime end of NFI/B gene and according to UCSC browser miRBase search there 
are  also  no  annotated  microRNAs  in  close  vicinity  (UCSC  bioinformatics  browser). 
Therefore,  further  investigation  was  focused  on  already  annotated  transcripts  found 
near the c153 region.  
Initial searches with the NCBI databases to identify already annotated transcripts in the 
region were performed. Based on NCBI BLAST searches within the mouse, the c153 
region is located 110 kb 5 prime of a hypothetical protein Loc76455 (NCBI reference 
assembly NT_039260.6/Mm4_39300_36), which is a shorter transcript associated with 
the  NFI/B  gene  (Table  2).  The  alternative  Celera  reference  assembly 
(NW_001030747.1/Mm4_118890_36) mapped the c153 region 62 kb from the 5’ side 
of  Nuclear  Factor  I/B  locus.  The  results  from  the  analysis  of  the  mouse  genome 
database  match  approximately  the  65  kb  distance  that  the  conserved  human  c153 
region  is  found  located  5’  from  the  human  NFI/B  gene  (reference  assembly 
NT_008413.17/Hs9_8570).  Results 
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Using the UCSC bioinformatics browser, subsequent searches revealed an expressed 
sequence tag (EST) named AW106080, which spans the conserved c153 region (Fig. 
3.28A). This AW106080 transcript, was originally identified in a Sugano mouse embryo 
mewa cDNA library and is comprised of two transcripts. EST AW106080 aligns to Chr4 
(81969552-82176886) on the UCSC genome browser. The transcript part 1 is located 
at Chr4 (82176886-82176746) and transcript part 2 Chr4 (81970000-81969552). The 
c153 region is found between the two transcripts at Chr4 (82038634-82038298); with 
STAT5 site TTCATAGAA located at Chr4 (82038478-82038469). Thus the AW106080 
EST  sequence  flanks  the  c153  site,  but  there  is  still  a  138  kb  separation  between 
cDNA part 1 and 68 kb from cDNA part 2. In GenBank the accession AW106080 is a 5’ 
EST that is linked to the cDNA clone (ID IMAGE:2225331) and is associated with the 
putative  identity  of  a  mouse  mRNA  NFI-B2  isoform.  Within  the  Ensembl  database, 
AW106080.1  is  listed  as  supporting  evidence  for  the  Vega  (Vertebrate  genome 
annotation  database)  annotated  transcript  Nfib-010,  with  genomic  location  at  Chr4 
(81969552-82176981). This transcript is also classified as a product belonging to the 
NFI/B gene. Here the c153 region and STAT5-binding site is located within the first 
intron of the NFib-010 transcript. Apart from the mouse AW106080.1 transcript there is 
also an additional comparative human mRNA  (Homo AK131233) transcript, which also 
flanks the c153 region with exon 1 and 2 (Fig. 3.28A). This human mRNA is located at 
Chr9  (14077860-14388982)  within  the  human  genome  and  was  found  in  a  cDNA 
library  from  amygdala  brain  tissue.  AK131233  is  considered  very  similar  to  nuclear 
factor  1/B  according  to  NCBI  nucleotide  sequence  database.  Taken  together,  the 
information indicates that the conserved c153 Stat5-binding site is in approximate 62 
kb proximity of NFI/B, and is spanned (or within the putative first intron) by a NFI/B 
associated transcript. This is the case both in the mouse and human, supporting the 
idea that this sequence  maybe important and  possibly involved in  NFI/B regulation. 
Since NFI/B is the closest known gene found near the conserved c153 region/STAT5-
binding site, the question arose if NFI/B is differentially regulated during the different 
mammary gland developmental stages investigated. 
To determine if the different transcripts are expressed in mammary gland tissue RT-
PCR primers were designed for two different transcripts (NFI/B and AW106080) to test 
the expression levels in the four mammary gland developmental stages. For NFI/B a 4- 
to  7-fold  increase  in  relative  RNA  expression  was  observed  during  pregnancy  and 
lactation when compared to virgin mice (Fig. 3.28B). An even stronger 12-fold increase 
in NFI/B relative RNA levels was observed during the stage of pregnancy and lactation 
when compared to Involution (Fig. 3.28B).  
 
 Results 
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Figure 3.28 Expression analysis of transcripts associated with the c153 region.  
(A) Excerpt from UCSC Genome Bioinformatics Browser (BLAT search details) window showing 
different  transcripts  spanning  or  in  close  proximity  to  the  c153  region  (location  marked  by 
vertical arrow). 
(B) Relative expression level of the mouse mRNA NFI/B. 
(C) Relative expression level of the mouse EST transcript AW106080. 
Transcript expression levels were determined by quantitative real-time PCR in samples derived 
from  Balb/c  mouse  mammary  gland  tissue  of  four  different  developmental  stages.  The 
developmental stages are indicated at the horizontal axis of each panel. Designation of stages: 
V,  adult  nonpregnant  female  (Virgin);  P,  approximately  10-15  days  post  conceptum 
(pregnancy); L, day 5 of lactation (lactation); I, adult females that weaned from 4 to 6 weeks old 
pups (involution). 2 µg of total RNA prepared from homogenized mammary gland tissue was 
reverse  transcribed  into  cDNA  and  then  the  relative  transcript  amounts  were  quantified  in 
triplicates  by  real-time  PCR  using  the  specified  primers.  The  relative  RNA  level  for  each 
transcript was normalized against the geometric average of the 3 housekeeping genes (18S 
RNA, YWHAZ and CyclophilinB). The results shown are representative of the trends observed 
in two independent experiments. 
 
This data shows that NFI/B relative mRNA levels increase in a similar pattern, as do 
the  milk  proteins  during  the  differentiation  specific  stages  of  mammary  gland 
development. The expression of NFI/B correlates nicely with the in vivo association of 
STAT5A to the conserved c153 region during the same mammary gland development 
stages, pregnancy and lactation. Taken together with the functional in vitro data using 
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reporter gene assays the results are suggestive that the conserved c153 region via 
STAT5 may be involved in regulating NFI/B.  
For the AW106080 transcript no more than a 2.5-fold variance between the different 
conditions was observed (Fig. 3.28C). This indicates, that there is no more variation in 
AW106080 transcript expression between the different developmental stages than has 
been  observed  for  the  HKGs.  In  addition  the  AW106080  transcript  appears  to  be 
present  already  in  virgin  mice  and  in  the  subsequent  pregnancy,  lactation  and 
involution stages tested. The cycle threshold (Ct) values reached in these quantitative 
RT-PCR experiments, during the exponential phase with the AW106080 primers, are 
comparable  in  level  to  those  found  for  the  housekeeping  gene  YWHAZ  (Ct  19-21). 
These results suggest that the AW106080 transcript is present, but appears not to be 
regulated during differentiation.  
 
 
3.2.7.3 Multiple putative transcripts are found associated with the c236 region 
 
Using the UCSC browser multiple mRNAs and ESTs were located that span or are in 
close  proximity  to  the  c236  region/STAT5  binding  site.  The  following  two  mouse 
mRNAs Ak017143 and Ak042126 from GenBank and the 4 mouse ESTs BU610001, 
BY716854, BB236757 and BB638939 span the c236 region (Fig. 3.29A). The mRNA 
Ak042126 and the two ESTs BB236757 and BB638939 appear to group together in a 
similar region that is distinct to the region (exons) covered by the mRNA Ak017143 and 
the EST BU610001. In addition, there are two transcripts, one mRNA (AK013579) and 
one EST (CA979556), that are in close proximity (130-500 bp) to, but do not span the 
c236 region. The mouse mRNA, Ak017143 was identified in a cDNA library made from 
pregnant  mouse  ovary  and  uterus  tissue.  The  product  has  not  been  classified  yet. 
Primers designed against mRNAs Ak017143 failed in the quality control, but primers of 
the EST BU610001, which spans a similar region to mRNAs Ak017143, passed quality 
control.  In  quantitative  RT-PCR  these  primers  showed  high  Ct  values  (31-33) 
suggesting that there is maybe very little cDNA template available in the samples. Also 
there is no consistent trend discernable between the different experiments (Fig. 3.29B). 
Taken together, this indicates that hardly any template cDNA of BU610001 is available 
in the samples, making it difficult to ascertain difference between the stages. Due to 
the different types of annotated transcripts found around the c236 region additional 
primers need to be designed and tested, that also cover these different mRNA and 
ESTs. Especially, candidates like the mRNA Ak042126 need to still be covered, since 
the comparative expression data from different tissues indicate their elevated presence Results 
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in  mammary  gland  tissue  (S.O.U.R.C.E  search,  BC050254,  EST  expression 
information). 
 
 
Figure 3.29 Expression analysis of transcripts associated with the c236 region.  
(A) Excerpt from UCSC Genome Bioinformatics Browser (BLAT search details) window showing 
different  transcripts  spanning  or  in  close  proximity  to  the  c236  region  (location  marked  by 
vertical arrow). 
(B) Relative expression level of the mouse EST transcript BU610001. 
Transcript expression levels were determined by quantitative real-time PCR in samples derived 
from  Balb/c  mouse  mammary  gland  tissue  of  four  different  developmental  stages.  The 
developmental stages are indicated at the horizontal axis of each panel. Designation of stages: 
V,  adult  nonpregnant  female  (Virgin);  P,  approximately  10-15  days  post  conceptum 
(pregnancy); L, day 5 of lactation (lactation); I, adult females that weaned from 4 to 6 weeks old 
pups (involution). 2 µg of total RNA prepared from homogenized mammary gland tissue was 
reverse  transcribed  into  cDNA  and  then  the  relative  transcript  amounts  were  quantified  in 
triplicates  by  real-time  PCR  using  the  specified  primers.  The  relative  RNA  level  for  each 
transcript was normalized against the geometric average of  the 3 housekeeping genes (18S 
RNA, YWHAZ and CyclophilinB). The results shown are representative of the trends observed 
in two independent experiments 
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3.2.7.4 Multiple putative transcripts are found associated with c831/Zswim6 
 
The clone c831 has a conserved STAT5-binding site that is located in the first intron of 
the Zswim6 gene. This first intron has a size of over 100 kb and the STAT5-binding site 
is located 62 kb downstream from the first exon of Zswim6. An example for functional 
regulatory STAT5-binding sites located within the first intron, about 200 kb away from 
the  first  exon,  of  a  gene  it  regulates  have  been  described  in  the  literature  for  the 
NCAM2 gene (Nelson et al., 2006). Based on the data that STAT5 binds in vivo during 
lactation and pregnancy to the c831 STAT5-binding site region (Fig. 3.10F) and also 
confers transcriptional activity in reporter assays (Fig. 3.26B), the question arose if the 
association of STAT5 with this novel binding site has a functional consequence on the 
mRNA level of the Zswim6 gene during mammary gland differentiation.  
Primers  were  obtained  based  on  the  Zswim6  linked  mRNA  AK030163  from  Primer 
Bank
TM. AK030163 mRNA has been identified in a cDNA library obtained from adult 
mouse  testis.  The  primers  cover  exon  14  and  the  3’  end  of  the  Zswim6  gene.    In 
quantitative RT-PCR experiments the relative RNA levels of Zswim6 (AK030163) were 
always at least 4.5-fold higher in virgin  mice  and during involution compared to the 
pregnant  and  lactating  stages.  (Fig.  3.30B).  The  involution  stage  retained  a  strong 
increase  over  the  pregnancy  and  lactation  stages.  These  results  indicate  that  the 
transcript (AK030163) is more strongly expressed during involution and in virgin mice 
and  suggest  that  the  expression  levels  might  be  downregulated  in  pregnant  and 
lactating  mammary  gland  tissue.  Interesting  to  note  is  that  transcript  (AK030163) 
displays a similar trend in the expression pattern as found for SOCS3 (compare Fig. 
3.30B and Fig. 3.27F). Also, like SOCS3 the overall relative RNA levels for Zswim6 are 
significantly  lower  than  for  the  positive  controls  ß-casein  and  WAP  (compare  Fig. 
3.30B-D  and  Fig.  3.27D-F).  This  may  also  be  due,  as  proposed  for  SOCS3  in  the 
study, to a weaker induction and or a more rapid turnover of the Zswim6 transcripts. 
Because the transcript from AK030163 does not span the c831 region found in the first 
intron of Zswim6, two additional primer sets were designed based on the AK122528 
transcript  that  spans  the  c831  region  (Fig.  3.30A).  The  primers  designated 
(XM3583115) and  (AK122528) cover the exon 1 to 2 and exon 6 to 7 boundary of 
Zswim6,  respectively.  For  XM3583115  the  Ct  values  (30-36)  were  in  a  high  range 
compared to the HKGs, suggesting that there is very little cDNA template available in 
the samples. But interesting is, that in the involution stage the relative RNA levels are 
decreased 3- to 4-fold in comparison to pregnancy and lactation (Fig. 3.30D).  
 
 Results 
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Figure 3.30 Expression analysis of transcripts associated with the c831 region.  
(A) Excerpt from UCSC Genome Bioinformatics Browser (BLAT search details) window showing different 
transcripts spanning or in close proximity to the c831 region (location marked by vertical arrow). 
(B-D) The relative expression level of the mouse Zwim6 mRNA: AK030163, AK122528 and XM3583775, 
respectively.Transcript  expression  levels  were  determined  by  quantitative  real-time  PCR  in  samples 
derived  from  Balb/c  mouse  mammary  gland  tissue  of  four  different  developmental  stages.  The 
developmental stages are indicated at the horizontal axis of each panel. Designation of stages: V, adult 
nonpregnant  female  (Virgin);  P,  approximately  10-15  days  post  conceptum  (pregnancy);  L,  day  5  of 
lactation (lactation); I, adult females that weaned from 4 to 6 weeks old pups (involution). 2 µg of total RNA 
prepared  from  homogenized  mammary  gland  tissue  was  reverse  transcribed  into  cDNA  and  then  the 
relative transcript amounts were quantified in triplicates by real-time PCR using the specified primers. The 
relative  RNA  level  for  each  transcript  was  normalized  against  the  geometric  average  of  the  3 
housekeeping genes (18S RNA, YWHAZ and CyclophilinB). The results shown are representative of the 
trends observed in two independent experiments. 
 
For transcript AK122528 the Ct ranges between 25 and 30. Here there is no more than 
a  maximal  3-fold  change  between  the  involution  (lowest)  and  pregnancy  (highest) 
stage (Fig. 3.30C). But the pattern is similar to the data obtained for the XM3583115 
primers.  These  results  contradict  the  patterns  found  by  the  Zswim6  primers 
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(AK030163). A detailed investigation into the possible Zswim6 mRNA isoforms/splice 
variants that are possibly expressed during mammary gland differentiation needs to be 
performed,  to  get  any  indications  of  potential  regulatory  function  of  STAT5  in  this 
region. 
 
 
3.2.8  Identification  of  novel  over-represented  DNA  motifs  within  the  STAT5A-
ChIP enriched sequences 
 
A major step in transcriptional regulation is the binding of the transcription factor to the 
target DNA in a sequence-specific manner.  
Because the enriched DNA from the ChIP assay is at least 100 bp or larger this does 
not  allow  for  the  direct  identification  of  the  shorter  transcription  factor  binding  sites 
within the larger enriched DNA sequences. Known and defined binding sites can be 
identified,  but  variations  from  an  already  known  binding  site  or  novel  binding  sites 
would remain unnoticed within the ChIP-enriched sequences.  
Often  the  binding  specificities  of  some  transcription  factors  is  less  pronounces  and 
involve  very  short  stretches  of  nucleotides  (about  4-8  bp)  that  also  may  contain 
uninformative  positions.  Binding  affinities  of  transcription  factors  are  encoded  as 
position weight matricies (PWM), where these matricies specify the sequence motif by 
allotting a base distribution for each of its positions. 
The search of all the STAT5 ChIP-enriched sequences for the consensus GAS motif 
TTCNNNGAA  using  TESS  allowed  for  the  identification  of  34  individual  clone 
sequences (Table 4) containing exactly this motif. In this search of the non-redundant 
sequence  data  set  14%  (34/236)  of  the  sequences  contained  this  stringent  defined 
STAT5 consensus motif. Therefore, an analysis with Trawler (Ettwiller et al., 2007) was 
performed  by  Dr.  Mirana  Ramialison  (Wittbrodt  Group,  Developmental  biology  Unit, 
EMBL in Heidelberg) to identify any over-represented transcription factor binding motifs 
within the STAT5A ChIP-enriched sequences. 
To clearly identify over-represented DNA motifs within the ChIP-enriched sequences 
the sequences have to be compared to a background data set. This background data 
set  was  specifically  built  taking  into  account  the  distribution  of  the  STAT5-ChIP 
enriched  sequences  in  the  mouse  genome.  Using  a  BLAST  search  alignment  the 
genomic location of each clone sequence was mapped and its position in regard to 
surrounding annotated genes  was determined. From the list of 236 clones that had 
been unambiguously mapped to the mouse genome, those that still contained highly 
repetitive sequences (example satellite DNA sequences) were removed. And any clone 
sequences that overlapped with each other were combined into one sequence contig.  Results 
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Table 4 List of 34 clones containing the STAT5 sequence motif from the TESS analysis of 
the non-redundant ChIP-enriched sequence data set. 
The list displays the 34 clones that contain STAT5-binding motifs in their sequence that conform 
exactly to the TTCNNNGAA motif as determined by using a TESS string search of the non-
redundant 236 sequence data set. The total length (bp) of the DNA sequence searched is listed 
for each clone or contig. The individual STAT5 motifs found for each clone are shown and the 
location (bp) of the STAT5 motifs within each clone sequence are given. 
 
 
This final dataset composed of a total of 198 sequences contains only non-redundant 
sequences  that  mapped  to  the  mouse  genome  and  non-repetitive  DNA  sequences 
(Appendix 9.1). The highly repetitive sequences had to be excluded for the subsequent 
Trawler analysis, since motif elements within the repetitive sequences would dominate 
over  all  other  over-represented  motifs  in  the  sequences.  Interesting  to  note  is  that 
almost  48%  (96/198)  of  the  clone  sequences  are  located  in  the  intron  regions  of 
annotated transcripts (Fig. 3.31A). 
 
Name Length STAT5 sites  Location
25 386 TTCAGGGAA 232
37 393 TTCT AAGAA 127
73 467 TTCAGAGAA 426
76 430 TTCTCGGAA 284
80 422 TTCAGAGAA/ TTCAGGGAA 141/ 339
90 394 TTCCCTGAA 293
98 429 TTCAAAGAA 336
153 282 TTCTATGAA 114
177 329 TTCAGGGAA 2
194 394 TTCTTGGAA/ TTCAAAGAA 107/ 328
236 383 TTCCAAGAA 351
237 432 TTCAGAGAA 242
243 371 TTCCAAGAA 356
270 410 TTCTGGGAA 245
315 427 TTCTCAGAA/ TTCTCCGAA 260/ 281
320 420 TTCCGAGAA 169
469 401 TTCAGAGAA 133
591 386 TTCTTCGAA 275
594 366 TTCTACGAA 172
600 318 TTCTCTGAA 279
611 160 TTCCAGGAA 137
612 442 TTCCTGGAA 222
719 425 TTCAGAGAA 328
831 463 TTCCATGAA 147
838 463 TTCAAAGAA/ TTCTATGAA 252/ 327
878 434 TTCCCAGAA 394
888 374 TTCATGGAA 93
901 464 TTCCCTGAA 402
906 453 TTCCTGGAA 434
946 460 TTCGTAGAA 162
Contig 2 422 TTCCAAGAA 107
Contig 3 1293 TTCTTAGAA 1027
Contig 6 206 TTCCAGGAA 79
Contig 9 467 TTCCTGGAA 36Results 
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Figure 3.31 Distribution of the  STAT5 ChIP-enriched fragments  relative to the nearest 
annotated gene.  
(A) The chart depicts in percentage the upstream or downstream location of the STAT5A ChIP-
enriched fragments relative to annotated genes. For this purpose only the non-redundant and 
non-repetitive 198 sequence data set mapped by Dr. Ramialison using the Ensembl database 
was used. Sequences within genes were assigned to the intron category even if part of the 
clone sequence overlapped with an exon region of the gene. 
(B)  Distribution  of  the  distance  (kilobase  pairs  (kb))  the  clone  sequences  are  found  located 
upstream or downstream from the nearest annotated gene. 
 
 
The other half (102/198) is found distributed equally upstream or downstream from the 
nearest annotated gene. The distance of the clone sequences from the nearest gene 
varied. To note is that only about 2,9% (3/102) of the sequences are found located 
within  1  kb  upstream  or  downstream  from  the  nearest  gene.  The  rest  displayed  a 
variable  distributed  over  the  next  600  kb  distance  from  the  nearest  gene,  with 
distances  of  around  25-50  kb  and  100-250  kb  being  most  abundant  (Fig.  3.31B). Results 
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According to the distribution found for the sequences, an appropriate background data 
set  was  built  composed  of  randomly  picked  sequences  with  similar  genomic 
background.  
The  following  parameters  were  used  in  Trawler  Analysis 
(http://ani.embl.de/trawler/result/job_33704). The minimum number of times the motif in 
the sample sequences is observed was set to 10 occurrences. The minimum length of 
a motif had to be 9 bp. This was done since the consensus GAS STAT5 binding site is 
9 bp long (TTCNNNGAA). Only a minimum number of 2 mismatches in the motif were 
allowed. 
Overall,  sixteen  matrices  in  151  clone  sequences  were  found  in  comparison  to  the 
background  to  be  significantly  over-represented  as  determined  by  highest  z-score 
values. The z-scores represent the standard deviation of the occurrence of the motif in 
the sample when compared to the random background dataset. Only those motifs with 
a significant high z-score are displayed by Trawler (Ettwiller et al., 2007). The over-
represented  matrices  are  classified  into  families  and  each  family  is  subdivided  into 
clusters depending on position weight matrices similarity. The family motif 68 received 
the overall highest z-score (z-score =11) and is subdivided into 5 cluster motifs (cluster 
68, 79, 78, 80 and 83) (Fig. 3.32). The newly identified over-represented motifs from 
the  ChIP-enriched  sequences  identified  were  also  compared  by  Trawler  with  motifs 
already  described  for  binding  specificity  of  known  transcription  factor  collected  in 
database such as Transfac (Matys et al., 2003) and Jaspar (Vlieghe et al., 2006). For 
the  motif  family_68  the  cluster_78  is  clearly  annotated  as  STAT-binding  site,  even 
though  there  are  only  3-4  (GGAA)  well-defined  bases.  This  STAT  resembling  motif 
from  cluster_78  though  does  not  overlap  with  the  classic  GAS  STAT5  sites 
(TTCNNNGAA)  initially  identified  in,  for  example,  the  clone  c153  sequence,  but  lie 
adjacent to these sites (Fig. 3.33A). Therefore the consensus STAT5 GAS binding site 
motif is not found over-represented as already shown by the results from the previous 
TESS search. In the motif family_68 the cluster_79 is similar to the c-REL binding site 
and  the  cluster_80  is  annotated  as  bHLH  and  ETS-class  binding  site.  The  motif 
family_68_cluster_68 and cluster_83 do not resemble any motifs in the transcription 
factor databases and are thus novel over-represented motifs. Of the motif family_68 
the cluster_68 is the most prominent cluster. This motif family_68_cluster_68 is found 
significantly over-represented and is found also in the ChIP re-confirmed clones c153 
and  c831  adjacent  to  the  classic  GAS  STAT5-binding  motif  identified  in  these 
sequences (Fig. 3.33A-B). 
 
 Results 
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Figure 3.32 Over-represented motifs are found in the STAT5A ChIP-enriched sequences. 
(A) Excerpt adapted from the Trawler output (http://ani.embl.de/trawler_job 33704) performed 
Dr. Ramialison using the non-redundant and non-repetitive 198 sequence data set. On the left 
panel are shown the sequence logos representing the position weight matrices found for the 5 
individual clusters (68, 79, 78, 80 and 83) comprising the  family_68  matrix.  The size  of  the 
characters represents the relative frequency of the corresponding bases. The family_68 matrix 
achieved  the  highest  z-score  11.  Next  to  each  individual  cluster  matrices  are  reported  any 
motifs found to display similarities to known transcription factors binding sites annotated in the 
Transfac and Jaspar databases. The name of the transcription factor is listed next to its ID, 
which  allows  for  retrieving  information  on  the  transcription  factor  in  the  relevant  source 
databases. The degree of difference between the transcription factor consensus motif and the 
cluster matrices are evaluated by their degree of divergence. 
 
Matrix family_68
Transfac and Jaspar hits
No similar
matrices found.
No similar
matrices found.
      Name  Source ID Divergence  Consensus
       JASPAR MA0023 0.602  GGGGWTTTCC
      c-REL JASPAR MA0101 0.685  NGGGNTTTCC
      CREL TRANSFAC M00053 0.686  NGGGNTTTCC
      CP2 TRANSFAC M00072 0.709  GCNCNANCCAG
      Name  Source ID Divergence  Consensus
      STAT TRANSFAC M00223 0.694  TTCCCGGAA
       JASPAR MA0081 0.697  AGMGGAA
      ELK1 TRANSFAC M00007 0.898  NNNACMGGAAGTNCNN
      Name  Source ID Divergence  Consensus
      bHLH 0.657  NNCNNNTG
      ETS_class 0.825  RRRGGARR
cluster_68
cluster_79
cluster_78
cluster_80
cluster_83
NAGTTCCTGG
 TNCTKACTTCCTG
AGCCAGGAANN
NNANAGAGCCAAG
GCTCTCTGCResults 
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Figure 3.33 Diagram depicting STAT sites and over-represented motifs in two example 
clones. 
The sequences in the clone c153 (A) and c831 (B) that show similarity to a specific designated 
family motif cluster are in bold. STAT- and STAT5-binding sites are also marked in bold in the 
sequences. Note not all motif family clusters found by Trawler analysis in the representative 
clones are depicted. 
 
 
Overall, several over-represented motifs were identified using Trawler. Those identified 
matrices  that  do  not  resemble  motifs  from  the  transcription  factor  binding  site 
databases  are  novel.  Other  motifs  identified  resemble  the  binding  sites  of  certain 
transcription factor motifs. The motif family_68_cluster_78 was defined by Trawler to 
resemble the STAT-binding motif as defined in the Transfac database. This supports 
that this STAT5A ChIP enriched DNA library contains a significant over-representation 
of a motif that resembles the known STAT-binding motif. 
  
CCAGTTCCATGAACCTCCCGAGTAAACCAGTGCTACGTCTGGGCTC
ACCAGGAAGTTGATGCTTTTTTTATTTGTTTGTGCTCACAGATTCATT
GCAACATTTCGATGTTGAGATTAAGGCCGGCTTCCAGGCTTCCAGG
STAT5
B   c831
(TTCT)GGGAAGGATAAAGGAAGTCTGACTCACANNGGGAGTCGGAG
GAGGATAGAGCTATTGAAAGAACAGGAACAGGTATTTTCCGTCATATT
CATTTTCTTAAAATTGAATTAGGTTTCTATGAAAAGCCGTTTTGTAGA
ATAACAGCCTCTTNATGGTTTTACTAACTGAGACATAAAAGACTACCT
GAGGCATGTTATGATTGCTGAACACACNNNAAAAATCCCCTACTTGCT
GGTTATGCTGAATGATGATCAGAANAAGGCTCTTGT
STAT II
STAT IV STAT5 I STAT III
A   c153Discussion 
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4. Discussion 
 
 
4.1  STAT5,  RNA  polymerase  II  recruitment  and  histone  modification 
changes at different regions of the ß-casein and WAP genes  
 
The mammary gland is an organ that develops mainly after birth in the adult animal. 
The  mouse  mammary  gland  tissue  proliferates  and  differentiates  in  response  to 
systemic  hormones  during  puberty,  pregnancy  and  lactation.  This  process  repeats 
itself with each subsequent pregnancy. One of the main signaling pathways involved in 
the proliferation and differentiation of the mammary gland is the prolactin/Jak2/STAT5 
signaling pathway. This signaling pathway is crucial for the functional differentiation of 
the mammary gland, as has been exemplified by the phenotypes observed upon loss 
of these factors in genetically engineered mice (Wagner et al., 2004; Cui et al., 2004; 
Shillingford et al., 2002; Miyoshi et al., 2001). Germline deletion of STAT5a results in 
impaired  mammary  gland  development  and  lactogenesis  (Liu  et  al.,  1997).  STAT5 
deficient  mammary  gland  epithelial  cells  are  unable  to  form  epithelial  alveoli  and 
express  certain  milk  protein  genes  (Miyoshi  et  al.,  2001).  Conditional  deletions  of 
STAT5 from the mammary epithelial cells during pregnancy have demonstrated that 
STAT5  is  essential  not  only  for  the  functional  differentiation,  but  also  for  the 
maintenance and survival of the mammary epithelial cells (Cui et al., 2004).  
This work describes the recruitment of STAT5A, STAT5B and RNA polymerase II and 
the  pattern  of  post-translational  histone  modifications  at  two  milk  protein  genes 
throughout different  mammary  gland  development stages.  For this purpose the  milk 
protein genes ß-casein and WAP were chosen, since these are known STAT5 target 
genes and specifically expressed in differentiated epithelial cells of  mammary gland 
tissue.  Expression  of  the  two  milk  proteins  ß-casein  and  WAP  was  detected  in 
mammary gland tissue from pregnant and lactating  mice, but not in the tissue from 
virgin mice and mice having undergone involution (Fig. 3.1). Therefore tissue from the 
latter two mammary gland developmental stages (virgin and involution) was included 
for comparative purposes.  
This study has not only included the promoter regions containing the STAT5 regulatory 
elements of ß-casein and WAP, but also regions far upstream from the transcription 
start sites TSS (5’ region), the transcribed region in the main body of the gene and 
regions downstream from the end of each gene transcript (3’ region). This approach 
allows for a more complete picture of any changes in histone modifications occurring 
across the general regions of each gene.  
 Discussion 
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STAT5A  and  STAT5B  are  both  highly  related  proteins  that  can  bind  the  same 
regulatory  elements.  The  phenotypes  of  STAT5a  and  STAT5b  deficient  mice  have 
shown  that  the  two  have  redundant  and  non-redundant  functions,  suggesting  that 
some of their transcriptional targets may be identical and others not. In Stat5a deficient 
mice the expression of WAP is almost completely lost, while some ß-casein can still be 
detected (Liu et al., 1997). This indicates differences, in the ability of the two highly 
related STAT5 transcription factors in regulating WAP expression. A way, differences 
may be propagates is through the differential recruitment of factors via the STAT5 C-
terminal transactivation domain (TAD). This TAD domain is the most variable domain 
between  STAT5A and  STAT5B  and is believed to contribution to the transcriptional 
regulation of the target gene by recruitment of cofactors (Liu et al., 1995). In addition, 
differences  can  be  enhanced  by  differential  expression  of  STAT5A  or  STAT5B  and 
different  temporal  kinetics  in  the  DNA  –binding  by  the  two  STAT5s  to  regulatory 
elements. 
To analyze this, ChIP assays and specific antibodies were used to investigate the in 
vivo recruitment of factors to the endogenous target genes in mammary gland tissue 
during different stages of development. 
 
 
4.1.1  Both  STAT5A  and  STAT5B  are  found  associated  at  the  endogenous 
promoter regions of ß-casein and WAP in mammary gland tissue 
 
With  specific  antibodies  against  STAT5A  and  STAT5B  this  work  shows  the  in  vivo 
recruitment  of  both  STAT5A  and  STAT5B  to  the  endogenous  promoter  regulatory 
region of ß-casein and WAP in tissue from pregnant and lactating mice (Fig. 3.2 and 
Fig.  3.3).  Binding  of  both  STAT5A  and  STAT5B  is  also  observed  on  the  ß-casein 
putative enhancer region, containing the STAT5 binding site, in tissue from pregnant 
and  lactating  mice.  This  STAT5  binding  to  the  promoters  of  the  two  milk  genes 
correlates with their mRNA expression during pregnancy and lactation (Fig. 3.1A and 
B). In comparison, no STAT5 recruitment was observed in these regions (enhancer 
and promoter) in tissue from mature virgin mice or mice having undergone involution. 
These  results  clearly  show  that  both  STAT5A  and  STAT5B  are  bound  to  the 
endogenous  target  genes  during  pregnancy  and  lactation,  the  mammary  gland 
developmental  stages,  where  the  major  proliferation  and  functional  differentiation  of 
mammary  epithelial  cells  has  taken  place.  Although  other  studies  have  observed 
STAT5  binding  in  tissue  culture  cell  systems  using  mammary  epithelial  cells  to  ß-
casein and gamma-casein (Xu et al., 2007; Kabotyanski et al., 2006) this is the first 
description of in vivo binding of STAT5A and STAT5B to the endogenous ß-casein and Discussion 
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WAP promoter in mammary gland tissue. WAP is a direct STAT5 target gene that is 
largely confined to secretory alveolar cells (Miyoshi et al., 2001; Liu et al., 1997). The 
expression  of  WAP  begins  in  the  latter  half  of  pregnancy  and  its  expression  is 
considered as a terminal differentiation marker for mammary epithelial cells. The cell 
type and differentiation stage specific control conferred by the WAP promoter region 
has  been  utilized  extensively  in  transgenic  mice  to  target  and  control  expression 
specifically  in  differentiating  mammary  epithelial  cells.  Therefore,  it  is  relevant  to 
investigate STAT5 in vivo recruitment to the endogenous promoter in mammary gland 
tissue.  Interesting,  is  that  both  STAT5A  and  STAT5B  are  found  recruited  to  the 
endogenous WAP promoter, since in the STAT5A deficient mouse WAP expression is 
nearly  lost  (Teglund  et  al.,  1998)  and  STAT5B  appears  not  able  to  completely 
compensate for STAT5A. No difference was observed between the binding of either 
STAT5A and STAT5B to the two  milk protein regulatory elements  in the promoters 
during the investigated stages of pregnancy and lactation. This demonstrates that the 
endogenous STAT5 regulatory regions are accessible and consequently bound by both 
STAT5A  and  STAT5B  in  tissue  during  both  stages.  These  observation  are  in 
accordance  with  the  original  studies  in  mammary  gland  tissue.  Both  STAT5A  and 
STAT5B are found expressed and activated during pregnancy and lactation and both 
display  DNA-binding  activity  as  hetero-  and  homo-dimers  during  lactation  as 
determined  by  in  vitro  EMSA  assays  (Liu  et  al.,  1996).  In  other  cell  types,  like  the 
murine  Ba/f3  cells  line,  interleukin-3  induced  STAT5A  and  STAT5B  binding  to  the 
same regulatory region has also been observed. Here though, it could be shown that 
the binding to some targets occurred with different kinetics (Nelson et al., 2004).  
Therefore, it could be feasible that STAT5A or STAT5B might demonstrate different 
DNA-binding kinetics sometime during other time points of the 21 day pregnancy and 
subsequent lactation period. One complication for detecting different kinetics in DNA-
binding  on  target  regulatory  elements  in  mammary  gland  tissue  is  that  within  the 
mammary gland tissue the epithelial cells are not all perfectly synchronized.  
 
 
4.1.2 p-CTD RNA polymerase II is recruited to the promoter, transcribed and 3` 
region of ß-casein and WAP in mammary gland tissue 
 
In eukaryotes the RNA polymerase II is the most important RNA polymerase involved 
in the transcription of protein-coding genes. RNA polymerase II requires the assistance 
of general transcription factors to initiate transcription by formation of a pre-initiation 
complex  on  the  core  promoter  of  protein-coding  genes  (Kornberg,  2007).  On  the 
carboxy  (C)-terminus  of  the  largest  RNA  pol  II  subunit,  are  located  heptapeptide Discussion 
  126 
(YSPTSPS) repeats referred to as the CTD (c-terminal domain) (reviewed in Hirose 
and Ohkuma, 2007). The CTD of RNA polymerase II is phosphorylated at serine 2 and 
5, where phosphorylation of serine 5 occurs already during transcriptional initiation and 
at serine 2 during elongation. The phosphorylation of the CTD of RNA polymerase II is 
essential for transcription. 
 
Results  from  this  work  here,  demonstrate  that  the  p-CTD  RNA  polymerase  II  is 
associated  with  the  promoter,  transcribed  region  and  too  a  lesser  extent  to  the  3’ 
region  of  both  ß-casein  and  WAP  during  lactation  (Fig.  3.2D  and  Fig.  3.3D).  As 
expected, these results show the localization of a transcriptional active p-CTD  RNA 
polymerase II across the body of the endogenous ß-casein and WAP genes, when the 
mRNA  of  both  genes  is  expressed.  In  comparison,  to  the  other  ß-casein  regions 
investigated  that  show  bound  p-CTD  polymerase  II,  no  enrichment  of  p-CTD 
polymerase II was observed on the putative enhancer region (-6 kb) or 5’ region in 
mammary  gland  tissue  from  lactating  mice.  This  was  unexpected  in  regard  to  the 
enhancer  region,  since  observations  made  in  the  mammary  epithelial  HC11  cell 
system, showed a 3-fold phosphorylated RNA polymerase II accumulation at almost 
equal levels at both the ß-casein promoter and enhancer regions upon prolactin and 
glucocorticoid  induction  (Kabotyanski  et  al.,  2006).  The  authors  speculated  that 
possibly  there  is  a  looping  mechanism  involved  where  the  enhancer  and  promoter 
come into close proximity by looping out the intervening DNA. These results hint at 
differences  between  the  HC11  cell  line  system  and  the  mammary  gland  tissue.  In 
tissue during lactation, difference in p-CTD polymerase II load between the enhancer 
and the promoter regions of  ß-casein suggest that the p-CTD polymerase II on the 
promoter  might  not  be  in  close  proximity  to  the  putative  enhancer,  since  then  the 
enhancer  region  would  be expected to show a  similar high enrichment in the  ChIP 
assays.  This  might  indicate  that  there  is  no  close  contact  between  the  putative 
enhancer  and  the  ß-casein  promoter,  precluding  a  looping  model  between  the  two 
regions. Future chromatin conformation capture assays may be able to determine if a 
physical  interaction  actually  occurs  between  the  putative  enhancer  and  TSS  of  ß-
casein (promoter region).  
 
 
4.1.3  Changes  in  histone  modifications  across  the  different  regions  of  the  ß-
casein and WAP gene in mammary gland tissue 
 
The chromatin has to be accessible for transcription by RNA polymerase II to occur 
successfully.  One  mechanism  involved  in  the  dynamic  modulation  of  chromatin Discussion 
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structure is the post-translational modification of the N-terminal tails of histones. The 
histone tails are subject to many post-translational modifications such as acetylation, 
methylation and phosphorylation (reviewed in Kouzarides, 2007). Acetylation of histone 
H3  and  H4  as  well  as  the  di-  and  tri-methylation  of  lysine  4  of  Histone  H4  are 
associated with active transcription, whereas methylation of lysine 27 of Histone H3 is 
found at inactive genes or regions of heterochromatin. Two main mechanisms on how 
post-translational histone modification function have been postulated (Li et al., 2007; 
Clayton et al., 2006). Histone modifications such as acetylation are thought to shift the 
overall net charge of the nucleosomes, thus that there is a change in the DNA–histone 
interaction on the nucleosome leading to a relaxation or loosening up of the chromatin 
structure. In addition, the histone modifications can serve as potential docking sites for 
specific effector proteins and are believed to be read by proteins that are involved in 
chromatin remodelling and or in the process of transcription. Post-translational histone 
modifications have been found in distinct localized patterns within the genes and their 
surrounding  upstream  and  downstream  regions.  The  locations  of  these  histone 
posttranslational  modifications  are  regulated  and  are  involved  in  the  process  of 
transcription (Li et al., 2007). 
Therefore, histone H3 and H4 lysine acetylation at distinct regions of the ß-casein and 
WAP gene, namely at the enhancer (-6 kb only for the TSS of the ß-casein gene), 
5´region (3-3.5 kb upstream of the genes TSS), the promoter region, the transcribed 
region  and  3´region  (about  1  kb  downstream  from  the  3’  end  of  the  genes  mRNA 
transcript) were investigated.  
 
 
4.1.4  Histone  H4 lysine  acetylation is localized to the 5’ region  of  both the  ß-
casein and WAP gene during lactation 
 
Early studies had shown, that acetylated histones are associated with active genes and 
DNase  I-sensitive  chromatin  domains  (reviewed  in  Kouzarides,  1999).  And  the 
increased acetylation of histones has been associated with a less compact and more 
accessible  chromatin  structure  (Berger,  1999).  Genome  wide  mapping  of  histone 
modification  patterns  to  gene  expression  patterns  has  positively  connected  histone 
hyperacetylation with actively transcribed chromatin (Kurdistani et al., 2004; Schubeler 
et al., 2000). By using antibodies recognizing the general acetlyated lysine residues on 
the  N-terminal  tails  of  histones  H3  and  H4,  increased  histone  acetylation  in  the  5’, 
promoter  and  transcribed  regions  of  both  the  ß-casein  and  WAP  genes  during 
pregnancy and lactation was shown (Fig. 3.4 B, C and Fig. 3.5 B, C). This suggests a Discussion 
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more relaxed and open chromatin structure in these regions during the differentiation 
specific expression of these milk protein genes. 
Regions of localized histone hyper-acetylation have been described at other very distal 
cis-acting elements from activated genes. For example localized H3 hyper-acetylation 
has been shown at the locus control region (LCR) during gene activation in the human 
ß-globin locus (Schubeler et al., 2000). Most interesting is, that the results presented 
here clearly demonstrate a pronounced localized histone H4 hyper-acetylation found at 
the distal 5’ regions of the ß-casein (-3,5kb) and WAP (-3.0kb) genes during pregnancy 
and lactation (Fig. 3.4C and 3.5 C). This 5’ region specific histone hyper-acetylation 
has been observed  also  in  other genes from  different studies.  A similar localization 
effect of histone H4 hyper-acetylation has been described in the extreme 5’ region (-
2,8kb) of the E-selectin gene during TNFalpha induced expression in endothelial cells 
(Edelstein et al., 2005). 
Also  for  another  milk  protein  alpha  s1-casein,  histone  H4  hyper-acetylation  of  the 
upstream  distal  enhancer  (-3.4  kb)  has  been  demonstrated  using  ChIP  assay  in 
primary rabbit mammary cells (Jolivet et al., 2005). The extracellular matrix (ECM) and 
not PRL was shown to maintain a high amount of histone H4 acetylation upstream of 
the  alpha  s1-casein  gene  in  the  distal  prolactin-  and  ECM-sensitive  enhancer.  The 
study by Jolivet et al. (2005) provides evidence that the ECM regulates the PRL/STAT5 
dependent expression of the alpha s1-casein gene in primary rabbit mammary cells by 
local modification of the chromatin structure. It is therefore tempting to speculate that 
the localized histone H4 hyper-acetylation, observed in the 5’ regions of the mouse ß-
casein and WAP genes during pregnancy and lactation in tissue, may be under similar 
regulation by the ECM as seen for the rabbit alpha s1-casein gene.  
The N-terminal tails of the core histones can be acetylated at multiple individual lysine 
residues. The antibody against tetra-acetylated histone H4 recognizes the N-terminal 
tail of Histone H4 that is acetylated specifically at lysines 5, 8, 12 and 16. Acetylation of 
these lysines is conserved between different species such as in mice and yeast and 
the acetylation of these lysines has shown effects on the transcriptional potential in 
yeast (Dion et al., 2005). Individual point mutations in H4 lysine, 5, 8, and 12 barely 
showed any effect on the expression of genes in yeast, but when these mutations are 
combined  a  cumulative  change  in  the  expression  profile  of  specific  genes  was 
observed (Dion et al., 2005). This suggests a possible redundancy in function for H4 
lysine 5, 8, and 12. An exception is the histone H4 lysine 16, since point mutations in 
this individual lysine 16 of H4 resulted in a change of gene expression (Dion et al., 
2005). In yeast it has been described that this  modification has a functional  role in 
maintaining  transcriptional  permissive  DNA  domains  by  disrupting  the  formation  of 
higher-order  chromatin  structure  (Shogren-knaak  et  al.,  2006;  Dion  et  al.  2005). Discussion 
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Therefore  in  this  work  individual  acetylated  lysines  of  Histone  H4  were  further 
investigated.  
ChIP assays using site-specific anti-acetyl antibodies recognizing histone H4 lysine K8, 
K12 and K16 resulted in a distinct enrichment of the 5´region in the case of ß-casein 
and the WAP gene from mammary gland tissue of lactating mice (Fig. 3.4 and 3.5 D, E 
and F) This suggests that in the differentiated epithelial cells during lactation the ß-
casein  and  WAP genes have nucleosomes  at this 5’ region  whose  histone  H4 tails 
have been acetylated on the lysine K8 and K12 more strongly than in the other regions 
investigated.  
For  the  acetylation  of  histone  H4  lysine  16  a  smoother  distribution  was  observed 
across the different regions analyzed,  with only a slight enrichment observed in the 
5´region  of  the  ß-casein  and  the  WAP  gene  during  lactation  and  pregnancy.  The 
relative  change  in  this  modification  during  the  distinct  differentiation  stages  was 
minimal  in  comparison  to  the  other  histone  H4  acetylated  lysines  analyzed. 
Nonetheless  at  the  regions  investigated,  the  presence  of  this  mark  suggests  a  de-
condensed chromatin structure, since acetylated lysine 16 of histone H4 is involved in 
the prevention of the formation of higher order chromatin structure and is implicated in 
the maintenance of euchromatin (Shogren-knaak et al., 2006). 
Apart  from  suggesting  an  open  chromatin  structure  at  the  5’  region,  the  specific 
acetylated lysines on the histone H4 tails may serve to recruit bromodomain (factors) 
containing chromatin-regulating proteins. For example acetylated H4-K8 histone tails 
can mediate the recruitment of SWI/SNF complexes (Agalioti et al., 2002) that can in 
turn remodel nucleosomes. A recent study shows the recruitment of the bromodomain 
containing BRG-1 protein to the promoters of beta-casein and gamma-casein gene and 
that  the  SWI/SNF-dependent  chromatin  remodelling  is  required  for  transcription  of 
these mammary specific genes (Xu et al., 2007). Attempts to detect BRG-1 by ChIP 
assay  in  mammary  gland  tissue  resulted  in  variable  recruitment  during  different 
mammary gland stages, which could not be resolved (data not shown).  
The localized histone H4 hyper-acetylation observed in the extreme 5’ regions of the ß-
casein and WAP genes correlate well with the activation of the milk proteins during 
lactation.  It  seems  likely  to  speculate  that  the  changes  in  localized  H4  acetylation 
observed at the 5’ regions during lactation are due to the specific recruitment of histone 
acetyltransferase  (HAT)  activity  containing  proteins  by  differentiation-specific 
transcriptional activators. CBP is a histone acetyltransferase that can acetylate K8 of 
histone  H4.  The  CBP-acetylated  H4  K8  has  been  described  to  allow  for  BRG1 
recruitment to gene promoters via BRG1s bromodomain (Agalioti et al., 2002). HATs, 
like CBP and p300 are involved as co-activators in STAT5 mediated gene regulation 
(Pfitzner et al., 1998). In addition, another study has shown that histone deacetylase Discussion 
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activity is also required for transcriptional activation by STAT5, through recruitment of 
HDAC1 (Rascle et al., 2003). The chromatin structure and its accessibility is influenced 
by a dynamic process of acetylation and deacetylation of histone N-terminal tails by 
HAT  and  HDAC  activity  containing  factors.  Therefore,  the  recruitment  of  CBP  and 
HDAC1 to the ß-casein and WAP gene in mammary gland tissue was tested (data not 
shown). However, no reproducible binding of these histone modifying enzymes could 
be detected in the mammary gland tissue in ChIP experiments. These results imply 
that  the  enhanced  acetylation  observed  at  the  5’  region  during  differentiation  is  a 
modification  that  might  not  require  the  continuous  action  or  presence  of  HATs  and 
HDACs. However, it may be possible, that the association of CBP or HDAC1 might be 
to  transient  to  be  detected  in  these  experiments.  The  ChIP  assay  can  capture  a 
snapshot picture of what is happening at that moment in time as an average of the 
whole  in  the  different  cell  types  of  the  mammary  gland  tissue.  Thus  short  lived, 
dynamic processes in tissue samples may not be detected as well as in a controlled 
induced  and  synchronized  cell  population.  Alternatively,  other  HATs  or  HDACs  not 
tested  for  might  be  responsible  for  the  acetylation  or  deacetylation  of  histone  H4 
lysines in the 5’ region. For example in budding yeast complexes containing members 
of the MYST HAT family like Sas2 can also acetylate nucleosomal histone H4 lysine 5, 
8,12 and K16 (Fukuda et al., 2006). Further studies using high-resolution tiling arrays 
to narrow down the exact region of localized H4 lysine acetylation within the 5’ region 
might help to further delineate its involvement in the differentiation-specific milk gene 
transcription.  
 
 
4.1.5 Histone H3 lysine methylation changes across the different regions of both 
milk protein genes during lactation 
 
Methylation of the lysine residues on the N-terminal tails of histones correlates with 
transcriptional active or repressed chromatin. Specifically, lysine 4 of histone H3 can 
be  di  or  tri-methylated.  Di-methylated  lysine  4  of  histone  H3  is  a  mark  associated 
mainly  with  transcriptional  permissive  or  active  chromatin,  while  tri-methylation  is 
associated with actively transcribed genes (Santos-Rosa et al., 2002). Tri-methylation 
of H3K4 was detected in the promoter, transcribed region and to a lower extent in the 
3´region of the ß-casein gene during pregnancy and lactation (Fig. 3.6C). No histone 
H3K4 tri-methylation modification could be detected in the enhancer and 5´region of 
the  ß-casein  gene.  For  WAP  tri-methylation  of  H3K4  was  observed  mainly  in  the 
transcribed  region  (Fig.  3.7C).  These  results  are  consistent  with  the  findings  of 
Schneider et al. (2004) that in higher eukaryotes tri-methylation of H3K4 is strongly and Discussion 
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preferentially associated with the transcribed regions of active genes. In contrast to tri-
methylation of H3K4, the di-methylation of this residue resist the inactivation of the ß-
casein  gene  during  involution.  In  comparison,  using  the  same  chromatin 
immunoprecipitated samples, this remnant di-methylation of H3K4 was not observed 
for the WAP gene during involution (compare Fig. 3.6B and 3.7B). The persistence of 
the di-methylation of H3K4 mark at the promoter and transcribed region of the ß-casein 
gene  may  represent  a  genomic  mark  of  recent  transcriptional  activity  as  has  been 
described  in  an  inducible  system  for  the  GAL10  gene  in  yeast  (Ng  et  al.,  2003). 
Persistent hyper-methylation of H3K4 found within the transcribed region some time 
after transcriptional inactivation of the gene has been implicated to provide a molecular 
memory mark of recent transcriptional activity (Kouskouti and Talianides, 2005; Ng et 
al., 2003). 
In the mammary gland tissue investigated a persistence of the tri-methylation mark was 
not observed. This may be  because in this system more dynamic histone changes, 
which  can  be  more  readily  observe  in  an  inducible  system  with  synchronized  cell 
populations, can not be pinpointed so precisely. The H3K4 di-methylation mark was 
observed in all analyzed regions of the ß-casein gene during pregnancy and lactation. 
The question arises if the H3K4 di-methylation mark may be continuously distributed 
over the whole casein locus, especially since the expression of casein genes are co-
ordinately regulated during pregnancy and lactation (Hobbs et al., 1982). Of the five 
casein genes comprising the casein locus, ß-casein is located 10 kb and 60 kb from 
the  next  neighbouring  casein  gene  (Rijnkels  et  al.,  1997).  Continuous  H3K4 
methylation has been observed over other long stretches of DNA such as for a 17 kb 
region at the ß-globin locus (Kim and Dean, 2004). A broad distribution of histone H3 
lysine 4 di-methylation has also been observed across multiple active genes of the Hox 
cluster  in  human  and  mouse  (Bernstein  et  al.,  2005).  Future  studies  using  a  high 
resolution mapping may clarify if this is also the case for the regions neighbouring ß-
casein and/or the whole casein locus.  
The data here shows that methylation of H3K4 is enhanced along the regions of the ß-
casein and WAP genes and that this correlates with the active transcription of these 
genes.  The  changes  observed  in  H3K4  methylation  during  mammary  gland 
differentiation at the different regions indicate here also the action of specific histone 
methylation enzymes. The histone methyltransferases (HMTs) responsible for the di- 
and  tri-methylation  of  H3-K4  at  the  ß-casein  and  WAP  genes  still  need  to  be 
determined. HMTs contain SET methyltransferase domains that are highly specific for 
lysines  to  be  methylated.  For  example,  both  SET1  and  SET7/9  are  HMTs,  that 
specifically can methylate K4 of H3 histones (Wang et al., 2001; Briggs et al., 2001). 
The  mechanisms  by  which  H3  lysine  4  methylation  controls  transcription  is  still  not Discussion 
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clear (Francis et al. 2005). Studies in eukaryotes show a role for methylation of H3 in 
the initiation and elongation of transcription by RNA polymerase II (Gerber et al., 2003; 
Hampsey and Reinberg, 2003). The results of these studies suggest that histone lysine 
methylation may not only act as a stable epigenetic mark of potential active genes, but 
also may directly be involved in regulation of gene transcription. For example the cell 
type specific transcription factor pancreatic duodenal homeobox-1 (Pdx-1) was shown 
to link H3-methylation and RNA polymerase II elongation to Insulin gene transcription 
(Francis et al., 2005). 
Although, the mammary gland tissue systems did not allow for the detection of fast 
acting  dynamic  changes  in  histone  modifications,  a  good  correlation  between 
recruitment  of  STAT5,  RNA-Polymerase  II,  histone  acetylation  and  histone  H3K4 
methylation was observed at the differentiation stages when the milk protein genes are 
expressed in the mammary tissue. While lysine 4 histone H3 methylation is associated 
with transcriptional active genes, another methylation on the lysine 27 of histone H3 is 
correlated  with  inactive  genes.  The  tri-methylation  of  lysine  27  on  histone  H3  is 
correlated  with  the  silencing  of  homeobox  (HOX)  genes  (Cao  et  al.,  2002)  and  is 
associated with X chromosome inactivation (Plath et al., 2003). 
Histone  H3K27 tri-methylation, but  non of the  other tri-methylation  marks (tri-methyl 
H3K9  and  tri-methyl  H4K20)  investigated  and  known  to  be  associated  with 
transcriptional repressed chromatin, was observed at the ß-casein and WAP gene in 
either mammary gland tissue or the mammary epithelial cell model system used (data 
not  shown).  The  disability  to  detect  tri-methylated  (K9)H3  or  tri-methylated  (K20)H4 
modifications  suggests  that  these  histone  modifications  may  not  be  involved  in  the 
transcriptional repression of the two WAP and ß-casein genes investigated or may be 
due to epitope masking.  
Some  enrichment  was  observed  in  ChIP  assays  using  an  polyclonal  antibody 
recognizing  di-methylated  (K9)H3  on  the  ß-casein  promoter  (data  not  shown).  It  is 
therefore  possible  that  di-methylation  of  lysine  9  of  histone  H3  may  be  present. 
Alternatively, there might be a slight cross-reactivity of the polyclonal antibody with the 
histone H3 lysine 9 and 27 methylation mark, since the lysine 9 and 27 methylation 
sites reside within a highly related sequence motif ARKS on the histone H3 tail (Fischle 
et al., 2003b). 
When the milk protein genes are not expressed and active histone marks like H3K4 tri-
methylation have decrease or are not detected anymore, a slight increase in H3K27 tri-
methylation is found (at the transcribed region) in tissue from the virgin and involution 
stages  (V  and  I)  (compare  Fig.  3.6-7C  and  D).  This  indicates  that  mammary  gland 
development is associated with distinct changes in histone lysine methylation at the 
differentiation specific marker genes WAP and ß-casein.  Discussion 
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In this study mammary gland tissue was used, which is composed of epithelial and 
stroma  cells.  Only  the  luminal  epithelial  cells  undergo  functional  differentiation  in 
pregnancy  to  produce  milk.  The  general  level  of  histone  H3K27  tri-methylation 
observed  during  all  the  different  mammary  gland  differentiation  stages  might  result 
from simultaneous detection of this modification in other cell types in the tissue like 
epithelial and stroma (adipocyte and fibroblasts) cells. Therefore, to determine if the 
changes in tri-methylation of lysine 27 on histone H3 observed in the mammary gland 
tissue is also part of the repressed ß-casein chromatin of epithelial cells and not only 
due to other cell types found in the tissue, a pure mammary epithelial cell line was 
analyzed. 
 
 
4.1.6  Differences in the recruitment  of  STAT5, RNA  polymerase II and  histone 
modifications at the ß-casein and SOCS3 promoter in the HC11 cell line 
 
The HC11 mammary epithelial cell line is a model system to study mammary epithelial 
cell differentiation in vitro. Confluent grown HC11 cells can be differentiated by removal 
of EGF and addition of the lactogenic hormones prolactin and glucocorticoid leading to 
the expression of epithelial differentiation specific markers such as the milk protein ß-
casein (Doppler et al., 1989). With stably transfected reporter constructs the HC11 cell 
line has been used to define the minimal and essential responsive promoter elements 
in the ß-casein promoter (Doppler et al., 1989). Recent studies also used this model 
system to analyze the assembly and disassembly of transcription factors and cofactors 
at  the  ß-casein  promoter  in  response  to  prolactin  and  glucocorticoid  by  ChIP 
experiments (Kabotyanski et al., 2006). In addition to the ß-casein milk protein gene, 
other  STAT5  target  genes,  such  as  socs3  and  cis  have  been  shown  regulated  by 
lactogenic hormones in HC11 cells (Tonko-Geymayer et al., 2002).  
In  HC11  cells,  tri-methylation  of  H3K27  at  the  ß-casein  promoter  (Fig.  3.9A)  was 
detected.  This  indicates  that  this  repression-associated  marker  also  seen  in  the 
mammary gland tissue is part of the epithelial cell chromatin and not solely due to other 
cell types found in the tissue. The presence of the tri-methylated lysine 27 on histone 
H3 indicates, that the repression  of these  milk  protein genes could be  mediated by 
specific  histone  methyltransferases  (HMTs)  during  differentiation.  Histone  lysine 
methyltransferases complexes containing the Enhancer of zeste Homology 2 (EzH2) 
can tri-methylate lysine 27 of histone H3 (Cao et al., 2002). Therefore ChIP assays 
using antibody against Enhancer of zeste were performed in mammary gland tissue, 
but these did not yield reproducible results (data not shown).  Discussion 
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In comparison to the ß-casein promoter, only minimal levels of tri-methylated lysine 27 
on histone H3 were detected at the SOCS3 promoter (Fig. 3.9A) indicating that this 
gene might be regulated by a different kind of mode. Lactogenic hormone treatment 
induced binding of both STAT5A and STAT5B to the SOCS3 promoter, but no increase 
in the binding of STAT5A or STAT5B to the ß-casein promoter was observed (Fig. 3.8C 
and Fig. 3.9B). In addition to the failure to induce STAT5 binding, no recruitment of the 
RNA polymerase II to the ß-casein promoter was observed. In the case of the SOCS3 
the RNA-Polymerase II could already been detected on the promoter without hormone 
treatment in HC11 cells. The association of the potentially transcriptional active form of 
the phosphorylated-CTD  RNA polymerase II to the  SOCS3 promoter suggests, that 
RNA polymerase II has already been recruited to the SOCS3 promoter independent of 
prolactin induction and that the SOCS3 gene may already be transcriptional active at a 
basal  level  (Fig.  3.9C).  It  has  been  demonstrated,  in  another  study  that  SOCS3 
transcripts can be induced by STAT5-independent signaling pathways in HC11 cells 
(Tonko-Geymayer  et  al.,  2002).  In  addition,  the  presence  of  insulin  required  in  the 
medium for optimal HC11 culture may influence the SOCS3 basal level, since insulin 
itself has been shown to induce  SOCS3  mRNA expression in skeletal  muscle cells 
(Sadowski  et  al.,  2001).  This  correlates  with  the  presence  of  the  histone  marks 
generally associated with transcriptional active genes such as acetylated H3 and H4 
and di- and tri-methylated H3K4 found on the SOCS3 promoter (Fig. 3.9C, D). Apart 
from the repressive mark none of the other active histone marks seen on the SOCS3 
promoter  could  be  observed  on  the  ß-casein  promoter.  Even  prolonged  lactogenic 
hormone  treatment  could  not  induce  a  significant  change  in  histone  H3  or  H4 
acetylation or histone H3K4 methylation at the ß-casein promoter (Fig. 3.9C and D). 
This indicates a possible closed chromatin conformation at the ß-casein promoter in 
the majority of HC11 cells. The lack of STAT5 and RNA polymerase II recruitment to 
the ß-casein promoter suggest that the ß-casein promoter is not as accessible as the 
SOCS3 promoter in response to lactogenic hormone treatment. The same differences 
were  also  observed  when the  wap and the cis  genes in  HC11 cells  were  analyzed 
(data not shown). 
Overall, recruitment of the transcription factor STAT5 and the histone modifications that 
correlate  with  transcriptional  active  genes  and  open  chromatin  structure  could  be 
observed at the SOCS3 promoter. On a comparative level, this was not observed at 
the ß-casein promoter in HC11 cells stimulated with lactogenic hormones. It may be 
that additional endocrine and extracellular matrix-derived signals are required to fully 
open up chromatin structure of the ß-casein promoter. Especially, since the expression 
of  milk  protein  genes  is  regulated  by  a  complex  interplay  of  hormones,  cell-cell 
contacts  and  cell-extracellular  matrix  interactions  (Topper  and  Freeman,  1980). Discussion 
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Contrary to the cell culture system used, the mammary gland tissue seems to have the 
optimal conditions to differentiate and to alter the chromatin structure, which allows for 
the binding of STAT5 and recruitment of RNA polymerase II as determined in the ChIP 
assays. The success of the ChIP assays using mammary gland tissue from lactating 
mice, may be due to the fact that differentiation specific milk protein expression levels, 
such as ß-casein and WAP in cell culture models are generally lower than compared to 
the in vivo expression observed in lactating mammary gland tissue (Clarkson et al., 
2006).  Initial  characterization  of  the  HC11  cell  line  showed  by  use  of  immuno-
fluorescence that only 30% of the cells displayed ß-casein expression after five days of 
induction with lactogenic hormones  (Ball et al., 1988). Thus there might not be enough 
fully differentiated HC11 cells to detect factor binding efficiently by ChIP.  
Although  ß-casein  is  detected  in  the  induced  HC11  cells  this  does  not  necessarily 
equate  with  a  high  number  in  differentiated  HC11  cells.  The  ChIP  assay  provides 
information based at the genomic DNA level, where each cell has only two alleles of ß-
casein gene, while the detection of the differentiation specific milk protein RNA can be 
enhanced by mechanisms regulating RNA stability and is not limited by number per 
cell. Therefore, a low number of fully differentiated HC11 cells could contribute to the 
poor detection by the ChIP method of transcription factors and histone modifications at 
the  ß-casein  and  WAP  gene.  Even  after  long-term  treatment  for  68  hours  with 
lactogenic  hormones,  efficient  binding  of  STAT5A  and  RNA-Polymerase  II  was  not 
observed,  nor  were  comparable  changes  in  the  histone  modifications  found  in  the 
mammary  gland  tissue.  The  HC11  cell  line  was  initially  derived  from  the  mouse 
mammary epithelial cell line COMMA-1D, which requires in addition to the stimulation 
with  lactogenic  hormones  the  cultivation  on  extracellular  matrix  (ECM)  to  express 
endogenous ß-casein (Danielson et al., 1984; Schmidhauser et al., 1990). On the other 
hand, the  HC11 cell  line is thought not to require growth  on  ECM like the parental 
COMMA-1D, since this cell line can produce its own endogenous extracellular matrix 
components to establish differentiation competence (Chammas et al., 1994). The ECM 
appears to be an important component in mammary epithelial cell differentiation, since 
recent data have shown that the ECM controls the histone H4 actylation at the alpha1-
casein gene in rabbit primary mammary cells (Jolivet et al., 2005). This indicates that 
controlling the histone  modifications in the  milk  protein genes might be the level by 
which  differentiation  inducing  signals  like  from  the  ECM  and  surrounding  cells  can 
control  the  accessibility  of  the  gene  and  thereby  regulate  the  binding  of  the 
transcription factors like STAT5.  
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4.1.7 Model of the histone modification changes observed at the different milk 
protein gene regions in mammary gland tissues  
 
Based on the results from the ChIP assay the following model represents a summary 
of the findings observed at the different regions of the ß-casein gene during the four 
different mammary gland stages investigated (Fig. 4.1).  
In mammary gland tissue from virgin mice (V) and mice having weaned their young (I) 
no significant enrichment of histone marks associated with active transcription, such as 
lysine  acetylated  histone  H3  and  H4  or  lysine  4  methylation  of  histone  H3,  was 
observed at the five different regions of ß-casein gene investigated. No STAT5 or p-
CTD RNA polymerase II was detected in any of the regions (enhancer, 5, promoter, 
transcribed and 3’). Instead tri-methylated lysine 27 histone H3, a mark associated with 
repressed chromatin, was observed distributed across all regions of ß-casein (Fig. 4.1 
V and I).  
With pregnancy (P) (day 15) and lactation (L) (day 5) both STAT5A and STAT5B are 
found  bound  at  the  promoter  and  putative  enhancer  region  of  ß-casein  containing 
STAT5 recognition motifs (Fig. 4.1 P+L). This is accompanied by recruitment of the p-
CTD RNA polymerase II at the promoter and transcribed region of ß-casein. In addition 
there is a strong increase in histone H3 and H4 acetylation, with a specific localized 
enrichment of acetylated histone H4 (lysine 8 and 12) at the 5’ region of ß-casein. This 
enhanced  histone  acetylation  is  associated  with  transcriptional  active  transcribed 
genes and indicates an open and accessible chromatin structure. In addition, there is 
increased  tri-methylation  of  lysine  4  on  histone  H3  observed  in  the  promoter  and 
transcribed region of ß-casein. The presence of this active associated histone mark 
further  support  the  notion  of  active  transcription  in  the  region  at  that  stage. 
Furthermore,  there  is  a  strong  increase  in  di-methylation  of  lysine  4  on  histone  H3 
found spread across all five regions of ß-casein during lactation (Fig. 4.1 P+L). Overall, 
these histone marks known to be associated with transcriptional active genes together 
with  the  recruitment  of  STAT5  and  the  major  component  of  an  active  basal 
transcription  machinery  (p-CTD  RNA  polymerase  II),  correlate  well  with  the  active 
transcription  and  expression  of  ß-casein  during  lactation.  In  addition  to  an  open 
chromatin structure and transcriptional activity, the presence of the observed histone 
modifications  hint  at  the  action  of  HATs  and  HMTs  involved  in  the  regulation  of  ß-
casein transcription. 
Once the young are weaned, the STAT5 and active p-CTD RNA polymerase II as well 
as the active associated histone marks previously observed during lactation are not 
observed  any  more  in  the  regions  of  ß-casein  (Fig.  4.1  compare  I  and  P+L).  An 
exception is the di-methylated lysine 4 histone H3 mark (Fig. 4.1 I).  Discussion 
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Figure  4.1  Descriptive  model  of  ß-casein  regions  showing  STAT5  and  p-CTD  RNA 
polymerase  II  recruitment  and  changes  in  histone  modifications  during  different 
mammary gland developmental stages. 
Schematic representation of the predicted histone modifications and recruitment of STAT5 and 
RNA polymerase II to the endogenous ß-casein gene regions investigated in mammary gland 
tissue from virgin (V), pregnant (P), lactating (L) and involuting (I) mice. Depicted are the five 
different  DNA  regions  (enhancer,  5’,  promoter,  transcribed  and  3’)  of  the  ß-casein  gene 
investigated.  Each  region  is  represented  by  a  picture  of  a  boxed  nucleosome  with  one  N-
terminal tail depicted for histone H3 and H4. Only the lysines (K) residues that were investigated 
are shown. Acetylated lysines are indicated with triangles and methylated lysines by rectangles. 
Two or three rectangles indicate di- or tri-methylation, respectively. 
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This permissive mark was often found retained on the promoter and transcribed region 
of ß-casein and may potentially act as a memory mark for a recent transcription event. 
This is not so in the case of WAP, which in comparison to ß-casein did not retain the 
elevated  levels  of  this  histone  mark  in  any  of  its  regions  investigated,  hinting  at  a 
differential  regulation.  Meanwhile,  the  lysine  27  tri-methylation  of  histone  H3, 
considered a mark associated with transcriptional repressed chromatin, is observed at 
levels similar to those found in virgin mouse tissue (Fig. 4.1 compare I and V). 
In conclusion, these results indicate that the differentiation specific expression of the 
milk proteins ß-casein and WAP during pregnancy and lactation correlate with distinct 
covalent histone modifications. During the different mammary gland stages there are 
distinct quantitative differences between the 5’ region, promoter, transcribed region and 
3’ regions of the ß-casein and WAP genes with regard to STAT5 and RNA polymerase 
II  recruitment  and  the  localization  of  histone  modifications.  The  regions  of  the 
transcriptional active ß-casein and WAP genes (during pregnancy and lactation) are 
characterized by specific histone hyper-acetylation and lysine 4 histone H3 methylation 
(active and permissive histone marks). When the genes are inactive, the same regions 
lose the active chromatin  marks, but still retain  the repressive histone  H3 lysine 27 
methylation mark. 
 
 
4.2 Analysis of the cloned STAT5A ChIP Library 
 
For gene expression analysis, microarrays are used to identify regulated target genes, 
but this also can lead to the identification of secondary regulated genes. An advantage 
of the ChIP cloning procedure is the unbiased identification of novel and direct STAT5-
binding  elements  in  their  natural  cellular  environment  regardless  of  their  genomic 
location. This approach allows for new insights into STAT5-mediated gene regulation 
during mammary gland differentiation. 
The  in  vivo  recruitment  of  STAT5  to  DNA  in  the  intact  chromatin  environment  of 
mammary gland tissue has not yet been extensively studied. This is essential, since 
the chromatin environment has an important influence on regulating gene expression. 
Mammary gland tissue was used for cloning of novel STAT5-binding sites, because 
sufficient levels of differentiation specific STAT5-binding was observed in the tissue, 
but not in the mammary epithelial cell line HC11 (Section 4.1.6). 
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4.2.1 Verification of the STAT5A Library  
 
One  aim  of  this  study  was  to  identify  new  differentiation  specific  STAT5  regulatory 
elements in mammary gland tissue from lactating mouse. For this purpose the ChIP 
cloning method was used to identify novel STAT5 transcription factor binding sites. In 
this work, in vivo binding of STAT5A and STAT5B to the ß-casein and WAP promoter 
regions containing the STAT5-binding motifs could be confirmed (Fig. 3.10A-B). The 
specific recruitment of STAT5 to the promoters of these two differentiation specific milk 
protein genes occurred during the developmental stages of pregnancy and lactation in 
the  mammary  gland  tissue.  These  results  verify  that  the  conditions  for  an  effective 
immunocapture  of  STAT5-bound  chromatin  from  mammary  gland  tissue  has  been 
established and can be used to isolate potential new STAT5 targets. 
 
 
4.2.2  Isolation  and  validation  of  9  novel  STAT5  targets  from  mammary  gland 
tissue during pregnancy and lactation 
 
Nine out of a total of 25 clones tested from the ChIP library were verified to be unique 
and novel STAT5 targets, which can recruit both STAT5A and STAT5B proteins (Fig. 
3.10C-F  and  Fig.  3.12A-E).  This  recruitment  is  seen  mainly  during  pregnancy  and 
lactation when the epithelial cells in the mammary gland tissue undergo proliferation 
and differentiation. Therefore, the ChIP assay was used successfully to isolate nine 
new differentiation specific STAT5 targets from lactating mammary gland mouse tissue. 
In addition, these independent ChIP assays show that the  DNA sequences isolated 
represent true STAT5-binding sites. A general drawback of the cloning procedure in 
the ChIP cloning method is, that there is also cloning of non-specific sequences. In 
addition, not all identified transcription binding sites in the cloned sequences can be 
validated as true binding sites (Maston et al., 2006). 
Approximately 83% of the immunocaptured, cloned and sequenced fragments from the 
STAT5 mammary gland tissue library could be localized to the mouse genome with 
significant  sequence  similarity  using  the  NCBI  BLAST  search.    The  remaining  17% 
(22/128)  of  sequences  that  had  not  aligned  to  the  mouse  genome  with  significant 
similarity  often  displayed  repeating  sequence  elements  or  just  had  poor  quality 
sequences  with  lots  of  undetermined  base  (N)  calls.  In  future,  sequential  double 
immunoprecipitations with the STAT5 antibody during the ChIP assay procedure might 
reduce  the  nonspecific  sequences  and  enhance  the  number  of  STAT5-chromatin 
interaction sites identified.  Discussion 
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In this thesis, the success rate of 36% (9/25) achieved for verified clones containing 
STAT5-binding site, that bind STAT5A and STAT5B during pregnancy and lactation, is 
in accordance  with the percent range of verified STAT5-binding sites achieved  in  a 
study performed by Nelson et al. (2004). Here two independent STAT5 libraries from 
hematopoitec  Ba/F3  cells,  induced  with  IL-3,  were  generated,  one  for  STAT5A  and 
STAT5B, respectively. For the STAT5A library 25% (3/12) and for the STAT5B library 
35% (6/12) of the STAT5 binding sites were shown as verified by ChIP assay (Nelson 
et al., 2004). Although, this study elegantly combined a linker-ligation mediated PCR 
with a subtraction step to remove more of the unspecific sequences this measure did 
not  appear  to  elevate  the  overall  percent  of  verified  clones  that  bound  STAT5. 
Therefore the method used in this thesis was satisfactory. 
The  remaining  16  out  of  25  tested  clones  analyzed  in  this  thesis  did  not  give 
reproducible  and  strong  signals  in  ChIP  with  STAT5A  or  STAT5B  antibodies,  even 
though  their  sequences  contain  either  STAT5  or  STAT-like  binding  sites.  This  is  in 
agreement with the findings of another study, that evaluated a genome wide chromatin 
library of STAT5-binding sites from human breast cancer cells using in vitro EMSA and 
in vivo ChIP assays. LeBaron et al. (2005) found for half of their sequences that the 
presence  of  a  STAT5-binding  motif  did  not  assure  the  binding  of  STAT5  to  the 
immunocaptured  fragment.  The  reason  for  this  remains  unclear.  These  STAT-motif 
containing  fragments  could  have  been  immunoprecipitated  non-specifically. 
Alternatively, these fragments can represent very low affinity STAT5-binding sites that 
do  not  display  differences  in  the  recruitment  level  between  the  different  mammary 
gland developmental stages.  
The  high  background  is  a  problem  inherent  with  the  labor  intensive  ChIP  cloning 
method. Other variations of the CHIP technique are used to analyze transcription factor 
binding and so identify possible regulatory elements and their target genes. Chromatin 
immunoprecipitated DNA can be hybridized to DNA microarrays (ChIP-on-chip). These 
DNA arrays  may cover  promoter regions, specific regions surrounding  TSS or  CpG 
islands.  Therefore  the  ChIP-on-chip  experiments  are  limited  to  whatever  DNA  the 
mircoarray  covers.  Recently  though,  arrays  are  available  that  cover  the  entire  non-
repetitive sequences of the genome. Such genome-wide analysis have been used to 
identify new DNA regions bound by transcription factors like estrogen receptor alpha 
(ERalpha) in both cultured cells and in mouse liver tissue (Gao et al., 2008; Carroll et 
al., 2006 and 2005). In combination with general expression analysis under the same 
conditions  this  is  a  powerful  tool  to  identify  transcription  factor  regulatory  elements 
involved in control of nearby target genes. 
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4.2.3 Histone modifications and RNA polymerase II recruitment to 4 of the novel 
STAT5-binding regions 
 
In  general  active  promoters  are  marked  by  acetylation  of  histone  H3  and  H4  and 
methylation  of  histone  H3  lysine  4  (reviewed  in  Barrera  and  Ren,  2006).  Recently, 
Heintzman et al. (2007) has demonstrated in the human genome, that transcriptional 
active promoter and enhancers elements are marked by distinct chromatin signatures, 
such  as  methylation  of  histone  H3  lysine  4,  and  that  these  can  be  used  to  predict 
potential  regulatory  DNA  elements.  The  presence  of  a  member  of  the  basal 
transcription machinery and specific histone modifications, can be used as an indicator 
to determine if a specific DNA region is located in transcriptional active euchromatin. 
Both the phosphorylated CTD of RNA polymerase II and the histone H3 lysine 4 di-
methylation mark, correlate with active and potentially transcriptional active chromatin. 
Comparison of the different STAT5-binding regions with each other detected different 
strengths  of  phosphorylated  CTD  of  RNA  polymerase  II  and  histone  H3  lysine  di-
methylation  (Fig.  3.14).  According  to  the  histone  H3  lysine  di-methylation  levels,  all 
clones appear to be located in regions of potential transcriptional active euchromatin. 
But only the two clones 153 and 236 showed the most difference between the virgin 
and lactation stages. This indicates that both RNA polymerase II recruitment and the 
histone mark are elevated differentiation stage specifically during lactation for at least 
these two clones. This correlates with the differentiation specific recruitment of STAT5 
to these clones during lactation in mammary gland tissue. In contrast to the mammary 
gland tissue, no recruitment of STAT5 to the clones could be observed in the inducible 
HC11  epithelial  cell  culture  system  (Fig.  3.13.).  The  same  problem  had  been 
encountered  previously  in  this  work  for  ß-casein  in  the  same  cell  system  (Section 
4.1.6). Here, no STAT5 could be recruited or changes in the histone modifications be 
observed at the ß-casein promoter (Section 3.1.13). For epithelial cells especially, the 
cell-cell  and  cell-matrix  interactions  are  important  for  proper  development  and 
regulation  of gene expression (reviewed Lin and Bissell, 1993). Since the  STAT5A-
binding clones have been isolated originally from lactating mammary gland tissue, the 
mammary epithelial cell culture system may not be able to provide the same conditions 
as encountered by the differentiated mammary epithelial cells in tissue from a lactating 
mouse.  Experiments  are  underway  to  test  the  verified  clones  for  STAT5-binding  in 
another  mammary  epithelial  cell  line.  The  EpH4  cell  line  requires  growth  on  an 
extracellular  matrix  (ECM)  for  expression  of  ß-casein  and  may  therefore  provide 
necessary signals derived from the ECM to allow for STAT5 recruitment to the cloned 
regions.  
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4.2.4 Characterization of the novel STAT5-binding sites  
 
For purpose of discussion the information gained by computational and experimental 
means for each of the three clones (c153, c236 and c831), that contain novel STAT5-
binding sites, will be first discussed individually.  
 
 
4.2.4.1.1 Clone c153 
 
The  data  gathered  for  clone  c153  indicated,  that  the  STAT5-binding  site-containing 
distal 5’-flanking region of the NFI/B gene might be a cis-regulatory DNA region. This 
DNA region potentially mediates STAT5 induced NFI/B gene expression in mice during 
lactation.  Using  a  comparative  genomics  approach  it  was  determined,  that 
approximately  80%  of  the  339  bp  region  of  c153  clone  is  evolutionarily  conserved 
between the mouse and the human genome. The 339 bp region of c153 contains one 
consensus STAT5-binding site and 3 STAT-like sites (Fig. 3.15D). The STAT5-binding 
site I and the immediate surrounding sequence is highly conserved between the mouse 
and the 10 other mammals aligned. The high degree of evolutionary conservation for 
the 339 bp region and the STAT5 site indicate, that this site is functionally important. 
Elevated levels of di-methylated (K4) histone H3 and recruitment of RNA polymerase II 
mark  this  region  as  potentially  transcriptional  active  during  lactation  (Fig.  3.14B). 
Investigation into the potential function of the novel STAT5- and STAT-binding sites 
using reporter gene assays shows that the  highly conserved  339 bp region confers 
reporter  gene  activity  (Fig.  3.19B).  The  conserved  region  mediates  transcriptional 
activity  that  depends  on  the  STAT5  I  and  the  STAT-binding  sites  IV  and  III.  When 
mutated in the reporter gene assays the conserved c153 region reporter gene activity 
declines sharply (Fig. 3.21B). This indicates, that all three STAT sites are contributing 
to the observed reporter gene activity. The opposite is true for the other STAT-binding 
site II, which displays the least homology of the four sites and is located in a short 
stretch of lower homology within the 339 bp region. A mutation of this site appears to 
have no effect on the STAT5 mediated reporter gene activity. To note is that this STAT 
site II sequences has a consensus STAT motif with a central spacing of 4 instead of 3 
bp, which is the optimal spacing preferred by STAT6 (Schindler et al., 1995). This may 
explain why mutations of this site had no observable effect on the STAT5 mediated 
PRL induction reporter assays. Taken together, the data infers that this STAT site II is 
of less importance for the STAT5 mediated c153 reporter gene activity observed. On 
the other hand, the STAT5- I and STAT-binding sites IV and III, which display a high 
degree  of  evolutionary  conservation  within  the  mammals,  are  responsible  for  the Discussion 
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STAT5  mediated  c153  reporter  activity  observed.  Thus,  this  work  shows  that  the 
consensus STAT5-binding site I as well as the STAT-binding sites III and IV display 
high evolutionary conservation and are important in mediating PRL induced reporter 
gene activity of the c153 region.  
An interesting aspect regarding these three STAT sites is their close proximity to each 
other. The STAT5-binding site I is 11 bp from STAT site IV and is also right adjacent to 
the  STAT  site  III,  which  itself  is  comprised  of  two  STAT  motifs  in  a  head  to  head 
orientation (Fig. 3.15D). There is a distance of 7 bp from the consensus STAT5 site I to 
the outer most of the two head to head STAT motifs, that comprise the STAT site III. 
Thus, they appear in their layout to resemble two tandemly linked STAT motifs (site I 
and III). This close spacing of the STAT sites to each other has been described to be 
important in STAT5A dimer and tetramer formation (Soldaini et al., 2000). STAT5A can 
bind either as a dimer or preferably as a tetramer on tandemly linked STAT motifs. The 
optimal spacing distance for STAT5A tetramer-binding between two STAT motifs is 6 to 
7 bp in length (Soldaini et al., 2000). Often, a TCC or GAA half STAT gamma interferon 
activated sequence  (GAS)  motif is found at the distance of  more than 5  bp from  a 
consensus GAS motif (TTCNNNGAA). The STAT5 tetramers can bind to a wide range 
of tandemly linked consensus and non-consensus motifs (Soldaini et al., 2000). This 
would be the case, for the spacing between the consensus STAT5 site I and the STAT 
site  III  and  opens  the  possibility  that  tetramer  formation  at  these  sites  of  the  c153 
region are conceivable. 
Multiple  STAT5  responsive  genes  are  known  to  display  two  tandemly  linked  STAT 
motifs  (see  listed  in  Soldaini  et  al.,  2000).  STAT5  tetramer  complexes  have  been 
shown  to  bind  for  example  the  Glycosylation-Dependent  Cell  Adhesion  Molecule  1 
(GlyCAM1)  promoter,  interleukin  2  receptor  alpha  (IL-2Rα)  enhancer  and  the  CIS 
promoter  (Hou  et  al.,  2003;  Verdier  et  al.,  1998;  Meyer  et  al.,  1997).  Further 
investigation is necessary to determine if either or both STAT5 dimers and tetramers 
bind  to  this  highly  conserved  group  of  STAT  sites  in  the  c153  region  and  in  what 
combination  this  occurs  at  during  the  differentiation  stages  of  mammary  gland 
development. 
Apart  from  STAT5A,  the  in  vivo  binding  of  STAT5B  to  the  c153  conserved  region 
during pregnancy and lactation has also been demonstrated using ChIP (Fig. 3.10C). 
The  use  of  both  wild  type  and  constitutive  active  STAT5B  in  the  reporter  assays 
indicate,  that  STAT5B  can  also  positively  drive  the  c153  region  luciferase  reporter 
activity (Fig. 3.18B). This shows that STAT5B, as well as STAT5A, can associate with 
the STAT-binding sites and influence the transcriptional activity conferred through the 
STAT5-binding  sites  located  within  the  c153  region.  This  is  not  surprising,  since 
previous in vitro experiments have shown that both STAT5A and STAT5B homodimers Discussion 
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have  similar  DNA-binding  preferences  (Soldaini  et  al.,  2000).  Another  study  has 
demonstrated that their ChIP cloned STAT5 targets can also recruited both STAT5A 
and STAT5B in vivo (Nelson et al., 2004). Nelson and colleagues were able to observe 
different  kinetics  in  the  STAT5A  or  STAT5B  recruitment  to  some  targets  in  this 
inducible IL-3 Ba/F3 cell culture system. In this thesis no difference in the kinetics of 
STAT5A and STAT5B recruitment was observed in either the pregnancy and lactation 
stages  of  mammary  gland  development  investigated.  This  may  be  because  a  cell 
tissue  culture  system,  contrary  to  mammary  gland  tissue,  is  made  up  of  a 
homogeneous  population  of  cells  that  can  be  synchronized  and  induced  under 
controlled conditions.  
 
 
4.2.4.1.2 STAT5 recruitment to the c153 region correlates with the transcription 
of the nearest gene NFI/B 
 
Based on the assumption that STAT5 regulates transcription, a search was performed 
to identify the closest known genes or annotated RNA transcripts. The nearest know 
gene to the c153 region is the Nuclear factor I (NFI)/B gene. NFI/B belongs to a family 
of transcription factors that are involved in the expression of mammary specific genes 
like the  milk proteins  WAP  and  ß-lactoglobulin (Li and  Rosen, 1995;  Watson  et al., 
1991). The c153 region lies about 62 kb 5 prime to the NFI/B gene. The expression of 
NFI/B  mRNA  transcript  correlates  with  the  in  vivo  association  of  STAT5A  to  the 
conserved c153 region during the mammary gland development stages of pregnancy 
and lactation (Fig. 3.28B) and Fig. 3.10C). No significant change in RNA levels was 
observed for the EST transcript spanning the c153 region. This indicates that the EST 
transcription might not be influenced on a transcriptional level, by the binding of STAT5 
(Fig. 3.28C).  Due to the high  homology between mouse and human of the  STAT5-
binding site and the c153 region, it would be interesting to find out if the human NFI/B 
associated transcript expression also correlates to STAT5-binding in the c153 region. 
For further evaluation, a complete transcript annotation from lactating mammary gland 
tissue stage in this area would be required. 
The  elevated  expression  of  the  mouse  NFI/B  transcript  that  was  detected  during 
lactation is in accordance with other studies. Relative expression levels of the NFI/B 
gene  at  different  stages  of  mammary  gland  development  were  determined  using 
RNase protection and RT-PCR assays (Mukhopadhyay et al., 2001). Mukhopadhyay et 
al. found that NFI/B is already expressed in the virgin mammary gland, but that NFI/B 
displays  the  highest  levels  of  expression  during  lactation  and  decrease  again  in 
expression during involution. In addition, the authors showed that the major NFI splice Discussion 
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isoform NFI/B2 in cooperation with STAT5 and GR could activate transcription of the 
WAP distal promoter in transient reporter gene assays. Previously, both STAT5 and 
NFI have been implicated to play a role in WAP gene expression in transgenic mice (Li 
and Rosen, 1995). With this connection in mind, it seems quite possible that during 
pregnancy and lactation, STAT5 through the STAT5-binding sites within the conserved 
c153 region is involved in modulating the expression of NFI/B. The 339 bp DNA region 
from c153,  which is located 62 kb 5  prime to the  NFI/B gene  might act as a distal 
enhancer of NFI/B. Together then NFI/B and STAT5 could regulate the expression of 
the milk proteins. 
The  presence  of  RNA polymerase II on the c153  DNA  region  during lactation (Fig. 
3.14A)  does  not  preclude the region from being a  putative  enhancer. For example, 
RNA polymerase II has been shown associated with enhancers of genes, such as the 
androgen-responsive prostrate-specific antigen (PSA) gene (Louie et al., 2003; Shang 
et al., 2002). Another example is the ß-globin gene locus, where the distal enhancers 
in the locus control region act over large distances on the various globin promoters. 
Here  it  has  been  proposed  that  the  DNA  enhancer  associated  RNA  polymerase  II 
either  reaches  the  promoter  through  a  DNA  looping  or  tracking  mechanism. 
Specifically, for the human epsilon-globin gene locus a DNA tracking mechanism has 
been proposed. (Zhu et al., 2007). Alternatively the 339 bp DNA region from c153 may 
be part of a promoter of an until now still not annotated transcript for a coding or non-
coding RNA transcript. The fact that the 339 bp region induces reporter gene activity 
already in the promoter-less and enhancer-less pGL3 basic plasmid, suggests that this 
region is possibly either a promoter or part of a promoter. Searches for transcription 
start sites (TSS) in vicinity of the c153 region did not result in the identification of any 
new identifiable TSS (Dragon program for TTS search). This may be due to the search 
parameters of the program used. Most programs search for CpG islands to determine 
TSS  sites  and  currently  no  perfect  programs  are  available  to  identify  all  TSS  via 
bioinformatics  searches  (Sandlin  et  al.,  2007;  Birney  et  al.,  2007).  In  the  human 
genome about half the genes are found near CpG islands and are considered a good 
predictor for promoters (Bajic et al., 2004). Thus, the presence of a CpG islands has a 
high predictive value for the identification of this class of promoters. The nearest CpG 
island  though  that  could  be  identified  is  at  the  5  prime  end  of  NFI/B  gene  (UCSC 
browser).  
The cloned chromatin regions that are confirmed as positive for in vivo STAT5-binding 
by ChIP may be involved in the transcriptional control of nearby genes or alternatively 
of small regulatory RNAs (Cawley et al., 2004). Work done by Cawley et al. show that 
the  un-bias  mapping  of  transcription  factor  binding  sites  along  the  human 
chromosomes  21  and  22  appears  to  point  to  a  widespread  regulation  of  not  only Discussion 
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protein  coding  RNAs  but  also  of  non-coding  RNAs.  A  transcription  factor  binding 
search with the TESS program, showed a proximal sequence element (PSE) site near 
the  STAT5  site  I  of  c153.  These  PSE  sites  are  often  found  upstream  of  TSS  from 
snRNA genes, which can be transcribed by either RNA polymerase II or III (Li et al., 
2004). Thus, there could be the possibility that the conserved c153 region and STAT5 
is  involved  in  regulating  small  nuclear  RNAs.  A  UCSC  browser  miRBase  search 
though, revealed no known annotated microRNAs in close vicinity (UCSC browser) of 
the clone 153 region. 
 
 
4.2.4.2 Clone c236 
 
The c236 region contains two STAT5-binding sites in proximity (100 bp) to each other. 
In  terms  of  a  chromatin  context,  where  about  147  bp  of  DNA  wrap  around  a 
nucleosome, the distance between the two STAT5-binding sites would bring both in 
close proximity. Based on the histogram, depicting the degree of conservation between 
the different mammals for the 292 bp c236 region (Fig. 3.15D), there are many areas of 
high  homology  hinting  that  there  may  be  regulatory  potential  within  this  regions  of 
conserved  elements.  As  shown  in  this  work  by  the  use  of  transient  reporter  genes 
assays the region of c236 confers transcriptional activity that depends on STAT5A and 
the  more  conserved  of  the  two  STAT5-binding  site  II  (Fig.  3.24B).  The  STAT5 
recruitment to the c236 region observed during lactation in vivo and the reporter gene 
activity was overall weaker than compared to the other two clone regions tested (c153 
and c831). This  may indicate  overall  weaker STAT5-binding sites and  possibly less 
importance  of  STAT5  in  the  function  of  driving  gene  transcriptional  activity.  Further 
investigation into the multiple RNA transcripts that span this region is being performed 
to determine if there are modulations in the transcripts levels that correlate to the in 
vivo  binding  of  STAT5A  and  STAT5B  to  the  region.  Of  special  interest  would  be 
AK017143, a Riken cDNA (5031425E22) found in a library made with tissue from the 
reproductive organs (uterus and ovaries) of an 11 day pregnant mouse. In this Riken 
transcript  the  STAT5-binding  site  would  be  located  in  the  first  intron  of  the  cDNA 
(UCSC  Browser  REFsource).  Work is  in  progress to determine if this cDNA is also 
found in mammary gland tissue during pregnancy and lactation.  
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4.2.4.3 Clone c831 
 
The novel STAT5-binding site from the c831 clone is found within the first intron of the 
Zswim6 (Zinc finger, SWIM domain containing 6) gene and is evolutionary conserved 
between  6  different  mammals  (Fig.  3.15H).  This  evolutionary  conservation  of  the 
STAT5-binding site indicates that this STAT-binding site may be an important DNA-
binding element. Since functional sequences are subject to evolutionary selection, the 
relatively unchanged (conserved) region, infers that such a region might be functional 
(reviewed in Miller et al., 2004). Next to the STAT5-binding site about 13 bp away is a 
34  bp  region  with  high  homology  between  the  different  mammalian  species 
investigated.  This  is  a  unique  feature  within  this  clone  and  warrants  further 
investigation. Using TESS, a search for potential transcription factor (TF) binding sites 
was performed within this region for both the human and the mouse sequence. Some 
transcription factor binding site in common for both human and mouse were GATA, Lim 
only protein (Lmo2), c-myb, the homeodomain protein engrailed-1 (En-1) and yin yang 
1 (YY1). In the human and the other two primates investigated, there is also a TFIID 
site (TTATATT), which is not found in the corresponding mouse sequence (TTGTGTT). 
At  the  STAT5-binding  site  in  the  human  there  is  an  overlap  with  a  potential 
glucocorticoid receptor (GR), progesterone receptor (PR) and Oct-2 site. While in the 
mouse potential  Oct-1,  YY1, c-myb  and  Dioxin-Ah  Receptor complex (AhR) binding 
sites overlap with the STAT5-binding site. Within the mouse conserved 34 bp region is 
also a PR site. Many of these transcription factors have been observed to act on the 
transcriptional regulation of STAT5 target genes (reviewed in Litterst et al., 2005). For 
example, PR has been shown to repress STAT5/GR activation of ß-casein gene (Buser 
et al., 2007) and YY1 is implicated in the repression of ß-casein basal transcription 
(Meier and Groner, 1994; Raught et al., 1994). Because TF searches in even short 
DNA  sequences  result  in  a  multitude  of  possible  TF-binding  sites  it  remains  to  be 
experimentally  tested  if  any  of  these  additional  sites  are  bound  by  any  of  these 
potential transcription factors during mammary gland development.  
The finding of a conserved and possibly functional STAT5-binding site within the first 
intron  of  the  Zswim6  gene  is  in  accordance  with  other  studies.  The  location  of  a 
functional  STAT5-binding  site  within  the  first  intron  has  been  demonstrated  in  an 
independent study for the NCAM2 gene (Nelson et al., 2006). In an earlier study with a 
CHIP library made from IL-3 induced Ba/f3 cells, the analysis revealed that over half 
(54%)  of  the  STAT5-binding  sites  were  found  within  the  introns  of  known  genes 
(Nelson et al., 2004). Slightly less than half (23%) of these STAT5-binding sites were 
located within the first intron. Interesting to note is, that the STAT5 consensus sites 
within the NCAM2 gene lies within a very large intron, with about 200 kb to the first Discussion 
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exon  and  82  kb  from  the  second  exon  (Nelson  et  al.,  2006).  This  is  similar  to  the 
situation of the STAT5-binding site within the first intron of the Zswim6 gene, where the 
STAT5-binding site is located 62 kb from the first exon and 38 kb from the second exon 
(Fig. 3.15H). This very large distance from the  annotated TSS and how exactly the 
mechanism  would  be  for  STAT5  to  influence  transcription  from  within  these  large 
introns  remains  to  be  elucidated.  Potentially  there  may  be  an  alternative  not  yet 
annotated  promoter  and  TSS  within  Zswim6.  It  is  also  not  uncommon  to  find 
transcription factors binding regions within genes. Genome-wide analysis of ERalpha 
binding has shown that almost half the binding sites are located within genes and that 
the binding site distribution can span the whole gene (Gao et al., 2008). 
The reporter gene assay shows that the c831 region containing the consensus STAT5-
binding site can drive reporter gene activity. Mutation of the STAT5-binding site as well 
as  co-transfection  of  dominant  negative  STAT5  expression  constructs  abrogate  this 
activity  and  demonstrate  that  the  reporter  activity  is  mainly  dependent  on  the 
consensus  STAT5-binding  site  (Fig.  3.25B-C  and  Fig.  3.26B).  To  determine  if  the 
association of STAT5 with its intronic STAT-binding site has a functional consequence 
on the mRNA level during mammary gland differentiation, primers had been designed 
to multiple locations of the Zswim6 gene. The result obtained for the Zswim6 primers 
that cover the last exon 14 suggest that during binding of STAT5 the transcript levels 
are decreased during pregnancy and lactation when compared to the transcript levels 
of tissue from the virgin and involution stage (Fig. 3.30B). Taken together this indicates 
that STAT5 may act as a potential repressor. On the other hand, that would contradict 
the reporter gene assays. Since the tests are performed using a plasmid where the 
c831 region is not in its native chromatin environment and in a cell line that may be 
missing  potential  transcription  factors  and  cofactors  found  in  the  mammary  gland 
during differentiation, may explain differences in gene regulation. There may also be 
potential interactions with factors located at the highly conserved region adjacent to the 
STAT5-binding site. The results obtained for the primers covering the exon 1/2 and 6/7 
of Zswim6 (Fig. 3.30C-D) are similar to each other in that there is a strong reduction of 
transcripts  during  involution  in  comparison  to  pregnancy.  But  these  results  are 
contradictory  to  those  for  the  primers  covering  transcript  AK030163  (Fig.  3.30B). 
Therefore,  a  precise  picture  of  the  transcripts  that  get  expressed  during  mammary 
gland differentiation need to be first determined for Zswim6, before the influence of the 
potential  regulatory function of  STAT5-binding to this region can  be  determined. As 
with  all STAT5-binding sites found so far, one  would require correlation  with all the 
transcripts from the nearby area that are differentially regulated during mammary gland 
development. 
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4.2.5 Distinct over-represented motifs found in the non-repetitive STAT5 library 
sequences 
 
Transcription factors establish which sets of genes are expressed in specific tissues in 
response  to  certain  environmental  cues  by  binding  specific  DNA  target  sequences. 
These DNA target elements are often short in sequence and degenerate. Therefore 
searching DNA sequences for consensus binding sites by computational means alone, 
without  relevant  support  from  experiments,  would  yield  thousands  of  biological 
irrelevant binding sites for that particular transcription factor. 
The hormone regulated and mammary specific expression of ß-casein and WAP is in 
part conferred by composite response elements (Mukhopadhyay et al., 2001; Rosen et 
al., 1999) and is mediated by the cooperative interaction of STAT5 and other specific 
transcription  factors  like  GR  and  C/EBPß  that  bind  these  cis-regulatory  elements. 
Therefore searching for other motifs that co-occur in the STAT5A immunoprecipitated 
DNA might identify other TF that co-operate with STAT5A in mediating signaling during 
lactation. 
Surprisingly, the known consensus GAS (gamma interferon activated sequence) motif 
(TTCNNNGAA) preferentially bound by STAT5, was not found over-represented in the 
non-repetitive STAT5 library sequence data set, analyzed by Trawler. Instead a motif 
(family 68_cluster78) that partially resembles the known STAT-binding site was found 
significantly  over-represented  in  the  non-repetitive  STAT5A  ChIP-cloned  sequence 
dataset  analyzed  (Fig.  3.32).  Here  the  partial  4  base  sequence  GGAA  of  the  motif 
(family 68_cluster78) is found within the palindromic STAT consensus sequence. This 
implicates  that  the  STAT5A  ChIP  enriched  DNA  library  contains  a  significant  over-
representation of a motif that resembles part of the consensus STAT-binding motif. It 
might be, that during lactation STAT5A (in complex or cooperation with other factors) 
might have alternative binding site preference. Other transcription factors have been 
described which also bind motifs that do not have strong homology to the consensus 
sequence. For example, using a combined ChIP-CpG island microarray approach, the 
new target promoters identified for E2F, contain sites that do not resemble the classic 
E2F  consensus  motifs  previously  identified  (Weinmann  and  Farnham,  2002; 
Weinmann  et  al.,  2002).  Differences  in  stimulus  and  cell  context  as  well  as  other 
factors cooperating with STAT5 might modulate which subset of DNA target sequences 
are bound.  
Interesting is that the cluster_78 motif does not overlap with any of the initial identified 
STAT sites in the clone 153 already analyzed in the reporter gene assays (Fig. 3.33A-
B). Therefore, additional experiments are underway to clarify if this cluster_78 motif can Discussion 
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bind  STAT5A  and  if  mutation  of  this  motif  has  any  affect  on  the  STAT5  mediated 
reporter gene activity.  
The motif for cluster_79 resembles part of a c-rel consensus binding motif. C-rel is a 
member of the NFkappaB transcription factor family and is thus closely linked to the 
activation of the cell cycle regulator, cyclin D1 by the RANK-NFkappaB pathway in the 
mammary  gland  (Hennighausen  and  Robinson,  2005).  Cyclin  D1  is  also  a  direct 
STAT5 target gene and is thus an example of a gene where both the NFkappaB and 
STAT5  pathways  converge  to  regulate  a  target  gene  important  in  mammary  gland 
differentiation.  Although  the  actual  binding  of  c-rel  needs  still  to  be  verified  to  the 
representative  motifs  in  clone  c831,  this  hints  that  the  data  from  the  library  might 
provide  insight  into  possible  cis-regulatory  elements  where  STAT5  and  other 
transcription  factors  converge  in  regulating  targets  during  lactation.  From  the  other 
over-represented  motifs  it  is  noteworthy  to  mention  cluster  68-68.  This  over-
represented  motif  did  not  match  any  annotated  consensus  binding  sites  in  the 
transcription  factor  binding  site  databases  searched.  But  it  is  found  in  both  verified 
STAT5-binding clones c153 and c831. The role of the over-represented motifs in the 
STAT5 mediated transcriptional activity still remains to be investigated.  Summary 
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5. Summary  
The  mammary  gland  of  mice  serves  as  a  model  system  for  studying 
differentiation in an adult animal. With the beginning of pregnancy the mammary 
epithelial cells undergo functional differentiation to produce milk for nourishment 
of  the  young.  The  transcription  factor  STAT5  mediates  the  cytokine-induced 
induction of the milk proteins during pregnancy and lactation in response to the 
lactogenic hormone prolactin. In addition to transcription factors that mediate 
transcription  of  their  target  genes  by  recruitment  of  the  general  transcription 
machinery  to  the  DNA-regulator  regions,  specific  post-translational 
modifications  on  the  N-terminal  tails  of  histones  also  influence  expression. 
These  histone  modifications  can  affect  chromatin  structure,  which  is  a  main 
control barrier to transcription, by directly altering accessibility of the chromatin 
and  by  providing  binding  surfaces  for  protein  complexes  that  can  further 
modulate chromatin structure and regulate transcription. 
In  this  work  N-terminal  histone  modification  marks  that  associate  with  open, 
permissive and repressed chromatin where investigated in different regions of 
two milk proteins during four stages of mammary gland development. Using the 
chromatin-immunoprecipitation (ChIP) assays increased acetylation of histone 
H3 and H4 at the 5’ region, promoter and transcribed regions of ß-casein and 
whey acidic protein (WAP) gene were observed during pregnancy and lactation 
when these genes are expressed. The presence of these histone marks, which 
are  associated  with  a  relaxed  chromatin  structure,  correlates  with  the 
recruitment  of  STAT5A  and  STAT5B  to  the  promoter  containing  regulatory 
regions as well as the detection of the phosphorylated RNA polymerase II in the 
transcribed gene region. Both di- and tri-methylation of histone H3 lysine 4, that 
mark permissive and active chromatin respectively, were enriched in tissue from 
pregnant and lactating mice. In comparison tri-methylation of histone H3 lysine 
27, a mark associated with repressed chromatin, could be observed during all 
stages of mammary gland tissue investigated, but appears slightly elevated in 
the  tissue  from  virgin  mice  when  ß-casein  and  WAP  are  not  expressed. 
Together  these  results  illustrate  that  the  expression  of  the  two  milk  proteins 
genes at distinct stages of mammary gland differentiation correlate with specific 
changes in histone modifications.  
In  mammary  gland  tissue  STAT5A  is  important  for  the  mammary  gland 
epithelial  cell  differentiation  and  survival  during  lactation.  Yet  many  genomic Summary 
  152 
target regions that STAT5A actually bind and which are involved in regulation of 
gene expression during lactation still remain unknown. Therefore, the second 
part of this thesis was focused on the identification of novel STAT5-binding sites 
that are differentiation specifically bound by STAT5A in mammary gland tissue 
during lactation. 
In  summary,  the  results  demonstrate  that  the  ChIP  cloning  method  was 
employed successfully for the cloning of a STAT5A library and the identification 
of new STAT5 targets in mammary gland tissue from lactating mice. Nine of the 
newly  identified  STAT5-binding  targets  were  verified  to  differentiation 
specifically bind STAT5A and STAT5B in vivo during the developmental stages 
of pregnancy and lactation. Even though the selection of the tested clones was 
biased towards STAT5-binding sites near or at known genes and for multiple 
STAT5 binding sites, only one out of the nine validated STAT5-binding regions 
is  located  in  a  traditional  defined  proximal  promoter  (c398).  Except  for  two 
STAT5-binding regions (c20 and c194), which are located at least 10 kb from 
the  next  annotated  known  gene,  six  are  located  in  the  intronic  regions  of 
annotated mRNA or EST transcripts. Three, out of four verified STAT5-binding 
regions tested in reporter gene assays for functionality, display the ability to 
drive reporter gene activity in a STAT5 dependent manner. This transcriptional 
activity  is  due  to  the  STAT5-binding  sites  within  the  cloned  regions  as 
determined by mutational analysis. Of special interest is the clone (c153) that 
contains one STAT5 and three STAT-like sites within a 339 bp region that is 
evolutionary conserved by approximately 80% between the mouse and human 
genome. This STAT5-binding region lies about 62 kb 5 prime of the nuclear 
factor I/B gene. The expression of the NFI/B mRNA transcript correlates with 
the  in  vivo  association  of  STAT5A  to  the  conserved  c153  region  during  the 
mammary  gland  development  stages  of  lactation.  Together,  these  results 
suggest that this STAT5-binding site-containing distal 5’-flanking region of the 
NFI/B  gene  might  be  a  cis-regulatory  DNA  region  that  potentially  mediates 
STAT5 induced NFI/B gene expression in mice during lactation.  
 
 
 
 
 Zusammenfassung (German Summary) 
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6. Zusammenfassung (German summary) 
Das  Milchdrüsegewebe  der  Maus  eignet  sich  als  Modell-System  für  die 
Untersuchung  von  Differenzierungsvorgängen  in  erwachsenen  Tieren.  Mit 
Beginn  der  Schwangerschaft  beginnt  die  funktionale  Differenzierung  der 
Brustepithelzellen, um Milch für die Ernährung der Jungen zu produzieren. 
Aktiviert  durch  das  lactogene  Hormon  Prolaktin,  vermittelt  der 
Transkriptionsfaktor  STAT5,  die  Induktion  der  Milchproteine  während  der 
späten Schwangerschaft und Stillzeit. 
Nicht  nur  die  Transkriptionsfaktoren,  welche  die  Transkription  ihrer  Zielgene 
durch  die  Rekrutierung  der  generellen  Transkriptionsmaschinerie  aktivieren, 
sondern  auch  bestimmte  post-translationale  Modifikationen  auf  den  N-
terminalen  Schwänzen  der  Histone,  beeinflussen  die  Genexpression.  Diese 
Histonmodifikationen  wirken  auf  die  Chromatinstruktur,  welche  die 
Hauptkontrollbarriere  zur  Transkription  darstellt.  Dies  geschieht  durch  eine 
direkte Veränderung der Chromatinzugänglichkeit und durch die Bereitstellung 
von  Bindungsstellen  für  die  Rekrutierung  von  Proteinkomplexen,  welche  die 
Chromatinstruktur  weiter  modulieren  und  so  die  Transkription  zusätzlich 
regulieren. 
In  dieser  Arbeit  werden  daher  N-terminale  Histonmodifikationen,  welche  mit 
offenem,  permissivem  und  reprimiertem  Chromatin  assoziiert  sind,  in  den 
verschiedenen Regionen von zwei Milchproteinen währen der vier Stadien der 
Brustdrüsenentwicklung untersucht. ß-Casein und Whey Acidic Protein (WAP), 
sind  Milchproteine,  die  durch  Prolaktin  aktiviertes  STAT5  reguliert  werden. 
Diese Proteine werden am Ende der Schwangerschaft und während der Stillzeit 
von differenzierten Epithelzellen im Brustdrüsengewebe exprimiert. Mit Hilfe der 
Chromatin-Immunoprezipitations  (ChIP)  Methode  und  Antikörpern,  welche 
definierte Modifikationen erkennen, wurde die erhöhte Acetylierung von Lysinen 
der  Histone  H3  und  H4  auf  den  5’  Regionen,  den  Promotoren  und  den 
transkribierten  Regionen  der  ß-casein  und  WAP  Gene  während  der 
Schwangerschaft  und  Stillzeit  nachgewiesen.  Im  Vergleich  zu  den  anderen 
untersuchten genomischen Regionen, waren die acetylierten Lysine 8 und 12 
von  Histon  H4  auf  der  5’  Region  von  beiden  Milchproteinen  während  der 
Schwangerschaft  und  Stillzeit  stark  angereichert.  Die  Anwesenheit  dieser 
Histonmodifikationen,  welche  mit  einer  offenen  Chromatinstruktur  assoziiert 
werden, korreliert während der Stillzeit mit der Rekrutierung von STAT5A und Zusammenfassung (German Summary) 
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STAT5B  zu  den  Promotoren,  welche  die  regulatorischen  STAT5-
Bindungselemente  enthalten.  Zur  gleichen  Zeit  ist  auch  die  phosphorylierte 
Form der RNA Polymerase II auf den transkribierten Genregionen von beiden 
Genen zu detektieren, was wiederum mit der Expression dieser beiden Gene 
während  der  Stillzeit  korreliert.  Diese  Resultate  zeigen,  dass  es  möglich  ist 
auch  im  Gewebe  die  Rekrutierung  von  Transkriptionsfaktoren  und 
Histonmodifikationen zu analysieren. 
ChIP  Untersuchungen  mit  Antikörpern  spezifisch  gegen  Histon  H4  Lysin  16, 
zeigten eine gleichmäßige Verteilung dieser Modifikation über die verschieden 
DNA  Regionen,  mit  einer  nur  schwachen  Anreicherung  in  der  5’  Region, 
während  der  Schwangerschaft  und  Stillzeit.  Die  relative  Änderung  dieser 
Modifikation  während  der  verschiedenen  Stadien,  war  im  Vergleich  zu  den 
anderen analysierten Histon H4 Lysin (8 und 12) Resten, nur sehr gering. Die 
Acetylierung  von  Lysin  16  ist  in  die  Prävention  einer  höher  geordneten 
Chromatinstruktur  und  der  Erhaltung  von  Euchromatin  involviert.  Daher 
impliziert das Auftreten dieser Modifikation auf den untersuchten genomischen 
Regionen eine dekondensierte Chromatin-Struktur.  
Di- und Tri-methylierung von Histon H3 Lysin 4, sind Modifikationen, welche mit 
permissivem und aktivem Chromatin assoziiert sind. Um die Verteilung auch 
dieser  Modifikationen  in  den  Milchproteingenen  während  der  Stillzeit  zu 
analysieren, wurden Antikörper spezifisch gegen bestimmte methylierte Lysin 
Reste verwendet. 
Während der Schwangerschaft und der Stillzeit, wurde eine Anreicherung von 
Di-methyliertem  Lysin  4  auf  Histon  H3  an  dem  Enhancer  (für  ß-Casein),  5’ 
Region,  Promotor,  transkribierten  Region  und  der  3’  Region  von  ß-Casein 
nachgewiesen.  Ähnlich  sehen  die  Resultate  für  WAP  aus.  In 
Brustdüsengewebe von Mäusen, die keine Jungtiere mehr säugen, sieht man 
aber eine deutliche Abschwächung dieser Modifikation in allen Regionen der ß-
Casein  und  WAP  Gene.  Im  Gegensatz  zu  WAP  jedoch,  bleibt  die  Di-
methylierung (K4) von Histon H3 in der Promoter und transkribierten Region 
des ß-Caseingens häufig erhalten. Dies zeigt, dass die Di-Methylierung (K4) 
von  Histon  H3  auch  eine  Zeitlang  nach  der  Stillzeit  fortbesteht.  Diese 
Bewahrung  der  Lysine  4  Methylierung  von  Histon  H3  könnte  potenziell  als 
Markierung beziehungsweise Lesezeichen für eine kürzlich noch transkriptionell 
aktive Chromatinregion dienen. ChIP-Analysen mit Antikörper, spezifisch gegen Zusammenfassung (German Summary) 
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Tri-methyliertes  Lysin  4  von  Histon  H3,  zeigte  eine  Anreicherung  dieser 
Modifikation in den transkribierten- und öfters auch in den Promotor-Regionen 
von  ß-Casein  und  WAP  im  Brustgewebe  von  stillenden  Mäusen.  Diese 
Histonmodifikation,  die  mit  aktiven  Genen  im  Euchromatin  assoziiert  ist, 
korreliert  mit  der  aktiven  Transkription  beider  Milchproteingene  während  der 
Stillzeit. 
Im  Vergleich  dazu  ist  die  Tri-methylierung  von  Histone  H3  Lysin  27  mit 
reprimiertem  Chromatin  assoziiert  und  in  allen  untersuchten  Stadien  des 
Brustdüsengewebes  nachweisbar.  Eine  leichte  Erhöhung  wurde  in  dem 
Gewebe von Jungfräulichen Mäusen oder zu einem späteren Zeitpunkt nach 
der Stillzeit, wenn ß-Casein und WAP nicht exprimiert werden, vorgefunden. 
Zusammen  illustrieren  diese  Resultate,  dass  die  Expression  der  zwei 
Milchproteingene zu den untersuchten Stadien der Brustdrüsendifferenzierung 
mit  spezifischen  Veränderungen  der  Modifikationen  der  Histone  in  diesen 
Genregionen einhergeht. 
 
In  Brustdrüsengewebe  reguliert  STAT5  die  Differenzierung  und  sichert  das 
Überleben der Brustepithelzellen während der Stillzeit.  Bis jetzt sind nur wenige 
genomische Zielregionen, an denen STAT5A tatsächlich binden kann und die in 
der Regulation der Genexpression während der Stillzeit involviert sind, bekannt. 
Deshalb  befasst  sich  der  zweite  Teil  dieser  Arbeit  mit  der  Identifikation  von 
neuen STAT5-Bindungsstellen, welche differenzierungsspezifisch von STAT5A 
im Brustdrüsengewebe während der Stillzeit gebunden werden. Hierzu wurde 
die  ChIP-Klonierungsmethode  eingesetzt,  welche  eine  genom-weite 
Identifikation  von  neuen  und  direkten  STAT5  DNA-Bindungselementen  im 
Genom  erlaubt.  Neun,  der  identifizierten  Regionen  wurden  in  vivo  als 
differenzierungsspezifische  Bindungsstellen  von  STAT5A  und  STAT5B 
verifiziert.  Die  Bindung  von  STAT5A  und  STAT5B  wurde  nur  während  der 
Entwicklungsstadien:  Schwangerschaft  und  Stillzeit,  aber  nicht  im 
jungfräulichen  Stadium  oder  in  Mäusen,  die  Ihre  Jungen  abgesetzt  hatten, 
detektiert.  Trotz  einer  Selektion  der  getesteten  Klone,  die  solche  Klone 
bevorzugte, welche STAT5-Bindungselemente in der Nähe oder in bekannten 
Genen und mit mehreren STAT5-Bindungselementen haben, ist nur ein Klon 
(c398)  von  den  neun  validierten  in  einer  traditionell  definierten  proximalen 
Promoteregion  lokalisiert  worden.  Mit  Ausnahme  von  zwei  Klonen  (c20  und Zusammenfassung (German Summary) 
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c194), welche mindestens 10 kB von dem nächsten annotierten Gen lokalisiert 
sind,  befinden  sich  die  anderen  sechs  in  den  intronischen  Regionen  von 
annotierten mRNA oder EST Transkripten.  
Die  Konservierung  von  Sequenzen  zwischen  verschiedenen  Genomen  weist 
auf eine mögliche funktionelle Bedeutung dieser Regionen hin. Vergleiche der 
STAT5-bindenden Maus-Sequenzen mit genomischen DNA-Sequenzen von 12 
anderen Wirbeltieren zeigten, unterschiedliche Grade der Ähnlichkeit. Manche 
Sequenzen  wiesen  eine  starke  Homologie  zu  anderen  Säugetieren  auf, 
während andere Sequenzen nur Ähnlichkeiten zwischen den zwei Nagetieren 
Maus und Ratte aufzeigten. Während einige Maus-Sequenzen Ähnlichkeiten zu 
anderen  Säugetiersequenzen  aufwiesen,  was  auf  eine  engere  evolutionäre 
Beziehung  zu  einander  deutet,  zeigte  keine  der  neun  STAT5-
Bindungssequenzen eine Verwandtschaft zum Huhn Genom.  
Die  Fähigkeit  von  vier  neu  identifizierten  STAT5-Bindungsregionen 
transkriptionelle  Aktivierung  zu  vermitteln  wurde  in  Reportergenexperimenten 
analysiert.  Drei  der  vier  verifizierten  STAT5A-Bindungsregionen  zeigten  eine 
STAT5  abhängige  Reportergenaktivität.  Die  Transkriptionsaktivität  ist  dabei 
abhängig  von  den  STAT5-Bindungsstellen  in  den  klonierten  Regionen,  wie 
durch  Mutagenese  dieser  Stellen  gezeigt  werden  konnte.  Von  besonderem 
Interesse  ist  der  Klone  (c153)  welcher  ein  STAT5  und  drei  STAT-ähnliche 
Motive innerhalb einer 339 Bp Region besitzt. Diese ist zu 80% zwischen dem 
Maus und humanen Genom konserviert und liegt ungefähr 63 kB 5’ von dem 
Nuclear  factor  I/B  (NFI/B)  Gen  entfernt.  Die  Expression  des  NFI/B  mRNA 
Transkript’s  korreliert  mit  der  in  vivo  Assoziation  von  STAT5A  an  die 
konservierte c153 Region, während der Stillzeit. Zusammenfassend, weisen die 
Resultate darauf hin, dass diese STAT5-Bindungsstellen enthaltende 5’ Region 
von  NFI/B  Gen  vermutlich  ein  cis-regulatorisches  DNA  Element  darstellt, 
welches  STAT5  induzierte  NFI/B  Gen  Expression  in  Mäusen  während  der 
Stillzeit  vermittelt.  Insgesamt  demonstrieren  die  Resultate,  dass  die  ChIP-
Konierungsmethode erfolgreich für die Klonierung einer Bibliothek von neuen 
STAT5  DNA-Bindungszielen  aus  dem  Brustdrüsengewebe  stillender  Mäuse 
eingesetzt werden konnte. 
Eine  Analyse  der  DNA  Klonsequenzen  der Bibliothek  nach  dem  klassischen 
Konsensus  GAS  (gamma  interferon  activated  sequence)  STAT5-Zusammenfassung (German Summary) 
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Bindungselement  (TTCNNNGAA),  konnte  diese  nur  in  14%  der  Klon 
Sequenzen nachweisen.  
Um zu Überprüfen ob STAT5 eventuell alternative Bindungselemente benutzt, 
beziehungsweise über die Bindung an andere Transkriptionsfaktoren rekrutiert 
wird,  wurde  eine  Analyse,  der  DNA  Sequenzen  der  Bibliothek,  nach 
überrepräsentierten  Motiven  gemacht.  Eine  solche  Analyse  erlaubt  die 
Identifikation, auch von nicht bekannten Motiven, anhand Ihrer Häufigkeit. Als 
Vergleichssequenzen  (Sequenzen,  die  nicht  selektioniert  wurden)  für  diese 
Analyse,  dienten  zufällige  DNA-Sequenzen,  mit  ähnlichen  genomischen 
Lokalisationen, wie die Klonsequenzen. Mit Hilfe des Bioinformatikprogramms, 
Trawler, wurden die Sequenzen nach überrepräsentierten Motiven durchsucht. 
Diese  Analyse  kann  durch  die  Identifikation  von  Bindungsstellen  anderer 
Transkriptionsfaktoren  auch  zur  Identifikation  von  Kooperationspartnern  von 
STAT5 in der DNA-Bindung führen. Ein Teil der gefundenen Motive, weist keine 
Übereinstimmung  mit  annotierten  Transkriptionsfaktormotiven  in  den 
Datenbanken auf. Bei diesen kann es sich somit  um neue Bindungsmotive von 
anderen Transkriptionsfaktoren oder STAT5 handeln. Andere gefundene Motive 
dagegen  ähneln  annotierten  Transkriptionsfaktorbindungselementen. 
Insbesondere  ein  Motiv  wurde  von  Trawler  als  dem  STAT5-Bindungelement 
ähnlich definiert. Dies weist darauf hin, dass die STAT5A ChIP angereicherte 
DNA Bibliothek eine signifikante Anzahl von einem Motiv enthält, welches dem 
Konsensus STAT5-Bindungselement ähnelt. Weitere Analysen müssen klären, 
ob dieses Motiv tatsächlich ein alternatives Bindungselement darstellt, welches 
in  vivo  von  STAT5  (alleine  oder  im  Komplex  mit  anderen  Faktoren)  im 
Brustdrüsengewebe  von  stillenden  Mausen  gebunden  wird  und  so  potenziell 
STAT5-Zielgene reguliert. 
 Abbreviations 
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7. Abbreviations 
 
A   Absorbance 
Ac   Acetyl 
Ahr   Dioxin-Ah receptor complex 
Arhgef3   Rho guanine nucleotide exchange factor 3 
ATP   Adenosine 5’ triphosphate 
bp   base pair 
bHLH   basic-Helix-Loop-Helix 
BLAST   Basic alignment search tool 
BLAT   Basic-like alignment tool 
C   Carboxyl terminal 
CBP   CREB binding protein 
ChIP   Chromatin Immunoprecipitation 
Chr   Chromosome 
CIP   Calf intestinal phosphatase 
CIS   Cytokine-inducible SH2-containing domain 
CT   Threshold cycle 
CTD   C-terminal domain 
DBD   DNA binding domain 
DEPC   Diethylpyrocarbonate 
DMSO   Dimethylsulfoxide 
DNA   Deoxynucleic acid 
dNTP   deoxy nucleotide triphosphate 
ds   double stranded 
DTT   Dithiothreitol 
ECM   Extracellular matrix 
EDTA   Ethylenediamintetraacetate 
EGF   Epidermal growth factor 
ELF5   E74-like factor 5 
EMSA   Electophoretic mobility shift assay 
EN-1   Engrailed 1 
EPO   Erythropoietin 
ERalpha   Estrogen receptor alpha 
ERBB4   Epidermal growth factor receptor (ERBB) family 
EST   Expressed sequence tag 
Expi   Extracellular proteinase inhibitor 
EzH2   Enhancer of Zeste homology 2 
FCS   Fetal calf serum 
g   Relative gravity 
GAS   Gamma-interferon activated sequence 
GH   Growth hormone 
GITC   Guanidinisothiocyanate 
GM-CSF   Granulocyte/macrophage colony stimulating factor 
GOI   Gene of interest 
GR   Glucocorticoid receptor 
GTF   General transcription factor 
HAT   Histone acetyltransferase 
HDAC   Histone deacetylase 
HKG   Housekeeping gene 
HMT   Histone methyltransferases 
HOX   Homeobox 
Ig   Immunoglobulin 
Igsf3   Immunoglobulin superfamily, member 3 
IL   Interleukin 
Inpp4b   Inositol polyphosphate-4-phosphatase, type II 
I   Involution 
IP   Immunoprecipitation 
IPTG   Isopropyl-beta-D-thiogalactoside 
IRES   Internal ribosomal entry site 
JAK   Janus Kinase 
kb   kilobase Abbreviations 
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K   Lysine 
L   Lactation 
LB   Luria Bertani 
LCR   Locus control region 
LINE   Long interspersed nuclear element 
LMPCR   Ligation mediated PCR 
Lmo2   Lim only protein 2 
µ   Micro 
M   Mol 
Me   Methyl 
mef2   Monocyte enhancer factor 2 
MGF   Mammary gland factor 
min   minute 
Mm   Mus musculus 
mRNA   messenger ribonucleic acid 
NCAM 2   Neural adhesion molecule 2 
NCBI   National center for Biotechnology Information 
NFI/B   Nuclear factor I/B 
NH2   amino-terminal 
OD   Optical Density 
p   Plasmid 
PBS   Phosphate buffered saline 
PCR   Polymerase chain reaction 
p-CTD   Phosphorylated C-terminal domain 
Pdx-1   Pancreatic duodenal homeobox 
PIC   Pre-initiation complex 
PRL   Prolactin 
P   Pregnant 
PR   Progesterone receptor 
PSE   Proximal sequence element 
qRT-PCR   Quantitative real time PCR 
RANK-L   Receptor activator of nuclear factor (NF-kappaB)-ligand 
RBm27   RNA-binding motif protein 27 
RE   Recognition/response element 
RNA   Ribonucleic acid 
RT-PCR   Real time PCR 
SDS   Sodium dodecylsulfate 
SH2   Src-homology-2 domain 
SOCS   Suppressors of cytokine signaling 
STAT   Signal transcducers and activators of transcription 
TAD   Transcriptional activation domain 
TBP   TATA-box binding protein 
TEB   Terminal end buds 
TESS   Transcription Element Search System 
TF   Transcription factor 
TSS   Transcription start site 
UCSC   University of California Santa Cruz 
UV   Ultra violet  
V   Virgin 
WAP   Whey acidic acid 
wt   wild type 
Y   Tyrosine 
YWHAZ   Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta  
  polypeptide 
YY1   Yin and yang 1 
Zswim6   Zinc finger, SWIM domain containing 6 References 
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9. Appendix 
 
 
9.1 STAT5A library sequences 
 
STAT5A Library (non-redundant, non-repetitive DNA sequence dataset) 
Clone ID  Sequence 
 
11-M13for_3
  TGCCCCCTACCGGNTTATTATGAAACTGCAGGCCGCTCAACTCACCGCCCTCCTGGNTTGTAGGTGTCATCTGTGGTCATCCGGTCCTCACCA
TGTGGACCCCGCGAGTGCCCCCTCCACGCCCGGNCCTGTCGTTTTTCCTGNTGTTGCTCCTGGGGGTCA 
13-M13revfor
  NNTTCNNTTCCTATTACNNCACAGTTAGAGACTGTGGGTTTGGGGTTTCNAAAGCTCACCCGTGTGTGAAAACAGGGAGACTTGGTACTTAAG
AATGGTGCCCAGACAGAACTCAGCATACTGTTNTTACAGGAAGACCAGGGTACACCATCCCTAAGTCACGTGCTTTTCTGGTGACATAATCCTCATATAATTT
CAACATTTCTGAAACACTGCAATCAGAGGCTAAGATCCAGCGATTCTGTTTTCAGATATTCTCAGGAAGCCAAAAGCAAGGGCCCGGGTTTCTGTGNGTTCA
GTCTTCTCAAACCCATCTAAACGTCCACTGGCGGATGAGCGGGGACACGAGCTCAGGCACAGGCCATGCACGGAAGGCGTGGAGTTGACTCAGCCNNAG
GAATGAAGACGATGCTGGGACAGGCCACAGTATGGACCAGTCTTTGGGCTCATATGAGCTGCAGGGNNGTTGAACTTGGGAGCAGAATGCGTGCAGGGGT
GGAGGAGGAGGCAGTGTTAGTGTTTAGACTTCCGATGGGGAACCATCTGGAAGCTGTGGGATGAGTGGTGGTGGCAGCCAGGCAGCGNGGTACAGTGAG
AACTGCTGAGNAGAGCAGGGTCGGTGTTGTGTGTTCCATCTCGAGAGAACGGTAGAGGGGAACCAGAGGCAAGGTGCTGGACACCTGTCCCGTTCTGTCA
GTTCAGT 
14-M13for_1
  CCACAGGCAGCCAGAGAATGGGGTATGGGGGTGTTATGTGAGACCCGGGCATATTGTCCCTCTGAGAATCTATGCTCTAGATACTGGACTCA
AACAAGGTTCTGTACAGGGNgTCCTCAGATCCAGGCCAGGGCTCATGGAAAGGGTAACTAAGAGCTGGTGACTGCTGTCTGTATGATGGGGACCCAAATGC
TAGCATAGGTGGGCTTGTTGCAGGATTGGATAGCTCTGTGAGGGGACGGCTTGGTCTTGGGGCTGGGTCCCTGCTCTGTCTGATACCAATGCTCATCTCCC
TAATACTGACCTTATCCCATGCCTTGGCACTCTGTGAATGTGCTTTGGGGAATGATTAAAGCTTATGCGGTCTCT 
151-M13rev_3
  CTCACATCTTCCTTATTAGCAGTGAGACCACAATTTAACGTCTCTGAGCCTCAGACTTTTCATCTGTAAAGTAGGGATAACAGCAGTCAGCATC
CTAACGTATGAGTCAAGGATGTTGGGAGAAAACTGTGTAGTGCCTGCTAGGAACCCAGTAAATGCAAGTTCTACTCTTCTATATTGTCAGGAAACACCAAGG
TCAAAGCAACAGGCAACCTTGGCTTCTAAACCTGCTGTCACAGGAGGCTGCTCTCTCTGGGAGAGTGTAAGAGCATCCCCAGGGAATGTTTAGAAAGGAAT
CTAGGCTGGCAGCGTGGTGGCCTAAGCAGACTGTGGGGAGTTCCATTCCAGGCTGCATTGTATAGTGAAGCATTTGTCTCAACCACCACCAACCACCACC 
153-M13rev_4
  GGGAAGGATAAAGGAAGTCTGACTCACANNGGGAGTCGGAGGAGGATAGAGCTATTGAAAGAACAGGAACAGGTATTTTCCGTCATATTCATT
TTCTTAAAATTGAATTAGGTTTCTATGAAAAGCCGTTTTGTAGAATAACAGCCTCTTNATGGTTTTACTAACTGAGACATAAAAGACTACCTGAGGCATGTTAT
GATTGCTGAACACACNNNAAAAATCCCNTACTTGCTGGTTATGCTGAATGATGATCAGAANAAGGCTCTTGTGAATAACCTGACC 
154-M13rev_1
  CATGTCTCAGTCAAAACCAATAAAATAAATAAATACAAAATCGAAAGATTAAAATGATTTGAAGATCAGAAACATTTGAGACTAAAAATATTCCTT
CTCCACACAACTTGGCTCTGTTTGTTTGTTTGTTTGAGATTGGGGCTCACTATACATGCCTGGCTGGCCTGGAACTCTTACCATATAATTCAGGCTGCCCTCC
AACTCACAGACATCTGCTTGCCTCTGCCTCCAAGTGCTATGGTTAAAAGTATGGATCCCCGTGCCTGGTAGCTGATTTTGATAGAAGGAAAGAAAAGAGTAC
CTCCTCAGGTGAGAGGTAGGATGCCACAGCTGAAAGATGAGTTATATATAGTCAGTGAACTAACTGGCTTCTGAATATCTTC 
155-M13rev_2
  GGACATCTCAGAAGAGGTCTCAGACTGTCACACAGCAAATAAACAACAGGGCTGGAGGGCTGGCCAGGTCTGCTTGGCTGTGTTCCTCCCTC
CTCTAGCTGCCCCTCTGTGGCCCTGATTGTTCCCAGGAAAGTTGCAGGAGTGGGGTGGAGAAGAGGTGACTCCCACAGAGCCTGCCAGGTCTAAGATACA
AGGACAGGACTCTAAGTTCACTTTCCTGAAGCGTTTCAGCCTGCTTTGGCAAGTCCTAACCAAGGATCCTCAGGTTAAAGACACAAAGAAGTCTGTGAGAGC
TGTCACCTCAGGGCCTGGCTCTGGCAAGGACAGGCCCTGGCAGGCCTCCTCCTCTTCCTCCCTCTCTGCCTTGGCTTCTCTCCTGCCGTAACAGA 
158-M13rev_3
  CCCCAATGGATCATGTCTCTGGAGCCCACCCCAGACACTCAGTGTAGATTGCTTCCTTACAGCCTCTGAGGAGGACCACAGCAACTCGGCCT
GCTTCGCCTGCGTCCTGCTGAGCCACGGGGAAGAGGACCTGATTTACGGGAAAGATGGCGTGACACCCATAAAGGATCTGACAGCTCATTTTAGGGGAGA
CCGATGCAAAACCCTGTTAGAGAAACCCAAACTCTTCTTCATTCAGGTGCTTTTGAGGGCAGTGGGACTGCATGTGGGGAAAGCTAACAGGGCAGGAGCGG
TATTATCTGTACAAATCAACGTGCCATTTCCCTGGGGAATGCACGCTGGGGCCGGGGCTTCCTGCCCAGAAATGGTTGGTACGGGCACTTGCTGTATTT 
160-M13rev_4
  ATGCACATGGGCTCTTCTGTCATTCCTGTGGTACTTCATAAATAGTGATTTTAGTACGTCACACACTAATTTGTCTTTGAGCCACATCCAGGAAG
TCAACGTCCAAACTGCTACATCAGTTATAACCTTTGTTGTCCATCTGAGTCCTCCAAATGGTCATCCTCGCCTTGTAATTATACAGATACTCTACTCCTGATAG
AGAATCAGTCACTACTTGAGATGAAGCAGACTAATCCTTGATCTTCTAAAGAATTTCCACGCTCTGGCCAGTCTATTTCAGTAGCTGTGTCCCCTTTCAAGCT
GCATGTGCATCACTAAAAAGCCTTTTAAAATTATCCTCCTTTTCTCTTCTCCTTCTCTTCTCCTTCTCCTCTCCTCTCCTCTCCACTCCtCTCCTC 
162-M13rev_2
  AATGTAGAGTGCAATTTCTCTGTTGATGACAAACTCGCCCACGTGGGCTTCGTCATGGGTTTTCAGAATGAAAACAAAGTGCATTCATGGGGGT
CACTCCAGGTCATAGGGGTCACTCCAGATTAAAGTTACCTAGATAGTCGTCTATACTGCTGAGATTTAGTTTCACATGTGTGAGACAAGAGAGGCGAGAATA
TTCCCATCCCCGTAGATCCAGCAGGATTGGCTTAAGATTACGGCTGCAGAGGGCTTTGGAAAGGCTAAGGGGCCACAGGCATCCAGCTGTGAGTTATAAAT
GCCTGGCACGTGTCCACAGCTGCCGCGTGCAGGTACTATTTTTGAGCAGCCTTCCAAGCACATTTCTAGAACCTTATTCCTGCATATTTGCCAGGGGAAAGT
TGATTTT 
163-M13rev_3
  TTCTTACCGTCTACCATGTAGGCCCCGGGGATCAAACTCAGTCCTTGAGGCTTGGCAGCAAACACATTTACCCACTGAGCTACCTTGCCAGCC
CCTCATTTGCTTTAATTCTTAGAGAAATTTGAAAATTCCCTAGACACAGGCCCAGAATGGTCAAGAAACTTGCCAGGAGTCGGTCAGAGAGGAGTCGTGGTG
CCCAGCTAGGAAGACCAACTCTAGGTTTTTCATTGACAACTCCAGATTCTCGGGGCCTGTGTCAGGAAGATAGAGATGGCTTCTCTGTCTGGCAATGTGCCT
TAGGTTCCCGGCAGCCACCCCAGGTCTGCAGAGACCTCTCTGCAGCCACAGCCCCCAGGCCCCTCCACCTCCTGCCTCCTGCTTCGCCTGTGGCTTATAA
CCCCATAAACCTTTTG 
169-M13rev_2
  CTTCCATGGTGTGGTCAGTAATAATTTGCCCATGGACCATTAAGTAATCACCAAGTCATGTAAATAAAATTAAGTACAATCAGTAAAGGGAAAAT
ATTTTTAAAAATCAAAATAGGATGGGACTTAATTGAAAAAGAAAAGTTTTTGTATGATGAAAGACAGTAATAGGGGTGGAAATGACCAATATTCATCATATACA
TGCATACACTTGCTAGAGAATAGAAGAAAATGAAACAATGCTTTTTATGTTTGTGGTTATCAAATGCCATTATATAAAATAAAATTTGAGCCAGAAACAGTCTTC
CAAGATGCCATAAAAAGTTTTACAT 
175-M13rev_2
  GAACTGAAGCAGAGGTTCTCTACCCCACTGATGTGAGTACCGACTGCTGATTCCTAAGGCTCAGGCTACTCGGTCTTCTCTGACTTCTCTGTTT
GGGGATTTCCTTTTGGCTGAAGGGCGTTGTAGTGGCTATTCCTGGTTGTCAACTNGACAATATTTGGAANGAACTACAATCCGGAATTGGAAGGCTCACCAG
TGATCCTTATCTGGAGGCTTGGAGATCCTTATCTGGATCTTGGTTTGAAGATCTTGAGCCATAGTGGCTATGGATTCCAGAAGATTGAATCTCCGAGTTTAAA
GAACACACCTTTAATCTGGGCTACGCCTTTCATCTGGGATTAAAGGTGTGGTGGAACACACCTTTAATCTGNGCTACACCTTCTGCTGGAGA 
177-M13rev_3
  ATTCAGGGAATCCCATATGTCTCTTTGCCGGTCTCGGNATTTCCCAAGTGTCTTAATCAAAATAACAAAGACAGCAGCGTGTGACAGTTCCCTT
TCTGTTCTGGNTGTCCTTGGGCCACAATGCAAATTGTAGTCATGTTTCCCCATCNTCTTCTATCTGAAGAGTTCTTGGTTTTTCCTTGTTCGCCCAGAGGAGG
AGGACAGCAGAATCCCNAAGAGTAGCTGGTCCTCAGTCTATGTGTTTTGTCACTATCCTCCTCTCACGCCATCAAGAATTCNCNGNGNNACCACTCAGGATG
CCGTCAGTCACGTGGGTCTCTTGGTTTTTC 
17-M13revfor
  CNNTGTGGCTTTGTTGCTGCCNNCCCTCCAACTTCCAGCATTTANGCAGAGGCAGCCACCTCTGTTATTCCTACATTTCCACCCNTTTGTTTTT
AGATTTTTACAGCCTAGTGGGAGCTGGGGTGCCATTGCCTCAGCATTGTTGATCCCAGCTCTGAGGATTCCCTGTATACTGGACTGTGCCTGTCTTATGTTG
TTCTATCTTCCATGATCTCACCCATCATTGACTACCAGCCCTTAAAGAGACATCACTCCAAAGGAATGTCATGCAAGGGGGAGATAAGGAACAACCTATATG
GTGGCCTCACAGATCTTGGCTATCCAGACATAGATCATTTCCTTGAGGTGGGGGCCACAATCAGGATTTTTAAGAGCCATCAGCACCTGGAGGGCTACCTTA
CTTATGGAGCACTGCCTTAAAATATGTGGTGAGAGATACTTTAATAAAATTATTATTAGTAGGACAATTCTTCCCATCATAACATGAATGGCTATCCATGAGGG
GTCAAATACCCTCTTAANATTTTCCCACACTTTGCTCAAGAATTCAGTATCTAGGAAAAGCACAGATACAATGGTTGCATTG 
180-M13rev_4
  CTCCAACCCCAAAGTCATTCTTGACCCTAAAAAAATTGAAGGCCAATCCGGCTCTCAGAGATCCCGTCTGAGCAAAAGGGAGGAGGCAGTAGGAppendix 
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TTTCTGTGCTCTGGGAAACCGTGGGACTCCACGAGGCCTAAGAACAGGAAGTTAGAGGTGAAGGGCAGAAAGCAGCCTTTGGCAGCTGACCTGCTCTGGG
GGCTAGGGTTTCCTCTGCACGTGTCCCCAGTATCTGTAACATTTGAGCCTCGCTCCTGCTCACCACCCTGCCTGCCTCCAGACAACACTCTCTCACGGCAT
CGTGTTCATTTTAACATCCGGCCCCCTCTCAGAGACGTCAGGCAGGAAACTTGGAACCAGGTGGATTACCAACAAAAAGATCTCCAGAGGGACAGGAGGGA
CAGGGAGA 
186-M13rev_1
  TCATGGTCATGATCATGGTCGTGACCGTCCTCGTCGTGGTCATGGCCGTGTCCGCCGCAATGCAGGTGCGTGCCGTGCGGGTGGCAGGATT
CGTATTCATGGCTATGGCCCGGCAGGCCATAGGTGCTGTTCTGCTGGGTGTAGGCGACGCCCAGATAGCCGCGCGACCCGATCCAGGATGCGCCTAGTG
TGGCGGTGCGGCTGTCGTTGGCGGATCCGTCCAGACGCTTCTCGCTCCAGTCAGGAACCTTGTAGTCGTCGGTCTTGCGCCGCGCCGCCTCGATGCGGA
CGGCGAAGCCGTTTCCGCCTGCGGTCAGGCCGGCCACCGCCGCCTCTTCATTGTCCGCCGAGCCGATGCGGACTTCGGCGGCGCCCTCTCT 
188-M13rev_2
  TNNCTTGCACGTGAAAAAGGAACTCTGAATTCCCCTAGGCGCCGGTTGCGCGGAANTAGGAGACCAGGCTCCCGCCCCTTCCACACTCCCGC
CGGGTTGCGGAGGCCATNCAGTGGCCCGCGCAGCCTCCAGGGGGCGAAGCACCCCAACCGACAGCAGTCTGTCGGTCCGAGCTCCATCATGTTTATTCC
CCAGCANAGGCTAACCGGTGGCAGAGGTCCTTGCTCTGGGTGTNANCTCTACCTTCCCCACCTGCACCCCAAGNTGACTTGGTCAGGTTCCAGTGCTCTG
CCGTCGAGTTGGCCATGTTTNNNTAGGCCCCACTATACTTTGTGTTGACACCGTGTCCCTCAACGACAGAGGTTTGAAT 
189-M13rev_3
  ATGATAGACTGAACCTCTGAACCTGTAAGCCAGCCCCAATTAAATGTTGGGTTTTTTTTTTTTTTAATAAGATTTGCTTTGGTCATGGTGTCTGTT
CACAGCAGTAACTAACTAAGCAGTACCTTAAGACACCATCCAACCACACACACACACATCAATCCACCCAACCAAATATCATCCATCCATTCACCCACCCTCC
TGTCCTTACATGAAGACAGGCTGATTTTTTAAAATTATGTATCTATATATCTATATGTATGAGCTATCTTCAGACACGCATCAGATCCCATTACAGATGGTTGT
GAACCACCATGTAGTTGCTAGAAATTGAACTCAGGACCTCTGGAAGAGCGGTCAGTGCTCTTAACTGCTGAGCCATCTCTCCAGCTCGAAGA 
190-M13rev_4
  CTAACGGCCNNCAGTGTGCTGGAATTNCGCTTGCGGNGACANNGGAGATCTGACATTCCTAGTCACCCACTCTTGTCTTGTTTCCTACAAAAT
GAAACCGCTACCACAGTGCCTGATTCCATCACTTGTCTTGAAAGTTAATTGTTCCTCACATAGTCCAGGCTTCAGCTCAATACACAAGTAGCAGATACTGCAG
AAGAATTGCATGTTCTATCCGTCTTTAAGTAATTCTAGTGCACACTGAGAGTAAACGAACAATGATACCTGTAATGAGGAAACAATTGTCTTATGTAAACAAAC
TTCCCCCAAAAACATAGAATGANACATGTTGGTATTCTTTCNTTCTTTGTGGGTGCANAAAGACACAATCTCAATTTTCTAATTTTTATTCCTCANCTTGAACTN
CTTCATGGGNATGATCANATCTGACAGTGTCGCTTTCTG 
194-M13rev_3
  AGGAAGTAGCTGAGGAAGTCTGGGAACTGCTGCTGACCCATTGTTCTTGCCTCAGGCCAGGTGGCAGGGCAGCTTCTGAGGCCTGGACTTGC
CTGGAATTGCTCAGTTCTTGGAAACAGAGATTTAGGCCTAGTCTCCATAACTGCCGATCTGAAGCTTGTCATAGAATCAGCCTAACCTTTTCATTCCCCCCTT
TCAGATGGGCCATCTTGAATCCTTGAGATGTTTCTGAGGCACCTACACTAGCCATATTGTGCTTCAAACCACTCTCGTTACCAAGCATGGGTCTTCTCCAGCT
GAGACACTCAAGGCCATAGGGCCATCATATTCAAAGAACCTGCTCTTCTGGATAGCTGGGCTGTTCAAAAGAAGAAAGCTGGATTCATTTATTTAA 
195-M13rev_4
  GTTATACTCTCAGTACCTTACAGAACCTCATTATCATGCCTGGGCCAGGCAGTGTTTTTGCAAAAAACTTTACTGCATATGTACACATTGGTTGT
TTGTCCAATCTTATGCATGGTGGCCAGCAGTAGTCAGTGCCACTCAGCAACGGCACATGTGGCTTCCTACAATTGATTGCTTGGAGACACTGTCTTAGTTAG
GGTTTTACTGCTGTGAACAGACACCATGACCAATGTTAAGTCTTATAAAAACAACATTTAATTGGGGCTGGCTTACAGGTTCAGAAGTTTAGTTCATTATCATC
AAGGTGGGAGCATGGCAGTATCCAGGCAGGCATGGTGCAGGAGGAGCTGAGAGTTCTATGTCTTCATCCAAAGGCTGCTAGTGGAAGACTGACTTCCAGG
C 
19-M13for_2
  GAACCTCTGAGAATACGGTAGGTGCTTCACCTGCTTCTGACCAGGTCCCTGTCACATGACACACTCCCTACATAGGAACGTGACCAGTGGTTA
GGTAGATCAGAACTTAGTTCTCCATGCTAATGAGTTATCCAGAGGGTTTAAACAATAAGCTTTCCTCCTCAGGACATTCCTTCCTGCAAAAGGTATTTAATCTC
TGGTCCATCCCGAGAAGGTGGTATGTACCCACTTTCCATGATGAACAATCAATAACCAGTTTGGAACCCAGGACTGCCTCTCTGAAGAACTACTGTGGGGAG
CGTGGAGGAAGCCTTTGTCTACAGAGCTTCTACAGAGCTACACCATCTTAAGTGTCCTGAAAAAGGCCCCTCCACAC 
19-M13rev_2
  CCTGCACCACCATTGAGTACTGGGCTTGAGTGAAAAAACCACTGGGCTGAGGCTAAAGCCGGGGTTCCCAAGCTCACGGGCATCCAGGTGCC
ACTGGAAACCACATGGAGTCAGGAATGAAGGGGATCCATGGGCCTGGGGGGGGGGCCAGGGCGGGGGGgGGTACCAAATTCCTGA 
1-M13for_1
  CCCTGCTGATGCGCAAGGCAATCGCCGCCTGCCCGGATCTCAgAATCCTTATCCTCGATCCCCACAGCGAGTTTGCTGCTTCCCTGCCCGAG
CACAGCGTACGCATCGACAGTTCGACGCTCGACCTGCCCTTCTGGATGTTTCATCTGGAAGAACTCGCTGAAGTGCTGTTTCGCGGGCGCGAAGCCATAGC
TGAAGAAGTTGACCTTTTGCGGGATCTCGTTCCCGTCGCGCGCCAGATGTATCGCAATGGCGGATCATCGGCCGTCACGCGCCGTGGTTCGGATACTCTG
ACCGCCGACACGCCCGTGCCCTATCGCATCGCAgATCTGCTGAAACTGATCGATGAGCGGATCGGTCTGCTGGATGGCAAGGCGGAAAGGCCG 
205-M13rev_1
  AACCCCGACTAAGACAATTACCATTTATAGCCTTTTGTATTTAATTGTCCCAGAGAGCAATGCTTATATGCACAGATTATGATATCATGTACCCC
CTTCTACTGATACTGAATTTCTTAGTGACTTTGTTCAGCTGAGTGCACTATATGATGCAGCATTGGAATGTGAGAATCAATATTTAACTTGATATTGTTTATAAT
ATCTATGAGAAGGGTGGAGTCTAACAAGACACACACAGAGATCTCTTAGAATGCCTCTAACACGTTATTCCCTCCAATTTTGATTCCAGTTACCACTTAGGAC
TGAGAAAAATTAGACTCTCCTAAACATGCTGTTTCATTCAAAGTTAAAAAAATAACCTTCATAATTGATTTAAATAGTA 
207-M13rev_3
  TCCTCTGCAAAAGCAGCCAGCACTCTTACCTGATGAGCCATCTGTTTATTCCATATTTGTGTATGTATGACTGGACACATGTAGAANTCAGAAAA
CAACATGTGGGAGTCCGTCTCTGTCCACCCTGAAGGTNTCAGGGATCGAACTCAGCTCCTCAGGATTGNCAGCATGCNCCCTTACTGTCTGAGCCATCTTT
NAGGNC 
208-M13rev_4
  CAGGGTTCGACCTTCGAAGACCNGCGTCgCCAGTCGTCGGAAaAGCTTCAGGANATCGNCTTCGGCGGCTACGCCATCGGCGGCCTGGCCG
TGGGCGAAGGCCATCAGGCCANGTGCGAGGTGCTGGATTACGCGCCCGAGTtCCTGCCCAAGGATCGCCCCCGCTATCTGATGGGCGTGGGCAAGCCGA
TCGATCTGGTCGAGGCGGTGTATCGCGGCGTGGACATGTTCGACTGCGTCCTGCCGACGCGCGCCGGGCGCCaCGGTCAGGCCTGGACCTGGGACGGC
CCGCNGAACCTGAAGAACGCCCGCTTCGCCGAGGATCAGGACCCGTCTGGACCCGACCATCGACGGCCCGTCGTCgCAATATTCAAAAGCCTATCTGCAC
CACCTGATCCGCGCCG 
209-M13rev_1
  ACAAGGCTAGTTGTTCCCCTTTTCTATATGTTTGGCTCTGCCTTGTGATGGATTATTAATGATGTGCTAAATCCACATTCTCTTCTTGTGCTATTT
GCTCTAACACGTGCAGTTTTTTCTAGACTAGAGAGATGCTGAATAGTCTTGTGGCCCGCAGATATGATTCACTGTTCTTTCATTGTAGATGGAGACAGAGGCA
GACAGACAGTAGAAATCAGAAGTGGAAGTAATAGCCATCTCAGCAGCTGCTTCATGGTTCTCTGGGAAATGGAGCAGCGAGTGGGGCTGAAGACAATCCAC
CTGACAGGCTTAGTCAGTACAAGATTTCAGTCTTACACTGTCAGGGCATATTAGTCACAGAGTGTTTCCCAGGTATGAGTTAT 
20-M13rev_3
  CACCCCTGAGTGCCACAACCAGTCAGGTACCCTCAGTGAAAGGACAGGTGTCCTGCCAGTAGATGGCCTATGTATGTGGTCCCATAAAGAGA
AAGGACATTGAGGTGTAAAAGTCCTTTTGGGATTCCTGTGATTCTATATCTACTTGTTCTGCCTCCTAGAGTGAAGAGGCCTCTCCTGTGGGGTCATGTGAG
GGTGCCAAAGCCTCTGtACGACATGTGGATTTGGGGCTAAATAGATAGCCCTCACCCCTTGGGCCTCTTGGGGACCACTAGGATTGTGGGAGACCATCCCC
CCTGGCAGTCAATGATTAGCTTTGGAGACACCAACTTGGGCTATCCCTGCAGGTCCTCAGTCTCCaAGAGCCATGAGTATCCA 
219-M13rev_1
  CTGAAGAATGACAGCAAGAGGGACTTGGCAAAgATGCTGTTAGATTGCTACCAGGTGGGGTCAACTGCAAGCCATGCACAACCAGACGAGAG
GCAGGTGANAGGGTCTGAGATGCTGTGTGATCCAGGTCATGCCCAGCAATACACAGGCTGTACAATAGTGAGTGCCTGCTCTTGCCCCACTGTAGACNgGC
ATTGTGACCCAGTCCTGACTGGCATAAAAAGCTTCCTGTTTTAAGAGTGACTTGCCAGGTGTGTGGTAACCATGTGACTGGCTTACTTGATACGTATTCCCAA
TATCTAATACTTCCTGGTTATTAGCATCCTAGACTCTTGGCTAAACAAAGGCCAATTTTTCAATCTGTTCAGTCTCACCCCAACT 
233-M13rev_4
  GGCCTTTCTGTTGAGTGGAAATGCACCTTAACTTGGTGCTGCCAGCAGCCTGCAGGCCCCAGCCCTGTTGAGATGAACACAGTTGACAATAAA
GGAATGAGTATCATTGTGGAGTCGCTTGCCTGCTTCTCTCCCTTTGCCTCTATCCTGCATTCCCCTTTTCAAGCTCGCCTTTCTCTCCAGCTTTTTCAAAAAGT
GTTTGGAGGCTGCCCACAGCGATCAGAACATCGGAGGAGAAATAACTGCTCAGTGAAAGGATGTCTGTAGAGCTGCTGGATTCGCTTGGCTGTTAGGGGG
CTTGTGTAGCACGTTCAAGACACTGCTCCATTCCTGGCACGGGAAGAAAGAAAAGGATAATAGGCTAGGGCTGGTAACAGAGCACAGTGGGCAAAGTGCCT
GCTGCCAAGGCTGGCAGCCTGATTGGATCC 
234-M13rev_1
  TACAGGTGGTGTTTGAGCAAGCTCAGCAGCTGTCTCACCGAGTTTGTGCGAGAGGCAAGTATTTCAGAGCATGAACATGGAATGTAGCCAGAT
CCCAACGTCGAGACAGGAAAGATGGGCTCACCTTGGTTTTAATGAATCAGCGAATGAGGCCAAGAATTTCAGAAGAGTCAGAAAACATCCAGTGGTGGAGA
AAGCATTACAGAGGAGTTTCTCAACCTGTGGGTCGCAACCCCTGTCTCAAACCTCTCTCTCCCCAAAAATATTCACATTATGATTCATAGCAGCAGCAAAATT
GCAGTTCTAAAGTAGCAATGGAAATACTTTTAGGGTTGTGAGTCACCACAACATGAGGGACTGTATTGAGGGGTCTCAGCTTTGGGGAGATTGAGAACTGCT
GCATTAGAGGGTCTACTTTTGC 
236-M13rev_2
  GAAAAATTGCCATCTATTTGAGCTTTTTTTTTTCCTCTATAGGAGTAGTTCATGCCTCTAAAATAAGTAGAAAAAGAAAAATGACAGGAAATTTGA
AATTCAAACTTCCAGGCTGCTACCAATACAGTTTCTAATAGGCTTTCAGAGTTGCTTCTAAATTAAATCAAAACAAAACAAAAACCCATTGAGTCCAGAGTTTC
TCATATTTGGTAAACTATTTGGGAAATTTCACAAACTCTGCACGCCAAGGGGCTTTGTTTATTCTCAGACTTCAACCTTGCCATTTTGTTTAGCTTCAGCAATT
GTTATAAAACTAAGGAGACAGCTGGTATAAACCTAGGAGCTCTCTTTTCCAAGAATAGACTACACATACATCCCAGGCA 
237-M13rev_3
  TACATGTCAAAAGCCAAAACCAACAAAAATTTTATTCAGAAATTAAAAAATAAAAGAGGTCAAGGTGGTGGTGGCACATGCCTTTAATCCCAGCA
CTAGGGAGAAAAGTGAGTTCTAGTACGTGCTGGGCTACACAGAGAGAAATTCTATCTTGGAAAACAACCAAACCAACCAAACAAACAATAAAATCAAGAAGA
GGTTCTGGAGAGATGGCTCAGAGGCCAAGAGCACTGGCTGCTCTTTCAGAGAACCAGGGTTCAATTTCCAGCACATGGCAGCTCACTACTTCCTGTAATTC
CAGCTCCAGGAGTTCCAAGAGCTTCACACGAAATACACATGTGGGGCAAAACACCAATGCACATAAGATAAAAATAATTAACAAAACAAAACAAAAAGAAGAA
AGGTATTCCAGAGTAGGTTGTTTCCTGCACA 
240-M13rev_4
  ACATGACAAAGGCTCATTGCTCAGCCATGGGAAAGGCCTTGTAAATTTCCAGAGCAGACTTGGCAGGGGCATGTACAAGCAGGCCTGTCTGAAppendix 
  173 
GAGATAGTTCAGGTTTGATTTTCTGAAACTGTTTCTTCTATGGAAGCATTGTTCCATAGAGAGAGGAACCAAGAGCAGGGTATCTATACCAGAACACCATGGT
AGACAGCAGGGATTTACCAAACCAAAGGGTTCAATCCCCAATCTGCAgGCCTGG 
241-M13rev_1
  CATGGCTGCTGCTCCTAACCATCTGGTTTAGCGTGAGTGGCTTGAATGACAGGAGCATCATAAAAAAGAAAGTACTCAGATGGTAAAGTGTTTG
CTGTCCAGCATGAGAACATGCATTCAATCCTTGGCACCCATGCACATAAAATGCTAGGCACAGTGGCATCTGCTTGCAATCCCAGCACTGGGGAGATAGAG
AAAAGAAATTCTAGGGTTCACTGGCTGGCCAGCCTATCTGAGTTAGTGAGCCCCAAGTGCCTAGCTAGTAACAATAGCTAGTAGCAACAGCAAGAGGCAGC
CCTGTCAGGGCCAGTAAGGCTTCAGAGAGCAAAGCATCATTTTGAGACCTTATCTCAATAAATAAGGTGAAGCAGGCTGCAGATACCTTAGGAAGAAAACAT
GCTTGCTATGTAAGTACA 
242-M13rev_2
  AGNTCATCANCTAGCTTCATGAATTTGATCAGTAATTTGGATGGCCTAACATTATTTCTTCTTTCCATACCCAGAGGATAAAAATATCTTTTAGGA
ATTTTTCCCCTGGGCCCATGTCTTCTCGAGACTTTTCCCCACTTTCTCCTCTATAAATTTCAGTGTCTCTGGTTTTATGTGGAGATCTTTGATCCACTTAGACT
TGAGCTTTGTACAAGGAGATAACAATGGATCAATTCGCATTCTTCTATATGATAACCACCAGTTGTGCCATCACCATTTGTTGAAAGTGCTGTCATTTTCCACT
TGTTGGTTTTAGCTCCCTTGTCAAAGTTCAAGTGACCATAGG 
243-M13rev_3
  AGGAAGTCCCTCAGGTTTGGGAAGGCGTCCAGGCACTTGGGCTCAAACATACGGTACTGGTCAAGAATGTNaTAAGCAAGGAAATCCACATAG
GTGACCTGCAGGAAGCCAAGGGTGAGCGCTCTGGAATCTGACACCAGGGAAGGATGGCAACCCCTCCTCCCCACCCCTCCCTTTACCTTGTCCCCTGCAA
ACCATGGCCTCTTGCCCAGGAACTCAGAGTAGAGCTTCATTTTCTCAGGGATGGTCTTCAAGAACTCTGGCTTCTGCTTCTCCTGAGGCAGAGAACAGCTG
GCTGTCACCACCTTTAGACTCAGGCTCCCCAGCAAAGGGTTTGGCAATGGAACAGCCACCTTTCCAAGAAAGGGCCA 
25-M13for_4
  GGCTCACAAGCATGGACCGCACACACATGCAGGAACTCTCACTTGACAGCATCGCGGTCAGAAAGACAAAGGTTTGAAAAGACAAGGTCAGA
AAGACAAGAGGAAAGGTTTGGCAGAGTGGGGATTGATGAGTGTTTTCCAAGACCAGGGNnNACTTTTAGAAAGAGGAAGGTGAAAGATTCCACCCTGCAGG
GACGGGCCTTAAGTTCTACAAGTAAACAACTCAATGTCTTCAGGGAATCCTTGAAACTAACCAGATTCACCCAGGCTTGTCCCCTGAGCATATGTCAGAAGT
AAGGACCACTGAGAGATACTTTCAGACAAGCTAACCTGCCTTGAAGAGGCTCAGGCCAGCTGAGTGATCTACAGGTGCCTGAGTGCCCACC 
260-M13rev_1
  GGCCCCATTGAAATTCCCCTTTGGAGCCCTGAGTTCTGAAAACTCCCACGGAGAATGAACCAGCTTGGAGTCCTGCAGGCCTTGGGCCACCC
TGACACATTCCTGAAGCTTCATTGCTGTGTGGTCCCTTTCAAAACCTTTGGAAAGTTCCAGGAGATCCATTTCTTGATCAATGTTTTCATCTTTGCCTGGAGTG
GAGCCAGAAGAGAGCAGAGCAGATGTCAGATCCAAAGCCTTTCTGACTCCACCACTTGACCGCTTGGTGGTTAATTTGTGCGGATGTAAATGAAATGCCTG
GGAAATGTTTCTCATTCAAGGGAAGACATGCTGTGATAAAACTCATCACTTATGTGCTGACTTTAAAAAAAAAGAGAGAGAGAGGCAAGCAAGCTCCTGTAG
AAGCTGG 
261-M13rev_2
  CAATACTGGCCCAGAACCAGGAGTTAGTACATGTCCCTGGGTTTGTTGAATGAATGACTGAATGAATTGCTGATACTGTTAGTGTTTGGGGGG
GGGGTCTTGATCCTTTCTCTGACATTAAAAGAATTAAAAGGCAGGGCAAATCTGCCAACTGA 
263-M13rev_3
  TCTATAGTCaACACTTTAgGTTGTTNNATTTTTCAAGAATTGTAGCTTAAACGTTTTGTTTATTTGTCATGTGTTTATACATATATGCTTGTGTCATG
CTATATGTGTGGCACTCAGAAAGTANCTTGCNNTCTGAAAAACTGGGAAGTATTTATGGGGAAGGAACAATTGGATAACTCCTACATTTACCATTTGTATTGC
AGAGAATGAACTTATGCTATCAACCTTGGCAGCAGGTGTCCTCATAGGCTGAGTCATATTACTGCCCTAGGTTGtTTCTTAGtATGACCCTAATATCAAGAAAT
GTAATATGTAGTAG 
264-M13rev_4
  AGATCACCACAGGCTTTTGTACTAAGTGTCACCTGCTTATTCTTTAGTTGAGTTCNNAACCAANAAGCATGTAAgATGCCCCCCAACTCTGGGA
GACCCAAATCACA 
265-M13rev_1
  NCCCCTAAACCTGAAGTGGTGTTTGTTGCTCTTGTTGAATNCCAAACCGGCTCCCGACATGGGACTAGCGAATGAACGAATGAtGCTCACTGG
ATCCGGAGACCCCAAAGAGGAAGAGGAGGAGGAAGAATTAGTGGACCCCCTAACAACAGNGAGAGAGCACTGTGAACAGCTGGAGAAGTGTGTAAAGNCC
CGGGAACGACTAGAGTTNTGTGATAAGCGCGTGTCTTCCCGATCACAGTCGGAAGAGGGCTGTACAGAGGAGCGCTTTNACTTCCTGCANGcacGCGGACC
ACTGTGTGGCCCcACAAGCTCTTTAAAGNCTTGAGTAAATATGCAGATTCGCCTGCCTTG 
267-M13rev_3
  AAGAAcTTATAAATGGAGCTGGAGCCTCACCTAAGAGTCTGAGGAAGACTAATTAGAGATGCACAAAACCAGAANNCAGAGACCAGTGCCNTA
GGGATTTTCACCAAATTTATGACNnCAGGATCTGAGAGACATGGAGTATCATTGTAATGAAAGTTTTCTTCATTAGTGCTAATAACAACTACAGGGGATAAGG
GAAGTGAAGCTGACTGAAAGAGGTCATTAAGGTTTGGTATGGGGATGGAAAAAAATTCATAAACAGAAAAAAAAATATTCCCTCACATTGAGCCCATGAGAA
GCTAGATAGTACAGTTTTTTAAAAAAGGAGTTCTTAATCAAGTACACTAGCATTATGTTGCATGATTATTGCAGTTTTTAATAACTCAATTAAGCAATTTCCATTT
TAAAATGTAAGCT 
268-M13rev_4
  CAAAGACGGGACTCAGAGCAGCCTGGCCTTCAACCCCTGNNCTCAGCCTACACCACCTATTGGAGGTGGGCCCTGGCTGTGTCTGGGACAG
AACTACCCTTAACCTGCTTCTGAAATGCCTTTGCTTGTTCCTGGCTACCCAAACAGTGACCCTGACACAAACCTAGTGTTGGCTATAGAGGCTATATGATGAC
AGCCCATTCCTCCTTCATGACATTACTGTCCACAACAATGAGTATCATGTCCTTATCAGTATCAGCAGCCAGNTGACCTTGAAACTCTTGCAAATTGGGACAG
ACTTGATCTGCCCCACTTTGTCCTTCCATTGTGACCTTAGGCAGACACCCAGAGAGTTAGTGCAGGGGGCTACAAGAGGATGAGAGTACTCAGTACAaAGC
AgGGCAGTCACTGTGACTTC 
270-M13rev_1
  AGTAGAAGGGAGGGGCATTCCATTTGAAGGTTTTTAGAGATATGAGAGAGGGGATTTGTTCTGGATGTCAGCTGAAGAAGAAAGTCAGCTGGG
TGCTTTCTCTGCCTTTCTGAGCTAGCAGGCTTTCACCCTAGCAGTTTGGCTCCTGAGTCTTCACTGGTAAAATCAATCGATTGAGATTTTGTTCAAAACAGCT
ATCTGCCAAAACTAAAACAAAGGCCTAACCCCATCAAAGTCCATAAAGTTCTGGGAAAGTCTGAAACTGTACTAACCTTGCTTTTTAGCTCCTATAGTTCTATC
TGGCTAACTGCTCTTCTTAACTGAAGAATAACAACCCAGAACATGGTTTTTGTACTTAAAAGTTGACCCTGAGAAAGGCTCAGGATCCCAAGCACCCAGTGTA
GTTGCCA 
271-M13rev_2
  AAGTTTTCTTCTATAATTTTATTGAAGATATTCCCTGGCATCTTAAGTTGGGAGTCTTCACTGTTGTCTATACCTATTATCTTTAGGTTTGGTCTTC
TCAAGGTGTCCTGGATTTTCTGGATTTTAGGTTAAGATCTTTTTGCATTTTGCATTTTCTTTGACTGTTGTGTCAATGTTTTCTATGGTATCTTCTGCCCCTAAG
ATTCTCTCTTTTATCTCTTGTATTCTGTTGGTGATGCTTGCATCCATGTCTTATGATCTCTTTCCTAGGTTTTCTCTCTCCAGAGTTGTCTCCCTTTGTGATTTC
TTTATTGTTTCTATTTTCATTTTTATATCANnGATGGTTTTGTTCTACACCTTCACCTTTTTA 
272-M13rev_3
  AGCTTTATaATGCTGTCTTCTCTTCAGCTTGAACTTACTAAATAACATCAGTTTGAGATTCCTCATTTAACATTTAAATTTAACATTAATTGAAATTC
CTTTCTATAGGAGTTGATGTAGTTGAGGTAGAGAACAAGGTGGGTTTTAGTTGCTGTTGGTATCTACTTTCTAATTTGTGTATGTTGAATGGGCCCGTAATAG
CATGTGTGAACATCAGAGCACAGCTTGCAGTAGTGGGTCCCCCTTTATCAAGTAGGTCGCAGGCATGGAATTCAAGTTGTCAGNTGTTGGCTGGCACTTTTC
CTACCAGGCCATCTCATTGGCTCACGGTGGAATAAGTGTTAATAAGCAGCAGTAGTTGGTGCTGTGAGCAGAGCTTTCACTGCTGCCCAGCCTTGTTGCCC
ACTGCAGTGTG 
273-M13rev_4
  CCTTCTAGCCGAACAGTTTCTTTCATAGCAAAGTAtTAATGTTAGAGAGtGGGAGGAGGAAGTCCTGGTCCCACCTCACCTGCTCTGGATCTTG
GCAGGCGGTGAGACAGCCCTGAGAACCTGGACGCGCTACTTTTGTTGCTGGAGTCTTCCTGTGTACATTGTTGAGTCAGGAGCTAGGTTAGATCAGCATTT
CCNNAACATTGTTGTAAGAAATTCCAGTACTCTTTGAGGAGTTTTGAAGTATCCATANGTAAAAAGTTTGCTTGATCGAATTNnAGCGAGAAATGCCCTTTAGA
GACTCCCAGTGCGCCTTGGCATATATAGGATATATGATAGTCCNAAATAAAGTTGTCTTTTCTACAGATTTTCGCCCAgTGAGTCTCAAATGCATT 
27-M13for_1
  AgGAGGTGGGGGAATCATTACACTATCAAATCTTTTTAAGGGAGAGGGTAAGACATCTACGAACTACAGCAGGGTGGTTTCCTTTGGGAGATAT
TTTGTAAGACCTAGATCTGTATATAGTAAAATAACATAACCTGACCAGTTGACATTGGTTGTCAGGAGGAGCAGAGGCAGATACTTTATTTGGTTCCTTTTTAT
CGGGCAGCCCCTTTTATTGAGTACGTCAATAGGAAAGCAAAGTGGTATGGATAGGGGGCCCAGTAAAGACAACACAGGTCTTACCAGAATCTTGAGTGGAG
GAAGCACCTGAGGGTCTTGTTCAGTACTGAGATGGGCAGTGAAGCTCTGCCGGGTACAAAGATCTCTCATTGTACTGAAAATATACTCACTTCTG 
27-M13rev_2
  CAAACTCACTTCATCACACTTCTTATTCTCCAGTTTCTTATTTTAAAATGAATATATTCCTGTCAAACTCTAACTCATTGTAAGTACAAATGACTGG
GAACAGGTTCCTCTTTAAAGGGCAcCACTATATTTCTTGTaATTCCAGCTTTGGACCACTCTAAACACAGCCATATGTTTCCATCCCTGGnNCACATCCATGAA
GTCCTCCTGTCCTGAAATTCCAATGAGCCAGTCAAAGTTACTACCAGCGATTAAGCTAGAAGAGGAGATCCCTAAAATGACAGGCCACCAACAAGACAAGTC
ACCAACAGAGACAGAGCTGAAAGTCAGGGAGATCCTGGAGAAGCTGGATCGGCAGATACCTCCCAGACCCTTCACCCACCTCAACTACACCACAAGCGCC
ACACACAGCACGGCCACCATCCTCAACCCTCAAGATACATACTGTGTGGGGGACCTGCTGGACATCCTGGTAGAGGCTAGAGACCACCTAGGAAACAGGA
AGGGGTATGGTGGGGACTTCATGAGGGCCAGGATGTTCTCCCCAGCCCTGAAGGCAGGCGCTTCTGGAAAGGTGACAGACcTCAACAATGGCACCTACCT
CGTCAGCTTCATTCTGTTCTGGGAGGGCCCGGGTCTCGCTGTCTATTCTGCTCGTGCACCCCAGTGAAGGGGTGTCAGCTCTCTGGAGAGCAAGGAACGA
AGGCT 
28-M13for_2
  CAGCTAAAAGCTAAAAGAGTGTGTCTAGTTATCATGTTAAGTAAAAACAATATGAAGGATTCTATATAAGTATGGTACCATATGCCTTTCTTTATG
TTAGTGTCACAGAATACTAAAGCTAGCAGAACATAAAGACTACATAATCGAAGCCACCTTTTAAAAAAAACAACTGAAAATAAGGAACCAATGGGATTTGTTG
AACATGGATAGTGTTAAAATAGATAACTGAGGCCTTAATTCCAAACCCAACTAGTAAAATGTCTAAGGGAAACACAAAGAACAGTCTTCAAGCTATATGCACA
AGCAGGAAGTTCCCAAATGGGGCTCTGGTCACACAGGAACTAGAAATGACAAATGGACAAATGGTAGTGCATAAAA 
28-M13rev_2
  GAGACTACTCTAAAGTGATTTTCACAATGGCTACACTAGTTTGCAATCACACCAGCAGTGAANAAGGGTCTCCTTTTCCCCTCAGCCCTCTGGC
ATTTCTTATCTGAGTTCTTGATGACTGCTATTCTGAACAGGCTAAGGTGGTGTCTCAGGGAAGTTACAATTTCCATTTTGCCAGTGGCTGTAGATGCTGAATA
CTTTAAAAATGCTCATTGGTCATTTGTTTNnCTTAAGAAGTGTCTATTTATACATCAACTCACTTTTGAGCGAGAGCAACAGCGAGAGGTGCGGTGGTGAAGA
GAGAAAAGAGAGAAGAGAGAGGAGGGGAGAGGGGAGAGGAGAGAGAATGTATGCGTGTATGCATGTAATATTTTAGTTCTTTACAGTTCTGGAGAGTAGGC
CCCTCTGAAGTATAG Appendix 
  174 
2-M13for_2
  CCCCCTCACCCCCCCATCCCTGCCTACTTCCAAGGCCAGGGTAGCAATGTCTGGGCCAATCACAGATCAgATCACCGACACAAACTTGTGCCC
CTCCCCTGCAACTAACATTCACATCAACTCTGTTGATGTGATGGCAGGGACCACCTCAATACATAATGGGAAAGTTAAGGTATGGAGAGTGAAGTCACATCC
TGCCTTGTTCAGGTTCGGGCCACCAGCAAAGAAATGTTACAGTTCTGATTTTAGGTGTCTCTCNnTCAATCCCCTGACCAAACATTGGTCATTGACCAGATGG
CCCCTCTTGGATGAACCCTGCTCTCTGGCTCCATGGTTGCATTGTTTCTGCCTGAGAGTAAGTATAGTACCCTGCCTCTGGAAACCTGGGCTTGAAA 
303-M13rev_1
  ACACTTTATACTTATCCATAAGTACAAGGATAAACATTGAGAGTGTAGTTATGGATTATGCTGGTTTAATAAAGTGGTANTTTTAGATTCATCTAC
TCCATGATTAGGTTTTCAGTACCAGGAATGTTTTCTTTCATGTTGAGAGGGTCTTATGTCaAATTAGAGAGCTGTTGGTTACTGCTGATGTGTATACGCCACTA
CTGCACCCTTAGGGATATTGCCATGCTGGTCATTGTGATTTATTGGCCTAATAGCTGGGTAGGGCTGCTGGTTGCTTCCCTCCTTTGGAAGCTTGCATGGCA
ATTTCTGGTCCTTGAGGGAGGAAGCTTTCGGATTAGATTCAGCTTGGGTCCTCTGGGCTCNGAGTCTGAAGTGCCTGATGTCCTCATTGTTTCTTCCATTCTT
TAGCC 
306-M13rev_3
  GCCCCAAATCCAGCATGGAACTGGATCCACACAGTGGCCTCTAGCACAGCTGTGAAGAGGCTTTACCTCTTTAGATGATACACTAGGAGCATG
AGGACTGGAATTCCTCTCTCTAGAACCTACATAGAAGGCTGGGCTTAAGGGAGTACATCAGTAATCCTAGTTTTGGGAACTAGAGACAGGTGAATCCCCAGG
GTTTGCTGGCAAACCAGCTGGTGAGCTCCAAGTCCAGCTAGAGACCCTATATCAACCAGTAATGGGGAAAAGCAATTATGGAAGAAAACTAATGTCAATCTT
TGGCCTACTTGTCAATGGACATACATATGTATATGCACATACAGTGGACCCATACAAGATAATCACACACACACACACACACACACACACACACACACACACA
CACACACACTGGATTTTG 
307-M13rev_4
  GCCCAGTCCCCATGATGCCTTGTATTTCTCCAAGGCTTTTACTTCCTGGGGAGTTNNTCAACACTAACAGACACAGGCCTCAGGTATTTTGGGA
TGGGATCACACCTCATCAGTTTAAGGCTGCACACAGGGACCCAGGTTCCATGAGCAAATGAAAGAAGGGAGGGTCCCACTGTGACACTCTAGGTGACTTTT
CTATTTCAAAATTGAATCCTGCAAACCAGAGAAACACAGTGGGCTCCTAGGCCTGGAgCTGGCACA 
310-M13rev_1
  GGGTGACACCCAAGGGGGGCTCACCTTCTCCTCAGAGAAGAGGAAGGGTAATGGGGGGGAGGGATTGGTAAGGGTGGAACTGGGAAGCGA
GGAGGGAGAGGGGCTGTGATGGGGATGTAAAGTGAATAAAAACAAAAACTAACAAACAAAAACCCCTATGTTTTCTTCAACTGAGTAAACTCCTTAGAAAAC
CACACCAACATTTTCTAATTTTATAGCTGTTTTATAACTATGTTAGAGAATGTCCTAATTTTTAGGAAACACATGATGAAGTACTATGAAGAGACATAATATCTG
GATTCTC 
312-M13rev_2
  TATCCGGCCTTCGAGATTCCCGATGCCGTGCTGGCCGAATGGCGCGAGCTCGGCGGCCGNGGCCGCNATGCGCGGCGCGCCNGGATCGAG
CGGTCGCGaGCCGCCTGCAAA 
313-M13rev_3
  ATGGCAAGAAGGAGAATCTATCTTAAAAGGGTTTGAAGAACCATTGGCTCAAGGTTGTAGCTAAATGGCAAAACAAAGTTGCATCCCTGTCTAC
AGGAAAGCACAGATAAGACCTGTTGTTTATAACACGCCCACCCATATTTCTGAAGTGTTAATTCATTCCAGAAATCTGGAACAAGCTGCTGCAAGCTGGATTT
GTCTAACATGGCAGTACTGACAAGGTATTCAACCATGCTGCAATTTACATACCGAATGCCTGGATGCACCCTTCTAACAAGTTAACTAATTATCTTTCCAAATC
AAGCCTGCAGACAGTATCCACGTGCTTCTGGGCTCATGGTAGCTCCCATGACAGTCTAGGTTTCCCTCCTCAATAGGCCACACACACTGCACACAAGAATG
GTCCTTCACCCTTCTAGGG 
315-M13rev_4
  AGCTGAACTCTAAATTCTGAATAACTATTCTCCAAATGCAAAGACATACACATTCATCAAGGAAACTTTTGTAAAGCTCAAAGCACACATTGCAC
CTCACACAATAATAGTGGGAGACTTCAACCNCACTCTCATAAATGGACAGATTCTAGAAACAGAAACTAAACAGACACAGGGTGAAACTAACAGAAGTTATGA
AAAAATGGATTTAACGGATATCTACAGAACATTNTATCCTAAAACAAAAGGATATACCTTCTTCTCAGAACCTCATGGCACCTTCTCCGAAATCAACCATATTA
TTGGTCACAAAACAGGTTTAAATAGGTATAAAAAAATTGAAATTGTCTCATGAATCCTATCAGATCACCACAGACTAAGGNCATCATGACCTTCAATAACAACA
TAAATAATAGAAAGCCACATT 
318-M13rev_3
  CCTGTTTCTTACATTTAACTCAGTCAGGACAACTGTATGGTGCCAATTTAAATAGTTTTATTATTCCATGTTACTTGTTTTGGGTCCCTGTGGAAC
AAAGCTACACCTTCTTCTTGGACTGACTTAATCCACCTCTTCAATGGTGGGGCCTGAAGAAGCACCACCAGATGGGGGAGCTCCTCCACCTGGGAAGCCAC
CAGGCATTCCCCCAGGCATGCCACCTGCACTCTGGTACAGCTTGGTAATGATAGGGTTGCAGACTTTCTCCAGTTCTTTCTGCTGATGCTCAAATTCTTCCTT
CTCTGCAGTCTGAGAAAAAAAGAAATCAAATTTATTAAAAGATCTCCAATTACTTTGGGGGGGGGGAGACTGACAACTAAGCCTAAAGAACCCTTAGCTATTG
AGTCACTCAGACATCCAAGGA 
320-M13rev_1
  CTGTTTGAAACAAGGAACAGACACTTAGTCAGGTTCTTAAGACACNNTTTTTGTTATAGTTATCCCAAACTATAGTGTTGGGAGCTATTAAGACA
ACTCTTGATCTCTGAATTGGGCCTCTCCCCCTGAGAAGAAAAGGGGGTCAAAAGCGGGCCACCGACACATGGATTCCGAGAACCACGGGAGGTTCCAGCC
CTAGGTCATCACCGATGTCCTGACCACACCCTGATACCACCAAGTTCCTGCTTCCCGGTGTAGCTGCCAAAAGAAAGAATTTCTATTGCCCCCCCTCCCATA
AATACTTCTCCTTTTGCTTGTATTGCCCCATCCCTCCCACTGATAAGTATCTGTACTTCCCCGtTTTCCTTGTGCAAnTTCTACTGCCCCATCCTTCCTGCTGAA
AGGCACTTCCCCCTTTTT 
321-M13rev_2
  AAAATGCCTCTTAAGATCTGGCCATAGGCAGGCATGGTAGCACATGCCTTNAATCTCAGCACTCANGAGGCATAGGCAGGNAGATTTCTGTGA
GTTTGAGGACAG 
322-M13rev_3
  AAAACTTCTTCAAGTTACTCTAGAAATTGCCAAGAATATCCCCGTGGTTCGTAGTTTGAGAAATACAAACAAGCTGCAAAAGAGAGGTGTGAAC
CTGGGGAGGCTTCCTCATGAATGTCATTCTCTTCATTCTTTTACAGCACTACAGTGTAAGAGAACAATGAATAAACCCTGAGTGAAGTAAGATGTAGGGATAA
GGCAGAGAGCTTGCCAAGCATACACAAAGCATAAATGGAGAGTGCTGGTGCACATCTAGAACTCCAGCACTCAGGAGGTGGAGGCACAAAGATCACAAGTT
CAAGGCCATCCTTGGCTACACAGTGAGTTCATGGCGAACCTGAGATTTAAAAATAAAAGTTAAGTGAAACACGTGCCACTGCTTACAGAGAATTC 
323-M13rev_4
  TGATTTAGTAAAGATGTGGAGATCAATATAACACGTTTGCCAACAGATGTTCAATAACATAACTGGGGTGTCATGAGCAGAATTCAACTTGTATA
AgCTGCACAGGAAAAAATGG 
324-M13rev_1
  TATTTCCTGCCGTCTACTCCTCTTGGGTGAATTTGCTTCCTTTTTTTCTAGAGCTTTTAGATGTGTTGTCAAGCTGCTAGTATGTGCTCTCTCCC
GTTTCTTCTTGGAGGCACTCAGAGCTATGAGTTTCCCTCTTAGAAATGCTTTCATTGTGTCCCATAGGTTTGGGTACGTTGTGGCTTCATTTTCATTAAACTCT
AAAAAGTCTTTAATTTCTTTCTTTATTCCTTCCTTGACCAAGGTATCATTGAGAAGAGTGTTGTTCAGTTTCCACGTGAATGTTGGCTTTCCGTTATTTATGTTG
TTATTGAAGATCAGTCTTAGGCCATGGTGGTCTGATAGGATACATGGGACAATTTCAATATTTTTGTATCTGTTGAGGCCTGTTTTGTGACCAATTATATGGTC
AATTTTGGAGAAGGTCCCGTGA 
32-M13for_4
  GGGCTAATGACTGGAGGGGGGCATGGCCAGATCTGGCTTTAGATTAGACGTAGTATAGACAGGAAGAGCCAAGTCCTAGCAGATAAGACAGA
GACTACAGAAAAGAAGGAAGAAATCATAGTGATTTGATAATGGCCTTGGGATTAACAAAAGTTTAAGGAGGTAGCCTCAGCAGGAGTTGGCTCTTAGTCGAT
AGAGCCATTATCTAAGACTGTGAAAATAAAACACTTGAGTGGGGAGAGAATTAATGAGAGTCCTCCATACGTTAAATCCGAGTTATCTTGAGATATCATGATG
GACACATCTTGTAGTTGAATAGGAAGGCTCTAGATCTAGGCTGCACTGCATATCTGGATCCAGGACTAGAGAGAGTATTCCGGACAGG 
32-M13rev_4
  CATGTCTTGAGTTTCTTAAGAAGTTTTTCCTGATACCCAGGAAGTTGAGACAGGAACCTCCGGAGTTCAAGGGCCTCCTAGGCTATGCAATGA
GACTCTGTCTCTAACAACAACAAAAGGATACAGGCATTTGGcACTTTATATCAGGCCTGCCCAATACAaCAGCTCCATCTCTTTATACGTGTCCATGGCTGCT
GGTTTGTCCCTGTCCGGAATACTCTCTCTNGTCCTGGATCCAaATA 
349-M13rev_2
  GTCAAATCTATTATCCTGTTCTGAACTACTCAAGCCATATGAATNNGAAAGAAGAGAAATGATTCCACAAAGTTGTCATCCTACCAAAACATCAT
GGACATACTAACAATAAATACAAATAAATATTTCTGCAAATCTCCATTACTTATGTGTTCCATAAAAGCCTAAATGCTGACTGGTAGGTGTAGTGGTTTGAATA
AGAATGGTCTTCATAAACTTTTATAAGTATTGCCTTGATAGAGGAAGTATATTACTGGGACCAGCTTTGAGATTTCAGAACTGCATTATAGGCCAAATTTCTCC
CTGTTGCCTGTAGATCATGATGTAAACTCTCAGTTACTTCTTCAGCACTATGTCTGCCTTTATGTTGTCATGTTACCCACCATAAGAATAATAAACTAAGCTTC
TGTCACTGTAAGAAATCCCCCAGTT 
34-M13revfor
  ACTTGCCTATTCCAAAGTGCAAAGGGCAGCCTGCTTCCTCCTCCAACCTGCTCGCCAGCCCGCTGCCATTCCCTGATACTTCCTAATTCACCTT
CCACTGCCATGACCACTGGCATGTTTTCATTCTTCATTCCTGGCTTCTCCTTCCTCATTCCTGGCTTTATCATCTGTTTAGTAAAACTGAGAGAGGCTTGGCA
GGATTCAAGGCTACGCTGGAGGACAAAAAACAGTGGTGAAATCCTAAGACATCAACCAGAGTAGGGTTGGGGGAGCCAGTACGCTGGTCTTGAGGTCTGC
ACGAGATAGGCCCTGCTAACACTCTGCTGAATTATGCTCTACAGGAGCTGGTACGCAGTCTTACCAGGCGCCAGGACTGTCTGGGATTAAGCAACCATAGG
TACGCTGGGTATTTATTCCATCAGATATACAAAGCAGAACGTTTCTCACACAGACATGGTGCCTTTTGCTTCAGTAAGGACACTACGGATTCACATGTGTCGC
CTCTCTATCTACCTGTCATCTCCCAAAGTTCAGCA 
355-M13rev_1
  CACCGCATATCACCTCCTCCAGGACCTCCACCAAACCCACTACCATCACCTCTGCCGCCACCTCCTCCAGGACCTCACTATCTCTCCTCTATC
ACCTTTACCAATAACCTTTGCCATATTTCCCACCACCACCTTATTCATCGGTTCTGCCAGGACTTCTACTATTATTCTTCACCATCACCTCTATTTTCCACAACC
ATATTTCATGCTATCCCCTCTACCATTCTGTACCACCACCTT 
357-M13rev_3
  TTAAAGTCATACAGATCACAGGGAAGGTGGCGCATGTATTTAACCCCCAGCATTGGAAAGATGGAGGCAGGAGGCTCTCTGTGGGTTTGAGG
TCAGCCTGATCTAGACAGAGTGCTCCGCAGATAGCCACACAGAGAGAGCCTGCCTTAGAGAAATAAATACCTGATGAAATAGAATTGAATTGAGAGTCCAGA
AATTAACCCACTCAGCTATGACCAACTGATTTCAGATAAAGGTCCAAGGTGTACTGAGTCAGCAAACCCTGCTGGGGCAATCTGACATCAGGTGCAAAGAGT
GCAGTCCACATGGTGACACCTGCCTGTCCCCTACTCGGGAGGCTGAGACAAGAAGATCAGTAGTAGTTGCAGTAAATCTCCACCCAAATATGCCCTGGCAA
TGAAAACACAACTCAATTAATATGAATACATGCTGTGCGCCTAGATTGGG 
358-M13rev_4
  TTCCTCACACTATATTAAATATGGCTGTAAGCTTAAGCAAAAGTACCAGTTTATTGGAATGCAAGATCTACTTGTGTATATATGGACTACAGAAA
GCAATTCCAACCACTTAGGCAGATGGGAGATTCCCACAGCAAAGATATTTCCAGAATTAGTTCATAAGTACAACAATGTTCTAAACATCAGATAATTCTTCAGTAppendix 
  175 
GACAGGCTCCTAAGCAGAAAGTCTCAGAGGATGAGAAAATTAGCAAAACTCGAAGATGGAAAACATAAAAGCTGCAGTTGAGATGTCTGTTATTTTTAATAAA
TTCTAAATCATTCAATTTGGTCAAGGAAGTGTCAGGAGCCAGATGCTGGGTGGAAGCCTGGTAGCTCAGAGAAGCAGAAAAAACATCTGTTCACCTTTCTCT
TCATGTGAAATCCCAGAAGGAAATCTCTTTCTGCC 
359-M13rev_1
  GACAGGATAAAGATGCCCTGACTGTCTTGGGTGGTCCTGAGAAGAGCANTGTTCAGAGCTTGTTGCTGGCAGGGATTTATCCCTACACACTGT
GGTAGACGCCCTGTGATGTGCATGTAGGCTGTTTCTGGGATATCACACCACGGAGCCAAAGNAAGTGAGTGTAGCCATCTCACCAGGGCTAGCCTCATCAG
GGTCCTGGGAATGCACACACATGTTTGCAGAAGGTAGTGTGGGGAAACCTTGTGGCAATGTGCTGATCCATGCAATCCATCCCATGCNAGTCATTGCGGAT
CTCACTGTCACTTGGCCCATGAAAGGCACTGACAAACATATACATATTtTTATGTTTTAGAGTGGACTTTAGACATACTCATTGCTTCATGACTAGAATATTGGA
AAACGCC 
35-M13revfor
  GCTCCTCTTTCTGACTTTTAAACTGCCGACATAACAGACCCCGAGAAACTGTAATCTCCCCCAGGAACATCATCTGAGGCCACGTGGGAACCC
GTGTAAGAAAGCTGTGACTGTCCCGTGAGCTGTGGTTGGGGCAGAGTGCAGAATGTTCTTCCACAAGTGGCCTTCTAGAAATAATTGCAAACCCCATAAAAA
GTGGATGCTCTCAAAAGGGGCGACATGAAGGGTATGGCTTGGGATGTCCACGTTCTCTCTGTGGGAAGGGTGGGGTCCTGGGAGGAATATTCTTGGCTTTT
TCCCACAGGTGCAAGGATGATAAGACATAATACCAAGTGTTTTTTCACTTGCTGTTCTTGTATTTGCTTAAGCTCTCTGTAAACATCATCTCATGTTTTGCTTG
CTTTAATAATAAAAGAGTGAGAAGTTCTTTATTTGCTCTATTCTTGAGTTCAAACGCTTAGAGTCCCCAGGTTATCCCACAAAGATCTTTGGCTTTCAATCCAG
GGAGACTTTGTTAGCCTTGCTGGTCGCTGTCCGCTGCTGGGTTCGGATCTAAAGAGCCAGTAAATGTCAGAAGCCTGGAGCCACTGTGCCACCTTCAGAGG
AGCAGAGATTTCACACCGTCTGACAAACGCCACATCA 
363-M13rev_4
  CATATACACAATTAGAGTTAATCTTGGTTCAAGAAATAATAAATAGAAAAATTTGTTTGACTTGCTCCAAATAACAACTGCCATGATTTTCTCCAA
CAGAGGGTGAAAAACTATTTAGAATATGTTTTAGTATCTGTGCCAAGAATTTCATAAACCTGATTTTCTAGCTTGTTTATGTTGTTCTTACTAGCCAATATATGA
CATATGTCCTTGAGATACCTGAGGACATGGTTGGAAGGACAGACAGACAGATACACACACACAGACACAACATTTCATTAATAACAATTCTTTAGTTATAAGA
CAAAGTTCTACTGGAAGTGTTGATTTCTAATCAAACAATGATGCTAAGTAGTTGTAAAATTTCAGGAGACATACTTGAATCTTAGGGACCTGAAGGTCATAAG
GTTTCCCACCTTATTATGATGATATACC 
371-M13rev_3
  GTCTCAAAAAACAAAACAAAACAAAACAAACAAAAAAACCAAAAACAGTAGCAAAATTATGGTTATGAAACAGCAATGAAAATTATTTTATGGCT
GAGGGTTACCACAACATAAGAAACTGTATTAAAAGGCTGCAGAATAAAGAAGGTTGAGAAACAGTACTATACATGATCCCAATGACACACTAATTAAATATTA
ACACATTAGTCCTCCAGTATATAAAAGGGTAAAGAACTGTTACCTCTTGTGGCCTTTTCATTTACTTTTATAGCATAATAATCCTAGCTTATATTAGAACACTCA
AAAAGAGTACTAAAAACAGCTTTATTGTCTTTTTGTTATGGGTAAAGAACCAATCTAAGTCTCTCCAGAATCAAAACTCTAGAAAACTTGTCGAGAACACAGAC
AAACAGTAGAACTCAGCCGGCCTGGGATGCATTACTTACTTTAT 
372-M13rev_4
  TCTTATTGGGTTCAATATAGTCTGTTATCACTGTTTTGTTCATTACTCATTTTAATCAGCTTGTCTTAGATGTATAGCTCATGGAAGAGTGATGCC
TGACCTACTTTAACAGGAACTGTGGCCTCCAGAATTGGCTACTTTCAGTGGTAAAACTTCAAGAGGCCTGGTAAATCCTGAGAAGCTAGTCAAGTCTTCAGG
CTGGCTCTCATGTCTTCGGGACAAGGTCTTTGTCATTCACTGAGTAAGATCTTTCTAGCTCAGTAAGATGTCCCAGGCTCATCCTATACTTTCTGTGACCCAG
ACCTGAAATCATCCATTGGTACTAGCATATTTGAAACCAGAGACATTTTGAGTATTAGAGTATGTATGCCATGGCACAGAAACTTGAGCCAGGTGGACAGGC
TCAGCCAGCCAGGAGACTGTGTTCTTGTCTGGCTCTGGGCCTTGGTCCTCACTGAA 
376-M13rev_2
  ATGCAACCAGCACCTACAATGTCGGCTTTATAAAAAAATCGTTCACAGGTGTTATCCATTTATTTATTTGTATCTGCGTGGGTGACCTCTGTAGT
CACCCGTGGAGGTCAGAAGACAATAGGAAACAGTTCTCCCTTTGCACCATTGAACTAAGGTCGTCAGTGCCTTGGTGGCAAGTGACTTTATCTACCGAGCC
GTCTTACACCCATCTACAAACTTTTAATACTTAGAGCAGGCTACATATAGCATGCCAAGTCCAATGACTGTCTTCAGACTTGAGTTGATTAGACACAGAGAAA
GACTGGATGCAGAAGTAACTATTGATCTGGACTCTAAGACAAGCTGCTTCCAAACAGCATATGATGTAGCTTGCTCACTGCCAACAGATAGTCACTCTCCAC
TGGATTTC 
377-M13rev_1
  CTAACATGATATGACATCTAGCCTTCCAACATAGGGAACATGAAGTGAGAGTGGCCAACAGACCCTCTCACACTCTGCTGTCTTTGTCCATGAA
CATGAAGAACTCCAGGTACCAACATTTGAACAAGCCACGGGGCCGTCCATGTTTATGTTGTGTTAGGCTTAAACAGATAGGACAGAGCAGTGGTCAGCTAG
GATCAAGTAGACTCCATCTGACACATAGGTGCTTGACAGATGTTGAGTGAATGATTGAAAGGGGGGGGGGGGAAGTACCAAGAGACTTAGGAGGAGCTCA
AACAGGGAATCTCCCCTGTGAGGAGTCTCCACTTAAGCCTTCTCTTTTTACAAGGCACCCCTACCCTCTTGCACCCCAATCTCACACCCTCTTCAACACTCAC
AACTTCCTGCAAAGGTGTGTGTGTGTTGGGGGTGGATCTCTGTCTGATCTCTTAAGTTTTGCCCTTATGCCTGAACCAACTTTTCCA 
37-M13for_1
  TGTNCACAGCAGTAAAATCTTAACTAGGACAGAAGTTTTACCAGGGAACTCGGGTACTGCTGTTATAGGCCTGTGATAAAAAATTAGTAGTGAT
TACGAAgAGACCACCATCACTCTGGTGAAATAtTCTAAGAAGTGTTTTCTAAGATCAATAAGAAACTGTGTTCCAGCCGGGTAGTGGTAGCTCATGCCTTTAAT
CCCAGCACTTGGNAGGCAGAGGCAGGTGGATTTTTGAATTAGAGGTCAGCCTGGTCTACAGAGTGAGTTCTAGGACAGCCAGAGCTACACAGAAAAACCTT
GTCTTGAAAATCAAAAACAAAAACAAAGAAaCaGAGAGAGAGAGGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGA 
37-M13rev_1
  CTATCTATGAAACACAATTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTTTCTCTCTCTCTCTCTCTCTTTCTTC
CTTCCTTCCTTCCTTCCTTCCTTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTCCTTTTCTCTCTCTCTCTCTCTCTCTCTCT 
380-M13rev_3
  TCCTTTCCACGGGTCTTGAACCCGAGGAAAAGTTTAGGTCAGGTAAGAATACCTGGGGAGAGATTAGAAGGAAGGAAAAGAAAAAAGAAAAGA
AAAAAGATCGATTAGCGGAGGTCTCTAGGAGATACTCGTCACTAGATGAGCTCAGGAAGCCAGCTCTTAGTAGCTCTGAAGCAGATGAAGAATTCTCCTCTG
AGGAAACAGACTGGGAGGAAGAAGCAGCCCATTACCAGCCAGCTAATTGGTCAAGAAAAAAGCCAAAAGCGGCTGGCGAAAGCCAGCGTACTGTTCAACC
TCCGGGCAGTCGGTTTCAAGGTCCGCCCTATGCGGAGCCCCCGCCCTGCGTAGTGTGTCAGCAATGCGCAgAGAGACAATGCGCAgAGAGGCAATGCGCA
gAGAGGCAATGCGCATAGAGGCAGTGCGCAGAGAGGCAGTGCGCA 
392-M13rev_4
  CCACAATGACCAAGTTTGATCACTTCTAAATACCCCACACCTCTAAGCGCTACAGCTAGACTGAGTTTCTGCCCTTTTAATATCACTGGCATAAA
ACTTTGGTTATTAAACTTCTGTGTTAGTTTAGGAAGTGTGGTGGTTTGGATAATGGCCCCAATAGGTTCATATTCTTGAATGCTTAGAGAGTGGCACTATTTGA
AAGGATTAGGAGGTGTGGCCTTGTTGGAAGTGTGTCACTAGGTGTGGGCTTTGAGGTTTCAAAAGTCTAAGCCAGGCCCAGTGGCTTTCTCTCTCCCTGCC
GCCTGTAGATCTAGATGTGGAATTCTCACCCTCTTCTTTAGCACCATGTCTGCCTATGAGCTGCCTGCTTCCCACCCCAGTTAAATGCTTTCCCAATACAAGC
CCCAATCAAACACTTTATAAGAATTGTCATGGTCACGATGTCTCATCAC 
395-M13rev_3
  GGCTGTGAGCCCAAGATAGCCCCTTTCTCCCTTAACTTGTTTTTGTCAGGGCATTTATTACATCGATAGGATAAGTAACGAATGCACTCTTTTTC
CAAATCATTTAAATGACTAAAATCGGGTTAGTAGGCATAGCTGTGAATCAAAAGCAGCTTTTCCTGCTTCTGGAGTATGCGTGCTTCATAAAATATGGCCTCT
CCCATGCCAAGACTCAGCAACAGTTCAGTTCTTTAGGAGCAGCTCTAGTGTCATGCTTACAGTAGATTGACTAAAGTATCCGTTTTTGCATAACTCCTGGAAG
AGCTGAAGTGGTATGATTCTTGATTTTGCAGATATTAATCACAGCGATCCTTCATGTTGTAAGGGGTCTAGGAAGACTTTGTAATCCTAACCAGCTCATTTAAT
GCTTTGCTTTTTATTAAAATATTCATACTTATGGTTTTTGGCTACTCAAATTATTTTATTTTGAATATGTTACTTTTGGGtGTGTGGGAGATGCTGTTTAAGTAAA 
398-M13rev_2
  ACGCCCGTGCCCGGCCCCGGCCCCCTCACACCTCACACCACAGCGGACTAGGACCAGGCGNGCGGCCGGGACTCCCGCCTCCCCTCCCCC
ACGCCCCCGCGGGTCCCCCAACGCCCATGCCGCCGGCCCGGCGCGGCCCGGCGCACTCACATCGGCTCCAGTAACTTGGCCAGCCAGGACTTGAGGGC
ATCCACATCTTCTATGAGCATGGTGCAGGGAAGGCGGGCTCGGCCGCCGCTCCTCCTAAGGCCCGCCGCGGGTCTACGTTCGCCGCCGCCTCACGTTCC
CTCACAGCTCCGAGTGCCCTGACCCACCGGGCATCTTATAGACTTCACCTACTCCCTGGGCCGGGGCCTAACAGGAACTAACCCAAGAGCCCCACTCAAC
CTAGCCCGGAGGCCCAGGTGGGC 
3-M13revfor
  CTTAATGATGCTTTAAATTCNTTGCAGAGAGGACACCCTTTGGCCTCNGTTCCAGCCAGACTGTGTTTTCTGTCTGCTTTTGGCACGTCACTGG
AAACACCAGACTCGTTCTAAACCTTTAGTCCTTGGATTCATTAAAAATTAATTGACTTTGATGGGCATAATATTTCTACACTATTTGGGAGGTACAGTACATTG
CTCTGACNCNTGCCTGCATTGGGCAATGATCAACTGAGANCAATTAAGCGGCTCCATCACCTGCAGCTTTGTCAGGCCTCCATGGTGAGGATATTCAAATTC
CTCTCCATTAGCTGTTTGGATGCCAGTCCCCGGATGTTAAAAGATATTTTAAAATTAATGATTTGCTTTCTCAGTGAAGAAATTTTCAGTGTTGCTCAACTCTG
ACTTGGCTCTTATCATCTTTAATCCAAACACAATAGGAGGGAGAAAAAAATATCNNTTCTTTGATCTGAATAAAGCATTGTCTGGAAGATTAAAATAAGTTCCA
CCAAAGGTCACCAGAAGGTGATCCGGCAGTAGCTTAGGCATGCTATCTAATTGAAAAAATAGAAATCCTTAAAAATTAAAACTAGGACAATACAGGAGTTTTC
TAATGAGGCAAATCTCAATAAAGGANNTAAGAGAGCTAATAGCTTGAGGCCTTGGATACCTGCTT 
400-M13rev_4
  GaAATTAAATAGCTCCCAGAAAAgTAGCTGCAGGTTTGTCAATTCCTGGCTCTGTCAAACTAATCATCAGAAATTCTTGACTCTTTGACATTGGC
AAAGTCCAAGGCTTCAGCTTGTAAGACCTACTCCTGGAAGGCCCAGCTCAAGCCTACCTCTACCACGAAGATCCCCAACTCTGCCCANGACTCNCTGTGCC
TTCTCCAGAATGACTTCCTTCTTCCTTTTTCATGANAAAGGATNCCCTCCTCCTTCTTTGT 
406-M13rev_1
  GGATCAACAAACTATAGCTCAAGGACTGAACTGTACATAACACCTGTTTCTGTCAAATTCTGTGGACGCAGACATGGTCACAAACATACAGATT
GTCTATGGCTGGTTTTGCACTGCAAGAGTTGAAGAGAATTAAAAGAGAATCCAAAATTTATAGTTAAAAGCATTTGGTCCTTTACAGAAGTTTCATAACCTTTG
ACCTATATCATTAACCGGGTTTGGGTTGTTATACCTTGAGTACATATACATGTGTGTGTATGCATGCGTGTACAGACAGACAGACAGACAGATACAGAGTTAT
ACTTTGCATTTGATATCCCTTCTGCTTCCAATAGATGGTCCCATATACTTGCACATTCTGGCAGCAATGAATAGACTCAgTGCATCTTTAAAATAAGAGCACAT
GAaATGAAgAGGTAAATGTGTTAgAAGTGTGTGTTAAAACAGAAACACTTTTGTCGCATAGG 
43-M13rev_2
  CAATATGTTCCAGACTCATTCCTCTGTGACAAGCAACCCCATTTGTTCCTTAGGACAGCCTCCTTCTAGNNTATGGTGTGCCCCAAAATCAGCT
CATAAATATATCTTTGTCTGGAATAAAAAGTCGAACTGTTACTTCTTGTAgGATCTGTCCTTGGCTTAACACATCGTTACGATAGCGAGGTGTGGAGGTGTCG
TTGTGTGCAAAGTGGGAGAAGCTGCCGAGGCTGAAGTGATGGGGGCTCTTGACGGGCTTGTTGACCTGCAGGCAAGTATGTAACTGGAGAGAGCTGAGCA
AGAGGCAGCTCAAACTCTTCCTCCAGGTTCTCCAGTGCGCTCAACTGTGGTCAAGCCAGGAGGCTGCGGACCAACCTCTGGCTCACACAGCCTCTGCCAG
GGCCCTCACACTTCCAAGCGCTCTGTTTTCCTTCAACCA 
45-M13rev_3
  CACGGCAAGCGTTACGCCGTCATCGTCAACGAGTTCGGCGAGATCGGCATCGACAACGACCTGGTGGTCGGCGCCGACGAGGACGTGTTCGAppendix 
  176 
AGATGAACAACGGCTGCGTCTGCTGCACGGTGCGCGGCGACCTCATCCGCGTGGTCGCGGGCCTGATGAANCGCCAGCGCCCCGGCAAGCCCGCCTTC
GACGCGATCATCGTCGAGACGACCGGCCTGGCCGATCCCGGCCCGGTGGCCCAGACCTTCTTCGTGGACGAGGACGTCAAGGCCAAGACCCAGTTGGAC
AGCGTCACCACCCTGGTCGACGCCAAGCACGTCATGGCCCGTCTGGACGACAGCAAGGAGGCCCGCGAACAGGTGGCCTTCGCTGACCGGATCATCTTG
AACAAGGTCGATCTGGCCACGGCGGACGAACTGGAGGCGGTGGAGGCCCGTCTGC 
465-M13rev_2
  GGAAAGAACAAGGACCTTGATAGATCCAGGAGGAACCCCAGTGTGCAAAAGGTGCCATGTGCCAAACTGGCTGTGTCCAGGGATCCTGGAAA
AGTGCCCTGCCAAACCCCTCTTTCTCCCTGAGCACCCATTTCAGATTTTGAAGTGCTTGTGGACAGCATAGCTAGAGAGATCCCTTCCATTCTTTCTGGGGG
AAGATGACCTCTCTCGTAGATCTGGGA 
466-M13rev_3
  CACACACACACACACCAAAGAGGTCTGTAGAGCTGAGATCAGATGGATGGACTCAGGATTCTACTCCATGAGGTTAGCATTGTCAACACATCA
ATCTATATGACACCCAGAGGTACACCCTTCATCCCTGAGTGTTCTAAATGGTTTTGAACATAGGCATTTCACTATCTTCTCTGGAAATGGGCACTCCTAGCAA
CTATAATTCTTCTATTGGGGTGTCTAAAGCTACTTAGCATGGTTTAACTAGTCCTGTGGGTTAAAAATCAGGATCGTAGTGGAGCATGTGTCCTTCTTACCAG
TTGGGGCATCTTCTGGATATATGCCCAGGAGAGGTATTGCTGGATCCTCCGGTAGTACTATATCCAGTTTTCTGAGGAACCACCAGACTGATCTCCAGAGTG
GTTGTACAAGCCTGCAATCCCACCAACAATGGAGGAGTGTTCCTCTTTCNCCACATC 
467-M13rev_4
  GTCGTTGCTCAAACCTCTGCATACTTGATCAGAAACGAGGTGGCCTTTGCTGTGTTTGTTTGTTTGTTTCTTTGTTTGTTTGTTTTTTGGGGGGG
TTGTGATCAAAGTTTTAGGGTAAATTATTCTCACAATGGAGGTTTTAAATAAGCAATCTAGTATATGTTGAAGGCTTATCAACTGAGACAAGAGAGCAGGAAAC
ACATTTTAAGCAGATTTACTATGTTATAGGTGACTTCCATGCAGTGTGCAAATTCAGCAGTAGAAAAACTAGTATTTCCTTTCTGTCTCTTAGAAGAAGCATAT
TTGGCTATAATTTATAAGGTTGGTTGGGCCTTTAATCTACTTTCTTTCTAGAATACATCATTAATGTTAGTAAAATTTTCTCTCCAGAGAGATACGCAAGGATAG
GACACTTATAAGGGTATTTTTAAAACTTGCTTATTTTCTGGAGTTTTGATCATGTT 
468-M13rev_1
  CCGACGGGACTGTGCTGGGGGGACAGTTCACAGAGGAAAGGGTAGAAATGCTGAGACTGGAGTTGGGTTTCAAAGATAATCCTTGTGAGGTT
AGCATTCCAAAGCAGGGGTACTGGGGGGAACAAAGGCAGATGCCATCTCAGGGATCCAGGACACTCACCTTTACCTNCCTGTCTCTNGGTGGTGATGCACT
GGATCCCGTCCCAGAGGCGTGCCATCACCCTAAGTTATTTTTTTTCTCCTTTCTGAGGTTAATATATTTTTTAAAATCACTATCAGCTATTGACTTGGAGTNAA
ACTTCTGGGCTGGGGTGAGCCATATGGTCTCATCANCATCACCATCACCATCATCATCATCATCACCATCATCACCATCACCATCACCATCATCACCATCATC
ATCATCACCATCNTCNT 
469-M13rev_2
  AGGAANANTGGGGTGCGTTTGAAAGAGTAAGTTTTAGAGGAAAGTTTCTTATAGATTCGTGGATGGAAACTTAACAAATATGTCACTGGAGTTG
AGCCAGCAGAGAGGTAAGCCACATGACAGGAAGGGAGCTTCAGAGAAAGCAGGGAACACNGAAGCCCAGGGTACCAGAAGAGTATCTGGCCTCTGGGCA
GCACCCAAAAGAAAGAGACAGAGGAAAGGTGGCCCCACCTTCCTAAAGCATGCTCCCTTAACCAGGCCATTGACCTGCCAAACTCGAANGTTGGGTCTCTA
CCAGANATTTAATCTTCCTGTCTANAAGGAACTACTTTCCCCTTGGTGNGATTTTCCGGAACTGNGATAGCTTTCCCAGCAAGATGTTACTCTNNTAGGGCTC
TGCT 
46-M13rev_4
  CCCTCTCAGCCCCTCAGGGTGTGGAAGTTGCTTTGCAGCACTCACCCTGAACTCTTCCTCCAGCCCGATCTTGTCAAAATGGGTGGCTGTGCT
ATGGAGCGTCTGCAGGTGCCTCTCCAGGGAGGACACATCCAGCTCTGTGTCCCCATAGAGGTAGTATTCCAGTAAGGCTTGGTAGATGAATGTATACTGAA
CCTGTAGGGAGACAGGGGGTGCCACTCAAGACTGCCCCATCGCTGGTAAAGCAAGGCCGAGGAGCAAGAGTGATCATGTGGACTGGTCGTCTAGGGTAAA
ATAAGATGACAGTAATGACCACTACCTCCGAGGGCTCCAGGGGCTATGTCAGCTGCTTAGAATCACCACCATGGCATATGAACATGCTAAGGATCAGGGTC
ACCAGCCTTTGTGACTCCATGGGAGGTAATGACAGAGTGGGAGGTATACCAG 
470-M13rev_3
  GTGTGCCACGCTGGCGAGGCAAGACCCACAGCTAGATCTTGGAAAACGGAAGCAACTGGGGTGGGACAGGAGCTCAACAAAGAGGAGTGTG
GGTATTCAGAAAGCCAACTGCCATCTTCTCGGTGAAGGAAGTCGTCCTTCATTTAATGCTTCTGTCTGCTCTCAGAGACCTGGTTGTGAGAGTCTCTACCAG
TACTCTGTGGGGGCCTGGACCGTTCCCTGAGGAAGCATGGTTCTG 
471-M13rev_4
  ACTGCTTTGATAGGTGCCACCATTTTGACAGATGCTGTCGTTTTGACAGCTGTGGTGGTATCTTATGGTGGCCTCAGGCTGGAGCCGCTGCTT
TAACAGCTCTCCTGCTGCTCGGGGGTTACAGGGATCTCAAAATATATCGCTTTCTCTTTCCCCTGTTTTCTCCTCCCCATCTTTCCCTTTCCCTGCTCTGGTG
ACTGAACCCAGGGCTTTCAGCACACTAGGCAAACCCTCTGTCTCACTGTCACATGCCCTANTCAAAGGCAAGACTCCTAACCCAGCTAAAGGGCANGTTCA 
473-M13rev_2
  CTTGCCAATCACTCTGCATGTCACCATTCTCTGACCCTGTGGTTTTGGCAGGATGTAGGGGTCCTCACAAGTGCTGCTGTAGATACAGCTCAG
TACATTGCTGTGTGTGATAGAGAGGTCAGGCAGAGCTAGCCTGCTTCGCTCATCTGCTGCAGCCAATGGAGACATTTCTGAACTGCTGTGGGATTGACTGC
ATCCTCGGTTGTTGCTTCAGTAAGGAAGTGAAGAAAGTGCCTGTCCGTATGTTCTGGGTTAGGGTTTTCCAGGCCATGCCTGTCACCTGCTGTTCTGCCTCA
GTCACTTTGGGACGTAGCAGTCATGTGCTTTGCAGATGTCAGAAGTAATCTCCCGTCCTCGTGTTTTTCAGCTGCACTGGCGTCTGTTGAGAGCTCACAGAG
CTGAAGCTGTGGACCTCAGTGGTGTAANAAGATGTACAATATACCTTAACTCTATGAAATTCATAGTTCGGATGC 
53-M13rev_1
  TCTTCGGTCGCGTGACCGGCGTGCGCACCACCGAACGTACCGCCGAGGCGTCCATCATCCAGACCCGCCACCGCATCCCCGAGACGCCGCT
GCGCGAGGGCCAGACCATGGTGTTCCAGGTGCCCATTCCGGAGCCGCTGCGCTGGCTGGAGCCGAGCGAAAGCGAAACGCGCACGATGCATGCGCTGG
CCGAATACGGCGCGATGCATGTCAAGCTGTATGAGGACATCGCGCGCCACGGTCATATCGCCACCACCTACGACTATCCCGTGATCGTCAACCAGCGCTA
CATGATGCGGCCGTCGCCGATTCCGAAGTTCGACAACCCCAAGCTCGACCGCAGCCCCGCGCTGATGCTGTTCGGCGCGGGCCGCGAGAAGCGCGTCTA
TGCGGTGCCGCCCTATACCCCGGTCAAGAGCCTGGATTTCGTCG 
550-M13rev_3
  CGTCCGCAAAACCGAAACTGCGATCGCACCAAACTTAGAAACAGAACACAAACATCAGACCAAAACAGAACAAAGAATCTTACCTCTAAGTGG
GTCTAGGACCTCTGGGTGGTCGCGCTGATTCCCGGCCAACGCACCAAAATGAAAGACCCCCGAAGGGAGACCCTCACTCAAGCACTCAAGCCCCGGGACA
GCCGCGGACCCAAGAAGACACTGAGACCGTACTCAAAATGTAGAAGGCAAGATTTAATAGAACAACAGCAAGAAAGCACATGGAACATAGACCAGAGCTCT
GGGATCGAAACTCATGCACCTAGTGGTGTAGAGGAGAATCAACGGCCAGCCAAATTTTTCACAGGCTTATATAGTAAAACTCAAGGGGGGAGAGCTGGGCA
GGGGAAAGTACAAGTTTACATCAC 
551-M13rev_4
  GTCCCCCAGACCTGGCTCAAAGGCCAGAGAGCTGGCATATGTGTCAAATGTCTTCCAGCAGCCTTGACAGGCAGAACAGGAAAATCAGGCCA
GGGCGGGTGTCTGCAAGCTATCCGGG 
556-M13rev_3
  GAATTCCCTATCCCATCCCCCCTCCCTCTGCTTCTATGAGGGTGTTGACCCACCCACCAACCCACTCCTGCCTCACTGCCCTAGCATTTCCCTA
CATTGGGGCAATGGGACTTCCTAGGACCAAGAACCTCTCCTCCCGTTGATGCCCAACATGACCATCCTCTGCCATGGATCCCTCCATGTGTAGTACTCTTTG
GTTGAAAATTTTATTTTTTTTCTATTAAAATCGATTCTTCCCTCATACAATAGAATCAAGCCCCACTTCCCCTTTCCTCTTCCTCTCTTTACACCCCCTGTCCCC
AAGATCCACTCCCAATCTGTTTCCTTTTCAGCAATAAGCAAACATCCAAAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAG
AGAGAGAGAGAGACAAATAAGACCA 
558-M13rev_4
  GCCATCTCACCAGCCCTTGTTCTCATTTTTTAAGTTTATTATTTATTTTTTTACTTGCATACACGTGTGTGTGTGTATATGTATGTTTGAGTTTGGC
ATGTGCATGTGAGCGCAATGTCCAAGGAAGCCAGAAGAGGGCGCTGAATCCTCCAGAGCTCAAGTTACAGGTGACTGGGAAGCCACCAGAGCAGGTGGTG
CTCTTAACTGCTGAGCCATCTGTCCAGCTCCTTAGGTTCAGTCTTTAGAAATGGCGTGTATTTATGGTACAAAGCACTGCTATCCATTAGGACATTTTTTTATA
TGTCTGTCTTTTACTTCCTTCACATTTCTGGCATTACCCTCTCTTGTGTCTGACCCCCCTTTTGATTTCCTTCTCTTTCACTCCTGCTTTCCCCCCAACTCCCTT
CTGGCCC 
55-M13rev_2
  ATCTTTTTCAATCCATTTATCATTTTATCATTTGTATAAAGCAGGGCTACTGATTTTTTTAAGTTAATTTTATATCCAGCCACATTGTTAGAGACATT
TATCACCTGTTGGAGTTCCCTGGCAGAAACTTTGGGCTCaCTCATCTGTACTACCATATTATCTATGAATAGCTATACTTTGACTTCCTCCTNTCCAGTTTGTA
TCCCCTTTATCTCAAGTTTTCTTATTACTCTGTCTAAATCTTCAAGNAnTATATTGAATAGATGTGGCATCAATGGGAAGGCTTGACTTGTCCTAtATTTTAGAG
GAATAGCCTTAAGTTTCTCCCCATTTCATTTGATTTGGCTATGGCCTTGCTGcATATTGCCTTTATTGtGTTTAGGTtTCTGCCtTG 
560-M13rev_2
  CTCCTGTGGTCTCAGCAGGCACCTGCTCTTGCATGCACACAGTCACACGCACACACAACTTACACATTCGAAAAGTAAACCTTAAAGAAAGAAC
ATAATTCCCAGTGACTTGAATGGCTTGGTATTAGGGCCTTTTTCTCCAAGTTCAGAAATACTTTTCTGAAATGTCGCGCCTCTGTGGCCTGCATGCAGGTCTT
GGCAAGAGTTTAACCTCACAGAAAAGTACCTGGCTGCTCTGGTCTATCCCTGTTGCTCAACTGTGCCAGGTTTTATATGTGAAGTTTCGATAGCATCCAGCC
ACACTCATGAGCTTGCTTGGTATCTATGGCTACAACTCCATAATCAAGTACTGCAATAGTGGCTACCAAGTATAAAACTATTCACTATCTGGACATTTCAGGG
AGTTTGT 
568-M13rev_3
  CTGCTCTTTGGCTGNCACGTTGACATCCTTACTTCCTGTTTGCTTGGTGTTTTTTGCCCTTCAGCTTTTTAATGGTCATGCATTACCAATACCCA
GGGCAGCCATGACAGAGGACCTTTAGGGAAAGGATTTAGAATATTGCTGAATGTTGGGAGATGGAAATAATAGATATACAGGGGAAATTCTTCCTGTTGAAA
ATTTGCAAGTGTCTTGAGCCCTGGGTATGTAAACTCTTCCTGTTGCCTGCAGGGGATATAGGGACTGACTGTTGTTACTCACTCCTGGGGATGCTGTCCAGA
TATGGGTATTGTTATCTTGGCTGGGATGCTGTCTGGTGTGGGGACTGACTCTTTTTTTATTAATCATTTTATTTGCTTACATTTCAAATGTCATTCCCCTTCCCN
AGTCTCCTCTCCATGA 
569-M13rev_4
  GTCTTGTGCTCCCACCCCCTGAAGACATGGCTTGGGTAACTCCCTGTAGCAGCTCAATTGTGCAAGAGGGAAAAGGAAGAGCCCAGGGGCAA
GTGGTTGAAAAGCAAGCTCATTTGTTTCAGTAGAACCTAGGCAGCCCCACGTTCAGGGTTGGCAGATCCCCCAGGTAGCATCCCCCAATTACCCTCTGGCT
CTTCTATTTGCCCGGGCACTCTTAACAGTGCACTTCCCCGGCTGGGCCCACTCACCGTCTCTGCGGACACACAGGCCATCAAGCCCAAGGTGAGCAGGAT
CCACGCGCGCTGCATATTCCCCAGGGGATGTGGCTCCTACCCGGCATAAAAGGAAGCCCATATCAAGCC 
571-M13rev_2
  GTACACTCATGTATCCGCCCTGGACATTTTGATTGAGATGAGGTAGTTTGCCAGCTGTGTTCTAACCATGTCTACTGTGAACATATGGTCTGTA
TAAAGCTTACCTGGGTAGCAGGCACTGTTACCATGGCACAGAGGAGACTCTCAGATGCAGGACTCCTGTCCACCACAGCAATGATGCCAAATATTATGCTG
ACTGTGGCCATCCGGGACCATTAGGATTGTTTACTAAATAATGGCAGCTGGGGTCCTACCGTCAGATCCTTTAAGTCAAAATCTCTACAACTGTTACTCTTAGAppendix 
  177 
CTAGGAGTGACCTTGTGTTCCTCCTTCTCCAGGAGACTGCAGCCCTGTCTGTGTGCATTTTGAGACGTCGCAGCTGGTAAGGCAGAGTACTGCTGGCATCC
AGTGGGAAGA 
574-M13rev_3
  AGCTCCTCACCTCTGAGTTCTCTTCTTTTACTCTTCGTGACTGCAAAACAAGGATATGTCCATTAGAATCCATGGAATTCCACAGAGCCACGATA
CAAGACAGCCAGTGGTGGCCGAGGGTGGTTACCTTCTCTTGGGAGGCGGCTGCCTTCCCCTCCTCGCTCTTCTCATCCATCTCGTCATCGCTCCACTCCCA
GTCGCCGTCTTCAGTCTTATGAAGGTGACCGCTCGACCCAGGAACTCGCCTTACCTGCACCAAAATAAGCCACACTTTCAAGGGTCGGATGGACAGAGCAC
TCACTGGTACTGCTACTCCAGGTTATCCAGCANACACAAGCCTCTGAAAGGTAACTCAAGAGGGTCTCAACCCACGGGATAACTGGAAGCTAACATACCAAA
AGANAAANNNCCTTAGACTTCCCC 
579-M13rev_4
  ACTACAACTCCCGGCAGCCGCGGCGGCTCGCGCAGCTTTGTGGGAGCAAGAAGCCGCTTGGTCCAATCTGCCGGCTTCTGCCACCGGAGAG
AGCACCTAGGGGAGCGCAGGGCTGTGAGTGCCGGACGTGCAGAGCTGGAGTATCTAGGGCTTGCTCGCGATAGGGCCTCGCGAGCGCCGCGACTACTTG
TCCCAGAAATCCTCGCGCGCGAGGTCTTCTTCCGGTTGGTCGTTCCTGACTTCCTGGCAGCCCGTAGCCGCACGGACCTGGACGGAAACTCCGAGGCAAC
TCCTCACTTGTCGGAGATCTTTGCAGTGCGAGCGAGCGATCTCCGCACATGCGCAGTGGGTGTCTGCGGTGCCCACTAgTCGTCTAAgGCTGCAgCGCTGC
CgTTCCgTGTGTGTTG 
580-M13rev_1
  CTCAGGGAGAGACCCTGCCTCAAGAGAATAGGACAGAGTGTAGATAGAACAAGGTACCCAACTTACTCTGGCCTCCTTTCTTACCCACATGCA
CACATTCTCTCTCTCTCTTTCTCTCTCTCTCTTTCTCTCTCTCTCTTTCATACACACACACACACACACACACACACACACACAGACACCACAAATGTGGGGG
GCACACACATGTCCATACTTGTGGACACACAACAAAACAGAAAAATGAAAGGCAAAAAGGCTCTTTAAAAGCAAAGCTACTGAGGATAGATACTGTCAGATG
AAATCTCAGTAACGACGGCAAACTGGTACAGAGATGCACATCTTGAGGAAGCTGTGGATGATATTCTTGCAGGGTAAATGTTAATAATCTTGGAAAAAATTG 
581-M13rev_2
  CCTTGCGGAGAAAAAGAGATCTGAATTCATGTTGGAACAATGTANGTAAGGGATTTCCNCAAGCCGGATCCGTAACTTCGGGATAAGGATTGG
CTCTAAGGGCTGGGTCGGTCGGGCTGGGGCGCGAAGCGGGGCTGGGCGCGCGCCGCGGCTGGACNAGGCGCCGCCGCCCTCTCCCNCGTCCGGGGA
GACCCCCCGTCCTTTCCGCCCGGGCCCGCCCTCCCCTCTTCNCCGCGGGGCCCCNTCGTCCCCNGCGTCGTCTT 
584-M13rev_4
  TTATTTGTACATATGTATGTGTACACGTGCACATGTGTACAGTGCTCAAGCTTCCATTTTTGGGCTCCCCCATAATGATGGACTATATCCTANAA
TGGTTGGCTCAAATAAACCCATGCTCCTCTAAGTTAATTTTTAAGTTTAACCAACAACTCGGAACTAAAATGGAATTTTCCAAgTTTTACACAGGGGAGAAACT
GaGAGCACAAAACAAGCAACTTATCTGTGAAGTCTTAAGTCAGGATNNANACCCAGCTACTCTGCATCACAATCCAgaTTCTACCNTGTCACCACACA 
585-M13rev_1
  CTTCACTTCCCAGACACAGGAAAACAGCAAGAACGCCTCTGAATAAAGGGGACGTTTGAAGGAACTCTTTCACAAGCAGGAGAAAGCCagNAG
TCACTTGTCAGTAGAATGAAGATCACATCTCATACACTGagAGAGATCCCAGGTCATGTGAGCAATNAAAGATTTTTCTCAGGAAGAAACAAAATGGGAATAG
ATTTGAATGTAGAAGTAAACAGTGCTTTGGAGTGTTGTTGTGTTAGCAAAATTAGATCATTTAAAAATGAGACCCAGGAAAAGTTAGTCCTCCCCCTGTGGAC
AACCCTGCACATTAAGTGAACGGTGTACATAAAGTCACCATCAGTGTTGGCTTTTATGTTGGTGCCACTCCAGAAGAAAGGACGTCTTCACAGCCCACCACC
ACACTTA 
591-M13rev_2
  CTTCATCTTCTGCAGAAGTGCGTCTACTTCTGGAGCTGCTAGCATTTGATTCTCCACTGAGGGCTAGGGCTGCTTTGTGGTTACTCTTCTCTAA
CTTGGGGGAGCACAGATCATCACTAAGGACGTTAGTACTTTGACAGAAGCCCTTGATCTCTGATGGGCTAGCTCTCTGCTAGGCACTGGGGAGGGTGGAAT
AAGAAATAGCTCTGCTCAGAAGGATCTTATCAGATAGGAAGACAGTCTAGAGGGCACCCAGCAGAAGGGCAGCTTGAGCTTCTTCGAAGTGAGCTTCGCTG
GGACTGAAGCTGAGGGTAGATGGGgAAAGAACCCCCAGCcTCAgGGCACAGGCTGTCCAGAATACTTTGGAGAGATTGCTGTAACAtTTT 
592-M13rev_3
  TACTTAAAATGTAAAAAAGAAAGTTCTGAAGGTCACAGGCCTAAAGACANACTTAAGCCAAAGCTACAACTTCGTAAGAAAGTCAAATCCTATAA
AAGTCCTGTTCTATCAATACCGCTGGCATCCTTTTAGTGACGACTCCCAGCCTGCATCCTTGCTACAAATTCACCTGTCGCCCCGCCCTCCCCGATGCAGTA
GCGGGACCATGGGTTGTCCCGCCTTCTTCCATGTTANTAGACCCGCCCCTGATGCTGATTGTCTAGGGNGACAA 
593-M13rev_4
  ACTCGTCACCCACTTCCTCCTCCACCAGTCTTAGAGACTGGCATTTCAGCTTCATTTTAAATGGCCTCAGACAAAACCATTAAAAATTCCTAATG
CTCTATCCCCTTTCTTGCCACTGAGAAGATGGAGAAAATGGCCTTTTCCTTGAGTGGAGAGCAGTGAGGTGAGAAGGAGGTTAGATGGGAAATTGAACAGC
ACCCTCGCTTCCTCTGATGACTGAGCTATTTGGATTGACACCGTCTCCTCCCCGGCCAGTCAGTGTAGAGCTGAGCTCAGAATGCCATTAAAGACCACACCA
TTGGATATTCCCATCACGACTTGGAGGGTTCAGGATTTTAATACAATAAAACTTTATGTCATTTGCCATTTAAAAATACCCCCCCCCCCAGCTACCCTGCTATA
TGCAGGTGAGCC 
594-M13rev_1
  GCATCGAAcCAGCGCCTGTCCGCCGCCCCGACCATCGGCCNGGACACCTTCGAGGGCCGTCGCCAGGCCCAGTCGAACGTCCTTCTGCAGA
CCATCCACGAGGCCCTGGCCGAAAACCGCGCCGACCTCTACCTGCAGCCGGTCGTTTCGCTGCCCCAGCGCCGGACCATCTTCTACGAAAGCTTCACCCG
TCTGCGCGACGCCTCTGACCGCGTCATGATGCCGGCGGAATACTTGTCTCTGGCCGAGGGCGAGGGTCTGGTTCCCGCCATCGACAATCTGCTGCTGTTC
CGCTGCGCCCAGATCGTGCGCCGTCTGGCCCGTCAGGACCGCAAGGTCgGCGTCTTCTGCAACGTGGCCnnnnng 
597-M13rev_4
  AGTCAGGATTTGAATTTATATTGTGTTGTCTGACTGAGCCTGCAAGGGATATTGTGAGAGAATCCAGGAGTCTTTTGTTTTTGTTTTTGTTTTTGT
TTTTTTCAAAACTAACCCCTTTTTATTGTCAAACACCGAATGCTTTTCANAACACTCTCCCATCTAAAATCTCCAATCTTCTCGACAGCCCTAGGANTTATATAA
AGCCAGGACTGAATGGCTCATTTTACACCACAAAAGCGCC 
598-M13rev_1
  TTCAAGCAGCCTGTGCTGGACCTTTGCTATTATAAGCCTGGGATGACTTCTAGATGATATAGCAACCACTCCCACCTGGGTCAGAGGGAGATT
ACCATAGACTTTGATGGCGAAATAGAAGTAATGCTATGATTGGTGTGGCTACTACCCTCTGTGAATGTGAAGTGTGCTGTGACCTAGCATCCCTCCTCTGGC
TAGGTGTAAGGGTCTCATCTTCAAAAACCCTCCTGTGCTTGTTGCTCCTGGTGTTGCAACTATAGGCTTnnnnnnnTTTCAAATTAgAATGGCCCTCACCTCTAA
GCTTCNTCCCCTGCACGCTAG 
599-M13rev_2
  AGACTCACAGAGTCTAGTGACTGGAGGCAGGGCAGACTGGCTAGTCCAGGATTGAGATCATCCAGCCCTGGTTTCCTCCATTCCTGTACTGAT
TCTTCCAACCTGCCCTCACAACTACACACACCCTGACCGGTTGGGCCTGTCCCTTGTAGGCAGTCTCCTGCAGTGCTCTTTTCTGTGCTCTCTGGAGGAAAG
CTGAAGGTTTATACTGACATGGAAATGAGTCACGGAAGGGACGGACTGGAGACATTTAGGAAAGAACCCCTCCTGTGTTCCTGGTCACTTACTAGATGGGA
GAAGGTAATGGGAGAGTCTAAAAAGATTAGTGGCCTGACGTATGAGACACTGGCCTCCTTAAATGg 
59-M13rev_3
  CTTTGAGAAACTGGAGAAGTGTTGCAAAAGTGCAAATATTTTGAATTTCCTGAGATTGAAAGGTTGTAGTTATTTTCTGTGGAGATTTTTTTTTTC
CAAAATGCATAGTGTTCTACCTGAAAGCCATTAAAAATTCATATTTCCTTCTCTGCGTGGAGTTTTCTATGTGTTGCTGAAAATGCTATCCCAGAACACAATGA
AAAAGGGAGAAATGGGCAATCCATCTCAGAGTTCTCATTTAGCCTGCTGTTAATTTGTCTCAGTTTTATATAGAGAGGTAGTAGAATAAACTCTTAGAATATTA
TGAATATAAAGAAAAGCCTTACCGTTTTCCATAAGTGTTCTCCTAATTTTGAAAAAAAAAATTATTTACATCTTTCAGCTCCCAAGCAAGTTGGCATCTCTCAAA
GTCTCTTTTTAAAGAACAGTAGGTGGGTTATGCCTTGAAAAAT 
600-M13rev_3
  GCCCTTGAGCACATCTGGTCTATAGGACTTGAAGAACCAGCTAACTGAGACTTGAGCANAAATTGCTTTCCTTGCAGTATGTTCTTGTGTAGAT
ACTGCTGCTTCTAAGGTTTTTATCAACTAAAATCAATTTGTCTGACAAGCCTGCCTTTGTAGGACAGAGAGGATTTTCTTTGTGTGGGTTGGTAAAACTTGTAA
TTTTTTTTTTTGGAGTTACCAGAATATTCCAGTTAGTGCAATCCCTNANCAAACGAGGNGCTCCTGATAACCATTGCATTTTCTCTGAATTGAGTTATNAANAT
GCATATTTCCTTGCGG 
602-M13rev_1
  CTGTCCGGTTCTGTGGCGCACCCTCTCACCTGTTCAGACTAATTTCCTAAGTTCGGCAGAATCCTGGAACCAAGTCCCGGGAAACCTCCCATC
AAATAGGAAAACTAAATAAAAGTATGGACTGCTCACTGAAATGATAAGAATAACTATCAGTATATGAATAGGCCTAGTGTCATAGGATATGTGCTAAAGTAATA
TCACCCTTTCGAAAAAGACTTAAATTCTATTTGTAATTTTCTGTAATTTCTTCTAACCAAGTAAACACCATGCAACTTTTCATAAGTGGCTTGGCACTATATGTC
AACTTTTAAAATTGTCCACCTTAATTCAATAATCTGCTATCCAAGCCGATTCTCTACAAATTATTGGTTTGGTGACCTAGTTTGGTTTCTGTTtCTTGTGATGAAC
ATC 
604-M13rev_3
  TCCAACGCAAGGAAGGAAACTATGCCCTACAAAAGCAAGAAAGTAATCTTTCCACAAACCTACAAGAAGATAGCCACATGAACAGAATTCAAAC
TCTAACAACAAAATAACAGGAAGCAACAATTAATTTTCTTTAATTTCTCTTAACATCAATGAACTCAATNCCCCAATAAAAAGATATAGAGCAATAGACTGGCTA
CACAAACAGGAACCAACATTTTGCTACTTACAGGAAACCCACCTCAGGGATAAAGACAGACACTACCTCAGAGTAAAAGGCTAGAAAACAATTTTCCAAGCA
AATGGTCCAAAGAAACAAGCTGGAGTAGCCATTCTAATATCAAATAAAATTGACTTCCAACCCAAAGGTTATCcAAAAAAGANnnnnnnnnGGGGTACTTCATAC
TCATCAAGGGTAAAATCTACCAAGATGAA 
605-M13rev_4
  CGGGAGGAAAGTGGATTTTGAAACTCTCCCAGGGTACAGAGAGAAAATCGGGGAATCCCCTCTTGTGTCTCGATGTCTTCGTTCTAAGTGTCT
GTCTTATGTTTCCGGAAACGAACATGTGCTCGTTGTGTTGGTTTGTTTTCCCCGTCGCCCTGGGGAGTGGGGAGAGCCAGGGATGCCTGGTGGTCTCCAGA
CATCGGTCAGAGGGACAAAGTTTTGTTTATGAAATGGAAGCTTACCCTTCTAATTCTTTTGCCTGCTCGTGGAGGACGAGTAAGGGTTGCACGTGTCTGGAG
CTGTTGGTTTCTGCTTTGTGTATTTTGTGTATGTGTTTAGAGATATGTGAAAATTTAGAAAAGTGCTGGTGTAGCTGCTTCATTTGGTTTTTTTACTGATAACGT
GCTCTGCGTGTCTTCCCA 
606-M13rev_1
  AATTGGAGCATGAGGGTTAAGGTTCCCTAGGTCTAGAGTGGCGCCTGCGGCGTAGACGAAGCTTAAGAGGATTGTCAGTGGCTGCCACTGTC
CAATTGTCGTCGTGGTTTTCTTCATCTTGACTGGCGGCCCTCTTGACGTGGGAGGCATGGATCCAGGAGGCGATTCCGTCAACTTTTACCACAGTAGGGGT
TGTCAGTAACACCAAATAGGGTCCCTTCCACCGTGGCTCGAGGCTGCCGGTTCGATGCCGTCTGACCAAGACTTTGTCTCCAACTCGGAACCCGTGGGGTA
CTGCGGTGGTCCCTGGGGTATAGGCTGCTTTCAGTTGGTCCCAAATCTGGGTCCTAATCACTTCTAGGGCCTTTAAATGAATAAGCAAAGAGGAGGGTAAG
ACAGGGTCAGAGTCGGAAACTAATGTTCCACCAGCTT 
607-M13rev_2
  GGCTTCAGGGCCGGAAGTTGTGGTAGCTGGAGATGCCAGAGGCCGCCGAGCTTGCAGATCCTGAGTGGCGAGGCGGGGTGCGTGGCTCGG
GAATGTCGTTTCCTTCGCCCCAGGTTGTGACAGCAGCTCTTCTCGAACCCGAGTACTTCCTGGGTACCAGGTCAGGTCTTGCTACTCGGACCCCGCGCCCGAppendix 
  178 
CATCGCGTCTGGTTGCTATGGAAAACAGCTGTCGCCTTATGAGAGGCGCTGAAAATTGCCGCCCTGGGTTGTAGATGCTCATGGGAATCCCGCGGNTTAAC
CAAACCGAAATAGTCCACCCTGGGAAAAGCGGCTGNTGGAAAAGACTCCTTTGCTTCNCATTTTCTCCCTGCATGAAAANANAANCCTTGGAACC 
60-M13rev_4
  ACCTGCtGTAACAATCCCTGGATGGAGCAgAGTGTGTCTTCCTCTTGCCTGACTGGTTACATGTGACCTTTTGTCCATATATATATAGCTGAAAG
TAAATGTGTGTGTTTTATGACCATGTAAAGCAATAGCCTCTCCAGACTGTCAGACTTGCTCATTAATCTAGCTGTCCTGGATAATTTTTACATGGATTATTTTAA
TGtTGAAAGCaATCTTGAAAAGCCACAGGGTaCTTCTATCATGCACAtAtCAGNTTTGTCCcATGCAAAACACgTATACaACACACGCGCGCACNCACACACACA 
611-M13rev_3
  GTGCCGCAGACAGGACCCGGTCCCNACATCTTTGGAGAGGCGCACTGGCTATTGGCAGGCATCTCTTTCCAACCTGACGTCAGCTGAGTGCA
TTCAGCTTCNAAGTAACTGCATGCTTTCTTCCCGCTGACATCATTTCCAGGAATAGACACACCAATTA 
612-M13rev_4
  CCATCTTTGACTTTTATACAGATTATGCAGGGTGAGGGCTTTCCAACTAGACATTTACACGATTAGTTGACACTTCAGAAATCACAGCTTGCACA
AAATTTTTAGCTAGTGACAAATTTAACTTACTATATATAGTAGTGGTGAACTTGAGTCATTTGCCTTTGACAATGGTCATTTCCCTATACCCAGGGTGCAGTGG
CTGTTGCTTGCTGGTGTCTTAGTTCCTGGAACAAGTTGTGCTTTTTCCAGTTACTAAGTTCACACTAAGGACATGGGAGACATAAGATGGAATCTGAACACAA
AATGGAATTAGTTAGGCGTGGTCCTTCAGTCTGCACATCCAGGAGCATTTGTTCCATCTCCGTCCCTCCTAAGACATGCAACCAATAAAGAGAGTAGAAACT
TAAAGGGTCCTTTGGGAAGTCNAAGTGTGTTGGCTGGC 
614-M13rev_1
  AAGGGCTGGAGAGGATGAGAAGGCAGGCTCTCTGGCACTTGGGAGGATGCCTGAACAACTGCACATCCCCTAAGCCAGGAGCAGCTGCACC
CAGGCTCTGTGCTTCTGTTTCAGAGCCAAGCTGGCGCCCTGGGCAGTATGCTGTGGAATGACATTATTCTCTGTGACAGAGACACTGAGGAATACTGAATG
TTGTCCACATGGATGGCTATGTGAGTGGAAAAGACCCAGAGCAGATGTGAGCATTATGGAAAGACACCAGTAAGACAACAGACTCTGACCTCAGAACGGTG
ATGCCTG 
617-M13rev_3
  GCTGGTGCCTTGAGAATGACTTCAGCTTATGGGTCTTAATACTTGAAGTGGACACAGGGCATCAGCAGGATGGATTTCGGGTCCTTGGAGACC
GTGGTGGCCAACTCTGCCTTCATCGCTGCCCGGGGCAGTTTTGACGGAAGCAGCACACCGTCTTCCCGAGACAAGAAATATCTGGCCAAGCTCCGGTTGC
CCCCACTGTCCAAGTGTGAGGGTCTCCGTGACAACCTCAGCTTGGAGTTTGAGAGCCTGTGCTCAGAGCAACCCATCGGCAAGAGGCTCTTCCAACAGTTC
TTGAAGACAGACGAGAGACATGTGCCAGCTCTGGAGCTCTGGAAGGACATTGAGGACTATGACACTGCTGATGATGACCTGAGGCCACAGAA 
618-M13rev_4
  CATAGAGCCGGTCTCCTTGCTCAGCCAGTAAGGTCACCTGGGCTTCAGTCTTCTGCCGAAGACACACCACCTCTTCTTGGCTGCTTGACAGAG
CTGCTTCTGTGGCCTGAAACCTCCTCTGTTCAGAGCAGAGAGACAGAGGGTGGGATGCAAACAGTTAGAGCAGGTCTTGTGCCAAGATGGGGCACATGGA
CTTCNCAGTCTGGGAAAGAAAGAGGAAGAAAATAGGGGGCGGGGTGGGAGTGTGTGTGCCCCACGGACTTCAGAGATCTCACAGTGATCTTACACTTGAT
GTAAAAGCAGAAAGGACCTAAGTTAAAATTCCTAGCNNCCCNANGATTTTTA 
619-M13rev_1
  ACACTTCCAAATTCATTTAGTGCTCAATCCCTTAGAGCTGTAGTGCTGATATCCTCAGGAGCTTCTGTTTTCCAGCTAAAACACACACCGCACA
GCCCCGCCCTCTGACTGGCTCCAGCCTAAACCNGCCACATCTTTCTGATGTCCATAGGAAAAGTTCCTGTAGGTTGAAAATTCGATGCTTAGACTGGACCCN
NNGAGAATATACAGAGCAATCTTTCTATTTTAAGGTCCCCACCAGCAGTGTATTTGCAAAGTCCCCATGCCATGTAAACGCANATTGAGATATCTTGGTGATT
A 
620-M13rev_2
  AAAATGACCGCCTGTTCTTCGGGCCGTCGCACGCATCCCGGCCCGTGCCGCTGCACGGCTTGGCCAGCGTCTCCCAAATCAACCGCCTGAC
AACAGGCAGCCTTCTGACGTGCGCGCCCGCTTGCGTGGTCGTCATAGGGGCTCAGGTA 
621-M13rev_3
  AGCCCTGTTCCATTTCATGAAGTATGGTTATTTCATGGGAATGGTGGTACAGGGGCAGATGTACTTATCTGTGAGAAGTATGTGAAGATTTAAA
TTTGGTACTTTAAGCATCTGGTGCTATAGGGTGGTGGGCTGCTCGCATGACAGACCACCTTGTTCCTGCCCAGCCTTTGTGAACAACTGAGCAATTACGTAG
AGAGAGAATGGGATGGCATAGGGAGGGGTTAGTGTGCCACTTTCCTTTAATGGGCTTTAGAAGTGTTTAACAATAAGACTTAGAAATCTTCAAGGACTGAGC
TTTTCTATAAATGAATGATTTATTGTAAGTGTGCCTTCCTAGGCTTTTTAAAGGCCAGAATGTATTATCTCCCCTTCTTTTGTGGTACCTTAGTTTGCCATGCAT
GTTATCTGGG 
622-M13rev_4
  ACAGGACCAAGGGCCTCTCCTCCCATTGATGACCGACTAGACCATCCTCTGCTATATATGGAGCTGGAACCATGAGCCCCACCATGTATACTC
TTTGGTTTGTGGTTTAGTCCCTGGGAGCTCTGTGGATACTGGTTAGTTCATATTGTTGTTCCTCCTATGGGCTGCAAACCCCTTCAGCTCCTTGGGTCCTTTC
TCTATGTCTTTCATTGGAGACCCTGTGCTCACAGTCCAATGGATGGCTGTGAGCATCCACTTCTGTATTTGTCAGGCACTGGCAGAGACTCTAAGGAGACAG
CTATATCAGGCTCCTGTCAGCAAGCACTTATTGACATCCACAGTAGTGTCTAGGTTTGGTGATTGTATGTGGGATGGATCCCCAGGTGGGGCAGTCTCTGGA
TGGTCATTC 
623-M13rev_1
  TGTGAGACCCCACTCATGAGTCTCTGGGCTCCTGGGGCCTGGGCAGTGGCACTTCTCTAGCTCTGCCATCCACACTGCTTGTAGCTTGTCCC
CTAGGTTCAGGCTGGCCCCACTCCCCAGCAACTACTGTCCTTGGCATTCATCCAGTTAATACTGGCATCTCCAAAGTATTTGGGTCTCCAGGGTAACTGGGC
TACATATTGTGGGCACTTTTCAGGGACTCTAACTCTGCTGCTTGATGTCAAGCTTCAACTTCTCTCCATGTCCTCTTCAAATTCCTGGGGCTTCTACTTCAAG
CACATTCATCACTGACCTTCCTGCCTCTCCCAGTACAAAGCCTCAGCTACTGCAACACACCTTCAACATTCACACCACCTGGGAACCTCACATTGCCGAGTT
TGGCT 
624-M13rev_2
  TCGATCCTGGTCAGCCAGGGCTATTCGCCGATCGCCGCAGGCTCGCTGCACGGGGTGCTGCAACTGGCCACCGCCCTGCCGGGGCTGCTG
CTGCCGCCGTTGACCGGGCGGATGAAGGATCAGCGCGTCATCGCCGCCGGTCTGGGCGTGATGGGGCTGGCCGCCATACTGGGCCTGTATCTGGCGCC
GACCCTGGCGGTGGTGTGGATCGCCCTGTTCGGCGCAAGCATAGGCGGCGCCTTCATCCTGGCCCCGACCTTCATCGCGCTCCGGGGCGCGCAACGCCC
ACCAGACGGCCCGTCTGTCCGGCATGGTTCAAGCGGGTCGGTTATCTGAATGTCGGC 
628-M13rev_1
  GTAGTGTGCACAGTACCGTTTATGTGTAGTGTGGAGAGCCAAGAGAGCCAAGACAAGAGGCTGGGGCTTTAGGGTCCCAATAAATGAATGCA
AAATGATTAGAATGTTTGGAGAGTTAGTAGAAGTCAAGGGTCATTGTCTCCAGGTTTATTTGTGCAGACTTGTCTCGGAACCGTGCCTGCTGACACCTCTTCC
CTGAGTGCAGGATGGAAGGGAAATCTGTGGGCTTCATTAGGAAGACCAGGAGGGTGGAGGCTGCTTTCGCTTCAATGTCTTCAGCTCAACACATTCTAATG
TGACACTGGCCTACTTGGAATCTGACGTAGCCTGACTCCCCTCATAAGCATGAGGAAGGGAGGGAGCACCTCAGACTTGAGAGC 
62-M13rev_1
  CAGGATCCAGCTTTGAGTTTATGCCCTGACTTCCCTTTATGATAAACTGTGAGTAGTAGGTGAAGTAAACTCCTTCTCGGTCAGTTGGTCATTTT
ATTCCACAGTGTTTTTCACAGCAGTGGGAAGCAAATTAGTTCATCAAGTTTTTCATTTGATTTTCATTTCACTTCGGTGGCTTAAAAATTATTAGAATGTTGGTC
TGGTGAGATGGCTCAGCAGGCTAAGGTGCTTGCCACGCAAACCGGGTGACCTGAGCTAGAGCTCAGTAATTCATGTGCAGGGGGAAGGGGAGAATTGTCA
GATGCCAGAGTTGTCTCTGACCTCTGCATGCATGCCGTGACGAGCGTGGATCATAGACACAAAAGTAATACATAGAACTTCAAAGGCTTTGGCATGTAAGAA
CCTTAACATTTACTTCTGCAGCCAGAAAACACACACA 
630-M13rev_2
  CACCCAGCGGCCGTGCCCTTTGACTTGACCTCTGATCCTGCCAGCGGGTAGGCTGCAGGACCAAGGGGCGTCCTGAACTCGCGCACACCCG
CCAGGCACTTCTGTTCGGTTGGGCTCTCCTGCCCCCATCTGGGAAGGGTCCATAAAAGCCTTTCTCTTCCTTCCCTGCTCAAAACCACTAATTCATAGGACT
CCAGGGGTTCTGGGTTGAATACTGAATCAGTATTTCCTCACATCCCCAAGGATCAAACAACGCCAGCCGCGGAAAAAAAGGAATCTCCTTGAACCACACTTT
GGGTTAGTTCACCTTCCTCCTCTCTTTCCTTTTTTCCCTTTTAAACCAAGACCGAGTCGAGTGGTCAAGAAGAAAGCTGGGGACAACTTAGTTGGCTAACCTG
AGAAAAACCGGCGGCTGTCACTAATGAAAATGCTGTGTAATAGAAGACAGAGACAGTCACCACAATCCTGCGTC 
633-M13rev_4
  GGTTTGTTtATTTGCTCGTCAGCTTCTGTCCTGgAGCCTCANCCTGTCCCATGGNTCATTTTCCTCAACANGTGCCAGCACCTGCCCCAGAGTC
AGCCTCANAACAAAGAGGCTTTTAAGCACGTCTCATATGTGCTATGTAGGCAAACATTACATCACTCCAGGTTACTTTGCTTGCATCCCAGTAGCAAAATGAG
CTCATTGTTGCTTTGCTGTCTTGGTTTCCATGACNCTGCATGACCGCATAGGTCCGCTCCTACATAGCCATCCTGCAGGCTTTGCCCCANGTCATAAAATGG
AGTGCTCCTTGCACATCAACCATCAACACAGAAAGTGTGAGTTGAANAAGTTTATCTCACATGNGCTATAAATGNTGGCTCTACCNACAAGTATTGCCAAATA
CTTNTATGAANGTAC 
634-M13rev_1
  CNTGNAATTAATTATTTCTATCACcACCAACAGACACACACAAGCCAAGGAAACAAACGACTTCCCTATGAAGCAAGGGCTGAGGGCTGATAAT
AAAAATGGCAACTGAATGACAGCAAACTGTTTCTCCCCCCTGAGCTTGCCTGATAATTCCTTTTTTTTCCTCCCTGAATAACTAAAGGAGAGGCAGCTGCCAC
AGCAATCAGGATTCAAAACCCCATTAATATTGGTGACTCATCAGCCGGATTCTTTCTCTGTGTCTGGAAATGTCAGGATATTAAAAAAAGCTTTGTGGCATCT
CTANGAGTCAAATCCCCAGTCAGAGCTGTAACCACTTCAAAATATTCTTGGCCTCGTTTGGAAAATGGCTGTCACCTGGGACTTGGCCTGGTTTGTTTCTGT
CAGTGAAGGGCGAAN 
637-M13rev_3
  GCTGCACTGGCACGAGTCTTCAGGAGGGATTGGGATCAGCAGGGATGCTAGAAGTTCTCCTGTGTTCCTCTCTCGACATGCTTGTCATTAGTA
AAGAGCCCTTCATCACACGCCCTTTCATGTGCTTGTTTTAGCAGAACATCCTTCCACGTGTCTGCTTCGGCAAAGCTTTCCTTCACTAGTCTGCCTTAGCGAA
ATGTCCTTTCACCTGTGTGTGCTTTCCTTCATGTGTCTGCTTAGCAAAACATCCTTTCAGCTGTGTCTGCTTCAGGAAAACATTCCTTCACATGTTTGCCCCAG
CAAAACACCATCCGACACAACTGACTTTCCAAAGAACCCTTAACTTTCCATGTCAGAAGTCCATCTATGTAATGATAGGAAAGGCATTCTCCGTGCTGGGCAA
AGATATTTCAGTGTGGTTGCTTTGGAGTCACTCATGCTATGGTCAGTAGCCCTAAGCCATTCTTTTAAGTAAGCCCA 
638-M13rev_4
  GTGAGCACACACATAGCACAGCATCCATATGGAAACCAGAGGACAAGTCTTGGGAGTCGTTTACTCTATCCCCTGTGAGATCTTGGGCCATCA
GACTTACATGGCAAGCTCTCTAACCCACTGAACCATGTCATGTCCCCTTTATACTTTCATGTCTGTATGTCTATTTGGTATGTACACATACAAAACATTCGCTA
GCTGTGGATAGTGATGGAGTTTTTAGAAGGACAGGCACATGTTTATGTGGCGGATCCAGGATTGTTGGGGCTGGCCTGTGACTCTCATGTCCGGGTTCGAG
CCTGGGAGGCATCTTGGAGCTGAAAGAGAAGAGGGAATCTAGGGGGGTAGAGAAATAATAGAACCAAGACAAGCTAGTCAGCTCTTGCACCCCACGAGGC
TAGTCTCATTGCACGGGATAGAGTGAGTGCTTCAGCAGCCCGAGAGAGTTGCACGGCTAAGCACTGCAGTAGAAGGGCTCTGCGGCAT 
639-M13rev_1
  CGTCAGCGGCCGGGGCGCAGCGTCATGGCCGAGGCGGGGGCCAGTTGCAGGCCGCGCTGCTCAAGCCCGGCGGTCCAGCGGGCGGCGG
CCTCGACCGTCACCGGATAGGAGAAGCCGGTCCCCAGGGCCGAGCCCCGAACCTTGGCCTGGGCCTCCAGACTGTTCAGGGCGGCGATGATTGCGGCGAppendix 
  179 
GGCGACTGGGTCTGGTCGATGATGCGGTCGGCGCTGGCGCGCGCCCAGGCGCCGGGGCGGCGCTGGAAGGTCCCGTCGTCGACGAAGGCGACGCCGC
GCTGGCGCAGATAGGACAGATAGGCGCTGGACGCCGTGTCGGAGGCCACGAACTGGTCGCCCAGATAGTTGGTCACGCCGAAATAGCCGGTGGCGCGG
CCCAGCAGCCAGTCCATCTTGGCCTGGACATCGTCGGGCGTGCTGTTGGCCAAGAGGGTGTAGGGGCCGGGG 
64-M13rev_2
  CTCCTTGCCTGCCTTAGCTCCTGGACTTTGCTTTCAATTAACGGACCTTATTCAGCGCCGCTTCAGGTTTAAAGGAGGAGTGAACAGTGAGTCC
TCTCGCCCCTCCCCACCCATCTCCGGTTCACATTTGGTGCATGTGTGTGTTTGCCAGTTGCTTAACACATTCATGTTTCCCCTTGGAACTTACCATTCACTCC
AGGCTGGTCTGTCACTGTGGGACAGACACACATGACACACGACACACACCACCATCTCCTGCCCACCCATGCTCCTGTGCAGTACACAACTTTGGATATAA
ACAAAGTAAGGGGAGCTGTTAGGTAGGCACAGTGAGTGGACAAATCAGAGAACCACAATCTGCCTCTGGGTGACAGTGACCGTTGTGCAAGCGTTGGGTG
TGGTAATGGAACCTCAGGCCAGGCTCCGTGTCCCAGAACTCGATCC 
70-M13rev_3
  CCTTGGCGTCGACCATGGCCTTCTGCCACTGCTCGGCGGCATCAGGCTGGCTGACCATGACCGTCTCGATCGTCATGGCGCGACGTCCGAC
GTTGAAGGTGTACTGGATCGAAGGCTCCACCGCATTGCCGCACATCATCAGGCAGTCGGCGGTCAGGACGCCGTCCTGAAAATTGTCGAAGATCTCGGCG
AAATGGATGATGTTGGCCGTGCCGATGGCGTCGCTGCCGACGACGGCGTCCACATTGAAGGTGCAGCGGGGCGAGGTTTCCATCGCCAAGGCCTCGACC
TTGCCGCCCGTCACCAGGGCCTGGACGCTGCATCCTTCGACCTCATAATAGCGCACTGAGGCGGCGTTCTGGCTCGCCCGCCCTGTCACCCGCTCCAGCA
CCGATGCATCCGCGCCCAGCATGGCGGAGGTGAAGACACGGTCGATCTTGGACGCCGCCC 
711-M13rev_4
  GCTTAACCGTTTCTTTACACTCAAGGAGGCGCTGCaCAGCCTTGGTGCCATGTAAAGCCAGTGAGATCGGGCAGACAGCCTGACTGGGCTAC
TGGTCCTTGCTTTGATTTTCCTCTTGTTAATTTATTTGTTAGCTTTGGTTTTGTTTCCCAGCATGGTCTATACATTTTCCATTGCCTTACACTTCTATGTAAGTTC
TAGAGCTCATCACACCCAACAGTTGATAATGCTGCAGTTCAGTAAGTGTTAAACTCCTGAGTCCTCCGGTGGCTTCTTAATTCTCTAACCTTTCCAAATTCAAT
TGTTTTCAGGAGCTCCTAAGACAACATGATGAAGACATCCTGCAAATACAGGAGCTGAGAAAATCCAAAGAGGTAAGGGTTCCCATTCAGCTCTATGAAAGT
AGTGTCTT 
717-M13rev_4
  GAAACTCCAGCTTATACTGCTGACANANTCTAGCAGAGGAAAGCACTTGCCGGACTCTGTGATTGGCTCCCTGATCCGTGCTATACACNAACC
CCTCTGTGGCAGNCAGTCTTCCTCAATTGCNTGGCCGAATTACATACAGATTTAGGTCCTGAGACTGACCTGTGGCTTCATGTGACCTCCCCATGACACACC
TGGACAGAGCAGCNAGGGGACNGGNACAAGTGGCTTTTATCAGACAGGAGATGGGAATAGACCAACGGGAGGCCGAACAGGCGCTCA 
718-M13rev_1
  CCCAGTCCCCACTATTTTATTAAAGTGCTTTTGTATGTCTTCTCTGACTTTCTCTACTGTATTCTACTCACAGAATGCAGACTGAGGTATGGTTTG
ATGGAAGATGCCCATTCTCTCTTTAACAAATTTCCGGTTTTGCCAGCTTGTTTTGTTTGAAGCATGCAACCTTGAACAAACCGTTTACATTCCAAAATATTTTAT
CACTGCATTTCAGATATATGCCTTGCCTACTTTTTGTGATTATTGAAAGCAGATATGCAATCAAGTGCTTGAGAAAGTAAGGTGTTTATCAAATTGCTTTGTTTT
ATGTTTATGCAGCCTTTCAAAGCAGTCTGTAAACTCTTGAGGATAAGTCTATCCCGTGTGTTTATACACTTCATCACGGGCCATGGCGGTAAGAGCCATTGG
CGTGCGT 
719-M13rev_2
  AAAACAATGACCGCATATATGACATCTGCTGGAGAAACACAAAGTATGCCTCTATTCACACACAGATTGGCACCATTCATATTGTCTCATCCAGA
ATCTCCTGTCAGCTGTTTAAGCAACACTACCTTCAAGAAGAATATAATCCATACTCCAGAAGAGGTGGAAATCCTCACAATAGCCAGTAAACCCCTATCACAT
CAgAAGGTAGTTTGGGTTTTGGCTTGTCATTCCAACCATTCCTAGACAAGCATTAAGCCTTTTTAAGAGTCTGGTGTAGTTGTCCCTGGAAGGAGAGTTTGGG
CCAAAGTTCAGTAACCTGTGTAACCTTTCAGAGAAAGCCTGCTGTTTCGAGAATTTTGTGCAAAGCCCAGTATACCCTACTTTGTCTTGAGGCAACAGGTGGg
CATAaATTCAATGTTAGTATT 
720-M13rev_3
  TAGGTTTGTGAAACCCCTCCTATTTAAACACGACAGAAATAAACACCCTCTTCTGTAGACCTGTGGGTCACCAGCCCTTTGGCAAACCTCTATC
TCTAAAAATGTTTACATTACAATGAATTCACAACCGTAGCAAAATTATAGGCATGAAATAGCAACGAAAATAATTTTATTGTTGGGGGTATTTAACTGTATTAAA
GGGTGGTACCATTAGGCAGGTTGAGAGCCATGGATCTAGGGGAATCCTCTGGCTTCCTGCAATAATGACCTTGGCCTGCTGGGAGGCCAGTTTATAGTCCC
TGCTCCCACCCCCACCCCGACCTCTGCCCTCCCAAGGCTGCTTCCCTTAGCTCTGACTATGTGAACTCAAGGCTCACTTTCCTAGCAAGCTCCAATCCATGT
GACAAGACTCAGGGAGTC 
721-M13rev_4
  GAGTACACATGAGAACAGCGGCCTCGACCTAACACGCCCCCTGCCTGACGCGCAGCCTAGGAACCTAAACCTAAGCCGGCTACACACAAGCT
TAGGCGCTGATCTGGAGAACAGCCTGGGTGCGGACAACCCTCCCGCGCAGACTGGTCCATGGCTTTTTCTGCCAGCGCTTACCTGAACCACTTTAGTGAAC
TCCTCATACACCCGCATTTTTCAGGTGCGCCGCCATGGCTGCACCGGACCTTCTCGGCtTCTGTACTTGCTGAGAACGTGGAGAGAAAC 
722-M13rev_1
  CCCTACCAGACAATGTTCCTGCAGAACCTGTTACCTTACTTGGCAGGGATTTTTGTCAAGGGATCTACTACTGTGCCTAGTATGGTAACTACCA
CAGTGATATATCCAGCAACAAAAACCCATTATGCCCAGCAGACTCTTCAGCTCAAAACAGTGAGTCAAGAGGAGCTTGCACCTAAGGGGCTATTTCTGAATC
TCGACAACTGAGAATCATTAGTTAATAGGATCCAACACAGAGCTTTATGACTGCCCACAGACAGGTGAAAGCACACTAAAGACAGATCCCAATAGTCTCTCAT
CCAGAATCCTAGTACCCCATTATAAAAGCACTCAGCTCTCCACATGGACCAGTGCCTCCTTTCAATAAGAAGGGCCCAGAGATCTTTTTCTCAGAGAATCTTG
GGAAACACTCCC 
728-M13rev_4
  ACCACGGaaACATGAACATATGGAGGCTGGTTATTAAGTGCTGGCTTCTCAAAAGATAAGGAGTCAGGGCTGCCTTCGCCACTTACCCAGATT
CCTAACCTATCTGTTTACTGTGATGCTGGTTGTAAGAATTACAACCCCATGTGTTTCATATGTGATGGCCTGGCCAGCTCAATAATAATTGTCAACACTAATG
GGATGTCAAACCAAACAATGTGGTTTTTCCTAAGAAACCCGGAAATGGCAAATACAGtTTTCAGTTTAGCAAGGGGGGAAAAAAGGTTCAATTTGCAGTTTCA
AACATGAAgGGTTGGGATTCCTTAAAGCCTTGGGCTGACCTGGCATTGCTTGAGTTTGTTCGCCCAGACTCTATACTGACcCAGGGAAGGACCTCTCACAGT
A 
729-M13rev_1
  CCCAGTCAAGGAGAAGGTACTTTGAAATCTCTTTACTCAGCCTGCCAATGACACTAAACATGTCTGAATCTAGCTGTGTTTCCAGATCCAGTGC
ATGGCCCACAGCAACATGGTGAGATTCCACACCTCTCCCTCACTGGTCTCATGGCTATGGAAATCATTATGAATACTTAATGTTCCAAGTAATGAAAGTAAAC
TTCTATAGAGAACCATGGTTCCTGAGTAACATTCGGAGCTGAAAAGAAGTGATCCTACCCAGCCCAGGGGGAACGACCTACTATTAACCCTAGCTTCTGGCT
CCAGCTGGaAAGCTGGCATGCATGGGCAGGAAGCTATTCTATGTAAACTAGGACCATTGCTGAGAAGTCAGCTCTGCCCACCCTCAACATTAGCACCCAGT
CCAATCCTTTCTAGGAC 
731-M13rev_3
  AAGATNTGAATTCGTGTGCGCCACCATCGACCAGTGCCCCANTGCNCATCGAGGAGACCTCGCCCATCGTCCTGCGCTACAAGACNCCTTAC
TTCAAAGCCTCGGCCCGTGTGGTCATGCCCCCCATCCCCCGCCACGAGACCTGGGTGGTGGGCTGGATCCAGGNATGCAACCAGATGGAGTTTTTCAACA
CCTACANCGACC 
732-M13rev_4
  CGGGATCTGAATTCTCGCTGACCCGTTGCGTCCCGGCTTCCCTGGGGGGGACCCGGCGTCTGTGGGCTGTGCGNCCCGGGGGTtGcGTGTG
ANNAANATCCTCCACCCCCGCCGCCCTCCCCTCCCGCCGGCCTCTCGGGGACCCCCTGAGA 
739-M13rev_2
  GAACTAGGACACTGAACCTTCATGCAATCAGACGTGCCTTCCACAGGATGCCAACAGCAAGCTATCCTCTGtGCgGGGCTTAGCCTCGCACCC
CACGGCATAACGCANCATAATTTCTTTTAGAGCGGCcAACCGAATCTGAGGAGATTGTCCCGCCTCCACTGCAGCATANTTCTANGCTACCATGGCGAAAGT
GTTNTCCCCCACACTCTGCACCTAACACGNGTCAAACACANAAGANACAC 
73-M13rev_4
  ANnTGAATTCCCTCACTGGATACATCCTCTTATAATGTGTCCAGGAGAGTAGGGCAGGAGGCTCAACTGGATCTTTGGCTGGGATTCCCAGCC
CTGAGTAGTGTGATTGTCTAAGAGAATTTTGTGGGGTGGGGAAGAACTACTATAACATGGAAATCCTTTTACATTTGGACTCATGTCTGATGTTCCTCTATTTC
AGAAAATGTTCCTCTATTTCAGAAAATGAGAGACACTTCTAAATTACCTTATCAATGGTTCCTTTACCAATTATGTAAATTCCCCTTCTAAGCTACCCCAAAATT
TCTTGGACAAGTTATGGGAATCTAAACTCTCTTTTCATCCTTCAACATCCNCTCAGTGTTATACTCAGTGTTGCAATACTTAGGTTAACAATCCATTTGATTTCA
GTAGGAGATATCTGTGAGTTCAGAGAACTTATGAGTCTTTTAAACACTCAACCACCAAAA 
740-M13rev_3
  TGGGGTGGGGGGTGGGGCTCCTGGTACACAGTCAGTAAAAAGGCTGACTGGTCAGGAACTTGCAACTGGCACCTAAAAGGGAAGTTGTATAA
GGCTGAGCTCCTTAACTGGTCAGATCTGACAGTAACTCAGAACCTAGTGTCACAAGTGAATTACATTGTTGGACACCCAACTTGTGTTCAAGATTTGTTAATA
ATAGAGAAAATTCCCCAGAGACATTCATAACTTCACCTTGGGAAAGACTCAGTCACTGGGCCCCTACTATAGATAGCTCCAAAATTTCCGAAGCAGtAGCATG
CCTCATTTTCCAGGATCCAGTTCATTTTTTTAAATCCCTTTGTCAATGGGAGACAAAGCTAAATACACTCTCCTAAAAGCTATTACATCAT 
742-M13rev_1
  NAAATGAAGATATTATGAATAGACCTCAGTCTAACTATTAGACTATTGAAACAATGAATCTCAGAAATGAAACTTTCTCCAAGAATCTAATGCTGG
GAGGAGGAAAGGCCACCAGCCTGAGGGGGACTTAGCTCCTGGAAAGACACTTTACCCGGGGTTAACAATGAAACCTTATGGGATTCTACGGATGATGGAAT
GGGCCAACGGCAGCAGGACCACACCGTGGCTGAGACTGCTCAGAGTGGATACCTCTAGACTTCTATTTAAACGTTCATCTTGGACTGGAGGGATGGCTCAG
TAGTTAAGAGCACTTGTTCTTGCAGAGGACCCTGGCTCAAGTCCCAGCACACATGTGGAGGCTCATAACCATTGATTCTTCTGATCTCTGTGGGCCCCAGAC
A 
76-M13rev_3
  TCTTGGtGGTATACGATCCCTAAGAAAGTGGCTGAATTTGGTATTTAAATTAAACCATGAATTGTCTCCCTTGTGCTCCTTGGTCATCCCTTTCCC
CAGCAATTAACATAAATTTCTGGCAAACAAAAGAGCTNATGGAAGTGGGATAAGAAAAATGCACATTTGCTTGCTGGCCTTTCTGCAGTGGCATGGGGCTGT
GGAGTGAAAGGAATGTGGCTTTGCCTTCCCTCCACTTAGGAATCCTGTGCTGTCTGTGTGTCTGGAGACTTTAATAGCTGACATATTCTCGGAAGGAAAATA
GCATGCTTCTCATGGCGATGATGCTGTGAATCTCAGCCTCTCCACTCTGTTTTCATTAGAGAGTTGCCATAGATATTTCATTAAAAACCAAAGAAAGCTTTCCA
CATTAGTTTGAAACTATAGAAAATCC 
77-M13rev_4
  ATGAGGCATTAGTATGCTTAGTTCAATATATAAAGACTCTATCCAAAGAAGTGTCCAAAACATGGTAGAGTTTGTTCATGTGGATGTCAGAAAGA
TACCCTTTCTCCGACTTCCTAATGAATGGAATGAAGGGAAGAATCTACAAGAAAGGTAGAGGCAAGTATGAAGCAGACCTTGTACTTGCACACTTGCAAACC
TTTGCTAGATGCTGTAGGTTGCACAAACTGCCTTGCTAACATCTCATGAATACTCACAAGATCAACTAGCATCCATGAGGTGTTGAAATTGTCTATTGGAACC
AGGGAAGTGTGGGTTGAAAACACAAATTAGGTGCCGTACTCTGGACAGTGATTCTGATTAGGAATACTTCCAACCCTTAGAGAATCATTTGGACATGACACT
ATGGCATGAAGCCAATGGTCCCTAAGCACCATA Appendix 
  180 
78-M13rev_1
  GCTGCTATGGATTGAAAATATTTACAGAAATGAAGGCAAATAATGTCTGTACCAAACATTTCCAAGCAACATGTTTCCTTTGTTATTACTCCCTAA
ATAATANTACCATGTAGCATATTTACATAGCACTTGCACCTAGAGCCATATTAAAGNTTGCAGGAATATGCACGAAGGTTACAGCAGATATTCNCCCTTTTGTT
GGGTTGTTTTGGGTTTTCAGGACAAGGTCTTTGGCATTCCCCACCAGCCGGTAACTTGAATGGCCTTGAATCCCACAGGCACTCTTGCCTCTGCTGGCTAG
GCCCTTTTCATGAGGGACCTCAGGCTCTTTAACTTTTTGGTGGCTCCTGGTAAAGGAATGGGCCAATTTTCCCCCTGCCCAATATCCGTTAAATCCcGAAGA
GCAACTGTTGATAA 
7-M13revfor
  TCTGAATTCCCGATGAAGCAGTGGGACCCGGGCACTTCTTAGGGCTAAGAGACTGACAGCAGTCCATAGCAGAGGCGAATATATTTTATAGTA
CAGAAAATTGGGAGATTCCAGCAGTCTGAAGTTTTATAAGCTTAGGTAGGTAACTGTGTCAGCAGAATCATGGCTGCTACATAAGCTCTTAGTGCTGCTTGCT
TGGCTCTGACACTGTCACGGGAGGGACCAGGCCTCAGAGGGACCGTCTGGGAAGAAAGTGTAGAATTGTACAAACAGAGTGGAATTGTACATCCAAGGTG
AATTGGTGGTCAGTGGAGGGTTTCTGTTCTTGTTTTGTTTTGTTTGCAGTGCTAGGTGTCAAACCTAGGGCTGTGAACGGTCAAGGTGAGTGTTGTACTTCT
GATCTCGGCCTTACCCCACCCCGAGGAAAGGTTGACGCTGAGGAGGTGGAGGCTCTGATGGTTTTCCCTCCGAGCTCAGGGAGCGAGTGGTGACGATGG
CTTCGTGGTGCCCGTCGCTCCTCTCCACGCACATTGTAGTTGCTGTGTAGTGGACAGNTGCTGCTAGGCCGTCTTTGGTTTTAAAATTTGCACA 
809-M13rev_2
  CTGCATATGCTGAAGTCTTAATGCTTTTTTGTCCCTTCAAAGTTGCTGTGCTAAAATACAAACCCCCATGGTTATAGGTTAAGAGGTGGAGCCTT
GGGGCAGTGATCAGCCCACAGGAACACAGGCCTCATGGATGAGATCAACAAGAGGGAGATTTCAGACCTAGGTCTACTGATTCTGCGCTGTCTGCCACGTA
GTCATCATAGAAGGATACTATATAAGACTACCTATAAACTAGGACGCAAGTCCTCTCCAGACAGTAAGCCTGCTAAGGTCTTGATCTTGGGCTACCCAGCCT
CCAGAACAGCGGAAAAACACATTTCTATTGTTANAAGTTGCCTGCCTCTGGTGGTTTATTATAGCAGCCTGAATGGACTGAGACAGTGGCCTGTCTGTGTTA
GTTGTAAGTCCTGTTCAATAGAGAAGCCTCCATTACAGCACAATTGGGCTTTTTCAAGTGTGGTGAG 
80-M13rev_2
  CGGAGAGTACTCTTTACTGCTTTATTCCCTATGGCTTGCTCAGCCTACATGGACTGGGCCTTCACATATCAATCACTAATTAAGAAAACAGCATA
CGGCTTGATCTTATAGGGGCATTTTCTCAATTGACATTCCCTCCTTTCAGAGAACTCCAGTTTGTATGTCAAGTTGACACAAGATTAGCCAGGACAGTAGTAT
GTTTTATGATACATGTGTTCAAGACTTTCTTTAGGGGCTTAGAGAGATGAGTAAGTAGAGAGGATCTGAGTTCCTATTCTCAGGACCCACATAAAAAAGTCAA
GTGTAGTTTCGTGTGTGCCTGTAACTCTCTAGTTTCGTTCAGGGAAGAAGTCTGTGAATAGAGGATCTTTGTGGTTTGTTACTACAAACCTAGCTCCAGGTTT
ACTGAGAAACCCTGTCTT 
814-M13rev_3
  GAACCTACTTCCAGAGCCCCAGTCACATCTAGGACCACCCTACATGGACTTGACCTGCAGCACCAGTGtCTGCTATCACCCAGTGACACCACA
TTCCTGAAGTTCTCCAGCATCACGTCACAGTACAGCTTCCTCCCAGCAGCGTCCAGCAACCCCAGTTCTTCCTCATTGAAGACCTATGGTCATGTCCTTGAN
nGTCGCCATCTCCTACAACACCAAACACACAACTTCAACCTTGGTCTTCTGCAAGAAGGGTGAAGAAATCCAGGAAGGATGAGCAGGAAGCAACTGAGCTAA
GAACCCAGGGTCCATGTTTCTGTATGAGTCACCCACTTTTTGCTACTGCTCTGTTTTCGTTTTTGAGACAGGGTCTTGCTATCTAGCCTTGGTTGGTCAGAAA
CTTGCTATGTACACCAGGCTAAGCCTCAACTTGTACTAATCTTCCCACCTCTGCCCCTGCC 
826-M13rev_4
  AGGGGNNGGAATTCNNCCTTGCGCNANAAAAAGGAGATCNGACTTCCACNGTAGGTGCTTTTACCCTATCANCCNNTTCACTGGCTCCTGAGT
ATTTTAATAACACCGTTTAATATTGAACTCTGCTTTCTTTGACGTGTTGATTCTCATGTTAGCAGGCAGTTTAATTACTGCCTGCATATTTTAAAGCCGAGTAGA
TATAATGGTATACTTTGCTAATGGAGAGTCTATGCTGTTTCTAAAGCCTCCCCCCCTACACACACACACACACACACACACACACACAAACTGGTAGGATTTA
ACTTAGTTTCATGTTTCCCTCTGGGTTTGCCNGGTTTGTTTACAGGCTTTGCTGAGATGAGTCTACTGTAGCCCACACTTTGTTTGGACATGGTTTCCATCGC
TGAAGCCAGCTTTTTTGGCTTACCAGCCAAATGCCAGTAGTAGTAACTACAAGGTCTCCATAGATGGGCTTGGCTAGCCTAGCTCTCTTGTAATCCTTG 
831-M13rev_3
  TTAGAGATGATCCTGTCAGCAGCAGGTCTTGGCTTCTGCAGTTAGTCACTGGCTTTAGCTGCCCAGAGGAGTTTACAAAGATCACAAGATAACT
GCACCGTTATCTTGGTGGTTGTGTTACTCTGACGGTATCGCAGCCACGCCAGTTCCATGAACCTCCCGAGTAAACCAGTGCTACGTCTGGGCTCACCAGGA
AGTTGATGCTTTTTTTATTTGTTTGTGCTCACAGATTCATTGCAACATTTCGATGTTGAGATTAAGGCCGGCTTCCAGGCTTCCAGGTATAGAATTGCATTACC
CAGCAAAATAAGCACTAGCTGCGAGTGATTATTTCAATTTTAACTAATTCTTTTAAATAACATTAAACATTTGGTTCCCACTTTTGCATTGCATGTGGTTAGTGT
ATTGAATAGCTCAGGTATGGAATGTTTCATCATTGGAGAGATGTCTGCTAGACAAAGAC 
832-M13rev_4
  CTGGCACCTAGCATGAAGCAAAAGGTTTGGGATGCTGTCAGATCACACTTGATTAAGTGCATGGAATTCATAAGAAAAATTGAGAGTTAAGGAT
TCAGTCTAAAATAACCACACGGGGCTCACCCTAAGACTAGATTTAAATAGGTAACACTTGAATGGGTAGCAATTAGGGGAGAGACTAAAGAGTAAGGCATGT
GGTATCAGCCACAAATAATTTTGTACAGAACGTCATTGATTCTGTTCCTTCCCCTATGTGAGCTGCTCTGATTCTATGATTTATAANCAATAATATGCTCACTG
CTATAGAAGACACAGCTCCTGACAGCTGCTTACTAGTGCATTGGGTTTTCTGTCTGCTTCTGCTTTTTGTTCTTTTTGGCCAAAGAAAATAGTTGTTATAGTCT
CTGATTCCTGTGACTGTTATTGTTACCATTCATCTCTCCAATGAGTTTTACA 
836-M13rev_2
  CGAAGCCTGAAAGTGACCTAGGCCCTCTTCCTGACAGCAGTAGAGGGAATCCTCTGGAGAGAGGCCATTGGGTTGGGTGGCTACTGGATGG
GGAGGTGGATGGGCAGGCACAGGGGATGGGTATGCCCTGGGCTGAAAATGACTGGCTGATCGCTGAGGAGTGTATGGAGACCCTGTCTGCAGCATCACA
CTGTTGGGGTGGGAAAGCAGATGAACCAAAAGTCCTTCCTGAACTCATAGATGGTGGTGGANTTCCATAAANATAGTCACTGGTTGACAGTGAGTTCTGCCN
CTTGGTANCTGCATTATGGTTGTCGAGATCTACAAATTCTTTGGGACTCTCTGGCCNCTCCACNGATTCATCCATCATTTTCTTCTTCTNGNACCAGAATTGT
GTNCNATNAGGAAGAAACAACTTTATGAAATTNAGATCTCCC 
838-M13rev_3
  TTTGGATTTCTTCAGGATCCGTTGTTATGTCTCCCTTCTCATCTCTGATTTTGTTAATTAGGATGCTTTCCCTGTGCCCTCTAGTGAGTCTGGCC
AAGAGTTTATCTATCTTGTTGATTTTCTCAAAGAACAAGCTCCTTAATGATCTGAATGGTCCTATATCCCCTAAAGAAATAGAAGCAATCATTAATAGTCTCCCA
ACCAAAAAAAGCCCAGGACCAGATGGGTTTAGTGCAGAGTTCTATAAGACCTTCAAAGAAGATCTAATTCCAGTTCTTCACAAACTATTCCACAAAATAGAAA
CAGAAGGTACTCTACCCAACTCATTCTATGAAGCCACAATTACTCTGATACCTAAACCACAAAAAGACCCAACAAAGATAGAGAACTTCAGACCAATTTCCCT
TATGAATATCGATGCAAAAATCCTCAATAAAGTTCTTGCTAACCGAATCCAGGAACA 
839-M13rev_4
  TGTGTGTGTGTATGTGTGTGTGTGCATGTGCGTGTGTGCGTGTGTGTGTGTGCGCGCGCGTGTGTGCATGTGTGTGCACGTGTGCGCGTGAG
CGCGCGTGTGTGTGTATGTGTGTGTGTGCGTGTGCGTGTGTGCGTGCGTGTGTGTGTGTGTGTGCGCGCATGTGTGCGTGTGTGCGTGTGTGTGTGTGTG
TGTGTGTGTATGTGTGTATGTGCGTGTGTGTGTGTGCGCGCGTGTGTGTGGGTGTGTGTGTGTGTCTGTGTGCACTTGGTGTACATAGAGCTCAAAAGGAC
AACTTGGGAGGGTTGATTTACTCCTGCCATGTGGGTCTTAAGAATTGAACTCTGATCCTGAGGCTTGGTGGCAATCTCCATTACCCACTGGGCCCTCTCATT
GGCCCCANTAATCTTGTTCCTTCCTCTCCTGCTTGCGTGTGCGTNTTTCCNAATCAAGA 
843-M13rev_2
  GGCTCTGCTGTCAGCAAAACATGTAATTTAACTCTGTTTCTGCCACTGCTACAGCAGCAACTATGCATCTCCCTGGCTGAGCCTAGAAAATGCT
TCCTTAGGCAATTGTTCTCAAGTATGGAAAGACTAGGGCAGCCTTCGATGGATGGGTCTTGCTATGAAGATGCTTTTCCTATTGTCCAATGGCAAAGTGGGC
AGCATCTTGTTAATGGGTCCGATCTTGAACAACTCCAGCTGTCGGCACCCAGCCTGTCTGCCACTTTAGCCACGCTCATGCTTCTCTCCTCACCAAAATACA
TGTTTTTCACATTTCCCTGACTTCAATCCTCACTCTAAAGCCTTGTCAGCCCAGTGAGCATTAGCCATGCCACCGCCTGAAATAC 
854-M13rev_1
  CTGTCAGAATCTAAAGCTCACTGCCCAAACACGATGCCAGCCTGGCAGCTGAGAGAGGGAGCCCAGCTGTGGAGCTCCGGAGGGTTTTCCA
GGCCTCCCTCCGGGCATCCTTGTGCCATTTATGCAGGATCTCCCAATAAATACCAAAAGTCTGAGTAGCGGGAGCTCCTGCCAGCGGCTCACAGTTGGAAC
CACGCTTTAGAGCAGCAACGTTTTCCAGATGTACAGACTCTGAGCGGGGAGATCTGCTTAGAACAGGATAGATGTTTATCCTGCTCACTGAAGAGGGTGTGT
GGTAGACGCCCTTCTGGATACAAATGAAGGAATTCTCTTGAATATATTTAAGGGAGTGATAACCTGGTGAAGAAAGTACTAGAGGATTTTAGAAAG 
85-M13rev_3
  CGTCCTACGGCCATGCGCGGCGAGGGCAGGTTATAGCGACGCGCATAGTCGGCCAGGCAGTACAGGGCCGCCGAATAGGGCGTCGGGTTT
GCCGTGACGGGCGCNTTGCCGATAGGCGTGGCGTAGAGACCCGACGGCCCAGCGGTCGGGCTGACACAGCCTGCCAGCAGCAGNACGGATGCGGNGG
CACCGGCGACGCTGCGAATAAGGGTGCGGCGGATCATGGCAGGTTGGTGTTTCCATTCAGGCTGGTGCCTGCGTTGACGGCGCCGTTGTTGGTCTGGGT
GGAGTTCACGATGACCACGTTGTTTCGGCCCTGGACCACGACGTTCAACTGGTTGCCGATGGCNGTTGAGCCGCCGATGGTCGTGCCGTTGCGCGATCCG
CNGCCTGCACCGGCGTAgGCCGAGGCGGCTCCGCCCGA 
860-M13rev_2
  TTTCACATATGAGAGAGAGAGTTTAGACCTAAACCTGTCCTAAGTGACCACCCAGATCCCAGCAGGGGACAGGCTCTGATCCAAGTGAAGCAG
GCTCCCCAGGCAGAGCCCTGAACACTGAAGGAGCCTGCAATGACCTGCATTCAAAAGAAATAAACACAGGTTGAAGCCCAATGCCAAGGCCAACACCCACA
TCTCTTTCCCTCACCTTTGCCCACTTCGATAGCCAATCCCAAGGCAGCCTGGGGTTGAGATAGCAACCAAAATGGGCCAAACAAACTCATCTGGGGTTGGG
GCTGGGTTGTTTATCACTAAGGAAGAACCAATGCCAAAGGCAGCTACCATCGTGAACTTGAGCTCCGACTTCCTAAACAAACAGCTTCTGGTCGTTCTGGAT
TCAAAGGGCACTT 
865-M13rev_4
  GGTTGGGGGATCAGGTTACAGAGGTCCTGGGAGATCTAGTTGAGAGTGTGTTTCTGTTCAATGTTAAAAAATATATGTGGTATGTGTATGTGAA
TGTGCTCATGGTGTGTGGGTACAAGTGTGTGGTGGCATGTACAAGCACATGTNNNAGCATGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTAAGTG
CACATATGTGCATATGCATGTGAAGGCCAGAAGTCAATCTTGGATGTCATTTTTCTGAAGCTACCTGCCTTGCTTGTNGAATACAGGGTCTCTCGCtGA 
872-M13rev_1
  CCAGAAGTGTCAATGGCTACTCAGTTTTGGGACACTTCCCCACAAGAGCCCCAGGTGGAGCAGGGCCATTGGCATTGGCATTTGTGATAGGA
GGGCCTGCTGGGCTCCAGGGTCTGCCTTGGCAGGAGGCAGCTTTCCTGGGTCTCTCCATACAGACCTCCACTGCAGTCTCCAAACTGTGGTGCACTGCCC
ACTAAgGGTCTTTCCCTTCCAGATCCNnCCAGAGTTCTACTGCAGAATAGAGACTTCCTCTCTGTCTGAACCGGTGTTGGATCCCGTTCCTGTGTAACACACT
GCAGCTCTGTGGAAAGTCGTGATACTGTTGACA 
873-M13rev_2
  CGGCGACATGATCGCGATAGACCGCTTCATGCCAGACAAAGGCGGTGGGGTCGTATTTGCCGTGAATGGTCAGGGTCGGGGCCACGATCAT
GCCCGACAGGTCGGCGTCATAACCCAGCCGCGCCAGCGCCATCGGATCAGCCGAGAACCTCTGAACGCCCGCATTCAGCGCCGCATCATCATGCGATCC
GGCATAGACGGTGTCCGCGTTCGAGAAGGGATTGAGGCCGCCCAGCCGACGCTGAACCATGTCACGGAACAGGAAGGTGCCCCATGCCAGGTGGCCGAC
CAGTTGATCCTCCTCAACGCCCGTAACCGCCAGAATATCGGCCAGATTGCGTTTCTGGATCGCCGAACGCTGGGCCTGAGGCAGGCCGACGCCGGTGCAG
GTTTTAACACGCTCCGCCAATTGGGCGCGCGTCAGGCGTGAACCTTCCGGCAGACCCTGCCACAGCGGA Appendix 
  181 
874-M13rev_3
  CAGGCTTGCCAGGCTTAAAGCCCACAGACTGATTTGTGAACTAAGCAAACCATGAATTAGGGGGAATCACCCAAAAAGCTCCTCACACTAACC
CTGCTGTAGCCTTTAAAGGAAAGCTCCCCTGAGGAGACCCATGGTTACTGCAAAAGAAAACCGCTTCTGTCCTCACTTCACATCCTAGAGGGCAATTCTTGA
ATCACGGATGGTCTTTTTAAAGCCAGTGAACTGGGAGTCAACAATTCCTCATTTGCACGAAATCCAGAATGTGTTTAGCCCTTCACCTGGGAACAGCAGGAT
GAAAGCTGCCTGAACACAGAGGAGCTGGATGCCACCAGCCACCAGCCACCAAGCTGAGAGAGAGCCAATGAAGAACTCAGCACTTCACTTCCAAAATACC
CAAGTCGTGCCCTGAATTTTTAGGGCATAAAAAACATGTTCTACGTTTTTTTCTAATCTA 
875-M13rev_4
  CAGCCAGGGCTACACAGAGAAACCCTGTCTCGAAAAAAGAAAGTGCTGGTCCATCCATCCTTCGTCCCTTCCTCCCTCCCTTTCTTCAGTCAG
TCATGTCTTCACCACACGAATCCCAGGGAATGATTTGTGGCAAGCAGAGCCACTTGCTAGCCCTGTTTTTATTTCTCTTGGCATTTCTTCTGCTAGACAATCC
AGAGACTAACCTGGGTATCTATTTTTGTAGCTAAGCTGATCAACATGTTTATTAAATCTGTTTTTAAATTCAGAAAAGATTAGCATGAACTGTTNTTACCCAGAG
TGTTACATGGTCTCTTGATTGTNNACCCTTCAAATCTAATTATCTGTCATCAGAATATAGTTCTGATACTGGGAGTCTCACCACAAGGCTCTGCTATGTATGTA
GC 
876-M13rev_1
  TTGGCTTCCCTCAGTGTATATTATGACCTGGGATATGAGCCAAATAACCCCTTTTGTCCTCAAGTTGCTTTTGGTCATGCTTTTTATCACAGCAG
TAGGCACCCAAAGACACATATTAAAGAAATCATACACCATAATCATGTAGGATTTACCCTCGTAATGCAAGGTTAGTTTAACATGCAAGGAAGCGTAAACAGA
TCTCCATGAGAAACGCATGCAGGAGCGTTAACGGCAACATCATTCTCCAGAGCCAGAGCTATGTACGGCATCTCCACGCAGGGAAACACTGCTCTGAAATC
ACTCCACGCGGGGAAACACTGCTCTGAGATCACTCCACTCCACACAGGG 
878-M13rev_3
  ACCCACTTTCCACGCCGCCTGCTCCGATGATAGGAAAATGGCCCTGTTATCTCAGAGCAGGGGCCCAGGCTCTCACTGCAACAGNTCACCCA
CCATGCACTTTCCACAGNCTGGAGACTGCTGGGTCTGAGAGGGGATGGGAGCCAAAATCACCCAGCAGCAGTGACCCAGACAGACCACCTGAGCAGCGA
GTGTCACCACACACACACACACACACACACACACACACACACGCCTCCTAATCCTTTTTTTAAGCTAAGAAGCTTTCTGAGAGCCCTGGGTTACAGGTCTAT
CTTTCAAGCCCACTGTAGTATTGAAGAGATTCTTGCTTGGCTGGCAAGATTGCTCAGTGGGTAAAGCACTCACCACTCAACTCTGATGCCCCAAGTTTGATT
CCCAGAACCCAAACAAAGAAGAGAATCAACTCCACCAAG 
879-M13rev_4
  TCAATGTTTCATCCTTGCAACAAAAAGGCAACTAATACACATGGGTTATCAGAAGTAGGGAAGGTGATACAGGCTTTAAGTGTGTATACACAGG
CATACAACCTTGCCAAAAGGAATGGTAAAGAAAGAAAAGAAAAAAAGGACACAGATAAGAAAGTTGTATGCTCATAATGGCATTTCCAGAACTAAGTTCCCTT
TTCTATAATTGTAAATAATTTTTTAAACTGTCCTTAATAAACACACAAGTGAATGACTGTTGCTTATTGATGTGAGCCAAAGTATAGTTCTGATGTTTTATAATTA
GTCATGGGTTATGATACTATAAAACTACAATGAGCTAATTATAGTAATTTTGGTGGTGGTGGTGCAGGGTGCTTTGTGAACACCCTGTGCTTATAAGCTCACA
ACAGCAACAGATAAGAATGCTTATCTTCTCTTAAA 
87-M13rev_4
  TAAGGNATCAACATCCTTGGGAAGCTGGGACAGAACGTTACCGCTTGGCCTGGGGCAAAGGCCCACCACCATATTAATTCCAAAGGGCACCT
ACTCCTGCCCTTTGGAATTACTCCCCTCAGTTCTTCTTCCCTGACCCNGATGCCAGNACTCTCTGCAAGAGCATGTCTACCAAGCAACTGCATTTAAAACTAT
ATATCAGGGCTAGCAGGAAAGGCTGGTCTCCTGGGAAATCANATACTACATTTAAGAGGTATATAGATTTTGCCACCCCCTACTTCNTCGGAACTTGAGTTT
GAATGACTCCATGTGACTTCTGGGCATACTGGNATGCTTGTGCTNGGCCCCCTGCAAGGANAGAANAGAAAGATCNNC 
880-M13rev_1
  TGCCCCTCTGTTCTCCTCTCCAGAAGTTTGTAGGAGTGTCTGCATGTCTTTGTCTCCATAAGATCTTGATGCTTTGACATACTGACCTTAGTCTG
ACTCCCCNnCAAACATTATGTTTACTGCTCCTGAGTTCCCTCAGACTCAGCAACCTTGCACATTCTCTCTTGCTCATGCTCTCTCAATCCCCCCTCTCGCCCT
TGCTCTCTCCTGCACTCTCTTGCTCTCTCTCCCTCACTCATGCTCTCTCATGCACTCTCTCACTCTCCCATGCACTCTCTCGCTCTCTCGCTCTCTTCTCTCAT
CTCCCTGCATCTCCTCTACATCACTCCTTCCGTATTGCAGGCAACCCTCCCCACTTCCCACC 
881-M13rev_2
  CCACGAGTATGCCCGGAAGCTCGAGGACAAGGTGAGGCGTTCTGTTCCCCGCTTTATTCCTTTGACACAGGTCTCTCCCTGAACCTGAGCCCT
ACAAGCAGTCAGCAAGCCCAGGGAACCCCCTGTCCTCTCTCCTCCACCCAGTGCTAGGAGTACAGGATTATATTCCTGCAGAGATCCGAACTGAGNTCCCC
ACACTCGCACATCAGACACTTTACTTAATGCGACATCTCCCAAGCCAACCATTTTTTCCTTGATTTTGTGGAGCTTTGAATGAGAAAGGCTTCTATGAGCTCAT
ATTTTGGAAGGACTGGGGGGAGTGTCCTCATGAGGAAGCATAGCCTTACTAGAGGAGGCGTGT 
882-M13rev_3
  AGGGAAGAAAGAAACTAGAGGTTGAGGGGGTGGCTAGAGCAAGCAGAGAAAACCCTAGAAAACAAGAGCACTGGCTGACCCAGCCTGCCTC
ACTTGCCCACATCAAACACCCACGTCTACCCTGGCTCGTGCCCAGGATGCCTCCTGACTTCCTCCATCCCCCACTCAGCCCCAGGTCGTCTGCTGCTTTCC
TGTCTCCTGGCACCACCAAGCCTTGGCCAATGCCTTGCANGTTCCTCTACTTCTACCATGCAATGAGGCAGCTCCCCTGGTCACGCCATTTCCCCACCTAAG
CCAAGGGTATGCTTCTCAAC 
883-M13rev_4
  GCTGTTGTTCCAAAGCGGGAACCTTGTCTTTCAACACCNAATTATCCAGTAAGGTGTAAAAATCCAGGTGTTCTTTCGGCTGACGGTACGCCTT
GCCTTGAGTCGTCACCGAGCCATACGGCTCCACCGCGATGGGCCCTAACTCCTGCGCACCGGGATACCAATCATCAATGNTACGAATGGCGTTGCCAATTT
TTTGTGAGTGCATCGCCGCNnCATGATTGACTTGATAGANCGTCCGGCTTTTATCGCCTTTGCCCCGTTCCAGG 
884-M13rev_1
  GAGTGAGAGAGAGATGCAGGATTCTGACTTCTCAGTCACACGTTCGCCCGGGCCCTACCTCACTTCCCTTTCACCCCCCCCCCCAACACTTCC
AGAAGCATCAGAGGATGCAAGCATGCGAGAATTGAAGGGTTCAGCGAGCTCATCCACTCGCTGCTTCTCAGCTCTCTTCGCTGTCAGCTTAGGGTGTTGTT
CTCCAAAACTTTGGGATCTTTGCCTCTATTTACTCTTGGGACCCAACCTACTTGTTTTTGAGAAAACAAATCCATTTAAGTAGAGCTTCAAGTACACACAAACG
GAAGTGCAAATGGAACCAATCGCTAAGATAATATTCTTCATGCATTGAGCAACTCTCAAGAAGAGGTAAAGAAAAGTTAGGACACCTCGTCTTTCACCCTCCT
CGTTGCCTGGCCATTCCCACGTTTGCATGGCTTCCCCAGTTACGTTGACTCTGCAGCATCTCCCGTTGGCTCATGTTTTTGACCACTCATTGGTCTGGCATG
TGGCAATACTCTGTGACTGTAAAACTTCAGGAGGTAGGGTCTAACTGGCAAAACTAGTTCACTAAAGACAAGTCTTTGAAGTTTATACCTGGACCTGGGGCC
CTGTC 
888-M13rev_1
  ATGGATGGGCTTTGTAGTTCTGATATAAGCTCTCTCACCTACTGCCTAAGCATCATGCCTGACTGCTTGCTGCAGTACAGCTTGCCATAATATT
CATGGAAAACAACACTCTGAAATCACAGGCAAGCACCTTTAAATGTTTTCTTTTTTATGTTCCCTTAGTCGTAATGTCTCTTCACAGCTATAGAATAATAACTAA
GACAGGAGCTGGTGCCAGGAACTATAATACAGTATTATTGTTTGCAAAAAATATGAAGTATTTGGGAATGTTGGATTAGAAAAGCAGTTAAACATTGTAAGGG
TAGTTTAACAGGGCATCCTAGTAAGAGCATGGAAGCTGGTGTCATTGAGAGCAAGGCATACTGTGGAGACCC 
889-M13rev_2
  ACATTTACTCTCAAAGCCTCACATAATGCCTGGAGCCACATATCCTGCTCTCCTCTTGTTGAGAGTAGCTGTCTGTTTTGTTTTTAGGTAACAGC
GGTCACCTGTCATGATCGATCACTCTTGAAGAGTGAGTGTTGCCCA 
890-M13rev_4
  CCNAATCGCCAAGCTTGGCTCCGNAGCTCGGATCCCNTACCTAACGGCCNCCAGATGTGCTGGAATTCNGCTTGCGGTGANCNNNGAGATCT
GAATTCCCCCTCTAGCTGGTAGAACGGCTTGCCAGCGGCATACCTGCGAGTGTGACAAGAGAGCTGCTCTTTGCTTTCGCCACAACCTGAACACTTACAAC
CGCAAGTATGCCCACTACCCCAACAAGCTGTGTACTGGGCCCACCCCACCCTGCTGAGGCCCTGCTCGGCTCCATAGCCNCCCCAGGCTGCTGCAGTCTC
AGGCCCAGAGAAGCTCGGAACCCAGATTCCTCTCCCAGCAGACTCATCCCGCCCCCCCCCCAGAGATCATGANCCCTGGTCTCTGGAATTCGGATCTCCC
GGNTCACCGCACGCC 
892-M13rev_3
  TCAATATGTAGCCAAGGATGGCCCTGAACTTCCCTTCCCTTCTCTACTTCTATAGCACTGGGATTACAGGCCTGTGTCACCATGCATAGCTAGT
TCATGTTAACATTCCTATTTCATATCTGGTAGAGTTATTTAGGGAGACTGTAAACCTCTAGGAGGTGGGAGCAAGGAGGAGGAAGTAGGTTGGCCACCGGG
AGCATCCCTTGGAGGTGTATTACCCTTGGCTCCCTACAGTCACACCCTCCCTGCTTCCTCCTCAGCCACAATAGGAAACACTCTGACACATTCTTACTGCTAT
CATGGACTGATGACTGCGTCCCTTGAAACCTTTGGCCCAGATAGATTCCCCTCTCCCCAAGTTGTTTCTGTCAGGTGTTCTGTCTCAGGAACACACAGCTAA
CACTTTGGTGTTATAGATCTGTTTGGCTATTGGTCATATGTACTCCAGGGTGAAATAATTAG 
893-M13rev_4
  TTATTTAAGTATCTTTCCTCGCCAGAAAGCTGTAGTCACAAACTCATATAAGCATGCCTGTTTTCTTTTAAACTAAGTTCATAGGGGTCAGGCTT
GGGGGCAGGGTACCTGCCTGGGGAGCGACGGAAACTACATTTCCCGGGATGCAATACGCGAGACGATGGGGGTGGAGTTGAGCCCGTGGAAATTCGGCA
TTTATTTGTATTATTATTTTTTGGGGTGTGTGTTTGTGGACTAGTGCGCGGTTCGTGTCTGGAGCTAGATTTCCAGCGTGGTCTTTTTGGTGGTCGTTTAGGC
GTTTCTGAGGTTTGTTTACCTAACTGGAAGCTCGGCGAGGTGGGCAGTTCTTATGGCAGAGCGCAAAGAGCTGCTCTGTGTTACAGAGGCCCTGCTGAGGC
CCAGCGACTCCGCCCACATGCCCCGAGCCAGGCCTAGGGAAGAGACCTCGGCGACCTGGTCCTTG 
895-M13rev_2
  CAAATATGTAGGCAGGGCTGGGCAGCCCCAGCGTGGCTCTCTGGGGGCCTCCAGGAGGATGCAGGGGTATCAGGAGTGTCATTTTTCCAAA
CATGGACAATGCCAGACCTGTTGGGTCCACGTTGCCCTGTCAAGCCTGCTCCTGGGCCTCTCACAACTGAAGAAAGGAGTTGTCCCACAAAGCTCTGGGG
GTATGGGGACAATATGAACTGCCCTGAAGGAGACACTATACTCTTGTTCCAATGGAGGTAGGCTGTGAACGGACTGGGGCACAGGGCTACCAAACTGGCG
TTACATGGTGTTCCTACCTGGTGTTACATGGTATCTGGTGCTGGCTGGTTTGTTGAGGTGATAAGGTCCTGGGTGACGTGTCTTTTTGTTTGTTTAGTTGGTT
GGTTTGGTTTGGTTTGGTTTGGTTTTTTTTGAGACAGGGTTTCTCTGCATAGCCCTGGCTGTC 
898-M13rev_1
  TGCCTAGGATCTTGGCCTGGGAGAAGAAGGGAGGAGAAAGAGATACAACACACATACGCAGATGAGCACGCGCACACACACACACACACACA
TACACATGCAGATTACCACACACACAGAGAGCAAGAGAGAGCCACTAGAAGGTTCTGCTCTCTCCACAGCATCTCTGCAGCGTCATCTGTACATACAGGAC
CTGCTAGGTACTACACTAACTCCTAAGAGGTGCTTCAGGTTTATCTTCCCAACATAGAAACTCCATGATTACTCCTGACTACAGGTAAGCACTATGTCACACC
GTGCCACACAGTGAAGGACCGGAGACCATGTGACACTGCCCCAGTGCCTGGCTGTTCTAAGCACTTCCCCCATATTAACTTGTTTAACAGGACAGGTACTTT
TATCTGTCCCAGGAAGCAAGAGCAGAAGGACACATGTTGTCCCAAAGAGGCCCCACT 
89-M13rev_2
  CCATAGTCATGCATCTCTCTCCCTCTCTCGCTCTCTCACCCNGTTACTCTTTGGATCTTGATAGTTTCTATTCAACATGTAACTTTCTATTATGTG
GTAGATTCAAGGGATGTGGAAACAAAACAGAAAAACCTGACCTTTCCCATGTAAAGTTTACACTTGATTGAGATGGTAATTATATAAATGTAACCTGTGTGCTT
CACCAAAGCATCACTCGTGGGCAGACAGTGNCACAGTCCTTCNGGAAATGTCCTCACCGCTTCTTTCTTAATGTGCCTTCTATCCCTACAGTGCACCCCACA
GCCACAGGACGCAACATAGAGCCCACCGTTCAAGATGACTCTGCGACTGCGCAGACGGGAATTGAATGAGAAATGGCGGTGATTTCTTTCTTCCTTTCTTTT
TTAATCACTAAAGCATTTTTCATCT Appendix 
  182 
900-M13rev_3
  TGGATATGCTCCCAACGCACCCGGTCGGCGCTCATCGGATTTTCCGGCGGCTCGGGCGCCTCGCCCGTGGCCAGCAGGGCCTTGACCACGT
CATCAGCGTCGGCGGGCTTGGACAGATAGTCGACGGCCCCGGCCTTGACCGCAGCGACGGCGGTGGCGATGGCGCCGTATCCGGTCAGCATGACGATA
CGGGCGTCGGCGCGGCGGTCACGCACGGCCTCGACCACCTTCAGGCCGTTGCCGTCCTCCAGCCGCATGTCCAGCACGGCGAAGGCGGGGGCCTTGTC
GCGCAGTGCGGCGGTGGCTTCGGCAACGGATTCCGCCGTCGTCACGTCGAAACCGCGCGCCTCGAGGGCGCGGCCCATGCGGGTGCGCAGGGCCTGAT
CGTCGTCCAGCAGCAGCAGGGACTTGTCGGACAAGGCGGCGATACGGGTCTCTAGGTCGGACATTATTCTCTCCTGCC 
901-M13rev_4
  AGAGACATAAGCAAGTGGAAATATTACCCTGCCAGAAATGAGGGGGGAAAAGAAAAGTGCACAGTGCTCCCTGGTGGCATAAAGGCTGCTGG
ATAAACCACCCTGAGACAGGGAACAGGAGAATCTGAAGGGTGGATTCTGCTCCATTCTGGGGCCAGATCTCAAGCACCTGCCCTTCCTACAAGCAGAGCAG
CCCATAAGTAACGCCTGCCTGTAGAGGGGCAACCTCCACTGGTGCCCGTGACCCACAAAGAGCAAACGTGCCCGTTAGAATATATCAGGTATGTATTTCCT
CCTTTCCGCACACAGGATCTGGCGTTCAGATCTCATGTTCACGTCCCTCAGTAGCCAGAAGCGGATGAATGAGAATCCTACTGAGCGGTCACAAAGATGTA
CACCACTTCCCTGAAGAACCCTTTCCTAAGGTTTCCGGCGCTCTGTTCACCCCGTGGTCCACTCTTAGC 
902-M13rev_1
  CTGAATTTTCAATACATGCTCAGAACTACAGATGTAAGAAATCCAGCCCCATTTTAATATGAGTGCTAGGGATCCAAACTCATGTCCCTTTGCTT
CTGGGGCTGGCAGTCCACTCACTGAACCATCTCTCCACCCTCTATATCTGCTTACCTTAGTATTCATTTAAAGTCTACAAGATAGATAGAAGTTTTATGACACA
GACACATGATGTGACTTTAACAGAGGGAGGGATAGATGAAGCATGGAATACTTTTAGGGTGTGAAACTACTCTGTATGAGGTAATGATGGTAATGGTATAAA
TGTCATTATGCCAGTAGCCAAATGTGTATAACACACAACACCTAGAATGAACCCATTGATGGCTAGTGTTTTGTTAACTTGACCAAGCAAGAGTCATGTAAGA
AAAAGGAAACTTAACAGAGAAAATATTCCCACCAGTTTGTCCTGTGGGGC 
906-M13rev_1
  TGGTAAAATTTTGGGGTCACTTATATATGCTATCATATCATCTGCAAATAGTGATACTTTATTTCTTATTTGTCAATTTGTATCCCCTTGATCTCTT
TTTGTTGTCTTATCATTCTAGTTAACACTTTGAGTACTATATTGAATAGATATGGGGAGAGTATATATCCTTGTCTTGTTCCTGATTTCAGTGGGATTGCTTCAA
GTATTTCTCCATTTAATTGGATATTCACTGTTTGTTTGCAGTAAATTGCTTTTATTATGTTTTGGTACAGCCCTTGAACTACTGATCTCTCCAATACTTTTAGCAT
GAAGGGATGTTGTATTTTGTCAAATGCTTTTTCTGCATCTAAGGAGATGATAATGCGATTTGTTTTCAGTTTGCTTGTATAGTGGATTATGTTAATGGATTTTCA
TATATTAAACCAACCTTGCATTCCTGGAATGAAGCCTACT 
908-M13rev_3
  CTCCAAATTCCCTCTTCCTCAGAACTACCAAGATCACTGCAAACAGACTTTACCATGAGTTGTAGTTTGAATATGGCATATCTGTTCCAACCCAT
AAATTTCATATGATAAAGTCTTAGTTTTTTACCTAATGGCCTTTGGGAAGTGATCCACTACAACGGTTCTAACTTCACCAATGGGTTAATCTTTTGATATATACA
AAATCGGATGACCATATTAGGAAGTGACAGAAACTAGGAGATGCACATCTAATCAGGAGACAACAATTACTGGAAGATATGCTGTAGAAAGGGATACCTTGT
TTCCAGACTTTTCTGTTCTTTCTCTGGTTACTGGGTACCATGTGGAGAAAATCTGGCCTCTGTCACATGCTCCTTGCCATCGTGTTCCATCTTTCCCAAGGCT
TACATCGGTGGAGCCAAGAGTCTCTGAACTAAATCAGTCCTCCTTTGACTTGTGCTA 
909-M13rev_4
  TCCACTCGTATGGATCAATAGAAGCAACATATTGTCTTCACAGAGCTTTAGATCCTTGCCCAGATTGTTTTTCCCCCTAAACGTGGGATGCCCT
GAAGCTTCAGCTGCTGCGAAGAATAGAAAAGCAGCCACAGTGTTTCTCCACCAGAGTCGGTCCTGCCTCAATAATTTGTGTTCGTAAGTGACTCCCAAAGAC
CTCCTCCTAGAACCTGAAAGCAGAAGAATGGAGCAACACGGGTGCTCAAACACAACCCTAACTTCCAACGTGCTCTTTTGTAACAAGGCAGCAGAGCTAAA
GTTAGGAGCACACAGCTGCCCAGGCAGGGTCCGAGCATGGTCCCAACAGGAAGGAATCAACATGCTTGGGCTGGCAGCTGGGTAAACATTTCTGCTAAAG
CCTCACAGTTGTGATGGAGCCTCGTGTGCGGAGGGTACAGTTGGATGTGGAGAGAGCTGTTTAAA 
90-M13rev_3
  CAGAGCCACCCTNNTCCTCGGCTTAACCACACCAGTATCACCCCAGGAGAGGAAACGCACCTGTGTGCTAACCACTGAGACATTAAGTGGCTT
TGATCCTGTAGCATAAGTTGGTCTGTCTAAATGGCTCCGTGTGTTNCTTACGATACAATACAACTCTTTTAGTTGGTTTCCTTTTTCTCTTTCCTTCTTATTTCT
TTTTGCTTTCTTTCTTTTTTGGTNGGGACAGGGCTAGAGGAGAGCTCAAACTCATTCAACCCCNCCCCCCACTATCACaAATTATGCAGTCGAGTTCCCTGAA
TTTAAAGAAATCCCAGGGTTCGACATATCTGGCATGCAAAGAATGATCATCACCTGACAAAACCACATTCGTGATCATGGCACGTACCCTNCC 
910-M13rev_1
  CATCTATTAAAACTGAGGACATCATGAAATTTGCAGGCAAATGGAGAGAACTAGAAAATGTCATCCTGAGTGAGGAACCCAGGCTCGAAAGGA
CATACATGTTATGTCCTCATTGATAAGTAGTTATTTCGCAAAAAGATCAGAATACCATTATACACAACTCACAGATCACATAAAATTTAATTAGAAGGAATGCCA
AATTGTGGATACTTCAACCCACATAGTAGGAGAAACAAAATAATCCCAGGAGGCAGAAGAAGGGAGGGATGTGGATAAAAGAGGGAGAATCAGGGACAATC
GGTGGCAGGATCAGGTATATGGGGAGACAGGAGAGAAGGCCAGAGGGCCAGGAGTATTAATAGAAACATACAACCGTGTGGGAATGAAGAGCAGGGCAA
ATATCTAGAAAGTCCCAGACAAGATGGATGTGGAAGTCTCCCAAACCTCATCG 
911-M13rev_2
  TACATACGTGTTCTACGAGAAGACAGGACAGGAAACTGAATAAATAAAAGACACAAGGAGCTATCAGGTAGATACCAAGAAGGACCCAGCCAA
ACCCATGAAGAGCTCAGAAGCTGAGGTGGTCTTTGAGGTGTGCCCTGAGATGGAGGTACAAGGCTGGGTCTTTATACTGCCTTGTCAACCATTGTATCTAG
GCCACTACGAGAGTGGAGAATGACTTTGGCAAACAGAAATCATNTTCAGCTGAGGGAAATCCAACAGCCCTTCAACATTGGGTACCTGATGACTCTCCAGTT
CAGGTTCGCCCAAGGTAGCCATAGAGGACCTTGGTGGCTAGCAGCCATCATGCCAGAACACCTCCTCCTGGGCAATTGGCCTCTCCTTGGGCAACTAGGT
CCTGGTCTGCAAACCAGCATCACTGCATGTAAGGGACAAGAAAGGANATATGAATTCAA 
915-M13rev_2
  CCTCATTTCCATGTGCTATAAGGACACAAAGTGTCATAGAGGAGAGAGTGTCAGAGGGAAGACAGCATTTTCTTAGAGGCATGAGCCATGCTG
GGCTGATCTCAAACACATCCCTCACTACAGAGAAGCTGTATTCCCATCCTTACTCACTGTTTACACTCCATAGTCTAGTAAATTCCACAAAGGAAGGGAAACT
CAAACCCTATTTTATCCATTTATACATTCCTGCAACCTAGTTCATACAACCACTGTGTTAATACTTGCTGAACGCATGCATGAGCTGTGAGGGTCTGATGGTG
GCTCTTCCCAGTGCACACCCNAACAAGAGAAGGATCTTTCTCCTCAGGCTTCTCAGGCTAGGTCTCGGACCTTAGAGCTCANAGCCATAGGCTTAGAGCCA
ACGCCATAGNCCCTGGTACATTC 
943-M13rev_2
  ACACACACACACACACACAAAATCTATATATTTACACTCTCTGGGAATTCTAANTACAGAATTTCCTCACTGACATAAATCCNAGTGAGTCACAA
CTAAGAATATTAAAAATCTTTGTGTTTTCTGTTTTCCTGATAAATTGTTCATTCTGACCTTATACATAATTAATGTGAATTCCAATTCTAGTGTCAGACTTACCTC
CCTGTTGTTATGTAACTGATGNGTGTGNTACAACTAAGGATGATATCTTGGGCAGGTATCNTGGGTGGNTTACCTGGNTNAGCATACATCACCTGGTTTTTCT
TCCTCCCAGGCTTTGCTGTTCCAAAAACCCA 
945-M13rev_3
  TTCTAAGACAGCACTCCTGAAAACAAGATGGAAGGGCTTAAATTTTAGGCTCTGGCTTCAGAAGTCACAGAGTGCTGTTGCCATGGTGGTCTTC
TGCTGGTCGAGGCAGAAACAATGCCAGCCAGGTTGAAACAGTGGGGACATAGAGTCTCTGCTTTCTCAGTATAATGGGAGATACGATGATTGATGTATTTGG
AAACATCTGGAGATCTGAAGGGATTGTAACTTAGGAGTGAGTGAAGGCATGGCCCAAAGTGGCCAGTGGTTGAATAAAGGAAGTATATAATACGCATTTGCA
TGCAGATATTTGCATATACACCCATGTGAATATATACTGTAAATTCATGCACATGTGCAATATCTTTGAAATGTTCTCCAATCATGAAATTTAATTGCTGTTCAT
CTTATTTGATATGGAGATGGGAGGTAACTACTGATGAAGGAGCTACTATAGGGTTTCG 
946-M13rev_4
  TTGCTATACCAGTACCATGCAGTTTTTATCACTATTGATCTGTAGTACAGCTTTAGGTCAGGCATGGTGATTCTGCCAGAGGTTCTTTTATCCTT
GAGGAGAGTTTTTGGTACCCTAAGTTTTTTGTTATTCCAGATGAATTTGCAGATTGCCCTTTCTAATTCGTAGAAGAATTGAGTTGGAATTTTGATGGGGATTG
CATTGAATCTGTAGATTGCTTTTGCAAGATAGCCATTTTTAACTATATTGATCCTCCCCATCCATTATCATGGGAGATCTTTCCATTTTCTGAGATCTTCTTTAA
TTTCTTTCTCCAAAGAATTGACATTCTCATCATATAAATCTGTCACTTCCTTAGTTAGAGTCACACAAAGGTATTTTATAATATTTGTGACTATTTTGAAGGTTGT
TGTTTCCCTAATTTCTTTCTCAGCCTGTTTATCCTTTGTGTACAGAAAGG 
96-M13rev_1
  AGCCATGCTGGCGCATTTCTCCACCGAGGGCGGTTATGTGGTGGAGGGAGAACTGGAGCTTACCGTCGGCGATGATGTGCGGGTTCTGAAG
GCGGGCGAATCCTATCTCTTCGACAGCCGTCTGCCGCACCGGTTTCGCAATGCCTCGGAGGGCGTCACCATCGTCATCTCGGCCTGTACACCCCCCTACC
TTTGACTAATGGCGCTCAATATATTGAGCGGTATGTTGCGCAAAATTTTGAACGGTGTTAGGAATTCCGCAGGGGGCAAGGTCGCAGATATGGCGGCATCT
GGGGCGCGGCAGGAATGGAGGCCTGCATCGCGGCATATCCGGAGCCGGGTCCCGCAAGGCAGGCTGAGGAGACGACTGCGTTGATTGCAAAGCATGGA
AAAATGCCGTCGCAAAC 
97-M13rev_2
  TGCTGTTCCTTGCCTCTAANTTCAAGGACACAGTTTATGTGAGTAAGACAAGCTGAACAGCATGTGCCACTTAGCCACAGAGAGACCATTTGgA
TGCTGCTAAGCAAACAGGCACTCAGATTAGGGTTTTAAGGTGTTTCATGCCTGTGTGGTTAGAACATCAAATGTCTACATGAATTGTATGAAGAAGTAAGGTA
AGATGAGAACAAATCCACAGTTGCGTCTGGTGTGTGAATTGGGTCTGTGCAGCTGCACTGGTTGCCATCACTGTGGACTGGCACTTTGAAAAATTGTCTATG
GAAACAATTGGCAAGTTGCTCAGGGAAATTCATGTGTTTTAGAGTTCTTTCTCTTTACGTGTTTTGTTATGGTTTTGGGGATTAGTGAGAAGACAAACAACAAA
TAGTACTGGACAATTCTGCTATAAAG 
98-M13rev_3
  TGGGTCCATGTGCTGGGATGTGTGTGTATTCAGTGACAGGGCGCTAAGGGTNTCTTTCAGTGATTCAACCAGCTTCCAGACAACATGGTGAGT
CTGTACAGTATGGAACCTGGAAATAATTGGCAAAGGTGGCTATTAATTAAATAACCATACAAACAAAAGTGTCATTCAATTCAAAGCTAAACTAATACCATGAT
TAGAGATGCACCTTAATGGTAGAGTGTTTGCATGTGCAAGGCCCGGAAAAACATGCATGTGCTCTCACATGAGTGAGTACTGACNCTCTCTCTCTCTCTCTC
TCNCTCTCTCACACACACACACACACACACACTCtATTCAAAGAAGGAATTTGGCACCCATGAGCTAATGCAATANAATCAGCCCTGCTTTTACAGCaaaGTGT
TCCTGGGACACTGAGGAGGAGGGACT 
 
The Contig sequences belong to STAT5A Library (non-repetitive DNA sequence) dataset. Contigs were built for overlapping clone sequences by Dr. 
Ramialison Heidelberg, Original clone IDs comprising the individual Contigs are listed in parenthesis. 
 
Contig1 (828-M13rev, 914-M13rev)
  TCNTTTTCACNAGGNNNGNNANGGGNTGGAATTCCNCCTTGCGGAGAAAAAAGAGATCTGAATTCTTTAGTGNNTAAATGTGCATTTGTTGATT
TTTCTTAAAGTTTATTTCATTCACTAACAACATAGGATCATAGATTTTTTTCTTTGCCATTCAGAAGCTCATGGCATAGTGAAAATGGAGAATATTTTCACGCTT
GATAGATACATACTTGCTGTAAATTCAACCATAAGTGTACAAACACACATTTTATAAAAGACGCTGAAAAGATTTTTTTGAGAGAGGGTTTCTCTGTGTAGCCC
TGGCTGTCCTGGAACTCACTTTGTAGACCAGGCTGGCCTCAAACTCAGAAATCTGCCTGCCTCTGCCTTCCCAAGTGCTGGGATTAAAGGCAAGTGCCACC
ACTGCCCAGTCCTGAAAAGATTTTGTTTAGGATTCCTAATAAGTTCTGCACCAAGAAAAACATAATTACAAATGAATCTAGTCTATATTTGAAGTTGGAATTGG
AGA Appendix 
  183 
Contig2  (583-M13rev,  316-M13rev)
  GNNCCGCCCTGCGCCTCCACCTACTGGACTCTGCCGGAGAAGCTCCAGGTTGATTTTGACAAGGTTAGTGACAGATGTCTTTAATACGGCTGC
TCCAGACCTCAGTTTCCAAGAAGAGCTTTCATTGGAAGGGCAGAAATGTCACGCCTTCGTGGGGGGGGGGGTGCAGTACAGCTGTCGTATGCTGTTTCCAT
TTCTGTGTCCATCAGTCCTCCCCACCCCCCAACACACACACACACACACAAAGTGATCGGGTATGCCCTCAGGGTTGGAGAAAGCAGAAATGGCTCCAGCG
ATGTAGAAGAGAAAGGGGGTCCTTAAAGCGCAGGGGAGGCGGGGTCACAACTGGTATATCAGAGCCTACTCATTGGTCATTCGCTGCTGAGCTGCAGCGA
TCCTGGGCTTGCGTTTGCCTCTCGATA 
Contig3 (364-M13rev, 863-M13rev, 390-M13rev, 897-M13rev, 712-M13rev, 897-M13rev, 206-M13rev, 897-M13rev, 472-M13rev, 259-M13rev, 871-M13rev)
  AACTCTACATAAACCAGAGATACTGAAACTTATAGAGGAGAAAGTGAGGAAAAGCCTCGAAGATATGGGCACAGAAGAAAATTTCCTGAAGAG
AACAGCAATGGCTTGTGCTGTAAGATCGAGAATCGACAAATGGGACCTGATAAAATTGCAAAGCTTCTGTAAGGCAAAAGACACCATCAATAAGACAAAAAG
GCCACCAACAGATTGGGAAAGNATCTTTACCAATCCTAAATCAGATAGGGGACCAATATCCAATATATATATAAAAAACTCAACAAGGTGGACTCCAGAAAAA
TCAAATAACCCCATTAAAAAAATGAGGCTCAGAACTGAACAAAGAATTCTCACCTGAGGAATACCGAATGGCAGAGAAGCACCTGAAAAAATGTTCAACATCC
TTAATCATCAGGGAAATGCAAATCAAAACAACCCTGAGATTCCACCTCACACCAGTCAGAATGGCTAAGATCAAAATTTCAGGTCACAGCAGATGCTGGCGT
AGATGTGGAGAAAGAGGAACACTCCTCCATTGTTGGTGGGATTGCAAGCTTGTACAACCACTCTGGAAATCAGTCTGGCGGTTCCTCAGAAAATTGGACACA
GTACTACCGGAGGATCCAGCAATACCTCTCCTGGGCATATATCCAGAAGATGTCCCAACCAGTAAGAAAGAAACATGCTCCACTATGTTCATAGCAGCCTTA
TTTATAATAGCCAGAAGCTGGAAAGAACCCAGATGCCCCTCAACAGAGGAATGGATACAGAAAATGTGGTACATTTACACAATGGAGTACTACTCAGCTATTA
AAAAGAATGAATTTATGAAATTCCTAGGCAAATGGATTGACCTGGAGGGCATCATCCTGAGTGAGGTAACCCAATCACAAAAGAACTCACACAATATGTACTC
ACTGATAAGTGGATATTAGCCCAGAAACTTAGAATACCCAAGATATAAGATACAATTTGCAAAACACATGAAACTCAAGAAGAACGAAGACCAAAGTGTGGAC
ACTTTGCCCCTTCTTAGAATTGGGAACAAAACACCCATGGAAGGAGTTACAGAGACAAAGTTTGGAGCTGAGACGAAAGGATGGACCATCTAGAGACTGCC
ATATCCAGGGATCCATCCCATAATCAGCCTCCAAACGCTGACACCATTGCATACACTAGCAAGATTGTGCTGAAAGGACCCAGATATAGCTCTCTCTTGTGA
GACTATGCCGGGAAGAAAACACAGAAGTGGATGCTCACAGTCAGCTATTGGATGGGTCACAGGTCCCCCAATGG 
Contig4 (616-M13rev,319-M13rev)
  CATCCTTTCCTATGCACCCACACAGCTTCCCAAATCCATCTTTTACCGGAAGCTTTGCTGACTTCTTAGCTTTGAGCTTCACTGGCTGCTATGAC
CTCTTACCTGATGAATATGTAACTAAGGTACAGCGCACCCCCTACATCCCTTTAATCCCTTTACTGACTAACTGCTATTCTTCTGCCCAGTAGATCTCAGAGT
CTTTGGGCTGCCTGGGACACTCATTAGTAAAGCCATACTCTGTCTAAATCTCTGTGGAAGGATCCTTAGGTCTTGTTTTGTTGTTGTTGTTTTGATTTTTTGTT
TTGTTTCTTTCTTCCTCTTTTTGGATGGTGAGGTACTGTGTAGC 
Contig5 (896-M13rev, 218-M13rev)
  CAGCAGAGAGAATTGAAACATGCAACCTGGAGATATAGGTGGTTAGGAAGACCATCCAGAATGTAACAGAGACCTGGGAGGTAAAATATTCTT
AGGACTCAAAGAGAGGGACCTTAAATGAAATGTCCTATGTTGGAGAGAGGAATATTGTAGAGCCTACCTCCAGCAGAAAGAAAGAACATCAAGGAAGGGAT
GGGGTTGCCATCCCACAGTCAAACCTCTAACACATAATTGTTTCTGACTGAAAGAACTACAGGGATGGAAATGGAGAGGAGCCTGAGGAAAAGAAGGCCCA
GTGACAGGCCCAAAGAAGGATCCAGCTCAACGGGAGACCCCAAGACCTGACACTATTACTAAGGCTATGGAGTGCTCACAAAAGGGGTCTATTGTGACTGC
CCTCCNAAAGACCCAAAACACAGCTGAAAGAGTTGGATGCAGATATTTGTACCCAACCNATGGTCGGAAGCACTGATCGCTAATTG 
Contig6 (317-M13rev, 635-M13rev)
  ACAGTCATCAACTCCAGGAACAGACCGTAAATCCCAGGAAGTAAGCCATAAGTCACTGGCTCTGGAACAGATCATAAATTCCAGGAACAAGGT
CATAAAACCTCTCTCCCAAAGAACAGTTTGGACATAACCACAAGAACGGGAAATTATCTTATCTCAGGCTGAGCCATCCATGCTGGGCAGCCCGAATTCAGA
TCTCCCGGGAA 
Contig7 (360-M13rev, 835-M13rev)
  TTTCTTGCTTTTTCTAGGGCATGATTTCTGTCCTTGTATTGTTTTTTTTTCTGTTATTATCCTTTGAAGGGCTGGATTCGTGGAGAGATAATGTGT
GAATTTGGTTTTGCTGCGGAATACTTTGGTTTCTCCATCTATGGTAATTGAGAGTTTGGCCAGGTATAGTAGCCTGAGCTGGAATTTGTGTTCTCTTAGTGTC
TCTATAACATCTGTCCAGGCTCTTCTGGATTTCATAGTCTCTGGTGAAAAATCTGGTGTAATTCTGATAGGCCTGCCTTTATATGTAACTTGACCTTTCTCCCT
TACTGCTTTTAATATTCTATCTTTATTTAGTGCATTTGATGTTCTGATTATTATGTGTCGGGAGGAATTTCTTTTCTGCTCCAGTCTATTTGGAGTTCTGTACGC
TTCTTGTATGTTCATGGGCATCTCTTTCTTTAGATTTGGGAAGTTTTTTTCAATAATTTTGTTGAAGATGTTTGCTGGTCCTTTGAGTTGAAAATCTTCATTCTCA
TCAATTCCTATTATCCGTAGGTTTGGTCTTCTCATTGTGTCCTCGATTTCCTGG 
Contig8 (304-M13rev, 356-M13rev)
  TGCAAGGTCTGTAGCTGAAAATACTTCTTGCCAACTGCCTGGAGGGGCTGATAAGGGAAATGACTACATTCTGTAAATTAACATATTCTAAGCA
GGTCAGAAGTCTCCAGTTTATAAAAAAGACTGTGATAAAGATAGGTAAAATAATGCCCATTTTAGTTGCCATGCTTAAGTAATGAAGCTGTAAATTTCTTGACA
AGGATCACTGCCTTAGTGTTGGTAGTGGGTGGCAACTGAGTATAACCTTTAGGAATAACTACTGCTGAAAATTAAGGAAGGTATATTCTCAGACTCATTTCTT
AATTGCTTCTTCATTGTACTCTCTCATACCTGAACCATAAATCTGACTCTGGGTTTCTTCTTTTTCCTTAGCCAGCCAGATACTTTTGTCCCTGCACTGACACC
TGGGTCATTTCTCAAACACTAGTTTTTGTTTTTGTTTTT 
Contig9 (941-M13rev, 361-M13rev)
  CCCTGTTATAGCTGTCTCATATGAGGCTATGCCAGTTCCTGGAAAATACAGAAGTGGATGCTCACAGTCATCTATAAGATGGAACACAGGGCC
CCCAATGGAGAAGCTAGAGAAAGCACCCAAGGAGATAAAGGGGTCTGCAACCCTATAGGTGGAACAACAATATGAACTAACCAGTACCCCCCCCCCCAGAG
CTCGTATCTCTAGCTGCATATGAAGCAGAAGATGGCCTAGGCGGCCATCACTGAAAAGAGAGGCCTATTGGTCATGCAAACATTATATGCCTCTGTACAGGG
GAATGTCAGGGCCACGAAGTGTGAGTGGGTGGGTAGGGGAGTGGGGGGTAGGGTATGGGGAACTTTGGGATAGCATTGGAAATGCAAATGAGGAAAATA
CCTAATTAAAAAAANAGCTGCCTGTCACACAGGATAAATTTGGTATTAAAGAAAGTTNATGTGAAAGAAACC 
Contig10 (33-M13rev, 886-M13rev)
  TCTCCACTCCCTAGAGACCTCATCCGCACCTCGCACTGAATATCACCTGCTACTGGAAACCACCCCCGATCTCTAACTGAGCATCTCTGCAGA
GGTCTGTATACTTTTAACTAAATATGACCAACACTGAGCTGATTTCTGCCATCACCTTCCTCGTATTGTCCTATCTCAAACCAAACACCCTAGGATCACTTAAG
CCCACCTTTTTTGTTTGTTTGTTTTGCTTTAATACCCATGTCCATTACCTCAGCAAAACAAAGAAAACTTGTATTATTCCTACCTTAAAAATATAACTACAGGGC
TGGAGAAATAGGTCAGTGGTTAAGAGCACTGACTGCTCTTCCTGAGTTCAATTCCCAGCATCCACATGGTGGCTCGCAACCATCTGTAATGGGATCCGATGC
TCTCTTCTGATGTGTCTGAAGATAGCAACAGTGTACTCACATATATAAAATAAATGGAAGTGTAAGCTGAATAAACCCTTTCCTCCCCAACTTGCTTCTTGGTC
ATGATGTTTGTGCAGGAATAGAAACCCTGACTAAGACAGGATGCTACAAATTTATTCTTCACTGGCCTTGCAGAGAAGGAAAACCCCAAATCTGTAACAGTAT
AGGACGTACACTGAGGACAGAACTATGTCCACAGGGAAGAGGACAGGGTGCTAGGGCAGGTCATAGAAAGGAAACACCCAATGATATGCTTGCCCCCCTT
CAACAAATGGCACCCAGCTGTGTGCATGATATTTCATATATGCAGTCTGTTTCAGTGGTTCAGAGCTATTTCAAATGAGTCAGAACAACTGGGGAGAAAATCA
G 
Contig11 (4-M13revfor,476-M13rev, 41-M13rev, 476-M13rev, 631-M13rev, 07-M13rev, 631-M13rev, 404-M13rev, 575-M13rev, 404-M13rev, 824-M13rev, 575-
M13rev, 899-M13rev, 383-M13rev, 168-M13rev, 354-M13rev, 548-M13rev, 603-M13rev, 548-M13rev, 552-M13rev, 36-M13revfor, 595-M13rev, 36-M13revfor, 
904-M13rev, 15-M13revfor)
  CTAAATTGTTCAACTTTTTCAGTTTTCCACGCCATATTTCACGTCCTAAAGTGTGTATTTCTCATTTTCCGTGATTTTCAGTTTTCTCGCCATATTC
CAGGTCCTTCAGTGTGCATTTCTCATTTTTCACGTTTTTTAGTGATTTCGTCATTTTTCAAGTCGTCAAGTGGATGTTTCTCATTTTCCATGATTTTCAGTTTTCT
TGCCATATTCCACGTCCTACAGTGGACATTTCTAAATTTTCCACCTTTTTCAGTTTTCCTCGCCATATTTCACGTCCTAAAGTGTGTATTTCTCATTTTCCGTGA
TTTTCAGTTTTCTCGCCATATTCCAGGTCCTTCAGTGTGCATTTCTCATTTTTCACGTTTTTTAGTGATTTCGTCATTTTTCAAGTCGTCAAGTGGATGTTTCTC
ATTTTCCATGATTTTCAGTTTTCTTGCCATATTCCACGTCCTACAGTGGACATTTCTAAATTTTCCACCTTTTTCAGTTTTCCTCGCCATATTTCACGTCCTAAA
GTGTGTATTTCTCATTTTCCGTGATTTTCAGTTTTNCTCGCCATATTACAGGTCCTTTCAGGGTGCATTTCTCATTTTTCACGTTTTTTAGTGATTTCATCATTN
NTCAATTCGTCAAGTGGATGTTTCTCATTATCCATGATTTTCAGTTTTCTTGCCATATTCCAGGANN 
 
 
STAT5A Library (+/- 1000 bp extended DNA sequences of STAT5 confirmed clones. The BLAST was performed by Dr. Bulashevska, DKFZ, 
Heidelberg)  
 
Clone ID  Sequence 
 
20-m13rev_3.seq|chr11|1|97880023|97882439 
AAGAAGATCCTGAGTACTGCACAGTCTGTGGGCTGCAATGTGGATGGCCGCCACCCTCATGACATTATAGATGACATCAACAGTGGTTTGGTGGAGTGCCC
AGCTAGTTAAGAAGCAATAAGAAAATATTTCAATAAAAGACTATCTGATAACCAGTGTGTGTGTGTGTGGGGGGGATTTCCTATAATCCTCACTGCCCTGAGA
AGAAGGAGGAGGTCTTGTCCCACTTGGCAAATGAGGAACTATGTTCAGAAGTATGGAACAGATGAGAGTCTGGGTAGCCTTGCCTTGTGAGGTCTCGTATT
CTTCCCTCCCAGGGCTTCTCAGGTCTGATGATTGGTGAAGAGCTGCTTCTCTGTGCCCAGGTCAGGGTGCATGTCAGAAGACTGAGGTAGGGGTTGCAACC
AGGCAACTCTACCTGTCTCAAGCTGAGTTTTCCCACCTTCAACAAAGGCTGAGGCTGGGGTAGGCAGCTGGGACGGGAAAGATCAGAGATGCTGAAAGGG
CTGCGCTGAGGGGAGGGGGACCCGGAGCCCTGAGCCGTGCAGGGGCACAACCACTGTAATCCTGCCACCATGTGGTTGCTGAGAATTGAACTCAGGACC
TCTAGAAGAGCAGTCAGTGCTCTTAACTGCTGAGCCATCTCTCCAGCCCCAGCTGCTCCACTAAGGATCCAGGTACCCAGAGATGGAGACAACCAGGCCAG
GGAACATGATCCCATTTCTGCTTCCTGTGATAAGACATAGTGACTGGGGTATGTAGGACAGGCTACGTGATCAGAGGTGAATAGAGAGGTGGAAGGTGGGC
GAGGCGGGAGGAGGCCGGAGGAGGCTGTCTGTATAGAAGGACAACGGGGGTGGGGTGGGGGTGGGGTGGGGGGTGGGGGGCTTAATGTGAGGAAGGA
AACACTTCCCCAGGCAGGTTGTCTGTACAAACCCTCAGTGGATCCATGCCCTAAGGCAGGGCAGGACAGAAGCAAAGAGACCACCCTGAGGAAGTCTCCA
CCCCTGAGTGCCACAACCAGTCAGGTACCCTCAGTGAAAGGACAGGTGTCCTGCCAGTAGATGGCCTATGTATGTGGTCCCATAAAGAGAAAGGACATTGA
GGTGTAAAAGTCCTTTTGGGATTCCTGTGATTCTATATCTACTTGTTCTGCCTCCTAGAGTGAAGAGGCCTCTCCTGTGGGGTCATGTGAGGGTGCCAAAGC
CTCTGTACGACATGTGGATTTGGGGCTAAATAGATAGCCCTCACCCCTTGGGCCTCTTGGGGACCACTAGGATTGTGGGAGACCATCCCCCCTGGCAGTCA
ATGATTAGCTTTGGAGACACCAACTTGGGCTATCCCTGCAGGTCCTCAGTCTCCAAGAGCCATGAGTATCCAGCCAACAAGACGCCATGCCTCACCATCTTG
TGGGTTTGCTAGTGTATGAAGGCTAGAAGGCAGTTCACTGATCCAGCCCAACCCTGTGCTGTGCTCTCTTTTAAACATGTCGTTTTGGTAGAAAACCTGTAAT
CCAGTCTGGGGGAACTGTGTGTGGCAGCCCTCTGCAGCTTGTTCAAGGAAAGCTGGGTCTTCAAGAACTTGTTTGAAAGTGGAGAGAACAGACTTCCTGCT
CTTGGACTTTTTTGGAAACCAGCCCTTAGTTCTTAGTTCTTAGAATTTTTATTAGGCTCTGGGACATCTCAAAACACCCTGACCTCCCACTCTCCTGGGTTATT
GTTGGGCATGGCTGGATGTTTCAAAAGCCCTAGGAGTTACAAAGCCGGGGAATAAAGGCGGCTGTTGAGTGAGGCAGCCACATGTTAACAGGGAGGTTGG
AGGCCAGGGAACTAGGGGAGGGTTCTCTGTGCCTGACGGCTCGTAGGGTGTGCTACATGAAGCTGCAGGTTCTTTGGGGAAGAAGGGAGAAAGGAGTGA
GGAGAGAGGAGAGGAGAGGGAGAGGCGAAGGAGGGAGAGAGGGGGGGAGGGGAGAGAGAGAGAGACCCTTAGGGGATGGTGGGAAGGTCCTGTTTGA
AGCCCCTGCCCTGTTTGAAACAGGAGCTGTCCAGAGATCCCCCCCCCCCCCCCCCAAGAATTGGCAAAGGCTAAGTATGACTGCTCCTCTGGGCCATAAG
CCAATGTCACCACTGTGATGTCATTGTGAAGTAGAACTCTCTGGAGTCCATTATTTCATGTGGCCCTTGCTGCTGCTCAGAAATGGGTGGGCGGGTGGGAAAppendix 
  184 
CTGTTAAGGAAAGGAGCCCAGAAGCGAGGATTTTCTCAAGGACACAGAGTCGGTCGGTCGGTAGCTGAGCTGAGCTTTGGAATGGCTGATGGTGACGCGG
AGTTATTCTCAAGCATAAACTTTGCTGTCAGGTGACCTAGTTAGCGGCCATTCTGTGTCACGCCCATTGTTCTGTGACTGAGGGACTGGCTGTACACAGAAA 
 
34-m13rev_2.seq|Chr14|1|26176070|26178495 
CTGCACCATGAGAAGTGGCCAAGCAAACAGCATTGTGTTCTGCGTGAGCGTGCACACCCATCCTAGGGAATAGCATTTGGAACTATTTATAAACTTACTTGA
GGGGTGTGGGATGACAGAGGACCATAGAAATCTATTGCACGTCACCACCCTCACACTTAACTGAGCAGCCTACTCTCTACCTTATTTATTCACATACCATTG
CTCATTGGGTGGCATGGTGTCACCCCAACATGAAGGTTTAAATTAATACACACACATACACACACACACACACACACACACACACACACACACAAACACATA
CACAAACACACACACACACACACACACAAACACAAACACATACACAAACACACACACACACACACACACACACACACACACACACACACACGTTTCCAGTTC
ACTGATTTTTCTCATGTCATTGTTTGGTTGTTTTTTCCACGTAGAATAACCAGATTTGGGTTTATCCTGTTCTCTCTTGGGAGCTGAATGTTCTAAAATGTTCTG
TATTCCCTGGTTGGTAAAGTGTGGGGACTTGCTGCTGAGGGCACACGTGGGCCAGGCATCTGAAGGGATAAAACGTGCCACTGGGTACAGCTGGCACATG
GCAGAAGCATCACACGTATTTTATGTTTCTTTCTGGAAGTCACGTCCCTGAAAAGCTTCCTTGCTCAAAAATCATTGTCAAAGCTAAGAAGTAACCAGAAGGC
AAAGGAGTGTATCTGCTCTCTCCTGCAGCCTGGGTCTCCCGCCCCATGACAATGCAGGTTTTATCTAGCAGCCAAATGTGATCCCTGCCTTATCTTCAGCCT
TATCTTCAGCCAGACTGCAGACCTGTCTGTCAGCTCAGCTCCGAGCGAGATGCATGTCATCATCCCAGATTCAGCTAGAACACTCTGTCCTACCCTTTGGGA
CACCAAGATGGAGATCTGCGCACGTGGCTCTTTCCATCTCTGTACTTCTATTTCATTTTCTGGGAAGCTAAGATAATGAATGCTGAACTTTGGGAGATGACAG
GTAGATAGAGAGGCGACACATGTGAATCCGTAGTGTCCTTACTGAAGCAAAAGGCACCATGTCTGTGTGAGAAACGTTCTGCTTTGTATATCTGATGGAATA
AATACCCAGCGTACCTATGGTTGCTTAATCCCAGACAGTCCTGGCGCCTGGTAAGACTGCGTACCAGCTCCTGTAGAGCATAATTCAGCAGAGTGTTAGCA
GGGCCTATCTCGTGCAGACCTCAAGACCAGCGTACTGGCTCCCCCAACCCTACTCTGGTTGATGTCTTAGGATTTCACCACTGTTTTTTGTCCTCCAGCGTA
GCCTTGAATCCTGCCAAGCCTCTCTCAGTTTTACTAAACAGATGATAAAGCCAGGAATGAGGAAGGAGAAGCCAGGAATGAAGAATGAAAACATGCCAGTG
GTCATGGCAGTGGAAGGTGAATTAGGAAGTATCAGGGAATGGCAGCGGGCTGGCGAGCAGGTTGGAGGAGGAAGCAGGCTGCCCTTTGCACTTTGGAATA
GGCAAGTGCTCTGGTCTCATCTGGGGGCTCCCACTGAGGTGGGCCTATGACACACACATTCCACAGAGTCTCCCATGCTCCCCCACACAACTCTAGGAGG
GTCATTGTACTTCACAGCTAGCAAACCAAGCCACAGGAGGTTACATTATTGGCTCGAGGTTCTAAAATAATAGTCTCTGGCTAGGAAGATGGGCTTATATTTA
TCCCAGTATACTTTGTAAAGAATTGCTACATTCTTTGATCAAACTAACAGGAACGTTGTTACCTTCTGCAGAGGCTTTTGTGAGTCTGTTCCTAAGCTCCCCG
GGAGCCTACAAAATGTCTTAAAAGTAGTCTTGAGATTTGTACACGCCAGTTTCCTCAACTCTAAAGCAGGGTTGGAAGGCCCAAGGCTTGCTTTTCTCCTAC
CCAGCCCAGAGGGGTTGGGGTGGAAGCCAGGATATCCCTTCCACAGTGATAAACAAGGACAGAACTTAGTCCCACCCACAAGTTCCAAGAAGTCAGTAGG
AAGTAGCTGAGGAACTCCAAAGCCACAAAGGCCTTCCTTAGGGCCCAGTGGCCACGATCAGGCTATTAGCCATCTCTTAGGTGTCCCATGGGTTTCATCTA
GCCGGTACTGTCCCCAGCTGTACCTCATTTTCCAGACCTGGAAATGGGACTAGCATGTGGGGCATATTACTTAACATGTAACATTCCTGCCCAAAGTGCCCT
TCCCGAGATTCAGAGCCTGGGGGCACAGTCCTGCCGGCAGGCCTCCTATCTATCTTGTCAGAAGGTCTGACTCCTGAAGTGACACACAGCTCTAAGATTCT
GGCCCTGTCTGCTTCAGTAGAGTAAAAAAAGGTGCTGCTTGAAGTTGGGCAGGCAGATGTACAGCCAGGCCACAGAGAGACCTAA 
 
372-m13rev_4.seq|Chr7|-1|101210453|101212912 
ACTTAGGGCTATGCTTGGGAGTTCTGGGTAGCCTCACACAGTCATAGTAGTCCATCCTTATATCAAGATTTGGAGACAGTTCAGGGGACACTTGGTCCCTCT
GGGACTCACTTGTAACATGGAAGCTGTCACATATATTCACACACGCTATATCCACACACACTATATTCACACACACTATATTCACACATGCTATTTCCAGACTT
TGAAAGCTTTACAGCCCAGCAGGGATCCTAGCACTCTCTGCCCCTGAACTTGGCAAACATCCTCCTCCTAGACTGAGCTTCTCTAGGCAGTCTGCTCCATAC
CAGCCCCTGAGGAGCCAGGCTGCTCTGAGCCCTCCCAGGCATGTTAGGTCACCTTCCTTGTCTGGAAGTTACAGTAAGCCCAGGCGTCACATTCACCTCTG
CCTCCTTAGACTCAGCACAGAGCTGGAACTGGGGGCTGCGAGTTAGGTGGTGGGATCCAGTCACACACTTTCATGGACTAGAAAAGCAAACGAGGCAGAG
GGAAATGACTTCCTCAAAGCCATGTTTTATAGGTATGGGTTGGAGTTCATTCTTGAATTCTTTTGATGCTGGTAGAACCCACAGCTTTGGCCACGCCAAAGCT
CTGTCCTCCTCTTGCCTGAACTTTAAAACTCTCTTTAAAATGAAATGTATTAATGCTGCAATGTGTTTACTTGTGCATGCATGTGTGTTTGTGTGCAGGTGCAT
GTGTGTGCATGTATGTGTATGTTCCAATCATCTTATTCAGAGGCCGAAGGTGGGGAAGGGGGTGAAGATGTGATCCGGTGTCCTCAGCCAGGCAGATCCAT
CTGGCCGCCTCCTCACTGACAGCTGGGACAGGCCTCTGCTAGGAAGGTGAGAATCCGGCTACTATTGGGAAGGGGTGGTGTGGGGCTCAGAGCAGCCTG
GCTCCTCAGGGGCCAGTGTGGAGCAGGTTTCCTGGAGACACTCAGTCTAGGAGGGGGATGTTTGCCAAGTTCAGGGGCAGAGAGTTCAGTGAGGACCAA
GGCCCAGAGCCAGACAAGAACACAGTCTCCTGGCTGGCTGAGCCTGTCCACCTGGCTCAAGTTTCTGTGCCATGGCATACATACTCTAATACTCAAAATGT
CTCTGGTTTCAAATATGCTAGTACCAATGGATGATTTCAGGTCTGGGTCACAGAAAGTATAGGATGAGCCTGGGACATCTTACTGAGCTAGAAAGATCTTACT
CAGTGAATGACAAAGACCTTGTCCCGAAGACATGAGAGCCAGCCTGAAGACTTGACTAGCTTCTCAGGATTTACCAGGCCTCTTGAAGTTTTACCACTGAAA
GTAGCCAATTCTGGAGGCCACAGTTCCTGGTAAAGTAGGTCAGGCATCACTCTTCCATGAGCTATACATCTAAGACAAGCTGATTAAAATGAGTAATGAACA
AAACAGTAATAACAGACTATATTGAACCCAATAAGAATCCAAAGTAGCCTTTCCAGCTTGGGGCCAGCAGAATGGTTCCCGCAAAAAAGGATGGCAAGAAGA
AGGGCCATCAACGATGTGGTGACTAGAGAATACATCACCAACGTTCACAACCGCATCCATGGAGTGGGCTTCATGAAGCGTGCTCCTTGGGCATTCAAAGA
AACCCGGAAATCCTTCATGAAGGAGATGAGGACTCCAGATGTAAGCATTGACACCAGGCTTAATAAGGCCGTCTGGGCCAAGAGAATAAGGAATGTTCCGT
ATCACATCTGAGTGTGTTTGTTCAGAAAATGTAATGAGGGTGAGGATTCACCAAACAAGCTCTACACACATTCAAAACTCTACAGATGGTCAATCTGGATGAG
AACTAACCTGCTGAATGTCAGATAAGGTTGCAGAACAGAAAAAAAAGGACAGACAGACAGACAGAAAGAGAAAGAACTAAATTGAAAAGAAACCAAAGTATA
TACAGTTCTGGCAAAATAGATGCAATGTATGATCAGGAATGAATTATGTATAGTTTCAAGGCACCGCCTATCCAATACTTATTCATTACAAGGGAAAATAAGAG
CCTGAGAAATGGCTTGTAAGTAAAGCACTTGGAATGCAAGTGTGAAGGCCTAGGTATGGTCCCCATCACCTATGCAAATGCTGGACAGGCCTGGCAGCCCT
CTGCCATCTACGAGACAAAGCTGGGGGATTCCTGGGATAAGTTGAACTGGTGAGCTCTTGGTTCACAATGAATCCTGCCTCATTAAACAAAGTGGAGAGTTA
TCAAGTAGGACATTCCATATCATCAACTCCTGGCCTCTTACACACATGTGCACACGCATGTGCATCCAAGTACAGGGGCAGAGCCTGCAGTCAGGAACAAG
GCCCAAAGCCAGACAACAGCATGGCGTACTGAGTTGCTGAGCGCGTTTCTGGCATGGTGTACATAGCCTAATATTCAAAAGGCCCCCGGTTCCAAACACAT
GAAGTGGGAGGAATAACTT 
 
398-m13rev_2.seq|Chr18|-1|42400232|42402716 
CACCCAAGTGCTAGGATTATAGAGGTGGGCTACCATGCTGCCCCAAATTTTAACACCAGTGCCAAGCCACTGATTTCAGAACACCAGTCAGAATTTCTCATC
TAATAAAAACTCAGTTACCTATTTTTGGCATATTCCAGGGTTTTTAAATTTTTATTTATTTATTTATTTATTTATTTTGCCATTATTCATTCTCATTCTCTCAGTCTC
CCCCCTCCCCCATGGTTTCCCAATGCCCCATTTTCGCCATTAATTTCCTTTTAAATGATGTTTGCTGATGAAAATTCCTCCTGAAAAAAAAAAACAAATAAAAA
TATTGACATTTAGAGATGCAATGATGAGATATTAGTCTGGTGCCTTTAAATCCAGCACTCGGGAGGCAGAGGTAGGTATCTGAGTTCGAGGCCACAGTTCCA
GGACAGCCAGGATTAGATGGAGAAATCCTGTCTCAAGAAAAACAAAACAAGCAAACACACACACACACACACACACACACACACACACACACACACACAGA
GAGAGAGAGAGAGAGAGAGATAGAGAGAGAGAGAGAGAGAGAGAGAGATTTTGTAATTGAAGCTAAGCAGCAAAAAATCAGAAGTATGAACGCCGATCATC
AAAATAAGTGTGTAAGGAAGGAAAAAAAAATAGCAAGATCTTGCTTCTTGGCATTATGTCCAACATAAACGCACCGCACGTTGTGTTGCAGATTTACTACAGC
TGAGTCATTTCGGGACATCGGAGCGAGTTTCCAGGAAAAAAACCAGCGGAAGTAACCAGGAAGAGGGGCTCTCCGGGTTCCCCGAGGCACTCCCAGCAGC
AGACACCGGTACTGCGGGCGGCGGTGGCGGCATGGTCAAAAGAGGAGTCGTGGACCCTTTAAGAGACACAGCACCTTCTCTAAGATACCATCTTGCACCG
GGAGTTCACTGAACTCTCCACCTACCTTGCTAGGTCCCTCCGCCCTCACTGGGTACGGCTTGCGGGCGGGGCGAACGAGTCTTACGATTGGCCTTCTGCG
CGCGGCCCTCTACCGCCTATTGGTTAGTCGGCCCGTCACTCACCCTACCTCCCGCCCACCTGGGCCTCCGGGCTAGGTTGAGTGGGGCTCTTGGGTTAGT
TCCTGTTAGGCCCCGGCCCAGGGAGTAGGTGAAGTCTATAAGATGCCCGGTGGGTCAGGGCACTCGGAGCTGTGAGGGAACGTGAGGCGGCGGCGAAC
GTAGACCCGCGGCGGGCCTTAGGAGGAGCGGCGGCCGAGCCCGCCTTCCCTGCACCATGCTCATAGAAGATGTGGATGCCCTCAAGTCCTGGCTGGCCA
AGTTACTGGAGCCGATGTGAGTGCGCCGGGCCGCGCCGGGCCGGCGGCATGGGCGTTGGGGGACCCGCGGGGGCGTGGGGGAGGGGAGGCGGGAGT
CCCGGCCGCCCGCCTGGTCCTAGTCCGCTGTGGTGTGAGGTGTGAGGGGGCCGGGGCCGGGCACGGGCGTCGGGGCTTCCCGAGTCCACACACACACC
CCGGGAGCCGGCCCGGGCTGCAGGCCGGCGGGAGACTGAAGGACGGTGGCGACCCGGCATCTGAGGCGAGTGGCGCGACTGTCGAGGGATTTTTAAAT
GTGAAAGCTGAGGTGTGGGACGGCAGAGCGGGCTGGAGAGGACTTTGCAAACAGTGTTCAGGAGCCCCGGTGTCGAGGGCCTTCTCAGCACACTGGGGC
AGCGAGGGGCAGAGAGGGCGAGCGGGGGTCCTGAAGCTGAGTCGTAATTAGGGGGGAGCTCCGACGGATGAGGATATTTAAGGATTTGAAAGACCTCGG
AGTGCTGAAGTGGATATGCGGGCGTGGAAGGGCTTTGGTAAACCATTAAGGAGCTCCTGGGTCCGAGAGCAAGGAAACTGAGGGATTTTAAGGTATTCTTG
AGGAGTTGGTGGTCGAATTGGTGATTTTAAATTCCGTAGGATGTTGGGGGACGGAGTCGAGATTTTTATGCTAATTGAGGTTGAAAGGACTAACTAGTGTGT
ACTATGGATGATGGTGAGGTTGAAGCGGGTGTACTTGCAGTATCTTTTTTTTTTTTTTTTTTTTAAGATGCAGGTATTAGAGCAAAATAGGCACAAGAATAAAT
AAGGACCTGGCAAACATTGTTGAGAGATGACAGGGCGACTATAATTGGGGTGTAGGGTGACTGTTGAGGGGCAAGGAGAATGAGAGACCGGTTCTCTTAA
GATATTTTGGGTAGTGTCAGTTGTACAGATATGGTGAGGCTTGACGAGGACAGCAGAGGGGGTAACTTGGTTTATAACTTTTAAGAAAGTAAAGGCCGTGTG
GAGTGTTTGAGGATTCTTGGGTATAGCTAGCCTCTAGCACAGTCTTGTGAGAAAGAAAGGATAGAAGGCAGGAGAGACCAGTCTTTAGCCGGTTCTTTGAA
GAGAGCATGGGAAGCCGAATAGGAGGGAAAGAAGCCCAGCTTGCCCCCTTTTAATTTCTGTTTCTTC 
 
73-m13rev_4.seq|Chr8|-1|85008850|85011307 
TTCCTGTTTGAATCCAATCCAAAACAACTAGTATTAGTATACCAGGAAGTTTGTGGGTGATGCTTCCTCTGAACAGAAAAGTTACAAGACTCCTTCCTCCACC
TTCTGTCATGAGATTTCCAGGAACACTTTCCTAATCTCACTTAGGCTCACACACTCTTCTCTTTCTCTGATACTTTATCACACGGTGCTTTGAGCCAGATGTTA
TCATTTTCCTTTGACCTACTCAAGTGGAAACTTCATCAAAGCAGAAATTTCATTATCCACTGTTTTATTCCTTTTCTGAAGCAGTGAGTGGCCCATGACAATAA
TTTAATGAGTGAATAAAATGTTCTCTGAGATTTACCAACAATGTAAGTAATTCAAAGCCAAAAATAAATAATACAGCACAAGATGCCTTATCACAGACACATTC
AAAGGTATTGATACTTTAAAACTGACTGTACTTTGAGGCTGGAGAGATTGTGACCTGGATAAGTTGCATCATTTTTTAGTGACAGGGTTCTGAGAGAGAGGAC
CAGGAAGTCAGGAGATAAGAAGATAGGACACAAAGAAGATACAGCATAGGGTCAGGAGGTCTTGCTCAAGTTCTGTCTGATGCCAACCAAACTTATTAAGAA
ATACAACATTTTACATACTAGTTCCGGGGAGAGGGGTGGGGGGGGGACAGAGTTCAAAGAATCTCTCATACAATGGGACAAAGTCAGCAGGAGGCTAATCC
AGCAAAGTTGCACAAAATGAGCACAGGCATTACAAACTGAGTGCACAATCACCTTGCGTCTGATAACCCCAGTCTCTTTAAAGAGAAAAGCCAAGCTCCCAG
GACAAACCTTAACTGCTGTGAAGCTCTCTACCTGTAGCTCTAGAGTGGCCTTGCCCAGTCTCCTGAGCAAGGAAAAAGGATTGGTTCTTTTTGTCCTCTCAT
CAGGGCTTCTGAGAAAGCCTTGGATTGGTCTAGGTCTCAATAACTCCCCTTGTTTACTTCTTGAGGTCAGATGAATTTTGGTGGTTGAGTGTTTAAAAGACTC
ATAAGTTCTCTGAACTCACAGATATCTCCTACTGAAATCAAATGGATTGTTAACCTAAGTATAGCAACACTGAGTATAACACTGAGTGGATGTTGAAGGATGA
AAAGAGAGTTTAGATTCCCATAACTTGTCCAAGAAATTTTGGGGTAGCTTAGAAGGGGAATTTACATAATTGGTAAAGGAACCATTGATAAGGTAATTTAGAA
GTGTCTCTCATTTTCTGAAATAGAGGAACATTTTCTGAAATAGAGGAACATCAGACATGAGTCCAAATGTAAAAGGATTTCCATGTTATAGTAGTTCTTCCCCA
CCCCACAAAACTCTCTTAGACAATCACACTACTCAGGGCTGGGAATCCCAGCCAAAGATCCAGTTGAGCCTCCTGCCCTACTCTCCTGGACACATTATAAGA
GGATGTATCCAGTGAGGAGATCTTAAGAGGTTATCTTCATTCAGACCTGGTGGGTGCCTCCAGGACTAGTCAACCAGCACTTCAGTTCACCTTCTTAGAGGC
ACAGAGTTCTTTTGAATCATGAAGCATGTCCCCAGGGGGGACATCATCCTATAACCAGGGACCCAGATTCTCACTGCATTCTGTGAAACATCAATCGAATGG
GGCAACCTGGATCATGAGAAACTATAAAACGCAAGTGATTAAATAAATTGACCATGTCTGAGAAACTGAACTTTAGACGTCTCCTGGATTCCAAAGCCATAGG
CTATACTTGTCAAACAGACAGAAGGTTGTACCTGTACTGACCCACCAATGACAAACAAGCAGGAATGGTTGATCATACCCCAGTCTGGCTAAAGAGCAGTGA
AGAACTTCACATGAGAAAAACCCGTAAGGTCATACACCAGTCTGATATATTTAACTATTGGGTAATATCTTAAGGCATTTTTATTAGATATTTTCTTTATTTACA
TTTCAAATGTTATCCCCAAAGCCCCCTATACTCTCCCCACATCCTGCTTTCCAACCCACCCATTACCACTTCCCGGCCTTGGCATTCCTCTGTACTGGGGCAT
ATGAACTTTGTAATACCAAGGCCTTTCCTCCCATTGATGGCTGACTAGGCCATCCTCTGCTACATATGTAGCTAGAAACACAGCTCTGGGGGTACTGGTTAGAppendix 
  185 
TTCATATTGTTGTTCCTCCTATAGGGATGCAGACCCCTTGTGTAATATTTTAATAGCCAGTTATTTTAAAATAAACCTTGATTTTTACATGCATTATAGCCAGGT
TTTTGTAACTGTTTTGTTGTTGCTTTTTTTTCTTGTTTATTTTTGTTTTTCGAGACAGGGTTTCTCTGTAGCCCTGGCTGTCCTGGAGCTCACTTTGTAGACCAG
GCTGGCCCTGAACTCAGAAATCTGCCTGCCTCTGCCTCCTGAGTGCTGGGATTAAAGGCATGTGCCACCATGCCCGACTTTGTAATTGT 
 
721-m13rev_4.seq|Chr7|-1|97355236|97357517 
TAAATAATAACAGGAACTCTATTCTACTCATTGTTCATGTTCTAGACTTATTTCCAGGGTCTTGATATTTGTACTTGCATTTTTTAGGCAAAATGAGATTTATCTT
TCTATTATGTAGACTGTTTTCCAAAGAAAGACTACAAAGACCTTCTGAGAAGCAGACTTAACTTGAAAAACAAGGTTTTCTGAAACCTACCAACTACAATGAAG
TTAAAAACCTGTAATTGAGTTTATGCTAAATGCTAATCATAATAAAGTTCCCTTTTTATTAAGCTTTGCTTGCTTGCCAAAGTCATAAAGAACCTTTGTAAGACT
TTGAGGACACCTCATCCTTCTACTGTGGGTGTGTGTGTGTGGGTGTGTCTGTAATGGTAACATTTTTGCCTTTCTATATCTCAGTGTTGGCTCCTGGTTTTTG
ACACCACAACACGTGGCTTCATCCTCAGTCTCAAGATTCTTTTTCACTGTTTCCCAGCTGTCAGAGGAAGCATTAGTCTCTTCACCAGAGATTCGTGGAACAC
ACTGACAGTCCTGATAGAGACTTGGCTCCGGGTGGACCACCAGCATTCTTAAATCTTCAGACTTGCAGAGTAGTACCATTCAGAAAAATGATCTTAAACCTTT
CATTGATTCAACAGGAAGATTCTTGGCTTTCTTTTCTTTATCTTTCCGTTTTTCTTCTTCTTCTTTCTTATTGATGGATAACTTCTAAATTACTGTAACAAAGTAA
AACGAACTTCGGGGAGGAGCTGGAACTATGGCAACACTCACCCTAAGATTCTAGCAGGGCACCTCCAGGATACAGCTCCGGGTTTTGCCTCCAGCTCCCAC
CAGCCCCGCCTTTTACTCCACCCATCTTCCAGGATGCACTCTAATTTCCGTCTCCCAGCAGTAGCGGCAGCCAATCGACTCACTGGGCAGTGGAGCTTCAG
GAAGAGGCCTCTCTATCCAGCAACCCCACTGCTTTGTGGGATTGCAGCGAAATCGGTGCTGTAGAAAGGTTTCTCTCCACGTTCTCAGCAAGTACAGAAGC
CGAGAAGGTCCGGTGCAGCCATGGCGGCGCACCTGAAAAAGCGGGTGTATGAGGAGTTCACTAAAGTGGTTCAGGTAAGCGCTGGCAGAAAAAGCCATG
GACCAGTCTGCGCGGGAGGGTTGTCCGCACCCAGGCTGTTCTCCAGATCAGCGCCTAAGCTTGTGTGTAGCCGGCTTAGGTTTAGGTTCCTAGGCTGCGC
GTCAGGCAGGGGGCGTGTTAGGTCGAGGCCGCTGTTCTCATGTGTACTCTGACTTTGGGGTTTGTTGTTGTTGTTGTATTTAAAGTTCTGGGACTAGAATTC
GGGGTCTTAAGCATGCTAACTTATCACTCTATCCCAAAGTCACACTCCCAGCTCACTTGATAAAGACAAAACAAAATCATTGGGACAACGTGCTGTATAGTTT
TAAAAACTGTCAGGTATCTTATTTTAATGTCTCACAGCTCGGTTGTGCCAGATCGGTTATATTTGCATTCTCCTGTCCTCAGTTGGTGGCAGAACTCCTCTTAA
CTCGTGTACCTCTAACTTTCAGAGACAAGTTGAGCTGTATGCAAAACCCCAAGCTGACTAAAGGTCTGTAGAATTCAAGGCTCAGACCAAGCAGGCAAGAGT
CACAGGACGGCAAACCTATCATCCTCTCTCTTTTAAACATAGGTGGACCAAGAGAGCCCCTGTCAGAACTGTCAGTGTGCTCCACAGTGTCTCTGTAGAAGC
GATGTATTCTGCTTCTTAAATTTCCATATGTACACAGATACATACAAAATATACGCGTCTTGAGGAATACTTAAATTTTTTATCTTTTTTGTAGTAGGGGAGATT
GAGTGTAGGGCCTTATGCATGCTGAGGCATGTGGTCTACCACCGAGCTGTTACAGATCTCGCTCTTTTAGGGAGTTTGTTATGATGCAGATTATGTTCAATA
GGTTGGTGGTGTGAGGCAAGATCTGCATTTTGACCAGGCCCGGGGGTTTATGCCAGTGGATCCCCAGCAGTCTTAGATATTTAGGCAGAGTGGTCTCATTA
AGGAAAAAAAAAAATTTTTTTTTTCTTTGAGACAGGGTCTCACTATGTAGAGCAGGCTGATCATGAACAGGAAGGAATCAGCCTGCCTTTTCTTCCCAAGTGC
AGGGATTAAAGGCTTGCATCACCATGCCTGATGGAAAATGACTCTTAAACCTTCCATTCATTCATTAATTCAACAGGAAAAAATTAAAGTATTTTCAAATACTT
GAGTGATTTCTGTGTACCATGT 
 
882-m13rev_3.seq|Chr3|-1|101535707|101538021 
TTAATTCTTGCAATGATGGGTCTATGGTTCAATGCGTCCAAAGGATGGGCATTATAGTGTTTGAAGAGGAGCATTCTTGATGTGTGAGCCGTTGCCTTAAGTC
GTTTCTGGAACACTGTGGGTGGGAAATAAAAAAGTCTTTTTTTCTCTGTGTGTGTGGGGAGTTGGAAAGGGTGATGTTCTGGAAAGTGGCTGAGACAGCCC
CAGGTGCAGGCGCCCGGGAGGTGGCCAGGCTGTGACAGAGGGAGAAGGATGGCCAGGGCTGGCTACCAGGTGTTAGGAATGAGTAGAGGTAGGGCCCA
TTCTTAAGTGAGGTCAGGGAGGGGAGAACTTAACTGACTCCCGGGGGGCTAGAAAGAGAGCAAGGGGAAGCCACAAGGAAGGACTGTCTGGGGTGCAGG
CAGAGCAAGCTGAGGTAGAGAATTTATCTAGTGTCTAGAACTGTGTCTCTAGGTCTTGAGTCCAGTAAGACAGAATGAGTGATGGAGCATCCCCTGCTTAGA
GGCAGAAGGAAGACCTTCTTAGTTACCTTTTGTTTTGTTTTGTTTTGTTTTCAACACAGGGTTTCTCTGCGTAGCCCTGGCTGTCCTGGAACTCACTCTGTAG
ACCAGGCTGACCTCAGAAATCCACCTGCCTCTGCCTCCCAAGTGCTGGGATTAAGGCGTGCGCCACCACTGCCTTAAGCCTTAGTGGCTTTCATGAGCTGG
TTCTGGCTCAGGTTGCAGACAGATCTGGGGACCCTGGGAACAGGAGTCCGGGGCTGGCTCAGGCTTCTTCAGAGTATGGTGGACTTAGAGCCAGAATATG
CATGGCAGCTCCGGGCTCCAGATGAGCATCCTAGAAATTGCCTGCAGAAATCGTATAGCTGTATATCTAGACTTGAAGTCCCAGCGTGTGACTTCTGCTAGG
ATCCTAGCTCGTCAGACTGCACGGGGCCCACCTCTCTGGCTGGCCAGGAATCAGTGTCTGTCACCAGTCAGCTGTGTGAGGAAGCGGGCTCGTTGAGAAG
CATACCCTTGGCTTAGGTGGGGAAATGGCGTGACCAGGGGAGCTGCCTCATTGCATGGTAGAAGTAGAGGAACCTGCAAGGCATTGGCCAAGGCTTGGTG
GTGCCAGGAGACAGGAAAGCAGCAGACGACCTGGGGCTGAGTGGGGGATGGAGGAAGTCAGGAGGCATCCTGGGCACGAGCCAGGGTAGACGTGGGTG
TTTGATGTGGGCAAGTGAGGCGGGCTGGGTCAGCCAGTGCTCTTGTTTTCTAGGGTTTTCTCTGCTTGCTCTAGCTACCCCCTCAACCTCTAGTTTCTTTCTT
CCCTTTTCTTTTCTTTTCTTTTCTTTTCTTTTCTTTTCTTTTCTTTTCTTTCTTTTTTGTTTTTTTTTTTTGTTACCCAAAGTTTTTCTTTTTTAAGCAGTATTTTATTA
GAAAAGGTTTAAAATTATTTTTGCCCATTTTTACCCTCTCCCTGGTTTACTTTAGCTGGAATTTTTATTCATGTATTTTTGAGTAGGCAATGCATGCACGCTCGT
GTTCTTACCTAAAAGGAGTGTAAGAAAGCTGGGTGGGGGAGACACAAGCCTTTTACCCCATCACGTGGGAGGCAGAGGCAGGTGGATCTCTCTGAGATTAA
GGCCAGCCAGGTTCACAGTGTGTTCCAAGGAGCAGCATAGTGGGACCCTGCCTCAAAAAAACAAAAACAAAACAAAACCAAAAACCAAAAACCAAAAACAAA
ACCAAAATGTAATCAGGTCTGGATTAAGTCCGAACGCTCCCCACATCTGGGTTCTGTGTATGCCCTCCACCAGTGTTAACTCTTTCGTCAACTGCCCACAGC
TGAGCTGAGCCCATCTTGAGCCTTTGGCTTCAGCCCCCCTAGCATGGAAGCCTTGCCAGGGCCATAGGCATCCCCTCCAGACCAGGCTACCCATCTTCAGA
GAAGGCAGAGGCTGCAGGCTCAGGGATATCTCAGCTCTGGATTCTGCCCAGCCGTTCCCAAACCTGCAGTTCTAAGTGTTGCGGCTTCTAACTCCAGTCAG
AGCCTTCCACGCTGTTCTTCATCTGGCTCTCTGTGGTTTCTCAGAGTTGTTTTGATCCCGAGACCATGAGTCTGCACGTCCCCCTCCCATCACGTAAGGGAG
AGTCTTTTTTCTGGCAGAGAGGAGTGTGTAAGTTAGGAAACACAGGTGCTTTGAATTGCACAGTTCTTGGAATTAACAGTCTTGGAGCTCAGATGAGATTTTT
AAGGATTATCTATGTTCCTTTTTTTTTTTTTTTTTTAAAAAAAAAATAGGTATACAGAGAATTCATCCCTAGAAAGTA 
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